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Abstract
Smooth pursuit eye movement (SPEM) and antisaccade deficits have been proposed as
schizophrenia spectrum endophenotypes. An endophenotype is a behavioural or
biological deficit thought to represent, more closely than the disease phenotype, the
effects of an underlying disease gene. Oculomotor endophenotypes possess phenotypic
homogeneity, well-understood neural correlates and objective assessment and may
thus be used as phenotypes in linkage studies. This thesis investigated a number of
issues concerning the reliability and validity of the SPEM and antisaccade tasks as
schizophrenia spectrum endophenotypes (and two tasks thought to be unimpaired in
the schizophrenia spectrum, visual fixation and prosaccades). The schizophrenia
spectrum encompasses not only people with schizophrenia but any population with an
increased frequency of schizophrenia-related phenotypes or genotypes, such as
schizotypal individuals or first-degree relatives of schizophrenia patients. A valid
endophenotype should thus be detected in these populations. Study I investigated
reliability, namely internal consistency and temporal stability, of eye movements in
healthy individuals. Study II utilised first-episode psychosis patients and healthy
controls, aiming to detect behavioural oculomotor deficits in the absence of secondary
confounds that may be encountered in chronic schizophrenia. Study III assessed
performance in siblings discordant for schizophrenia. Study IV explored the
relationship between psychometric schizotypy and oculomotor performance. Study V.
examined possible state effects of procyclidine, an anticholinergic compound often
administered to schizophrenia patients, on performance in a patient group. The results
generally confirmed the validity of the SPEM and antisaccade deficits as schizophrenia
spectrum endophenotypes: Oculomotor performance was mostly stable both within and
between assessments. SPEM and antisaccade impairments were observed in first-
episode psychosis patients and schizophrenia patients and their healthy siblings.
Antisaccade, but not SPEM, impairments were associated with high levels of
schizotypy. State effects of procyclidine on SPEM and antisaccade performance were
observed, suggesting the need to consider the influence of pharmacological treatment in
future patient studies. These findings suggest that SPEM and antisaccade deficits may
be studied profitably as endophenotypes in schizophrenia spectrum research.
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Chapter One
Introduction to the Schizophrenia Spectrum
1.1 Chapter Overview
This chapter will provide an introduction to schizophrenia spectrum research. First,
important issues relating to the definition, description and diagnosis of schizophrenia
will be addressed. Then, the epidemiology and treatment of schizophrenia will be
described and the key findings of structural and functional brain changes in this
condition will be reviewed. The concepts of schizotypy and the schizophrenia spectrum
will be introduced. A particular focus of the chapter will be on the genetics of
schizophrenia. The chapter will conclude with a delineation of the research problem
that this thesis addresses. The research problem focuses on strategies needed in order
to overcome the clinical and biological heterogeneity and genetic complexity of
schizophrenia in the identification of disease genes. The approach to the research
problem that this thesis is advocating is the endophenotype approach, which will be
outlined.
1.2 Definition, Description and Diagnosis of Schizophrenia
Schizophrenia is the term used to describe a severe psychiatric syndrome including the
symptoms of hallucinations, delusions, disordered thought, abnormal affect and loss of
volition. The influential Diagnostic and Statistical Manual of Mental Disorders, Version
IV (DSM-IV),of the American Psychiatric Association (1994), defines schizophrenia as a
"disturbance that lasts for at least 6 months and includes at least 1 month of active-
phase symptoms (i.e. two [or more) of the following: delusions, hallucinations,
disorganised speech, grossly disorganised or catatonic behaviour, negative symptoms)"
(p. 273). The criteria required in establishing a clinical diagnosis of schizophrenia
according to DSM-IVare listed in Table 1.1.
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A similar definition is offered by the International Statistical Classification of Diseases
and Related Health Problems, Version 10 (ICD-I0), of the World Health Organization
(1992):
"The schizophrenic disorders are characterised in general by fundamental and
characteristic distortions of thinking and perception, and affects that are inappropriate
or blunted. Clear consciousness and intellectual capacity are usually maintained
although certain cognitive deficits may evolve in the course of time. The most important
psychopathological phenomena include: thought echo; thought insertion or withdrawal;
thought broadcasting; delusional perception and delusions of control; influence or
passivity; hallucinatory voices commenting or discussing the patient in the third
person; thought disorders and negative symptoms. The diagnosis of schizophrenia
should not be made in the presence of extensive depressive or manic symptoms unless
it is clear that schizophrenic symptoms antedate the affective disturbance. Nor should
schizophrenia be diagnosed in the presence of overt brain disease or during states of
drug intoxication or withdrawal." (World Health Organization 1992; p. 325).
The most important signs and symptoms of schizophrenia are defined according to
DSM-IVas follows (American Psychiatric Association 1994).
Hallucinations are sensory experiences that are not due to real stimuli, as they are
experienced only by the sufferer. In schizophrenia, hallucinations may occur in any
modality (e.g. tactile, olfactory) but are most commonly auditory (e.g. hearing voices).
Auditory hallucinations of human voices most commonly provide a running
commentary on the sufferer's actions, directly address the sufferer or consist of a
dialogue between two or more people. The content varies, but is often pejorative.
Delusions are erroneous, often bizarre, beliefs, which are incongruent with one's
cultural norms, are held despite evidence to the contrary and are resistant to logic or
persuasion. Delusions often have common themes, the most common of which include
persecution (the sufferer believes s/he is being followed or spied on), reference (the
sufferer believes that gestures, comments or passages from the media or other people
are directed at him/her), religion (the sufferer believes s/he has special religious
significance) or grandiosity (the sufferer believes s/he has special status in a variety of
contexts, such as being a celebrity, great discoverer etc.).
Disorganised thinking, or formal thought disorder, may be detected through a number
of abnormal speech patterns, including loose associations (moving quickly from one
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topic of conversation to another), providing answers that are unrelated to questions or
displaying incoherent or incomprehensible speech.
Grossly disorganised behaviour includes a variety of disturbances, such as child-like
['silly'l, agitated, unplanned, unpredictable, or inappropriate behaviours.
Catatonic motor behaviours refer to a significant decrease in motor responsivity to the
environment, maintaining a rigid pose, resistance to instructions or attempts to be
moved, or, alternatively, excessive unstimulated motor behaviour.
Negative symptoms include flattening of affect, alogia (poverty of speech) and avolition
(inability to execute goal-directed, purposive behaviours).
A number of clinical subtypes of schizophrenia are specified in DSM-IV; these are the
Paranoid, Disorganised, Catatonic, Undifferentiated and Residual types.
Historically, schizophrenia was called dementia praecox by Kraepelin (1971). Kraepelin
observed cognitive decline (dementia) but recognised that the early (praecox) onset of
illness distinguished this condition from other dementias. Dementia praecox was also
distinguished from the other major psychotic disorder, namely manic depression, which
was thought to be associated with better prognosis (Kraepelin 1971). The term
'schizophrenia' was first introduced by Bleuler (1950), derived from the Greek words
schizo (split) and phrene (mind), referring to fragmentation of the mind and the often-
observed dissociation of affect from reality. Bleuler discarded the term dementia, as he
did not observe frequent deterioration over the course of the illness. Interestingly,
Bleuler referred to the schizophrenias, proposing the now popular notion of multiple
disease processes and/or subtypes instead ofa unitary, homogenous disease category.
Despite the consistent observation of a common set of schizophrenic symptoms the
clinical presentation is highly variable, both within and between individuals. Thus,
there is no single core symptom that is observed in all patients with a diagnosis of
schizophrenia; indeed, a popular criticism of the concept of schizophrenia is that there
may be two individuals with the same diagnosis who differ widely in their clinical
presentation and do not share a single symptom (Rosenhan & Seligman 1995).
One of the key clinical features of schizophrenia is psychosis, most narrowly defined as
hallucinations and delusions. Broader definitions of psychosis include symptoms such
as disordered speech and grossly disorganised or catatonic behaviour (American
Psychiatric Association 1994).
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Diagnosis of schizophrenia is based on information available from clinical interviews
and observations. This reliance on clinical information is critical, as no valid biological
(or neuropathological) markers of the disease are available (as in other neuropsychiatric
conditions, such as Alzheimer's disease; Bertram & Tanzi 2001). Similarly, the aetiology
of schizophrenia is essentially unknown. A number of genetic and non-genetic factors
are likely to playa role; however, these are not, at present, utilised in the diagnostic
process.
Differential diagnosis of schizophrenia involves the exclusion of a number of other
psychiatric and neurological conditions whose symptoms may overlap with those of
schizophrenia, such as schizo affective disorder, bipolar affective disorder (especially in
the manic phase), depression with psychotic features, dementia, certain types of drug
abuse and severe forms of obsessive-compulsive disorder (American Psychiatric
Association 1994).
Symptoms of hallucinations, delusions and thought disorder have been theoretically
grouped together as positive symptoms, with avolition, reduced or flattened affect,
alogia and social withdrawal representing negative symptoms (American Psychiatric
Association 1994; Crow 1980a, 1980b). Positive symptoms in this categorisation are,
therefore, defined by being abnormal through their presence, while negative symptoms
are defined as the abnormal absence of psychological function. Factor analytic studies
of clinical symptom ratings have shown, however, that symptoms tend to cluster more
reliably into three dimensions, commonly labelled as reality distortion (including
delusions and hallucinations)1, disorganisation (including inadequate affect and
disordered thought and speech) and psychomotor poverty (including poverty of speech,
paucity of facial and other emotional expressions, reduced motor behaviour and social
withdrawall? (Liddle 1987b). The first two of these dimensions thus constitutes positive
symptoms; the last constitutes negative symptoms (Crow 1980a, 1980b).
Just as the inter-individual presentation of schizophrenia is variable, the course of the
illness is often not linear and differs between people. Evidence from retrospective as well
as prospective studies points to extended premorbid and prodromal phases. The
1 This dimension is called the "psychotic dimension" by DSM-IV (American Psychiatric
Association 1994; p. 275).
2 This dimension is called "negative symptoms" by DSM-IV (American Psychiatric Association
1994; p. 275).
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premorbid phase is characterised by subtle cognitive, emotional, social and motor
deficits in otherwise clinically healthy children and adolescents. The prodromal phase
immediately precedes illness onset and is characterised by an increase in socially
deviant behaviour, eccentric ideas, unusual perceptions and experiences and
disordered speech (Allin& Murray 2002). Onset of illness is often insidious, making it
difficult to distinguish from the clinically similar but more subtle prodromal phase
(American Psychiatric Association 1994).
The observation of pronounced premorbid and prodromal symptoms has led to the
formulation of one of the most influential accounts of schizophrenia to date, namely the
neurodevelopmental model. This general model, posited in several variations by a
number of scientists (Allin & Murray 2002; Andreasen et al 1999; Luna & Sweeney
2001; Sawa & Snyder 2002; Tsuang et al 2001), argues that schizophrenia is a
developmental brain disorder. Abnormal brain development, resulting from genetic
predisposition and/ or early lesions, is thought to result in behavioural and subclinical
abnormalities throughout development, culminating in clinical psychosis after brain
maturational processes in early adulthood. Pre-clinical abnormalities concern
schizophrenia-related (sub-)c1inical symptoms, motor deficits, cognitive deficits and
social and interpersonal problems (Allin& Murray 2002; McDonald & Murray 2000).
The neurodevelopmental model, or at least aspects of it, is widely accepted in biological
schizophrenia research. However, as Allin and Murray (2002) pointed out, the model
cannot at present explain the precise mechanisms by which early brain damage and
genetic predisposition result in full-blown illness after a 'latency period' of about two
decades. Moreover, a number of cases with schizophrenia, such as late-onset cases, are
clearly not of a neurodevelopmental nature (Allin& Murray 2002).
Following an acute initial phase with severe, mostly positive symptoms, some cases
(about 20%) completely remit, whereas the majority go on to experience further
psychotic episodes. For about 35% of sufferers the course of illness from first episode is
chronic, resulting in greater functional impairments with each episode. However, there
is also evidence that some features of schizophrenia, in particular positive symptoms,
improve after the initial acute phase (Green 2001). Factors that are associated with
good outcome include an acute rather than insidious onset, older age at onset, a short
initial psychotic phase, a relative absence of previous psychiatric history and fewer
functional and structural brain impairments. Men are thought to have an earlier onset
of illness and worse prognosis than women (American Psychiatric Association 1994).
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1.3 Epidemiology of Schizophrenia
Epidemiology is concerned with the frequency and determinants of disease in a
population (i.e. the prevalence, incidence and risk factors; Bromet & Fennig 1999).
Epidemiological studies of schizophrenia are limited by a number of factors, such as
less than perfect reliability in obtaining the diagnosis, difficulties in determining the
date of illness onset (which has serious consequences for the identification of risk
factors) and difficulties in obtaining data from entire populations or, at least, truly
representative samples. Nevertheless, there is some agreement on basic epidemiological
findings in schizophrenia research.
The lifetime prevalence of schizophrenia (the percentage of the population who at any
point in time have schizophrenia) is thought to be about 0.7%. The incidence (the rate
of new cases each year) varies but is estimated to be about 0.2 per 1000 (American
Psychiatric Association 1994; Bramet & Fennig 1999).
Schizophrenia does not strike at random; its onset is often preceded by a number of
risk factors. A risk factor is a determinant of the illness, which antedates its onset
(Bromet & Fennig 1999). The identification of risk factors is of obvious importance in
providing a better understanding of the aetiology of schizophrenia. As noted above, the
aetiology of schizophrenia is essentially unknown, but a number of risk factors may be
causally implicated. The following are amongst the most reliably identified risk factors
(for review, see Allin & Murray 2002; Bramet & Fennig 1999; McDonald & Murray 2000;
Sawa & Snyder 2002; Torrey & Yolken 2000; van Os & Marcelis 1998).
Family history of schizophrenia. This is arguably the greatest known risk factor and is
discussed in more detail in Section 1.6.1.
Social class. Schizophrenia is somewhat more common in lower socio-economic classes.
Two hypotheses have been proposed to account for this finding. First, the adverse
physical and social environment of low socio-economic status might contribute to the
development of schizophrenia. On the other hand, the generally more accepted view
holds that downward social drift takes place before and/or after illness onset, due to
the functional, social and professional impairments associated with the illness.
Age and gender. There is a slight male excess of schizophrenia diagnoses, especially
with onset under age 35.
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Season of birth. People with schizophrenia are slightly more likely to be born in late
winter or early spring; this effect is more pronounced in females than in males and in
people with no family history of schizophrenia compared to those who have relatives
with schizophrenia. However, the effect is small, and season of birth may be a proxy for
other variables, such as maternal virus infection or diet.
Obstetric and early childhood complications. Obstetric complications are more common
in schizophrenia, possibly causing early brain damage, which may have a small
contribution to disease development. However, birth complications could already be a
consequence of genetic factors or prenatal environmental factors.
Viruses. Viral infection of the mother might affect brain development in utero;
alternatively, viruses transmitted in early childhood could have adverse effects.
Substance abuse. Cannabis use is common in the premorbid, prodromal and clinical
phases of schizophrenia. The direction of this effect, however, is unclear. While
stimulation of dopamine neurotransmitter systems may precipitate a psychotic episode,
cannabis consumption in schizophrenia has also been thought to reflect self-medication
of psychotic symptoms. The contribution of cannabis to the development of
schizophrenia is further unclear, as the general increase in cannabis consumption in
many Western countries over the last decades has not been matched by a
corresponding increase in the incidence of schizophrenia.
Maternal stress. The presence of extreme stressors, such as war, during pregnancy
appears to contribute to the later development of schizophrenia. The precise
mechanisms of this effect are unclear, but may involve increased smoking (to relieve
stress), dietary changes of the mother or stress-induced preterm delivery.
Geographic location. Schizophrenia has similar incidences around the world; however,
higher rates of schizophrenia are observed in urban than rural areas. The direction of
this relationship is unclear, possibly reflecting adverse effects of an urban environment
on the developing brain (e.g. toxins, viruses, diet, stress) or, alternatively, a trend for
schizophrenia-prone individuals to move into cities.
Migration. There is a slightly elevated incidence of schizophrenia amongst Afro-
Caribbean immigrants in Great Britain, possibly reflecting difficulties in adjusting to a
new (and hostile) cultural environment.
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It becomes apparent that there is no single major environmental risk factor for
schizophrenia. Each of the above variables is likely to exert relatively small influence on
the development of schizophrenia and may act in conjunction with other risk factors as
well as genes. Notably, psychological factors, such as parenting in general and
mothering in particular, do not feature prominently in most recent reviews of non-
genetic schizophrenia risk factors (Bromet & Fennig 1999; Green 2001). The current
scientific focus on genetic risk is probably supported not only by considerable evidence
but also by the relative absence of viable models of psychological risk factors. One
psychological approach, however, that has met with some success is that focussing on
expressed emotions (EE). Individuals high in EE tend to be overly protective and/or
critical of other people and tend to express emotional content more directly and
frequently than others. Returning to high EE family environments has been shown to
facilitate relapse into psychosis (Green 2001; Wearden et al 2000).
The study of non-genetic risk factors is further complicated by gene-environment
interactions and correlations (see Section 1.6). Thus, the likely presence of several
environmental risk factors, gene-environment interactions and correlations as well as
interactions amongst risk factors make the unambiguous identification of either genes
or environmental risk factors difficult (van Os & Marcelis 1998).
1.4 Structural and Functional Brain Changes in
Schizophrenia
1.4.1 Brain Structure
The presence of structural brain changes was long postulated in schizophrenia.
Neuropathological studies began with Kraepelin's, Bleuler's and Alzheimer's work
(Shenton et al 2001) but waned somewhat over subsequent decades during the middle
of the 20th century, when psychological and psychosocial theories of schizophrenia were
more dominant than biological ones (Green 2001). Modern research into brain structure
in schizophrenia arguably began with Johnstone et al's (1976) landmark report of
increased ventricular volume using computed tomography (C'T].It was the advent of
neuroimaging methods such as CT that allowed the study of brain structure in vivo and
the simultaneous demise of a number of psychological theories of schizophrenia that
led to a renewed interest in brain research in schizophrenia.
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Since Johnstone et al's (1976) report, a large number of publications have documented
the existence of subtle volumetric changes of specific brain structures in people with
schizophrenia. These studies are based on the assumption that the volume of a brain
structure is an important tissue property intimately related to its function (Caviness et
al 1999). Volumetric neuroimaging studies of schizophrenia patients usually aim to
clarify whether the volume of a given brain structure is reduced, increased or
unchanged relative to a healthy comparison group. Volume reductions are taken to
indicate the existence of a pathophysiological process such as cell death or shrinkage,
reduced neural interconnectivity, abnormal growth or excessive neuronal pruning
(Caviness et al 1999; Shenton et al 2001). Increases in volume may reflect, amongst
others factors, effects of pharmacological treatment such as an increase in receptor
growth (Shenton et al 2001).3 Findings from volumetric structural neuroimaging studies
using techniques such as CT or magnetic resonance imaging (MRI) have been
summarised in a number of reviews (Henn & Braus 1999; Lawrie & Abukmeil 1998;
Pearlson & Marsh 1999; Shenton et al 2001; Weinberger & McClure 2002; Wright et al
2000). The key findings are as follows.
The most consistent reports of structural brain changes in schizophrenia concern
increased lateral and third ventricular volume. Medial temporal lobe structures, such as
amygdala, hippocampus, superior temporal gyrus or parahippocampal gyrus have
frequently been found to be of reduced volume. There is moderate evidence of frontal, in
particular prefrontal and orbitofrontal, and parietal, in particular inferior parietal
lobule, grey matter volume reductions. Amongst subcortical structures, the thalamus,
cerebellum and corpus callosum have been found to be of reduced volume in some but
not all studies. Basal ganglia structures have been shown to be of increased volume in
medicated patients, most probably reflecting pharmacological treatment effects.
These findings generally corroborate neuropathological post-mortem examinations
(Harrison 1999). However, the precise role of the observed grey matter volume changes
in the pathophysiology of schizophrenia remains unclear. Similarly, the full clinical and
cognitive correlates of these structural brain changes remain to be elucidated; however,
there is growing evidence of relationships between (cortical) volume reductions and
3 In addition to volumetric analyses, recent techniques have allowed the assessment of
morphology, the shape Or form of a brain structure (e.g. Frumin et al 2002).
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neurocognitive impairments, suggesting that structural brain abnormalities may be
accompanied by functional decline (Bigler 1998; Szeszko et al 2000).
Two interrelated issues that may be addressed using structural neuroimaging methods
are: first, whether brain changes exist at illness onset or whether they are a function of
chronic illness, and second, whether they are static or whether they deteriorate further
over the course of the illness.
Findings from first-episode psychosis studies furnish support for the existence of
structural brain changes early in the disease process (Copolov et al 2000; Ettinger et al
2001; Fannon et al 2000; Hirayasu et al 2001; Lim et al 1996; Sumich et al 2002;
Zipursky et al 1998). First-episode studies circumvent certain methodological
confounds encountered in studies of chronic schizophrenia patients, such as long-term
antipsychotic medication, functional and social isolation, hospitalisation and putative
effects of disease chronicity and neurotoxicity. These studies, therefore, discount the
notion that structural changes in schizophrenia are entirely due to these secondary
factors.
To address the second point, there are some longitudinal studies demonstrating further
decreases in grey matter volumes and increases in ventricular volumes over periods of
several months and years, suggesting a neurodegenerative component of schizophrenia
(Lieberman 1999). However, the overall evidence of neurodegenerative processes in
schizophrenia is weak. As Weinberger and McClure (2002) pointed out, many of these
studies are fraught with serious methodological shortcomings. Additionally,
neurodegeneration appears unlikely, as the process of gliosis (an increased growth of
supportive glial cells in response to neural damage) has not been demonstrated in post-
mortem studies. Likewise, expression of genes known to modulate the cellular response
to injury has not been observed (Weinberger & McClure 2002).
A final remark on structural neuroimaging studies in schizophrenia concerns the effect
size of the differences in brain structural volumes between schizophrenia patients and
healthy participants. As shown in quantitative reviews of this research (Wright et al
2000), the volumetric brain changes seen in schizophrenia are very subtle (in the region
of 1-5%); indeed, overlap in variance between the two groups is probably as prominent
as the statistical significance of the differences in group means. These findings then
indicate the existence of reliably identified but rather subtle brain changes in this
condition.
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1.4.2 Brain Function
Brain function of people with schizophrenia has been examined in relation to specific
clinical symptoms as well as using cognitive tasks as behavioural probes. These studies
have used neuroimaging techniques such as functional magnetic resonance imaging
(fMRI) and positron emission tomography (PET). Regarding the neural correlates of
schizophrenia symptoms, it has, for example, been demonstrated that auditory
hallucinations are associated with neural activation in auditory association cortex
(Shergill et al 2000). Negative symptoms have been linked to reduced frontal activation
(Liddle et al 1992).
Concerning neural activation in response to behavioural or cognitive probes, the
behavioural deficits observed on many neuropsychological measures of frontal cortex
integrity, such as those of planning, working memory, or executive function, appear to
be accompanied by reduced activation in (pre)frontal areas (Weinberger et al2001). This
'hypofrontality' is thought to be one of the most robust findings in biological
schizophrenia research, believed to be of paradigmatic status by some (Tandon 1999).
Interestingly, however, increased brain activation has also been observed during
cognitive performance in schizophrenia patients. This 'neural inefficiency' is chiefly
observed during performance of well-practised, easy tasks and is thought to reflect the
increased neural resources required by schizophrenia patients to achieve normal or
close to normal cognitive performance (Weinberger et al2001).
Brain function in schizophrenia has, of course, also been studied behaviourally. A vast
number of studies have demonstrated that one of the core features of this condition is
impaired cognition (Green 2001). Cognitive deficits have been demonstrated using
standard neuropsychological measures and have been related chiefly to frontal and
temporal lobe deficits (Cornblatt & Malhotra 2001; Green 2001; Park et al 1995;
Sharma & Harvey 2000).
1.4.3 Neurochemistry
A number of neurotransmitter systems have been implicated in the pathophysiology of
schizophrenia; the most prominent of which is dopamine (DA). The dopamine
hypothesis of schizophrenia, in its original form, assumed that the positive psychotic
symptoms of schizophrenia were due to deficient DA transmission, particularly of
projections originating in the ventral tegmental area (Leonard 1997). This hypothesis
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was based on the psychotomimetic properties of dopaminergic compounds, the
antipsychotic effects of DA antagonists and the observation of side effects after
prolonged treatment with DAantagonists bearing resemblance to Parkinson's disease, a
condition with known DA deficiency (Leonard 1997). The revised dopamine hypothesis
accommodates the complexity of cortical and subcortical dopaminergic projections as
well as the existence of several symptom dimensions of schizophrenia and argues that
hyperdopaminergic state in the mesolimbic pathway is associated with positive
symptoms, while hypodopaminergic function in the prefrontal cortex is associated with
negative (and cognitive) symptoms (Friedman et al 1999).
In vivo PET studies have shown a correlation between binding affinity of antipsychotics
to DA (in particular D2-type) receptors and clinical efficacy of the drug. Imaging studies
of DA receptor density in schizophrenia have yielded inconsistent results (Leonard
1997).
Other neurotransmitter systems have also received attention, particularly those
interacting with DA. A role of glutamatergic dysfunction has arisen from animal and
human psychopharmacological models of drug-induced schizophrenia (e.g. using
ketamine and phencyclidine; Radant et al 1998; Weiler et al 2000). The major
glutamatergic projections extend from cortex to striatum and are compatible with a role
of these areas and their interconnectivity in schizophrenia. The serotonergic system has
also been implicated, not only because of its putative role in mediating the effects of
some pharmacological antipsychotic treatments (see Section 1.5).
Studies using magnetic resonance spectroscopy (MRS) have the potential to probe for
neurochemistry in vivo. These studies have provided evidence of reductions in N acetyl-
aspartate (NAA)in frontal and temporal brain regions. NAAis a measure of neuronal
integrity, suggesting abnormal neurochemistry in these areas (Leonard 1997).
1.5 Treatment of Schizophrenia
The treatment of choice for schizophrenia is pharmacological (Kapur & Remington
2001; Leonard 1997). Effective pharmacological treatment of schizophrenia began with
the serendipitous discovery of the antipsychotic properties of chlorpromazine in the
early 1950s (Leonard 1997). Chlorpromazine is still used in the treatment of
schizophrenia, although a large variety of other neuroleptic compounds exist. These
compounds are most commonly classified as typical and atypical antipsychotics. The
35
Introduction to the Schizophrenia Spectrum
definition of what constitutes a typical antipsychotic varies but usually involves action
on dopaminergic, in particular 02-type, receptors, and the generation of catalepsy in
animals or extrapyramidal side effects (EPS) in humans. Typical antipsychotics have
been shown to be clinically successful, in particular in the treatment of positive
psychotic symptoms (Leonard 1997). Atypical antipsychotics, on the other hand,
compounds that do not induce catalepsy or EPS, are generally held to be more
successful in the treatment of negative symptoms and cognitive deficits (Leonard 1997;
Sharma & Harvey 2000).
The main mechanism of action of typical antipsychotics is via the 02 dopamine receptor
(Kapur & Remington 2001). The action of the more heterogeneous group of atypical
drugs is less clear and is thought to involve other neurotransmitter systems in addition
to OA, such as serotonergic (in particular the 5-HT2 receptor subtype), histaminergic,
adrenergic and muscarinic systems. While associated with reduced probability of EPS,
atypical antipsychotics still produce side effects, such as sedation, seizures or sexual
dysfunction. In order to counter antipsychotic-induced EPS, anticholinergic compounds
are often administered (Leonard 1997).
Psychological approaches, such as cognitive behavioural therapy (CBT), play second
fiddle in the treatment of schizophrenia, probably due to the severity of the illness as
well as the lack of good basic cognitive function and the communication skills crucial
for the success of such therapies. There is, however, evidence of the usefulness of
psychoeducative programs on patients' knowledge of their own disease and its day-to-
day management (Penn & Mueser 1996). Further, CBT has been shown to be useful in
some studies in the remediation of core psychotic symptoms, such as delusions and
hallucinations (Turkington & Kingdon 2000).
1.6 Genetics of Schizophrenia
In addition to environmental risk factors (Section 1.3), the aetiology of schizophrenia
involves genetic factors. These will be discussed in the following sections, with
consideration of both behavioural and molecular genetic studies.
1.6.1 Behavioural Genetics
There is ample evidence of a genetic contribution to schizophrenia. This evidence stems
from genetic epidemiologic and behavioural genetic studies, such as family, twin and
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adoption studies. Studies of families with one (simplex) or more than one (multiplex)
members with schizophrenia have demonstrated that the risk of schizophrenia, which is
estimated to be at just under 1% in the general population, is significantly increased, at
about 16% in first-degree relatives of people with schizophrenia (Bromet & Fennig 1999;
Hallmayer 2000; Lichtermann et al 2000). The risk is slightly higher when the
schizophrenic relative is a parent rather than a sibling (Torrey& Yolken 2000).
Family studies cannot, of course, distinguish between familial and genetic factors.
Thus, the increased risk of first-degree relatives could be due to shared genes or shared
non-genetic factors, such as parenting, life-events, diet or exposure to teratogens and
viruses (Ott 1991; Torrey & Yolken 2000).
Other studies have compared the concordance rates of schizophrenia in monozygotic
twins, who have identical genes, and dizygotic twins, who, like siblings, share on
average 50% of their genes. Concordance is observed when both twins in a pair carry a
diagnosis of schizophrenia; discordance is noted when only one in the pair has the
diagnosis. Recent concordance rates for monozygotic twins are estimated to be between
45-75%, whereas those for dizygotic twins range between 4-15%, similar to those
amongst full biological relatives (Lichtermann et al 2000). Twin studies have also
allowed estimating the heritability of schizophrenia as well as the proportion of variance
due to shared and non-shared environmental factors. Heritability is thought to be at
about 50-87%, with most non-genetic influence due to non-shared environmental
factors (Kringlen 2000; Lichtermann et al2000).
Perhaps the most convincing evidence of a genetic contribution to schizophrenia comes
from adoption studies. These studies have used the adoptees' family study approach,
where the biological families of individuals with schizophrenia are studied, and the
high-risk adoptees approach, where the adopted-away children of people with
schizophrenia are studied (Ingraham & Kety 2000). These studies, while open to
methodological criticisms of sample selection, have produced the following findings.
High-risk adoptees studies have shown that these individuals are at higher risk of
developing schizophrenia than adoptees of non-schizophrenic parents. Adoptees' family
studies have demonstrated that these individuals have an excess of schizophrenia
amongst their biological, but not adoptive, families; they also have a higher rate of
schizophrenia amongst their biological families compared to non-schizophrenic control
adoptees (Ingraham & Kety 2000).
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Evidence concerning genetic influence on specific clinical subtypes of schizophrenia
(e.g. catatonic, hebephrenic, disorganised, undifferentiated, paranoid) is weak,
suggesting that the overarching syndrome of schizophrenia has a genetic basis, but not
its clinical (DSM-IV) subtypes (Lichtermann et al 2000). It has, however, been
demonstrated that an illness course defined by prominent, primary negative symptoms
may be more genetic than one defined by positive symptoms (Kirkpatrick et al 2001;
Lichtermann et al 2000).
One important finding from schizophrenia family studies was that first-degree relatives
of schizophrenia patients are at increased risk of developing not only schizophrenia, but
also other, related disorders, such as schizotypal personality disorder, schizoaffective
disorder and other psychotic disorders (Lenzenweger 1994). These disorders are
collectively known as schizophrenia spectrum disorders (see Section 1.7).
While family, twin and adoption studies, therefore, agree on a considerable genetic
contribution to schizophrenia, the mode of inheritance in multiply affected families is
less clear. The observed pattern of inheritance and the existence of non-genetic factors,
however, suggest that a single gene, transmitted in a Mendelian fashion, is extremely
unlikely.
1.6.2 Molecular Genetics
The key strategies that have been used in the search for 'schizophrenia genes' are
linkage and association studies. Linkage studies examine families multiply affected with
schizophrenia and investigate the co-transmission of the disease and genetic markers of
known chromosomal location (Ott 1991). Association, e.g. case-control, studies examine
candidate genes in affected and unaffected individuals. Candidate genes are genes
whose protein product is known and is thought to playa role in the pathophysiology of
the disorder, such as the D3 dopamine receptor gene or the catechol-O-
methyltransferase gene in schizophrenia (Egan et al2001b; Rybakowski et al2001).
While there have been many positive findings from linkage studies, suggesting an
association between the schizophrenia phenotype (i.e. the diagnosis of schizophrenia
based on observable signs) and a large number of chromosomes, there has been a large
number of failures to replicate. Studies have implicated chromosomes 1, 2, 3, 4, 5, 6, 7,
8,9, 10, 13, 14, 15, 18,20,22 and the X (Lichtermann et al2000; Pulver 2000; Riley &
McGuffin 2000). Of these, the most promising chromosomal sites are likely to be 1q, 5q,
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6p, 8p, lOp, 13q, 18p and 22q, given the evidence from replication of linkage, candidate
gene studies and other molecular genetic evidence (e.g. 22q deletions or velo-cardio-
facial syndrome) (Lichtermann et al 2000; Murphy 2002; Pulver 2000; Riley & McGuffin
2000).
Molecular genetic studies, therefore, suggest that a large number of genetic loci could
be associated with schizophrenia. This evidence, and a comparison of molecular genetic
schizophrenia studies with the success of molecular genetics in identifying major genes
in other neuropsychiatric disorders (e.g. Alzheimer's disease or Huntington's disease;
Bertram & Tanzi 2001; Ho et al 2001), rules out the existence of a single, major
schizophrenia gene (Kato et al2002; Tsuang & Faraone 2000). Amore likely scenario is
that the genetic contribution to schizophrenia stems from a number of genes, each
contributing a small or moderate effect. Polygenic models assume the existence of many
genes of small effect; oligogenic models assume the existence of a few genes varying
from small to large effect; and mixed models assume the existence of a single gene of
large effect against a polygenic background (Iacono 1998). Traditional polygenic models
assumed that genes co-act in an additive fashion. An alternative to additive action is
epistasis, which is defined as the interactive action of several susceptibility genes
(Skuse 2001). Which of these models best identifies transmission of schizophrenia is
unclear; however, any of these mechanisms could account for the observed clinical and
biological heterogeneity of the disorder and its non-dichotomous presentation, as well
as the non-Mendelian pattern of transmission within families (Kato et al 2002; Tsuang
& Faraone 2000).
The role of the environment in schizophrenia may not be ignored; indeed, the list of
possible environmental risk factors is extensive (Section 1.3). It is at present unknown
how environmental factors may contribute over and above the effects of genes; however,
it is thought that they precipitate the onset or relapse of schizophrenia (McDonald &
Murray 2000; van Os & Marcelis 1998). This then suggests an interplay between a
predisposing genotype and risk-conferring non-genetic factors. This interplay may take
on at least two different forms, namely gene-environment interactions and gene-
environment correlations (van Os & Marcelis 1998). In gene-environment interactions
genes are thought to increase the sensitivity for a certain (pathological) reaction to an
environmental stimulus, such as physical or psychological abuse. In gene-environment
correlations genes are thought to increase the likelihood of the individual seeking out a
certain (risk-conferring) environment, such as drug abuse. It is believed that both types
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of gene-environment interplay, sometimes in conjunction, occur in schizophrenia (van
Os & Marcelis 1998).
Schizophrenia is thus a genetically influenced but not determined disease (Gottesman &
Erlenmeyer-Kimling 2001). Schizophrenia is not alone in its status as a genetically
complex disease; indeed, comparisons with diabetes mellitus (Type-lor insulin
dependent) and coronary artery disease (leading to heart failure) have been made
(Gottesman & Erlenmeyer-Kimling 2001).
1.7 Schizotypy and the Schizophrenia Spectrum
The operational definitions of DSM and ICD for a diagnosis of schizophrenia are used in
clinical practice as well as in many scientific investigations in order to achieve objective
and reliable agreement on an individual's diagnostic status. One of the consequences of
the application of rigid diagnostic criteria is the creation of the dichotomies of
affected/unaffected, or ill/healthy. While useful in clinical and research. settings
(Rosenhan & Seligman 1995), there is growing dissatisfaction with this perceived
oversimplification of the schizophrenia phenotype (e.g. Tsuang et al 2000). Indeed, it
has been argued for a long time that schizophrenia may represent one state along a
continuum, encompassing severe psychosis as well as less severe disorders and traits
(Tsuang et al2000).4
The schizophrenia spectrum approach to the study of the etiology, pathophysiology and
genetics of schizophrenia, therefore, focuses not only on individuals with a formal
diagnosis of schizophrenia, but on any population whose members have a greater
occurrence of schizophrenia-related genotypes or phenotypes. The spectrum includes
people with schizotypal personality disorder (SPD), subclinically elevated schizotypal
traits or a family-history of schizophrenia (Claridge 1990; Eysenck 1992; Lenzenweger
1994; Tsuang et al 2000).
The key application of this approach to date lies in research; indeed, only SPD has
made the transgression from theory to clinical practice, being incorporated into the
DSM-IV. SPD is defined, according to DSM-IV, as "a pervasive pattern of social and
interpersonal deficits marked by acute discomfort with, and reduced capacity for, close
4 Interestingly, continuity of symptom severity and the existence of subclinical symptom
dimensions was also recognised in DSM-IV(AmericanPsychiatric Association 1994; p. 710-
711).
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relationships as well as by cognitive or perceptual distortions and eccentricities of
behaviour. This pattern begins in early adulthood and is present in a variety of
contexts." (American Psychiatric Association 1994; p. 641).
The key symptoms of SPD, according to DSM-IV, are: ideas of reference; odd beliefs or
magical thinking that influences behaviour and is inconsistent with subcultural norms
(e.g. superstitiousness, belief in clairvoyance, telepathy, or 'sixth sense']; unusual
perceptual experiences, including bodily illusions; odd thinking and speech (e.g. vague,
circumstantial, metaphorical, overelaborate, or stereotyped); suspiciousness or
paranoid ideation; inappropriate or constricted affect; behaviour or appearance that is
odd, eccentric, or peculiar; lack of close friends or confidants other than first-degree
relatives; excessive social anxiety that does not diminish with familiarity and tends to
be associated with paranoid fears rather than negative judgements about self (American
Psychiatric Association 1994).
Much more common than SPD in the general population, however, are subclinical
schizotypal personality traits. In contrast to a diagnosis of SPD, which requires clinical
interview and DSM criteria, subclinical schizotypal personality traits in the general
population are most commonly measured using self-administered questionnaires
(Johns & van Os 2001). The traits under study are features phenomenologically related
to but clinically less severe than symptoms of schizophrenia, including unusual
perceptions and experiences, suspiciousness, delusional ideas, magical thinking,
oddness, disordered thought structure and speech, social isolation and withdrawal and
physical and social anhedonia (Claridge 1990; Gruzelier 2002; Lenzenweger 1994).
Theories of schizotypy have emphasised the relatedness to schizophrenia and SPD as
well as the increased risk of schizophrenia. Indeed, a striking similarity between
schizotypy and schizophrenia concerns their symptom factor structure as obtained
through factor analysis. Schizotypy is generally thought not to be a unitary construct
but consists of a number of dimensions, most commonly including positive features
(perceptual-cognitive signs and symptoms such as delusions, thought disorder,
hallucinations and unusual experiences and beliefs) and negative features (mainly
social-interpersonal signs and symptoms such as social withdrawal and isolation, poor
rapport, aloof and odd social interactions and social and physical anhedonia) (Vollema
& van den Bosch 1995). Other dimensions that have been found in factor analyses of
psychometric schizotypy questionnaires include anxiety-related traits and
psychoticism/nonconformity (Vollema & van den Bosch 1995). Still other studies have
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shown an occurrence of more than one positive schizotypy factor, akin to Liddle's
(1987b) factors of reality distortion and thought disorder in schizophrenia (Mason et al
1995; Vollema & van den Bosch 1995).
This similarity in factor structure, particularly of the overarching dimensions of positive
and negative symptoms, has led some to speculate on the possible continuity between
schizotypy and schizophrenia (Johns & van Os 2001; Vollema & van den Bosch 1995).5
Powerful evidence for this proposed continuity was obtained by Fanous et al (2001). In a
large sample of schizophrenia patients and their first-degree relatives, these researchers
demonstrated an association between levels of positive and negative schizophrenic
symptoms in the patients and levels of positive and negative schizotypal symptoms,
respectively, in their relatives.
Additional evidence for the relatedness between the constructs of schizotypy and
schizophrenia stems from similarities in their psychophysiological and
neuropsychological correlates. Non-clinical samples of individuals scoring high in
schizotypy have significantly impaired performance on a number of tests shown to be
sensitive to schizophrenia, such as neuropsychological measures of temporolimbic and
frontal cortex function or psychophysiological measures of information processing (Croft
et al2001; Dinn et al2002; Kumari et al1997b; Nunn & Peters 2001; Steel et alI996).
Finally, college students with high scores on psychometric self-report measures of
schizotypy are at significantly increased risk of developing psychosis over a ten-year
period (Chapman et al 1994b).
Given the hypothesised and observed similarity of schizophrenia and schizotypy,
schizotypal individuals represent an ideal population in which to assess the validity of a
biological or neurocognitive marker of the schizophrenia spectrum. A considerable
methodological advantage of studying schizotypy is the relative absence of secondary
confounds commonly observed in the schizophrenia patient group, such as
antipsychotic medication, disease chronicity, institutionalisation, variable motivation
and social and professional impairments.
Another schizophrenia spectrum population that has received considerable research
interest is that of first-degree relatives of schizophrenia patients. These individuals,
5 However, see Stuart et al (1999) for a criticism of factor analytic studies supporting the three-
syndrome model of schizophrenic symptoms.
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expected to have in common some of the genes that led to the expression of
schizophrenia in their relatives, have increased rates of SPD and subclinical schizotypy
when established using clinical interviews (Kendler et al 1995}.6 Relatives have also
been shown to have a number of neurocognitive, e.g. brain structural,
psychophysiological and neuropsychological deficits, similar in kind but of reduced
magnitude compared to the patient group (Clementz et al1998; Egan et al 2000; Egan
et al 2001a, 2001c; Saoud et al2000).
Like schizotypy research, the study of healthy first-degree relatives of schizophrenia
patients overcomes some of the confounds encountered in studies of schizophrenia
patients. The likely existence of schizophrenia disease genes, the observation of
increased rates of SPD and the evidence of neurocognitive deficits make this population
ideally suited for the assessment of the validity of schizophrenia spectrum
endophenotypes.
1.8 The Research Problem
The above overview points to the identification of 'schizophrenia genes' as one of the
most urgent and difficult questions in schizophrenia research. Identification of genes is
crucial not only for a better understanding of the pathophysiology of schizophrenia but
may also be expected to lead to improvements in the pharmacological treatment of this
disorder (Mancama et al 2002; Scharfetter 2001). To summarise, the search for
schizophrenia genes is made difficult by the complex and heterogeneous phenotype of
schizophrenia (including schizophrenia spectrum phenotypes); the unknown (but non-
Mendelian) mode of transmission of schizophrenia; the likely existence of a number of
causal genes; the small effect of each (or most) of these genes; the existence of
environmental risk factors and interplay between genes and risk factors; and the large
gap between a putative gene and the schizophrenia phenotype. It is probably due to
these difficulties that linkage studies - one of the best methods to date in the search for
disease genes - have been inconsistent or unsuccessful. The variable phenotype of
schizophrenia means that it is unlikely to reflect accurately an underlying disease
6 Relatives do not, however, attract significantly higher scores on psychometric self-report
measures of schizotypy; in fact, they sometimes obtain lower scores than healthy controls. This
paradox has most parsimoniously been explained as a defensive response set, given the
apparent nature of many schizotypy questionnaire items in a schizophrenia-related research
project that the relative agreed to take part in (Catts et al 2000; Claridge et al 1983; Katsanis et
al1990).
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genotype in a one-to-one fashion (Hyman 1999); the (assumed) existence of multiple
genes with small effect means that it is statistically difficult to confirm the action of any
such gene (Iacono 1998).
A number of strategies have been proposed to circumvent these difficulties. Leboyer et
al (1998) suggested either widening or narrowing the phenotype of a complex medical
condition (such as schizophrenia). Both approaches propose studying a biologically,
and, by extension, genetically, more homogeneous phenotype.
The narrowing of the phenotype is referred to as the candidate symptom approach
(Leboyer et al 1998). This approach aims to identify a symptom or symptom cluster
potentially involved in the condition under study; such a symptom is required to be
clinically homogeneous, to have circumscribed biological correlates and to show a
simpler pattern of inheritance than the overall disease phenotype. It can thus be used
as a phenotype in linkage studies. One version of the candidate symptom approach
involves narrowing of the disease phenotype along clinical criteria, such as age at onset
or disease severity. An example of the success of this approach is the amyloid precursor
protein gene on chromosome 21q for early onset Alzheimer's disease (Bertram & Tanzi
2001).
Within schizophrenia research, a distinction between early and late age at onset has
demonstrated high and low familiality, respectively, but has not yet yielded
susceptibility genes (Leboyer et al 1998). Identification of a homogeneous symptom
cluster, however, may be more successful. For example, the deficit syndrome (consisting
of primary, enduring negative symptoms) is thought to be a promising phenotype in the
candidate symptom approach (Carpenter et al 1999).
An alternative to narrowing the phenotype is the endophenotype approach, which will
be discussed in the following section.
1.8.1 The Endophenotype Approach
An endophenotype (also termed trait marker or intermediate phenotype) is a specific
biological or behavioural deficit thought to be a more direct expression of a disease-
related gene than the disease phenotype (Iacono 1998; Leboyer et al 1998; Lenzenweger
1999; Ott 1991; Stoltenberg & Burmeister 2000). Endophenotypes are objective, reliable
and phenotypically homogenous deficits, and are typically assessed using biochemical,
endocrinological, neurophysiological, psychophysiological, psychometric or
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experimental psychological means." The crucial point is that, due to its assumed
influence by a disease-related gene, an endophenotype is expected to be observed at
increased frequency not only in the patient group but also in clinically unaffected
individuals with a genetic predisposition to the illness, such as first-degree relatives.
Indeed, the study of clinically unaffected individuals marks the aforementioned
widening of the phenotype (Leboyer et alI998). This then means that an individual with
observed endophenotypic impairment may be identified as a 'gene carrier' with regard to
the hypothesised endophenotype/disease gene despite the absence of a clinical
diagnosis. This feature opens up new avenues for genetic linkage and other molecular
genetic studies (Ott 1991).
An endophenotype is thought to reflect the action of a disease-related gene, or the
action of a gene in linkage disequilibrium with a disease-related gene. Hence,
endophenotypes have been used in linkage studies. Their advantages over disease
phenotypes in linkage studies include the arguably more direct biological reflection of
the effects of a disease gene, the objective and less ambiguous definition and
measurement and the greater statistical power through the identification of clinically
unaffected gene carriers (Iacono 1998; Ott 1991). Additionally, as some endophenotypes
are assumed to reflect the action of a major gene, the pattern of transmission of such a
deficit may be simpler than that of a complex disease phenotype (Iacono 1998).
Endophenotypes have been used profitably in medical genetics. Indeed, Stoltenberg and
Burmeister (2000) argued that the novel strategies of the endophenotype and candidate
gene approaches represent a "paradigm shift" in genetic research (p. 931). For example,
studies of serum iron concentrations in idiopathic haemochromatosis have led to the
observation of linkage to the HLA-A locus (Leboyer et al 1998). The inclusion of
electroencephalographic (EEG) abnormalities as an endophenotype in genetic studies of
juvenile myoclonic epilepsy has led to identification of linkage (Leboyer et al 1998).
Endophenotypes are also being studied in psychiatric disorders other than
schizophrenia, including bipolar affective disorder (Ahearn et al 2002), attention-
deficit/hyperactivity disorder (ADHD; Castellanos & Tannock 2002), and borderline
personality disorder (Siever et al2002). Additionally, endophenotypes have been used in
studies of complex traits such as general intelligence (de Geus et a1 2001).
7 The prefix endo- suggests that this phenotypic expression is not visible to the unaided naked
eye and thus differs from the external phenotype, or exophenotype (John & Lewis 1966).
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It becomes clear from the definition of the endophenotype that this approach aims to
circumvent some of the most serious problems of genetic schizophrenia research, such
as phenotype heterogeneity and genetic complexity. The study of more confined aspects
of brain function reduces this heterogeneity. As de Geus et al (2001) put it, "the use of
endophenotypes to find genes influencing a complex trait fully obeys Caesar's adage of
'divide et impera'" (p. 490; italics added).
A second advantage of this approach is that the extension of investigation to non-
clinical samples allows the confirmation of any given behavioural or biological deficit in
the absence of methodological confounds, such as pharmacological treatment and
hospitalisation, often encountered in the patient group.
A further benefit of the phenotypic homogeneity of endophenotypes is that investigation
of not only causal genes but also the neural correlates of disease is possible. Hence, a
growing body of research aims to clarify the functional brain correlates of some of the
behavioural endophenotypic impairments (McDowell & Clementz 2001; O'Driscoll et al
1999). Knowledge of the underlying neural correlates of an endophenotype, in addition
to the identification of causal genes, could provide a powerful tool in investigating the
pathophysiology of the disease under study. Indeed, the assumed genetic simplicity of
the endophenotype implies that a relatively specific neural site or mechanism (e.g.
dorsolateral prefrontal cortex or specific dopaminergic projections; Egan et al 2001 b)
mediates the chain of events from disease gene to disease phenotype via
endophenotype. Relatedly, Castellanos and Tannock (2002) suggested that it should be
a requirement of an endophenotype in neuropsychiatry to be "anchored in neuroscience"
(p.619).
A variety of schizophrenia endophenotypes have been suggested, including
psychophysiological and electrophysiological deficits of information processing
(Cadenhead & Braff 2002; Clementz 1998; Iacono 1998), impairments in cognitive
measures of attention (Cornblatt & Malhotra 2001) and working memory (Park et al
1995) and brain structural abnormalities (Dickey et al 1999).
In order to qualify as a promising endophenotype, a behavioural or biological deficit
must fulfil a number of criteria. These criteria, adapted from other authors (Cadenhead
& Braff 2002; Calkins & Iacono 2000; Clementz 1998; de Geus et al 2001; Gottesman &
Erlenmeyer-Kimling 2001; Iacono 1998; Leboyer et al 1998; Lenzenweger 1999; Ott
1991; Stoltenberg & Burmeister 2000), are as follows.
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Presence in the patient group and low base rate in the general population. In order to be
considered as an endophenotype in genetic studies, a deficit must be unambiguously
present in the patient group. Additionally, it should have a low base rate (i.e. be
uncommon) in the general population.
Heritability. There must be good evidence that the behaviour under observation has
significant heritability. Heritability can be established through adoption studies as well
as studies of healthy monozygotic and dizygotic twins.
Temporal stability. An endophenotype should be a trait not a state deficit. State deficits,
such as those accompanying changes in medication or exacerbation of clinical
symptoms, are not temporally stable and are thus unlikely to represent important
underlying genetic factors.
Specificity. It is sometimes suggested that a homogeneous endophenotypic marker will
improve the identification of disease-related genes if it is observed only in the patient
group under study and the associated spectrum (e.g. relatives). Specificity is, of course,
important; a deficit that is, for example, observed in every psychiatric patient group
may be an indicator of general brain dysfunction. Evidence of considerable clinical and
biological overlap between related conditions, such as schizophrenia and bipolar
affective disorder, however, may also suggest genetic overlap. Indeed, some of the most
promising susceptibility loci in schizophrenia genetics also appear to be implicated in
bipolar affective disorder (Jorgensen et al2002). Consequently, it is possible that lack of
specificity of a given endophenotype concerning clinically related disorders might not
represent a serious weakness; alternatively, such an endophenotype might be the
expression of a shared, predisposing disease gene (Stoltenberg & Burmeister 2000).8
Family studies. Given the increased genetic risk for many complex disorders in first-
degree relatives of patients, and the putative action of a disease gene on an
endophenotype, increased frequencies of endophenotype impairments should be
observed in clinically unaffected and affected relatives. The levels of deficit in unaffected
relatives may be expected to be between those of the patients and healthy controls, due
to the putative influence of other (genetic and non-genetic) factors, likely to be more
concentrated in the patient group.
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Independence of secondary factors associated with patient status. In addition to being
temporally stable and independent of short-term fluctuations in clinical state,
endophenotypic measures should be observed in the absence of factors secondary to
the disease, such as chronic medication, institutionalisation or effects on the brain of
disease chronicity itself. Recent-onset patients may be studied to address this question.
Schizotypy. Elevated levels of impairments on a schizophrenia endophenotype should be
observed in individuals with an increased frequency of subclinical schizophrenia
spectrum symptoms, such as otherwise healthy people with elevated scores on self-
report measures of schizotypy, or individuals with SPD. Due to the somewhat lower
levels of severity of subclinical schizotypal signs and symptoms in these individuals,
performance impairments may be expected to be less severe than those of the
schizophrenia patient group. On the basis of the assumed genetic and biological
similarity between schizophrenia and subclinical schizotypy, however, the pattern of
impairments should be similar in quality to those of schizophrenia patients.
A thorough examination of the validity of any endophenotype should thus address these
points. If these criteria are met, an endophenotype may be used in order to advance the
search for genes involved in the development of schizophrenia by inclusion as a
phenotype in linkage studies or in assessments of candidate genes.
Although several schizophrenia spectrum endophenotypes have been proposed, deficits
in specific aspects of eye movement control have been argued to be particularly
promising trait markers (Calkins & Iacono 2000; Clementz 1998; Flechtner et al 2000;
Holzman 2000). These deficits comprise of reduced accuracy of smooth pursuit eye
movements and an increased error rate on the antisaccade task. Several lines of
evidence argue that eye movement (or oculomotor) impairments might be a very suitable
schizophrenia spectrum endophenotype. This evidence includes, in addition to the
considerable body of evidence from previous schizophrenia spectrum studies reviewed
in Chapter 2, the advantage of a good understanding of the neural correlates of eye
movements and the relatively unambiguous assessment of these deficits. This thesis
will focus on eye movement endophenotypes in the schizophrenia spectrum and will
address some of the above criteria in order to investigate their validity.
8 The acceptable non-specificity of an endophenotype within a class of related disorders is also
necessitated by the less than perfect clinical delineation of overlapping disorders such as
schizophrenia and bipolar affective disorder (Iacono 1998).
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Chapter Two
Eye Movements in the Schizophrenia Spectrum
2.1 Chapter Overview
This chapter will review the literature of eye movement tasks as endophenotypes in
schizophrenia spectrum research. Basic principles of eye movement research will be
outlined first. Each eye movement task applied in this thesis, i.e. the smooth pursuit,
visual fixation, antisaccade and prosaccade tasks, will be reviewed separately. As the
smooth pursuit task was, historically, the first oculomotor endophenotype proposed in
the literature it will be discussed first, followed by the fixation task, a task often used as
an oculomotor control condition for smooth pursuit. The antisaccade, and its suggested
control condition, the prosaccade task, will be similarly reviewed. For each task,
methodological issues, such as stimulus presentation and data scoring, will be
considered first, before addressing the task's validity as a schizophrenia
endophenotype. The criteria relating to the validity of these tasks as schizophrenia
endophenotypes that will be addressed here are based on those listed in Chapter 1 and
include: performance levels in the patient group; neural, cognitive, clinical and
pharmacological correlates; heritability in healthy humans; temporal stability;
specificity to schizophrenia; performance levels in family members of people with
schizophrenia; performance levels in first-episode psychosis patients; association with
schizotypy; and evidence from molecular genetic studies. Following this review, other
eye movement tasks that have been studied in the schizophrenia spectrum, such as
memory-guided and predictive saccades and visual scan paths will be considered
briefly. Finally, a comparison of and examination of the relationships between the most
promising of these oculomotor endophenotypes, the smooth pursuit and the
anti saccade tasks, will be undertaken. The chapter will conclude with an overview of
the remainder of this thesis, including the rationale for the experimental studies
reported in the thesis and the hypotheses.
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2.2 Introduction to Eye Movements
Why move the eyes if we can move the head? is the title of a review article by Delgado-
Garcia (2000); Why study eye movements? is the title of the first section of Leigh and
Zee's (1999) authoritative book on the neurology of eye movements. Both questions will
be addressed briefly in the following introduction to eye movement research.
The eye is the organ for vision. The fovea is the part of the retina that is specialised for
high-acuity vision and optimal processing of colour and shape (Figure 2.1). Most
detailed processing of a visual stimulus is, therefore, achieved by retaining its image
within about 0.50 of the centre of the fovea (Leigh & Zee 1999). Stimulation of retinal
neurons (rod and cone cells) by light waves causes the transmission of neural signals
down the optic nerves via the lateral geniculate body of the thalamus to the primary
visual area of the occipital lobe, resulting in the experience of vision (Leigh& Zee 1999;
Reid 1999).
Figure 2.1: Cross-sectional Diagrammatic Representation of the Human Eye
Ciliary body
In foveate animals, the existence of constant, small (or large) head movements in an
absence of the ability to move the eyes would result in slippage of visual input across
the retina, thus causing blurred vision whenever the image has left the fovea. One
purpose of eye movements is, therefore, to enable high-acuity vision by compensating
for head movements. As accurate visual perception is only possible when images on the
retina are stable, most processing of visual information takes place when the eye fixates
a stimulus. A second main purpose of eye movements is to allow foveate animals to
bring or retain an image on the fovea independently of, thus without requiring, head
movements (Delgado-Garcia 2000; Reid 1999).
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Eye movements fall into several categories. Leigh and Zee (1999) classified eye
movements on the basis of their functions into vestibular, visual fixation, optokinetic,
smooth pursuit, nystagmus quick phase, saccades and vergence eye movements; their
key functions are described in Table 2.1. These eye movements may be summarised
further into two broad functional categories, gaze-shifting (those that bring an image
onto the fovea) and gaze-stabilising (those that retain an image on the fovea) eye
movements (Leigh & Zee 1999).
Table 2.1: Functional Classification of Eye Movements (Leigh & Zee 1999)
Type Key function
Optokinetic
To retain the image of a moving object on the fovea
To retain the image of a stationary object on the fovea
To bring the image of an object of interest onto the fovea
To retain the image of an object on the fovea during brief head
rotation
To retain the image of an object on the fovea during prolonged
head rotation
To reset the eye during prolonged self-rotation to oncoming
stimuli
To retain an image on both eyes' foveae by moving eyes in
opposite directions
Smooth pursuit
Visual fixation
Saccades
Vestibular
Nystagmus quick
phase
Vergence
The eye is held and moved in its socket by three pairs of extra-ocular muscles (Figure
2.2): the superior and inferior recti move the eye up and down; the lateral and medial
recti move the eyes from side to side; and the superior and inferior obliques allow eye
rotation within the socket. The eye muscles are innervated by brainstem motoneurons,
the oculomotor (ipsilateral medial and inferior rectus, inferior oblique and contralateral
superior rectus), trochlear (contralateral superior oblique) and abducens (ipsilateral
lateral rectus) motoneurons. Neural control of eye movements above the brainstem level
is discussed in the relevant sections below (Sections 2.3.5.2, 2.4.4.2, 2.5.4.2 and
2.6.4.2).
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Figure 2.2: Diagrammatic Representation of the Extra-ocular Muscles
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Why do people study eye movements? To the scientist (and the layperson!), the eye may
be a rich source of information about perceptual, cognitive and affective processes;
indeed, the eye has been called the "window to the soul" (Stern & Dunham 1990; p.
513). Consequently, eye movements have been studied in a wide variety of contexts,
including biomedical research; research into various psychological processes, such as
visual perception, reading, or visual art appreciation; and topics in applied psychology
such as car driving, the use of visual media and human-computer interaction
(Andreassi 1995; Leigh& Zee 1999; Stern & Dunham 1990).
2.2.1 Why Study Eye Movements in Schizophrenia?
As Everling and Fischer (1998) pointed out, there are two streams of research into eye
movements in schizophrenia. The first stream of research focuses on the
endophenotypic nature of eye movement deficits in schizophrenia. This literature, which
originates in the observation of impaired smooth pursuit performance in first-degree
relatives in schizophrenia patients (Holzman et al 1974), is based on the hypothesis
that eye movement dysfunction may be the behavioural expression of a schizophrenia-
related gene. The endophenotype approach to eye movements in schizophrenia has
generated the largest amount of research in this field and has mainly focussed on the
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smooth pursuit task (Holzman 2000), although the antisaccade task has, more recently,
also been suggested to be a useful endophenotype (Clementz et al 1994).
The second stream of oculomotor research in schizophrenia, most clearly delineated by
McDowell and Clementz (2001) and Broerse et al (2001a), follows methods of neurology
(Kennard et al 1994) and proposes the use of oculomotor tasks to study the cognitive
and neural components of the pathophysiology of schizophrenia. According to this
approach, the use of specific eye movement measures allows the identification of brain
areas involved in task performance in healthy individuals and laboratory animals; the
assessment of specific behavioural performance deficits in people with schizophrenia;
pin-pointing the underlying neural deficits in the patient group (using neuroimaging
methods, or on the basis of behavioural data, by comparison with brain-Iesioned
individuals); and, by deduction, the identification of brain areas likely involved in the
pathophysiology of schizophrenia (Broerse et al 2001 a; Kennard et al 1994; McDowell &
Clementz 2001).
This approach has mainly focussed on the antisaccade task, probably given its origins
in the human brain lesion literature (Guitton et al 1985). More recent attempts at
delineating the cognitive and neural substrates of smooth pursuit dysfunction, however,
have also adopted this approach (Chen et al1999a, 1999c; Sweeney et alI998a).
Importantly, the two approaches have recently begun to converge, such as in studies
aiming to elucidate the neural correlates of oculomotor endophenotypes in first-degree
relatives of schizophrenia patients (O'Driscoll et al 1999).
The research reported in this thesis is concerned with an evaluation of the validity of
the first stream of research, the oculomotor endophenotype approach. However,
hypotheses concerning the likely neural and cognitive correlates of eye movement
dysfunction and implications for the pathophysiology of schizophrenia will be made
wherever possible.
2.2.2 Eye Movements in the Schizophrenia Spectrum
The following review will consider four eye movement tasks commonly studied in the
schizophrenia spectrum, namely the smooth pursuit, visual fixation, antisaccade and
pro saccade tasks. After definition of each task, methodological issues, such as stimulus
presentation and data scoring, will be discussed before turning to the findings from
schizophrenia spectrum populations.
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2.3 Smooth Pursuit Eye Movements
2.3.1 Definition
Smooth pursuit eye movements (SPEM)are gaze-stabilising eye movements executed in
order to maintain the image of a slowly moving visual object on the fovea. Smooth
pursuit eye movement accuracy was the first oculomotor endophenotype suggested in
schizophrenia research. The key findings from the many studies of the smooth pursuit
task in schizophrenia will be described in the following sections.
2.3.2 Smooth Pursuit Stimulus
Stimulus presentation requires attention to two points; first, the type of physical
stimulus presented, and second, the temporal characteristics of the stimulus.
2.3.2.1 Hardware
In the first schizophrenia spectrum SPEM studies participants were required to follow
with their eyes a pendulum often consisting of improvised material, such as fishing line
and sinker, swung about 1m in front of them (Diefendorf & Dodge 1908; Holzman et al
1973; Pass et al1978; Salzman et al1978; Shagass et al 1974; Siever et al1986; Spohn
etal 1988). While this technique was reliable and inexpensive (Lipton et al 1983) and
provided a useful starting point for research in this field, its weaknesses are obvious.
Target characteristics such as frequency of oscillation, amplitude and waveform cannot
be precisely controlled and target position cannot be recorded.
Some subsequent studies have used cathode-ray oscilloscope (eRO) stimuli (Amador et
al 1995; Gooding et al 1994; Iacono et al 1981; Levin et al 1982a; Malaspina et al
1998); however, the most commonly used methods nowadays include light emitting
diode (LED)arrays, laser spots and video or computer monitors.
Light-emitting diodes are sources of (red) light that are commonly used in a variety of
settings, such as display panels or rear car lights. LEOs have the advantage over
conventional light bulbs of responding, i.e. being turned on and off, quickly, and being
robust and long lasting. Typically, LEOs are presented at eye-level to participants at a
distance of I-2m, horizontally aligned in a purpose-built hardware array. Diodes can be
controlled by a computer; concurrent logging of eye and target data is possible. LEOs
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are still being used and present a well-established and flexible means of displaying
pursuit stimuli. Studies reported in Chapters 4-6 employed LEDs (Section 3.2.2.1).
The laser spot method allows the presentation of a small visual target, usually projected
onto a clear background screen (Arolt et al 1998; Hutton et al 1998a; Rosenberg et al
1996). As the stimulus can be precisely controlled by purpose-written software, target
movement is sufficiently accurate and flexible for eye movement studies.
Most recently, however, the method of choice for stimulus presentation has been the
computer or video monitor (Clementz et al 1995; Clementz & McDowell 1994; Friedman
et al 1995b; Keefe et al 1997; Litman et al 1994; Olincy et al 1998; Sweeney et al
1992a, 1994a; Thaker et al 1999). Studies reported in Chapters 7 and 8 used computer
screen based stimulus presentation (Section 3.2.2.2).
One advantage of computer monitor based presentation is that stimulus properties,
such as shape or colour, can easily be manipulated. Such manipulations may be useful
in the investigation of cognitive processes during smooth pursuit or saccadic eye
movements (Rosenberg et al 1997c; Sweeney et al 1994b). Additionally, computer
screen based stimulus presentation lends itself to functional neuroimaging studies. The
disadvantage of such a stimulus display is the restricted horizontal range, making it
inappropriate for certain clinical assessments (Leigh & Zee 1999). However, the
horizontal range of computer or video monitors is fully compatible with target
eccentricities used in schizophrenia studies.
The target used in studies using computer or video monitors most often consisted of a
small, coloured, square or round dot (Cegalis & Sweeney 1981; Clementz et al 1995;
Clementz & McDowell 1994; Friedman et al 1995b; Ross et al 1999c), although letters,
numbers and other symbols have also been used (Cegalis et al 1983; Keefe et al 1997;
Sweeney et al 1992a; Thaker et al 1999). The monitor is usually presented at a distance
of about 40-60cm at eye level from participants, approximating the average computer
reading distance (Clementz et al 1995; Clementz & McDowell 1994; Litman et al 1994;
Ross et al1998e; Rybakowski et al2001; Sweeney et al1992a; Thaker et al1999).
2.3.2.2 Stimulus Properties
In SPEM tasks, the target is usually first presented in the centre of the participant's
visual field and is then moved horizontally to one side until it reaches the end point and
reverses. It is important to note the difference between sinusoidal and constant velocity
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(triangular or trapezoidal waveform) stimuli. The sinusoidal waveform essentially
replicates the pendulum design (Figure 2.3).9
Figure 2.3: Example of a Sinusoidal Target Waveform
15.0
10000 15000
Legend: x-axis, time (ms); y-axis, degree of visual angle
In the triangular smooth pursuit waveform the target never stops or changes velocity,
and experiences an abrupt direction reversal at the extreme eccentricity of each half-
cycle (Figure 2.4). In the trapezoidal waveform the target stops at the end of each half-
cycle and remains stationary for durations of typically a few hundred milliseconds,
before initiating a new half-cycle (Figure 2.5). A half-cycle is defined as the target
excursion between the most eccentric peripheral locations.
Figure 2.4: Example of a Triangular Target Waveform
10000
Legend: x-axis, time (ms); y-axis, degree of visual angle
9 The representation of eye movement data in Figure 2.3 is identical in principle to other graphs
used in this and the following chapters: The vertical axis displays stimulus amplitude, with the
participant's centre of the visual field (00) displayed as the midline. Target movements to the
participant's right visual hemifield are depicted as an upward movement of the target line in the
graph; target movements to the participant's left are reflected by the line going down. The
horizontal axis displays units of time, usually milliseconds.
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Both sinusoidal (Gooding et al 1994; Green et al 2000; Holzman et al 1973; Pivik 1991;
Rosenberg et al 1996; Spohn et al 1988) and constant-velocity (Arolt et al 1998;
Clementz & McDowell 1994; Hutton et al 1998a; Lencer et al 1999; Litman et al 1994;
O'Driscoll et al 1998; Ross et al 1999c) targets have been used in schizophrenia
spectrum research. The key findings in schizophrenia spectrum research have been
replicated irrespective of target waveform. Investigations using sinusoidal as well as
constant-velocity targets have found high correlations between these measures and
have generally not reported differences between them in discriminating between
schizophrenia spectrum individuals and healthy controls (Amador et al 1995; Bartfai et
al 1983; Iacono et al 1981; Shagass et al 1974; Siever et al 1994).
Figure 2.5: Example of a Trapezoidal Target Waveform
1.0.0
0.0
-1.0.0
15000 20000
Legend: x-axis, time (ms);y-axis, degree of visual angle
A range of different target velocities has been used. Velocity of sinusoidal targets is
usually expressed in frequency (Hertz; Hz) and peak velocity (degrees per second).
Velocity of triangular or trapezoidal targets is usually expressed in degrees per second
(o/s). As the human smooth pursuit system may comfortably followtargets of velocities
up to 30-40°/ s (Carpenter 1988; Leigh & Zee 1999), most studies have employed
velocities ranging from 100/s to about 400/s, or 0.3Hz to 0.6Hz (e.g. Cegalis et al 1983;
Cegalis & Sweeney 1981; Gambini et al 1993b; Pass et al 1978; Radant et :::U 1997;
Roitman et al 1997; Salzman et al 1978; Shagass et al 1974; Spohn et al 1988; Thaker
et al 1999; Van Gelder et al 1990), although faster targets have also been used (Iacono
et al 1981; Levin et al 1982a; Schwartz et al 1999; Versino et al 1993). As accuracy of
the smooth pursuit system is affected by target velocity, and it has been suggested that
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target velocity also affects the effect size of comparisons between schizophrenia patients
and controls, a number of studies have combined different target velocities (Abel et al
1991; Hutton et al 2001a; Lipton et al 1980a; May 1979; Pivik 1979b).
Another issue that needs to be addressed is that of the range of horizontal target
excursions. Due to restrictions of the linearity of infrared oculographic recording
systems, and to minimise strain on the eyes, most studies have used comfortable
horizontal target excursions of ±10°, ±12°, or ±15° (Litman et al 1991; Matsue et al
1994b; Nkam et al 2001; Roitman et al 1997; Ross et al 1997, 1999c; Stuve et al 1997;
Van Gelder et al 1990).
Instructions to participants in the smooth pursuit task are typically to follow the target,
with their eyes, as accurately as possible wherever it goes. In order to avoid
contamination by movement artefacts, participants are required to keep their head and
other parts of the body still during the task.
In addition to this regular type of smooth pursuit task, which will be the main focus of
this thesis, other tasks, such as step-ramp and predictive pursuit tasks have been
applied to schizophrenia spectrum populations.
In a horizontal step-ramp, or Rashbass task (Rashbass 1961), the target first appears in
the central location, then abruptly moves to the side (the step), and then immediately
starts to move slowly at a constant velocity (the ramp). In foueopetal step-ramp tasks
the direction of the ramp is opposite to that of the step, so that the target moves back
towards and crosses the central fixation point. In foueofuqal tasks the target continues
the ramp in the direction of the step, away from the central fixation point.
Step-ramp tasks allow the assessment of closed-loop pursuit performance, similar to
the standard pursuit task, but also provide additional information on motion processing
and open-loop pursuit performance, obtained from the first few hundred milliseconds of
this task. Open-loop pursuit occurs in the first 100-200ms of pursuit initiation, when
perceptual feedback about pursuit performance is not yet available. Pursuit in this
phase is initiated, therefore, on the basis of sensory and motion input. Closed-loop
pursuit refers to the later phase of pursuit, where perceptual information of pursuit
performance can be utilised in improving accuracy of performance (Sweeney et al 1999).
These measures have been studied in attempts to locate the neuroanatomic deficit
underlying SPEM impairment in schizophrenia spectrum (Clementz & McDowell 1994;
Sweeney et al 1999).
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Some researchers have used predictive pursuit tasks (Thaker et al 1996b, 1998, 1999).
Thaker et al's task consisted of a predictable triangular waveform target, which was
occasionally blanked out (masked) for durations of SOOms, thereby allowing
measurement of gain during predictive pursuit in the absence of a physical target.
Trillenberg et al (1998) used a sinusoidal target that abruptly stopped after a number of
predictable half-cycles at the most extreme target eccentricity, again allowing the
assessment of predictive pursuit eye movements.
2.3.3 Recording
This section discusses eye movement recording techniques of relevance to
schizophrenia spectrum research. Recording techniques do not generally differ across
the (smooth pursuit, fixation, anti saccade and prosaccade) eye movement tasks
discussed in this thesis; therefore, methods discussed in this following section apply to
other tasks as well.
A wide variety of techniques have been used to record oculomotor activity (for review see
(Carpenter 1988, Appendix 1; Clementz & Sweeney 1990; Iacono & Lykken 1983; Leigh
& Zee 1999, Appendix B). In the field of schizophrenia spectrum research, the vast
majority of studies have employed either the electrooculographic (EOG) or the infrared
oculographic (IRO) techniques.
Historically, the first schizophrenia study employed a photographic method (Diefendorf
& Dodge 1908). The Dodge Photochronograph (Figure 2.6) made photographic recordings
of the eye using the movement of a sensitive photographic plate. Briefly, the
photographic plate captured filtered light rays of an electric arc, which reflected from
the cornea of the eye back to the plate. The light ray consisted of an arc light with
horizontal upper carbon and was projected onto one of the participant's eyes from
behind a condensing lens through an opening in an otherwise opaque screen placed in
front of the participant. From the cornea the light was then reflected onto the
photographic plate. An enlarging camera of fixed length (lS3cm) and a device for
producing regular motion of the sensitive photographic plate were used.
This ingenious method has proved to be of considerable accuracy; "it is fair to say that
the precision of those recordings has not been matched even with today's electronic
technology" (Holzman 1983; p. 33).
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Figure 2.6: Dodge Photochronograph
from Diefendorf and Dodge (1908), p. 456
Probably the most reliable and accurate method in neuro-ophthalmology is the
magnetic search coil (MSC)technique (Stahl et al 2000; Van Der Geest & Frens 2002).
This technique involves the participant wearing a silastic annulus under their eyelid
containing two coils of wire, wound in the frontal and sagittal planes. The participant is
placed in a magnetic field and the voltages that are induced in the coils can be recorded
to determine eye position. Despite its excellent resolution the main disadvantage of this
technique is its invasiveness, as the participant must wear a contact lens and can
usually not endure test session of longer than 30 minutes (Leigh& Zee 1999). The MSC
technique has met with little acceptance in schizophrenia spectrum research (however,
see (Levin et al 1988; Nieman et al 2000), presumably due to its invasive nature which
might pose a problem in the assessment of psychiatric patients, especially those acutely
ill. Further, the assessment of large number of individuals is time consuming.
Most early studies of eye movements in schizophrenia have used the EOG method
(Iacono & Lykken 1983; Levin et al 1982b; Lipton et al 1983). This technique has a
number of advantages (Table 2.2). It is a relatively inexpensive, reliable, accurate (to
within 1 or 2 degrees of visual arc) and unobtrusive method, which is readily available
in most psychophysiology laboratories. The method works on the differences in voltage
generated by shifts in the position of the eyes. A standing potential of 1mV exists
between the cornea and the fundus of the eye. Eye movements create a change in
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voltage potential generated by shifts in the position of the two globes and can be
monitored from periorbital electrodes, such as silver/silver chloride electrodes placed on
the outer canthi of the eyes (tin and gold electrodes may also be used). Electrodes may
be referenced to each other or to a neutral reference electrode placed in an area of low
electrical activity (e.g. earlobe, or mastoid). An additional electrode is used as ground
electrode for participants' safety and to reduce ambient electrical artefact. The main
disadvantages of the EOG technique are its restricted precision and its susceptibility to
effects of bioelectric noise. Factors such as facial muscle activity, eye-blinks and
twitches, skin resistance, sweat, changes in retinal metabolism due to light changes
and brain electrical activity may introduce artefacts into the recordings.
Most recent studies of eye movements in the schizophrenia spectrum have used the
infrared oculographic (IRO)method. IRO is a photoelectric technique that exploits the
reflection characteristics of infrared light when projected onto the boundary between
iris and sclera (i.e. the limbus, see Figure 2.1). Infrared light beamed onto the limbus is
reflected and subsequently picked up by detectors on both the nasal and temporal side
of the eye. With horizontal movements of the eye the detectors will pick up increases
and decreases in limbus reflection, together giving a measure of eye position (Iacono &
Lykken 1983; Reulen et al 1988).
Various commercially available apparatuses have been developed based on this
technique (for review, see Reulen et al 1988). The equipment usually involves the
participant wearing a light plastic helmet containing the infrared emitters and
detectors, ensuring minimal disruption due to head movements while at the same time
guaranteeing little discomfort to the participant. Importantly, unlike other methods (e.g.
MSC), IRO does not involve physical contact with the eye. However, the headset is
usually more obstructive to vision than, for instance, electrodes in the EOG technique.
The main advantage of IRO over EOG is its excellent precision (Table 2.2). Additionally,
IRO does not experience the problems of bioelectric noise encountered in EOG. IRO,
however, has a number of disadvantages (Carpenter 1988; Iacono & Lykken 1983; Leigh
& Zee 1999; Lipton et al 1983; Reulen et at 1988).
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Table 2.2: Advantages and Disadvantages of the Electro-Oculographic (EOG) and
Infrared Oculographic (lRO) Techniques in the Recording of Eye Movements
EOG IRO
Robustness to bioelectric noise
Robustness to ambient light
Precision
Range of linearity in horizontal target/eye excursions
Unobtrusiveness of equipment
Usability for prolonged recording
Suitability for participants with glasses
Recording of vertical eye movements
+
+
+
+
+
+
+
+
•
Legend:
+ denotes strength of the method
- denotes weakness of the method
• see Iacono and Lykken (1983)
First, photodetectors and infrared light emitters mounted close to the participant's eye
may restrict the field of view. Second, most IRO headsets cannot be applied to people
with glasses.P Third, sources of ambient light introduce noise into the recordings.
Fourth, prolonged exposure to infrared light may cause irritation or drying of the eye.
Fifth, the range of horizontal recordings is larger with EOG than IRO. Lastly, vertical
eye movements may be more reliably recorded with EOG than IRO.
Given these disadvantages, it may seem surprising that IRO is now one of the most
widely used techniques in schizophrenia spectrum oculomotor research. However, most
of these problems are relatively easily circumvented, e.g. by using brief assessment
durations and controlled light conditions. Others, such as restriction to horizontal tasks
of limited range, do not pose a threat to the most commonly used tasks in
schizophrenia spectrum research. As outlined above, most studies use horizontal
targets with maximum excursions of ±30°, well within the possibilities of most IRO
systems. It may be argued, therefore, that the key advantages of IRO over EOG, its
excellent resolution and robustness to bioelectric noise, outweigh its problems.
A number of studies have addressed the similarities and differences between IRO and
EOG in recording eye movements in schizophrenia patients and healthy individuals.
Generally, these studies have demonstrated a high degree of qualitative similarity and
10 Iacono and Lykken (1983) demonstrated a system that may be worn over glasses thus
circumventing this problem.
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high correlations of quantitative SPEM and prosaccade measures for simultaneous EOG
and IRO recordings (Iacono & Lykken 1981; Lindsey et al 1978; Ong & Harman 1979).
It has, however, been found that EOG recordings contained more spiky interruptions of
pursuit, masking as small saccades (Iacono & Koenig 1983; Iacono & Lykken 1981,
1983). These small spikes (2-3°) most likely did not reflect eye movements, but
unspecified biological signals or EEG activity, such as alpha or kappa waves (Holzman
& Levy 1977; Iacono & Koenig 1983; Lindsey et alI978).
Concerning the similarities and differences between the IRO and EOG methods, the
Clinical Research Branch of the National Institute of Mental Health and the Center for
Studies of Schizophrenia convened a small conference in August 1981 to resolve
methodological issues, differences and misunderstandings between SPEM researchers
(editorial to Schizophrenia Bulletin; Volume 9, Number 1; 1983; see also the reviews
therein). It was commented that "methodological disputes about recording techniques
were more apparent than real since the basic findings were robust enough to transcend
even primitive recording methods" (p. 11).
2.3.4 Smooth Pursuit Scoring
"Despite decades of research, the field of eye-tracking disorder in schizophrenia
continues to struggle with questions about which measures should be used" (Ross et al
1998c; p. 184). It becomes obvious from this quote that analysis of SPEM data is
riddled with problems. The reason for disagreements between researchers on SPEM
analysis, according to Braff (1998), is probably the complexity of smooth pursuit
performance itself, involving a variety of cognitive (and neural) processes. The SPEM
task complexity is reflected in the number of subcomponents that can be studied.
Previous approaches to SPEM scoring can be grouped into global and specific (Clementz
& Sweeney 1990) methods, although a distinction along the quantitative-qualitative
spectrum has also been made (Braff 1998).
The first studies by Holzman's group and subsequent replications employed qualitative
assessments of SPEM data as 'normal' or 'deviant' performance. Categorisation was
based on visual inspection of the congruence of eye movement recording with the target
waveform (Holzman et al1973, 1974; Holzman & Levy 1977). Reasons for adopting this
method were its simplicity, the fact that target traces were not recorded (and thus could
not be used in quantitative analysis) and the use of similar measures in previous
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studies (Benitez 1970). Shagass et al (1974) elaborated on Holzman's method and
provided examples of a 5-point qualitative rating scale (Figure 2.7), rating performance
from 1 (best) to 5 (worst). This scale, or variations of it, has been widely used (Keefeet al
1989; Lencz et al 1993; Siever et al 1994).
Figure 2.7: Example of 5-point Smooth Pursuit Rating Scale
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from Shagass et al (1974), p. 249; 1 = best, 5 = worst
In addition to this qualitative dichotomy Holzman and colleagues (1978b) distinguished
between Type I and Type II eye-tracking dysfunction. Type I dysfunction was described
by large amplitude, inaccurate saccades largely replacing the smooth pursuit
component. In Type II dysfunction small amplitude saccades and frequent, brief eye
arrests intruded on pursuit. This distinction, however, has not been widely used by
others.
Qualitative assessment has the advantage of providing a simple summary score. A
considerable number of studies have applied this method to schizophrenia spectrum
samples, yielding important findings. Some of the most important findings obtained
with qualitative ratings are those of SPEM dysfunction in first-degree relatives and
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schizotypal individuals, SPEM concordance in twins discordant for schizophrenia,
effects of lithium treatment in bipolar patients and independence of eye-tracking
dysfunction from typical antipsychotic drug treatment (Holzman et al1974, 1977, 1980,
1991; Levy et al1983b, 1985; Siever et al1994).
However, qualitative ratings may be criticised on a number of grounds. First, scoring
involves a subjective component which, despite good inter- and intra-rater reliability
(O'Driscoll et al 1998; Rosse et al 1992a; Siever et al 1994; Spohn et al 1988), may be
undesirable. For this reason, researchers have strived to employ objective measures of
pursuit. Second, and more importantly, qualitative ratings do not specify what exactly
the oculomotor deficit underlying 'abnormal' pursuit is (e.g. Abel 1986). For this reason,
researchers have developed specific measures.
Amongst the earliest quantitative measures were frequency of velocity arrests and
frequency of positive saccades (Holzman et al 1973; Pivik 1979b; Salzman et al 1978).
Velocity arrests were measured as the number of times pursuit velocity reached zero or
came near zero (Holzman & Levy 1977). Positive saccades were counted when eye
velocity exceeded target velocity by 33.33%. These measures were shown to be reliable
and correlated with qualitative ratings (Coursey et al 1989; Holzman et al 1973, 1974).
The validity of both measures, however, has been seriously challenged (Troost et al
1974) on the grounds of their arbitrary nature, the possibility of EOG recording
artefacts and their lack of relatedness to previously used measures of pursuit. Lindsey
et al (1978) confirmed that velocity arrests were significantly increased in EOG
compared to IRO recordings, suggesting contamination by bioelectric noise.
Given these criticisms, these measures were rapidly succeeded by other quantitative
procedures. At around the same time Lindsey et al (1978) and Iacono and Lykken
(1979a, 1979b) developed global quantitative measures of smooth pursuit. These were
developed given the newly emerged possibility of obtaining a record of the target trace
and advances in the development of microcomputers.
Lindsey et al's (1978) natural logarithm of the signal-to-noise ratio, or In(S/N), determines
the amount of 'noise' in the eye movement, or its deviation from the target movement.
For a sinusoidal target at a given frequency (e.g. O.4Hz), eye pursuit frequency within
this frequency range defined as 'signal' and a predefined range of frequencies is defined
as 'noise' (e.g. 1.2-12Hz). The natural logarithm of the ratio between the two is taken as
performance index, with higher scores indicating better performance. In(SjN) has the
65
Eye Movements in the Schizophrenia Spectrum
advantage of being scored relatively easily and objectively. It has been shown to be
correlated with qualitative and quantitative measures, and to discriminate between
healthy controls and patients, furnishing evidence of its validity (Grawe & Levander
1995; Levin et al1981b; Lindsey et al1978; Siever et al1989; Spohn et al1988).
However, as a global measure In(SjN) suffers a similar problem to qualitative ratings,
i.e, the lack of information regarding specific oculomotor deficits. Abel and Ziegler
(1988) undertook a computer simulation of poor In(S/N) performance in hypothetical
groups differing considerably and systematically in precise measures (such as the
frequencies of different kinds of saccades). In(SjN) scores were identical across groups,
demonstrating that this global measure might be informative in establishing an
abnormality without specifying where exactly the abnormality lies.
Iacono and Lykken's (1979a, 1979b) root mean square error, or RMSE, is a
mathematically related procedure (Lykken et al1981). It expresses the overall deviation
of eye from target and can be used for targets of all waveforms. RMSE is calculated as
the difference between eye and target position for every recorded data point. This
difference at each data point is then squared and the average of all terms is taken.
Higher scores indicate worse performance.
RMSE has been used by a number of laboratories in studies of schizophrenia spectrum
populations (Clementz et al 1992; Friedman et al 1995b; Iacono et al 1992; Ross et al
1996c; Sweeney et al 1993). Its advantages include the simple and linear quantification
of overall pursuit, the objective nature of the scoring procedure and its established
validity. Clementz et al (1996b) most vigorously pointed out the advantages of RMSE.
They argued that RMSE correlates highly with alternative measures, is temporally
stable in schizophrenia patients and normals and has been successful in discriminating
between different clinical and non-clinical groups. However, similar to qualitative
ratings and In(S/N), RMSE does not provide specific oculomotor performance scores.
Other quantitative measures that have been used in schizophrenia spectrum research
include phase-lag (Ross et al 1996a; Trillenberg et al 1998) and indirect measures such
as the amount of time spent in pursuit (Schwartz et al 1999).
Leigh and Zee (1999) summarise the usefulness of global (qualitative and quantitative)
measures as follows: "RMSE values are estimates of overall tracking, not just smooth
pursuit" and "finally, qualitative rating scales of pursuit as relatively "normal" or
"deviant" are of little value in determining the nature of the deficit" (p. 180). Abel and
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Ziegler (1988) in a widely cited review of smooth pursuit scoring techniques in
schizophrenia come to a similar conclusion. Despite these criticisms, In(S/N) and RMSE
have been widely used in schizophrenia spectrum research. Most recent studies,
however, have taken heed to Abel and Ziegler's (1988) call for the use of specific
oculomotor measures. The most frequently used specific measures are those of smooth
pursuit gain and the frequency of saccades.
Gain is arguably the best measure of smooth pursuit system integrity (Leigh & Zee
1999) and has been widely used in schizophrenia spectrum research (Clementz et al
1990; Hutton et al 1998a; Levin et al 1988; Litman et al 1989; Ross et al 1998c;
Schmid-Burgk et al 1982; Vee et al 1987). Gain is most commonly calculated by
dividing eye velocity by target velocity. A score of 1 (or 100, if multiplied by 100),
therefore, indicates perfect match of eye and target velocity. As it is the function of the
pursuit system to match eye and target movement (Leigh& Zee 1999), the gain measure
is often considered sufficient for assessment of pursuit system integrity. Gain is usually
calculated for small segments (e.g. 50-500ms) of steady-state mid-cycle pursuit for
constant velocity target waveforms or segments during peak target velocity in sinusoidal
target waveforms (Flechtner et al 1997; Gooding et al 2000b; Hutton et al 2000, 2001a;
Levy et al 1994; Siever et al 1994; Thaker et al 1996b) after eye-blinks, saccades and
artefacts have been excluded.
Another widely used measure is the frequency of saccades, usually expressed as the
number of saccades per unit of time. Different types of saccades are observed during
smooth pursuit. The most common distinction is that of intrusive vs. corrective
saccades. Intrusive saccades consist of anticipatory saccades and square-wave jerks;
corrective saccades consist of catch-up saccades and back-up saccades.
The first studies to evaluate saccadic frequency in schizophrenia, however, did not
always distinguish between different subtypes of saccades (Cegalis et al 1983; Cegalis &
Sweeney 1979; Mialet & Pichot 1981), or used coarse categories such as large and small
saccades (Spohn et al 1988), saccades in target motion and in opposite direction (Van
Gelder et al 1990), or saccadic intrusions and saccadic pursuit (Levin et al 1982a). With
increasing awareness of saccade subtypes and improvements in recording and analysis
techniques, more recent investigations have focussed on specific subtypes.
Anticipatory sacca des (AS)are defined as saccades in direction of target motion, which
end ahead of the target and increase position error (i.e. the difference between eye and
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target position}. AS are followed by about 50-300ms of reduced eye velocity, often
operationally defined as less than 50% of target velocity. Return saccades {to target}
may occur after a long inter-saccadic interval {Ross et al 1998e, 1999c, 2001}. Initial
studies suggested minimum amplitude criteria of about 5° {Whickeret al 1985}.
Ross and colleagues have stressed the importance of the AS as a potential genetic
marker and have further characterised it. Ross et al {1999c} investigated the effect of
required minimum amplitude for the inclusion of AS on schizophrenia-control group
effect sizes. It was found that inclusion of smaller AS (1°) improved the statistical
separation between groups. More recently, Ross et al (2001) characterised the amount
of post-saccadic slowing required for reliable detection of AS. Most previous studies
have assumed that AS are followed by post-saccadic slowing of approximately s50% of
target velocity {Clementz et al 1990; Litman et al 1994; Radant & Hommer 1992;
Rosenberg et al 1997c; Sweeney et al1994b}. Ross et al {2001}found that focusing this
criterion on 50ms rather than 300-400ms after the saccade maximised statistical
separation of schizophrenia and control groups. However, it also becomes clear from
their analyses (their Table 2, p. 331) that AS differentiated patients and controls
irrespective of post-saccadic slowing criteria. Additionally, as small AS {1-2°}were
unlikely to be followed by 300-400ms of slowed pursuit {s50%},it is not clear how AS
amplitude affected these results. This point is particularly important given the authors'
earlier finding of increased separation between schizophrenia and control groups with
the inclusion of smaller AS, obtained in the same sample {Rosset al2001}.
A considerable body of research has confirmed the validity of AS as a specific
oculomotor endophenotype in schizophrenia spectrum research (Lencer et al 1999;
Rosenberg et al 1997c; Ross et al 1998e), although evidence to the contrary has also
been presented (Clementz et al 1990). The main attractions of this measure are
probably its face validity as an inhibitory saccadic failure and its well-characterised
appearance.
Catch-up saccades (CUS) serve to reduce position error when the eye is lagging behind
the target. CUS are usually defined as saccades that begin behind the target. As their
function is to move the eye back to the target, a correctly executed CUS should end on
target. However, CUS often begin and end behind the target, or begin behind the target
and end ahead of it (Friedman et al 1991; Radant & Hommer 1992; Ross et al 1997). If
the latter is the case, a criterion of postsaccadic position error of at most 50% of
presaccadic error has been suggested, i.e. the saccade has to significantly reduce
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position error. Post-saccadic slowing criteria are not usually applied to the identification
of eus (Ross et al 2001). Instead, Levyet al (1994) suggested that eus are typically
preceded by reduced velocity gain, a feature which additionally serves to distinguish
them from AS.
Square-wave jerks (SWJ) are intrusive saccades that consist of pairs of saccades in
opposite direction. The first saccade usually takes the eye ahead of the target. The
second saccade returns it after about 50-500ms. Importantly, (parafoveal) pursuit
continues between the pair of saccades. This feature serves to distinguish SWJ from AS
(Ross et al 2001). Macro-SWJ have also been identified (Clementz & Sweeney 1990);
these are defined as pairs of saccades of larger amplitude than SWJ but relatively short
inter-saccadic interval (100-125ms)
Back-up saccades (BUS) are compensatory saccades that return the eye to the target
when it moved ahead of it. BUS may also occur after post-saccadic slowing following an
AS. BUS have not been studied in detail in the schizophrenia spectrum.
In addition to saccadic frequency, some studies have investigated the amplitudes of
saccades during pursuit (Cegalis et al 1983; Mather & Putchat 1982) or the 'desired
CUS amplitude' (Ross et al 1998c), i.e. the amplitude a CUS would require to move the
eye precisely onto the target.
An important question in smooth pursuit analysis concerns the relationship between
global and specific, or qualitative and quantitative measures. While most measures of
pursuit - not surprisingly - tend to be correlated, a number of studies have attempted
to examine the amount of variance of qualitative and global quantitative measures that
is explained by specific measures.
Ross et al (1998c) aimed to explain qualitative ratings (1-5) in terms of RMSE, gain,
variability (SD) of gain, CUS frequency, eus amplitude, desired CUS amplitude and
phase lag in 76 schizophrenic patients. Multiple regression showed that 4 of the 6
specific measures (gain, SD of gain, CUS amplitude, desired CUS amplitude) were
accepted by the model as significant predictors of qualitative ratings. Spohn et al (1988)
demonstrated that 79% of the variance ofln(S/N) was accounted for by the frequency of
'small' and 'large' saccades.
Variance in RMSE has also been partially explained by specific measures. Ross et al
(1997) used mixture analysis to obtain two groups of schizophrenic patients, with high
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and low RMSE scores. SPEM was also scored for gain, SO of gain, AS frequency and
CUS frequency, amplitude and desired amplitude. Gain, gain SO, CUS amplitude and
desired amplitude significantly discriminated between the high and low RMSE groups.
Similarly, Levy et al (2000) found that poor and good performers (based on qualitative
ratings) could be differentiated primarily by CUS and gain and secondarily by SWJ
frequency.
Taken together, these findings indicate that global qualitative and quantitative
measures may be largely, but not completely, explained statistically by specific
measures. This should come of no surprise, as both measures assess the same overall
behaviour, i.e. SPEM performance, in the same individuals. More importantly, these
results support the concurrent validity of specific measures, in particular reduced gain
and increased saccadic frequency (especially CUS), in describing global eye-tracking
dysfunction of schizophrenia patients.
What are the implications of this plethora of different scoring methods for the analysis
of SPEM performance in schizophrenia spectrum individuals? As Levy et al (2000)
pointed out, "ETD [eye-tracking dysfunction] is a multivariate process" (p. 172).
Similarly, Braff (1998) pointed to the complex (cognitive) nature of this task. Given
these assertions, the use of specific measures may be encouraged. Specific measures
are of particular importance, and in fact essential, if one wishes to pinpoint precise
neural abnormalities based solely on behavioural data (Clementz 1996a; Clementz &
McDowell 1994; Sweeney et al 1999; Thaker et al 1996b, 1998, 1999). Similarly, Hutton
and Kennard (1998) pointed to the importance of combining measures of saccadic
frequency and pursuit gain. For example, information on CUS frequency is invaluable
in the interpretation of reduced gain in schizophrenia. Reduced gain in the presence of
increased CUS frequency might indicate intact position error detection mechanisms,
while reduced gain in the absence of increased CUS frequency might indicate impaired
position error detection mechanisms (Hutton & Kennard 1998).
However, the validity of global measures has been demonstrated. Moreover, two studies
demonstrated that qualitative ratings were superior to measures of gain and saccadic
frequency in statistically separating healthy individuals from relatives of schizophrenia
patients (Keefe et al 1997) or SPD patients (Siever et al 1994). Interestingly, global
(categorical) performance measures continue to be used successfully in functional
neuroimaging studies (O'Driscoll et al 1999) and genetic analyses of the ETD phenotype
(Rybakowski et al 2001). In linkage studies it may be advantageous to classify
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individuals as 'affected' or 'unaffected' based on SPEM performance, ignoring further
between-subject variance. It may, therefore, be concluded, that different study designs
and research questions require different analysis techniques.
A further problem, however, is that while a number of specific measures have been
proposed, "...no one has definitely offered a compelling taxonomy and scoring method
that has convinced the qualitative "supporters" to adopt a fully quantitative approach"
(Braff 1998; p. 185). Although considerable work has been carried out on the
description of some specific measures, different laboratories continue to differ in their
use of scoring techniques, software packages and specific criteria. Until common
criteria are established which can be implemented objectively across different software
packages and laboratories, researchers will likely continue to disagree. It is, however,
reassuring that the basic finding of SPEM dysfunction in schizophrenia spectrum
individuals has been replicated many times, over almost 100 years, using the multitude
of scoring approaches and criteria described above (Section 2.3.5.1).
2.3.5 Smooth Pursuit Eye Movements in the Schizophrenia Spectrum
2.3.5.1 Behavioural Characterisation of Smooth Pursuit Eye
Movements in Schizophrenia Patients
The finding of 'impaired' SPEM in individuals with schizophrenia is believed to be one of
the most robust in schizophrenia research. Indeed, SPEM abnormalities were judged by
a panel of experts to be amongst the top 18% of most reproducible findings in
schizophrenia research (Tandon 1999). Observations of SPEM abnormalities were
judged as more reproducible than, for example, findings that stimulants such as
amphetamines model schizophrenia, that obstetric complications increase the risk of
schizophrenia or that schizophrenia is characterised by hypofrontality or reduced grey
matter volume (Tandon 1999). Since Holzman et al's (1973) seminal study, there have
been several dozens of replications of this finding. A large number of literature
overviews are available (Abel et al 1992; Arolt et al 1993; Clementz & Sweeney 1990;
Flechtner et al 2000; Holzman 1985, 1992, 2000; Holzman & Levy 1977; Hutton &
Kennard 1998; Lee & Williams 2000; Levin 1984; Levy et al 1993, 1994; MacAvoy &
Bruce 1995; Schwartz & Evans 1999). The rising number of peer-reviewed journal
publications on SPEM in schizophrenia since 1973 (including reviews) parallels the
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steady increase in the research effort into this phenomenon and is depicted in Figure
2.8.
Figure 2.8: Number of Publications in Medline on Smooth Pursuit and Antisaccade
Eye Movements in the Schizophrenia Spectrum since 1973
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Chronicling the research of SPEM in schizophrenia patients over the past 30 years
essentially parallels the development of ever more sophisticated recording and analysis
techniques, as described above (Section 2.3.4). Briefly, the early finding of a qualitative
disturbance of smooth pursuit eye movements in schizophrenia (Holzman et al 1973)
was soon replicated by other research groups (Brezinova & Kendell 1977;
Kuechenmeister et al 1977; Shagass et al 1974). Importantly, this observation could be
replicated irrespective of methodological variations in stimulus display (Cegalis &
Sweeney 1979; Shagass et al 1974) and recording techniques (Iacono & Lykken 1981;
Lindsey et al 1978; Ong & Harman 1979), supporting the notion that SPEM
impairments in schizophrenia are not bound to specific target characteristics and are
not due to recording artefacts.
Research in the following years began to use quantitative measures of pursuit in order
to overcome some of the problems of qualitative ratings, again replicating the early
findings. Thus, when compared to healthy individuals, schizophrenia patients
demonstrated increased frequency of velocity arrests (Holzman et al 1973; Pass et al
1978), increased phase-lag (Ross et al 1996a; Trillenberg et al 1998), increased RMSE
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(Clementz et al 1992; Friedman et al 1995b; Iacono et al 1992; Ross et al 1998c, 1996c;
Sweeney et al 1993) and worse In(S/N) (Grawe & Levander 1995; Levin et al 1981b;
Lindsey et al 1978; Siever et al 1989; Spohn et al 1988).
Improvements in recording techniques and analysis software as well as a better
understanding of the neurophysiology of eye movements, however, now allow a more
precise characterisation of the smooth pursuit deficits in schizophrenia patients. Mainly
since Abel and colleagues' (Abel 1986; Abel & Ziegler 1988) repeated attacks on non-
specific pursuit measures, schizophrenia researchers have adopted specific,
ophthalmologically informed measures. Thus, recent evidence paints the following
picture. When compared to healthy individuals, people with schizophrenia have reduced
pursuit gain (Friedman et al 1991; Levin et al 1988; Radant & Hommer 1992; Schmid-
Burgk et al 1982; Yee et al 1987) as well as increased frequency of saccades during
pursuit. The increase in saccadic frequency is mostly due to the occurrence of
compensatory catch-up saccades (Abel et al 1991; Friedman et al 1991; Hutton et al
1998a; Radant & Hommer 1992; Sweeney et al 1992a); intrusive anticipatory saccades
have also been observed by some (Ross et al1999b, 1999c, 2000, 2001) but not others
(Hutton et al 2000). Frequencies of intrusive square-wave jerks (Campion et al 1992;
Clementz et al 1990; Friedman et al 1992a; Hutton et al 2000; Lencer et al 1999; Levin
et al 1988; Litman et al 1994; Radant & Hommer 1992) and compensatory back-Up
saccades (Lencer et al 1999; Litman et al 1994) are generally not found to be elevated in
the patient group, despite some reports to the contrary (Flechtner et al 1997).
Studies using multiple target velocities have found evidence of greater impairments at
faster velocities (Abel et al 1991; Hutton et al 2001a; Lipton et al 1980a; May 1979;
Pivik 1979b), likely due to increased task difficulty. Other studies, however, have failed
to replicate this effect (Hutton et al 1998a; Sweeney et al 1999). Gender appears to have
no consistent influence on SPEM and differences between schizophrenia patients and
healthy individuals (Iacono et al 1992; Pivik 1979a). SPEM performance worsens with
age, but the differences between schizophrenia patients and healthy individuals appear
to remain (Muir et al 1992; Ross et al 1999a). SPEM deficits in schizophrenia have been
observed in a number of different geographic locations and ethnic groups, indicating
universality of the finding (Allen et al 1990b; Allen 1997; Allen & Johnson 1995).
An early criticism was that SPEM dysfunction in schizophrenia might be due to general
inattentiveness and lack of motivation. While variable motivation is, of course, a
pervasive feature of schizophrenia (Brown & Pluck 2000), experimental studies have
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demonstrated that superficial manipulation of state motivation as well as attentiveness
is unlikely to fully account for the SPEM deficits seen in this disorder. First, incentives
such as money and cigarettes do not appear to improve SPEM performance in
schizophrenia (May 1979). Second, reiteration of instructions during the task does not
lead to significant improvements (Brezinova & Kendell 1977; Holzman et al1974; Pivik
1979a; Shagass et al 1974). Third, presentation of distracting visual and auditory
stimuli (without the requirement of further cognitive processing) does not significantly
impair SPEM in schizophrenia patients (Pass et al 1978). Fourth, Pivik (1979b) could
show that an indirect measure of attentiveness, EEG alpha activity, was not associated
with SPEM dysfunction. Fifth, SPEM impairments in schizophrenia were found to be
comparable across high and low distracting room conditions (Mather et al 1989).
More evidence against an explanation of generalised inattentiveness or lack of
motivation stems from studies of other types of eye movements (Sections 2.4.4.1 and
2.6.4.1) which are often found to be unimpaired in the same patients who display
impaired SPEM (Iacono et al 1981; Levin et al 1982b). Other studies have shown that
patients are in general able and willing to follow complex task instructions, casting
doubt over the assumption that SPEM deficits are due to a failure to understand or
comply with instructions (McDowell & Clementz 1997). Additionally, studies of
psychiatrically and neurologically healthy and, presumably, normally motivated first-
degree relatives as well as healthy and discordant twins suggest that individual
differences in performance levels are mostly due to genetic factors and unlikely to be
related exclusively to state effects of motivation (Section 2.3.5.5.4). Due to the profound
levels of clinical impairments and drug-induced side effects seen in some schizophrenia
patients, however, the possibility cannot be excluded that poor motivation or
inattentiveness accounts for a small proportion of variance in SPEM deficits in
schizophrenia patients, similar probably to other neurocognitive tasks used in
schizophrenia research.
2.3.5.2 Neural and Cognitive Basis of Smooth Pursuit Eye
Movements
2.3.5.2.1 NEURAL SUBSTRATES OF SMOOTH PURSUIT EYE MOVEMENTS
Generation and control of smooth pursuit in humans involves a widespread cortical and
subcortical network. On the basis of evidence from animal lesion, human lesion and
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human functional neuroimaging studies, Leigh and Zee (1999) outlined the following
model, which is acknowledged by others as well (MacAvoy& Bruce 1995).
Visual input from the retina reaches occipital visual areas (striate cortex VI) via the
lateral geniculate body of the thalamus. Further processing of the pursuit stimulus in
extrastriate cortex is mostly localised to V5 (in humans; MT/MST in monkey) and
posterior parietal cortex (PPC). The importance of V5 (MT/MST) in smooth pursuit lies
principally in the processing of motion related information (e.g. velocity and direction),
as indicated by inaccurate saccades to moving targets after lesions to this area
(Newsome et al 1985). PPC appears to be concerned more with the semantic nature of
the target stimulus, suggesting attentional processing capacities. MT/MST and PPC
project directly to the frontal eye fields (FEF), which contain an area (in the inferior
lateral part) selectively involved in pursuit eye movements. FEF, MT/MST and PPC
project to the supplementary eye fields (SEF), which have also been implicated in
pursuit.
Descending projections from these cortical areas (directly or via the nucleus of the optic
tract) are those to pontine nuclei, which in tum project to various site in the
cerebellum. Cerebellar areas involved in pursuit include the posterior vermis, the
paraflocculus, the flocculus and the fastigial oculomotor region.
2.3.5.2.2 NEUROIMAGING STUDIES IN SCHIZOPHRENIA
Only a small number of studies have investigated the neural correlates of SPEM
impairments in schizophrenia patients. Such studies are of importance, as a precise
understanding of the neural structures and networks underlying impaired SPEM in the
patient group would aid the understanding of the effects of a putative gene on the
behavioural deficit.
The only functional neuroimaging study of SPEM in the patient group to date
demonstrated lower glucose metabolism in left and right frontal cortex during a pursuit
task; deficits were more pronounced for patients with negative symptoms (Volkow et al
1987). Restrictions in spatial resolution of Volkow et al's (1987) imaging method,
however, did not allow a more detailed anatomic description of the deficit. Amore recent
study compared functional activation of two groups of schizophrenia patients' first-
degree relatives with impaired and unimpaired performance during pursuit (ODriscoll
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et al 1999}. Differences in cerebral blood flow between the two groups were localised to
the FEF.
Blackwood et al (1994a) observed a relationship between SPEM and cerebral blood flow
in frontal areas, indicating that normal SPEM was associated with reduced blood flow in
bilateral frontal lobe and left anterior and posterior cingulate cortex. SPEM and cerebral
blood flow were measured on different occasions. Blackwood et al (1994a) argued that
this finding indicates the existence of "separate pathological processes" (p. 164).
However, if separate processes were at operation one might expect a zero correlation not
a negative one.
Ross et al (1995) observed correlations between RMSE and glucose utilisation in the
FEF and caudate nucleus. In this study, glucose utilisation was assessed using PET
during an attentional task; SPEM was measured on a separate occasion. Correlations
indicated that worse SPEM was associated with reduced metabolism in the FEF and
increased metabolism in the caudate, consistent with previous observations of
hypofrontality during cognitive tasks (Weinberger et al 2001) and the notion that FEF
damage might at least partially underlie the SPEM impairments seen in schizophrenia
(MacAvoy & Bruce 1995; O'Driscoll et al 1999). However, as glucose metabolism was
not obtained during eye movements in this study it is difficult to evaluate the specificity
of this finding.
Other researchers have studied the structural brain correlates of SPEM abnormalities
in schizophrenia. These investigations are based on the hypothesis that greater brain
structural abnormalities, such as reduced grey matter or increased ventricular volume,
might be associated with greater SPEM impairments, due to effects of illness severity or
a common neurodevelopmental insult. To summarise the key findings, three studies
(Bartfai et al 1985; Blackwood et al1991; Weinberger & Wyatt 1982) obtained evidence
of an association between increased ventricle size and abnormal SPEM. Other studies
failed to obtain significant associations between SPEM and measures of brain structure
(Jacobsen et al 1996; Katsanis et al 1991; Katsanis & Iacono 1991; Siever et al1986),
while two studies obtained evidence of an inverse association between structural brain
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and SPEM abnormalities, suggesting that temporal lobe (Levy et al 1992)11 and
ventricular (Smeraldi et al 1987) abnormalities are associated with normal pursuit.
Unfortunately, most of these investigations suffered serious methodological short-
comings, such as the use of low-resolution brain imaging techniques (Bartfai et al 1985;
Katsanis et al 1991; Siever et al 1986; Smeraldi et al 1987) and non-specific SPEM
(Bartfai et al 1985; Smeraldi et al 1987; Weinberger & Wyatt 1982) and brain structure
(Jacobsen et al 1996; Katsanis et al 1991; Katsanis & Iacono 1991; Siever et al 1986;
Smeraldi et al 1987; Weinberger & Wyatt 1982) analysis methods.
To conclude, three neuroimaging studies (O'Driscoll et al 1999; Ross et al 1995; Volkow
et al 1987) have demonstrated a co-occurrence of functional frontal lobe underactivity
and SPEM dysfunction in the schizophrenia spectrum. However, evidence from a fourth
study (Blackwood et al 1994a) is somewhat incompatible. Concerning the structural
brain correlates of SPEM in schizophrenia, the largely inconsistent findings from
studies with mostly inadequate methods necessitate further research. Future structural
neuroimaging studies of eye movements may benefit from using sensitive eye movement
recording and scoring techniques as well as volumetric measures of anatomically
defined brain areas known to be implicated in schizophrenia and oculomotor control
(Ettinger et al2002).
2.3.5.2.3 EXPERIMENTAL COGNITIVE STUDIES
Attempts at delineating the cognitive basis of the SPEM impairments seen in
schizophrenia have used both experimental manipulations and correlational studies.
The key cognitive processes thought to underlie impaired SPEM in schizophrenia
include attention, motion perception and working memory. and will be discussed in
turn.
A well-established phenomenon is that SPEM accuracy can be improved through a
simple manipulation of the visual target. These manipulations include the attaching of
letters to the target pendulum (Holzman et al 1976; Shagass et al 1976), the
employment of changing letters as targets (Clementz et al 1990; Rosenberg et al 1997c;
Sweeney et al 1994b) and changes in colour (Schlenker et al 1994; Schlenker & Cohen
II Lieberman et al (1993) reported the same relationship in an extension of the sample by Levy et
al (1992).
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1995; Yee et al1998) or other physical properties (Iacono et al 1981, 1982; Van Gelder
et al 1990) of the target during pursuit.
Such target manipulations have ubiquitously been shown to lead to improvements in
SPEM accuracy on a variety of measures, such as gain, RMSE, spectral purity,
anticipatory saccades and catch-up saccade amplitude (but not square-wave jerk
frequency) in samples of schizophrenia patients, their first-degree relatives and healthy
individuals (Clementz et al 1990; Holzman et al 1976; Rosenberg et al 1997c; Schlenker
et al1994; Shagass et al1976; Sweeney et al1994a, 1994b; Van Gelder et al1990; Yee
et al 1998). It is important to note that some - but not all - studies have required
participants to count the frequency of changes in target characteristics or respond to
them with button presses. Improvements in SPEM accuracy are, therefore, achieved
despite the introduction of a secondary task.
Importantly, statistical differences between schizophrenia patients and healthy controls
become smaller but generally persist during target manipulation (although Rosenberg et
al, 1997c, found that differences between first-degree relatives and controls were
abolished) and return to original magnitude after the removal of the attention-
facilitation condition, thus excluding the possibility of practice effects (Holzman et al
1976; Rosenberg et al 1997c; Yee et al 1998). Additionally, participants appear to be
unaware of their subtle improvements in SPEM accuracy during target manipulation,
suggesting automatic rather than voluntary processes (Van Gelder et al 1990).
While scientists, therefore, agree on the effectiveness of these manipulations in
improving pursuit accuracy, it is less clear how these improvements come about. The
most reasonable hypothesis appears to be that changes in the target characteristic lead
to improved attentional processing of the target, thereby 'locking' the eye more closely
on the target and improving smooth pursuit accuracy. A link between smooth pursuit
and attention has been suggested: Schwartz et al (2001) argued that people with
schizophrenia have particular problems with attentional tasks involving the integration
of temporal and spatial information, such as smooth pursuit eye movements. This
finding, although its precise mechanisms are not well understood, suggests that the
SPEM impairments seen in schizophrenia might be at least partly due to attentional
deficits. Kathmann et al (1999) argued that SPEM might be executed in an automatic,
rather than controlled, mode of attention. This assumption was based on the failure to
obtain a dose-dependent reduction in SPEM accuracy with the introduction of tasks
with low and high attentional requirements (Kathmann et al 1999).
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A hint regarding the neural substrate of a putative attentional effect comes from animal
studies. These studies have shown that posterior parietal cortex is particularly involved
in processing the nature of the visual target during pursuit (Lynch et al 1977). It is a
possibility, therefore, that relatively intact posterior parietal processing during pursuit
of an attention-demanding target in people with schizophrenia partially compensates for
SPEM deficits due to lesions in other (e.g. frontal) areas.
Other studies have linked smooth pursuit impairments in schizophrenia to deficits in
motion processing. Stuve et al (1997) reported a relationship between motion processing
and SPEM, which could not be accounted for by deficits in sustained attention. Their
motion perception test required participants to detect the direction of movement of a
sample of dots within a large cluster of stationary dots. Chen et al (1999a, 1999c)
demonstrated further that deficits in motion perception in schizophrenia were not due
to deficient sensitivities for orientation discrimination or contrast detection and were
selectively correlated with measures of open- and closed-loop pursuit gain but not
saccadic frequency or qualitative ratings of pursuit.
As damage to cortical motion-processing areas (MT/MST; V5) may result in reduced
pursuit accuracy (Newsome et al 1985), it has been speculated that SPEM impairments
in schizophrenia might be related to disturbed motion processing and abnormalities in
relevant cortical areas (Chen et al 1999a; Stuve et al 1997). While this hypothesis is
promising, a recent functional neuroimaging study failed to find an association between
abnormalities in V5 activation and SPEM impairments in relatives of schizophrenia
patients (O'Driscoll et al 1999).
Thaker and colleagues demonstrated that SPEM impairments in schizophrenia patients
(Thaker et al 1999) as well as their first-degree relatives (Thaker et al 1998) might be
due to deficits in the predictive mechanism of pursuit. As these researchers argued, the
brain has two sources of information on target motion available during smooth pursuit:
first, retinal slip [i.e, the difference in target and eye velocity), and second, an internal
representation of past target motion. The former may be expected to lead to a 'reflexive'
response; the latter results in a predictive response. In Thaker et al's (1998, 1999)
studies the pursuit target was blanked out temporarily (for about 500ms). During this
interval, slow pursuit eye movements are generated by the stored representation of
target movement, in other words based on predictive pursuit to extra-retinal motion
signals. Patients' gain, as well as their relatives', was particularly impaired under this
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condition, even at slow target velocities where gain to a regular (physical) pursuit target
was normal.
The generation of a predictive (pursuit) response relying on stored information from past
target motion resembles some conceptualisations of working memory (Abel 1999;
Thaker et al 1999). Relatedly, an inability to keep information on-line has been argued
to be one of the core cognitive deficits in schizophrenia, related to prefrontal
dysfunction (Goldman-Rakic 1999). Thus, it may be speculated that at least some of the
SPEM impairments seen in schizophrenia might be due to working memory deficits (see
also Section 2.3.5.2.4 on neuropsychological tests of working memory). Further
evidence for this hypothesis comes from studies of healthy individuals, which have
demonstrated that blocking working memory capacity (e.g. through arithmetic tasks,
such as subtracting series of 7s or 13s from 200), but not simple distraction, impairs
smooth pursuit (Acker & Toone 1978; Brezinova & Kendell 1977; Pass et al 1978).
However, these early studies used non-specific SPEM analyses and, therefore, require
replication. One working memory task that has not been used in schizophrenia SPEM
studies is the n-back task. Itwould be valuable to use this well-established measure of
working memory during predictive and non-predictive components of pursuit.
To conclude, the cognitive basis of SPEM impairments in schizophrenia is not entirely
clear. While some evidence points to an involvement of attentional processes, other
studies favour motion processing or working memory. The possible neural correlates of
these proposed deficits implicate frontal and parietal sites. Most likely smooth pursuit
tracking is a multivariate process, requiring all of these processes to different degrees.
2.3.5.2.4 NEUROPSYCHOLOGICAL STUDIES
In a second main approach to studying the cognitive and neural components of smooth
pursuit impairments in schizophrenia, scientists have examined the pattern of
correlations between SPEM measures and clinical neuropsychological tests.
Neuropsychological tests have the advantage of being standardised using normative
samples, thus allowing comparisons with the general population; tapping well-
established psychological and cognitive processes, thus providing a lingua franca to
interpret oculomotor deficits in psychological terms; and being sensitive to fairly
localised brain damage, thus allowing attempts to pinpoint the cortical/subcortical
correlates of oculomotor dysfunction (Lezak 1983).
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The pattern of correlations between SPEM and neuropsychological tests is not entirely
consistent, partly due to differences across studies in SPEM analysis methods and
sample characteristics such as disease chronicity and drug treatment. The bulk of the
research has focussed on two aspects of cognition, namely 'frontal lobe tests' and
attentional tests.
A first conclusion from the evidence to date may be that smooth pursuit performance is
modestly related to neuropsychological tests sensitive to frontal lobe function. The tests
that have been studied most often are the Wisconsin Card Sorting Test (WeST),
measuring set shifting, working memory and executive function; the Trail Making Test A
(TMT-A),measuring psychomotor coordination and motor speed and the Trail Making
Test B (TMT-B),measuring the ability to shift strategy, visuospatial working memory
and visual sequencing; and the finger tapping test, measuring motor speed.
Correlations with WeST (Grawe & Levander 1995; Litman et al 1991; Schlenker et al
1994), TMT (Bartfai et al1985; Grawe & Levander 1995) and finger tapping (Bartfai et al
1985; Grawe & Levander 1995) have been observed on more than one occasion. Radant
et al (1997) observed these correlations only for predictive but not regular pursuit.
Other studies, however, failed to find a correlation between WeST and SPEM (Friedman
et al1995b; Gambini & Scarone 1992; Nkam et al2001; Tien et alI996). Interestingly,
three of the studies showing no relationship as well as the study by Radant et al (1997)
used specific pursuit measures such as gain and frequency of saccades, whereas two of
three studies showing a relationship (Grawe & Levander 1995; Katsanis & Iacono 1991)
used global pursuit measures, suggesting effects of poor measurement in some of the
studies showing a relationship between WCST and SPEM disturbance.
In one of the most comprehensive examinations to date, Katsanis and Iacono (1991)
assessed correlations between RMSE and WCST, verbal fluency, auditory verbal
learning, the Benton memory test, TMT, finger tapping and the Wechsler Adult
Intelligence Scale (WAIS;Wechsler 1981). The pattern and magnitudes of the observed
correlations indicated that tests sensitive to frontal lobe function were better predictors
of SPEM performance than measures of temporal lobe (e.g. auditory verbal learning)
and global function.
Additionally, SPEM measures were found to be correlated with Necker cube reversals
(Bartfai et al 1985), word fluency (Friedman et al 1995b) and delayed response task
performance (Snitz et al 1999), further supporting the notion of frontal involvement.
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The second main focus of neuropsychological research has concerned tests of attention,
in particular the Continuous Performance Test (CPT).The interest in tests of attention
stems from the early findings of an involvement of attentional components in smooth
pursuit (Section 2.3.5.2.3). The CPT involves the serial presentation of visual stimuli
(e.g. digits) for very brief durations (e.g. 50ms). The participant's task is to respond (e.g.
through a button press) to the rare presentation of a target stimulus (e.g. a certain digit,
or sequence of digits). Given the visual attentional demands of this and the pursuit
tasks, correlations may be expected. The evidence, however, is fairly inconclusive.
Roitman et al (1997) reported a modest correlation between CPT and RMSE in male
chronic schizophrenia patients. Van den Bosch (1984) found inconsistent correlations
between RMSE and CPT in patients and controls. Three studies have failed to find a
significant relationship in patients and controls (Siever et al 1982; Stuve et al 1997) as
well as in first-degree relatives of schizophrenia patients (Keefeet a11997).
To conclude, the evidence linking performance on the smooth pursuit task and
neuropsychological tests is not entirely consistent, but provides modest support for a
frontal lobe involvement in SPEM. This literature is characterised by failures to
replicate, probably partly due to differences in SPEM analysis methods as well as small
samples (Bartfai et al 1985; Litman et al 1991; Stuve et al 1997). Replication studies
are clearly needed, utilising larger samples and comprehensive neuropsychological test
batteries. One mistake made in some studies (e.g. Bartfai et al 1985) was to use only
tests sensitive to frontal lobe function, thereby failing to provide evidence of the
discriminant validity of the relationship between these tests and SPEM performance,
akin to 'searching under the lamppost'.
2.3.5.2.5 NEURAL CORRELATES - CONCLUSION
The smooth pursuit performance patterns of schizophrenia patients appear to indicate
two deficits: first, reduced gain and increased frequency of compensatory catch-Up
saccades; and second, increased frequency of intrusive anticipatory saccades (MacAvoy
& Bruce 1995). In an attempt to integrate the review of the neural and cognitive
correlates of SPEM in schizophrenia and healthy individuals, several lines of evidence
appear to suggest that the fronta1lobe may be the source of both types of impairments
(Calkins & Iacono 2000; Levin 1984; MacAvoy& Bruce 1995).
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First, MacAvoy and Bruce (1995), in a comparison of animal lesion and schizophrenia
patient studies, came to the conclusion that pontine or cerebellar lesions are unlikely to
account for the specific impairments seen in schizophrenia. Impairments seen in
laboratory animals after lesions to these areas tend to be qualitatively different and
more severe. MacAvoy and Bruce (1995) argued that FEF lesions in monkeys best
mimic the pattern of SPEM impairments in schizophrenia, including reduced gain and
increased frequency of compensatory catch-up saccades as well as somewhat increased
frequency of intrusive saccades.
Second, a frontal lobe involvement in SPEM impairments in schizophrenia is modestly
supported by evidence from functional neuroimaging and neuropsychological studies.
Third, a number of studies have indicated that the vestibulo-ocular reflex (VOR;fixating
eyes on a stationary target while rotating the head) and the nystagmus response are
relatively unimpaired in schizophrenia, suggesting intact midbrain and brains tern eye
movement areas (Latham et al 1981; Levin 1983; Levy et al 1978, 1983a; Lipton et al
1980b).
Third, PPC recruitment during smooth pursuit in schizophrenia patients may be argued
to be relatively intact, given the normal improvements due to attentional facilitation.
More evidence suggesting that parietal areas recruited during pursuit are intact came
from a study of the optokinetic reflex (OKR; Hutton et al 2000). Smooth pursuit of a
target moving across a (randomly) structured background invokes the OKR, which, if
incompletely inhibited, results in reduced smooth pursuit accuracy. Hutton et al (2000)
observed similar reductions in pursuit accuracy in schizophrenia patients and healthy
individuals during pursuit of a target over a structured background. This finding
suggests similarly incomplete inhibition of OKR in both groups, pointing to relatively
intact inferior parietal cortex in schizophrenia.
Fourth, deficits in motion and velocity sensitive areas (MT/MST, VS) in schizophrenia
remain debated. Although there is evidence for an association between motion
processing and SPEM deficits (Chen et al 1999a, 1999c; Stuve et al 1997), studies of
step-ramp tasks have shown that damage to MT/MST should lead to inaccurate
saccades to moving targets (Newsome et al 1985). A number of studies have
demonstrated accurate saccades to moving targets in schizophrenia (Clementz 1996a;
Sweeney et al 1999; Thaker et al 1996b). More damagingly to this hypothesis, Newsome
et al (1985) also observed normal steady-state pursuit after lesions to MT/ MST. This
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pattern of findings strongly argues that MT/MST/V5 damage alone cannot produce the
SPEM deficits seen in schizophrenia. Additionally, O'Driscoll et al (1999) did not find
evidence of V5 underactivation during pursuit in poorly performing relatives of
schizophrenia patients.
Fifth, a particularly important role of the FEF (relative to other cortical areas) in
predictive pursuit has been described (Leigh & Zee 1999; MacAvoy & Bruce 1995).
Significant impairments in predictive pursuit in schizophrenia (Thaker et al 1998, 1999)
are in agreement with FEF dysfunction.
Finally, Levin (1984) suggested that SPEM deficits in schizophrenia might be largely due
to saccadic disinhibition. Levin argued that the failure to suppress saccades during
pursuit likely originates in dysfunctional frontal areas.
An important distinction, however, concerns that between the two different parts of the
FEF related to saccades and smooth pursuit, respectively (Berman et al 1999). Given
this distinction it is important to note that some frontal lobe hypotheses of SPEM
dysfunction in schizophrenia point to the saccadic FEF, such as the increase in
intrusive saccades during pursuit (Levin 1984), whereas others emphasise the smooth
pursuit FEF (Sweeney et al 1998a).
2.3.5.3 Clinical Correlates
A number of possible clinical correlates of SPEM dysfunction in schizophrenia have to
be considered. First, relationships between SPEM and severity of clinical symptom
dimensions have been addressed in a large number of investigations. Relatedly,
differences between acutely ill and remitted (asymptomatic) patients have been
addressed. Second, variables such as duration of illness, number of hospitalisations
and time spent in psychiatric hospitals have been investigated in relation to smooth
pursuit performance. Finally, a small number of studies have examined the relationship
between SPEM and neurological soft signs.
Two key findings concerning the symptom correlates of SPEM emerge from a review of
relevant studies. First, a relationship between SPEM and negative symptoms has been
reported on several occasions. This relationship was most clearly articulated by Ross
(2000). Second, however, a recent conjecture (Lee& Williams 2000) and evidence (Leeet
al 2001) suggest that SPEM dysfunction might be associated specifically with the
symptom dimension of thought disorder. As outlined in Section 1.2, schizophrenic
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symptoms tend to fall into positive and negative dimensions, with thought disorder
being one facet of the positive dimension. The two hypotheses by Ross (2000) and Lee
and Williams (2000) are thus conflicting, which may be explained in methodological
terms, as outlined below.
A number of researchers have observed a relationship between SPEM and negative
symptoms, using global as well as specific smooth pursuit measures and symptom
scales such as the Schedule for the Assessment of Negative Symptoms (SANS;
Andreasen 1984) or the Brief Psychiatric Rating Scale (BPRS) (Blackwood et al 1991;
Ciuffreda et al1994; Katsanis & Iacono 1991; Matsue et al 1993; Roitman et al 1997;
Sweeney et al 1992a, 1994a). These reports contrast with other studies reporting an
absence of this relationship using similar measures and scales (Cegalis & Sweeney
1979; Flechtner et al1997, 2002; Gooding et al1994; Kelly et al 1990; King et al1999;
Litman et al 1997; Rosenberg et al 1996; Schlenker et al 1994).
A relationship between negative symptoms and SPEM disturbance may be integrated
with the putative frontal lobe involvement in both (Kellyet al 1990; Volkow et al 1987).
Ross et al (1996b) argued that the expected relationship has not been observed
consistently as less than optimal measures of negative symptoms have been used. One
scale that has been used particularly often is the SANS.This scale assesses primary as
well as secondary negative symptoms, thereby introducing confounding variance due to
effects of medication or hospitalisation. Ross et al (1996b) suggested instead focussing
on primary and enduring negative symptoms. These symptoms are referred to as the
deficit syndrome and have been argued to occur in a significant proportion of
schizophrenia patients (Carpenter et al 1999).
In agreement with this hypothesis, Ross et al (1996b) observed a relationship between
specific SPEM measures and a diagnosis of the deficit syndrome. This relationship was
replicated and extended by Ross et al (1997) in a larger sample of patients, including
some of the 1996 study. A relationship between SPEM dysfunction and the deficit
syndrome had been observed in an earlier study by the same group (Thaker et al 1989a)
and was recently independently replicated (Malaspina et al 2002). Nkam et al (2001),
however, observed only a weak, non-significant relationship.
Ross (2000) argued that the co-occurrence of SPEM dysfunction and the deficit
syndrome may represent a homogenous subtype of schizophrenia, possibly indicating a
shared genetic basis. This hypothesis was based on the observed relationship between
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the two deficits, as well as similarities in their familial patterns of occurrence, their
status as trait markers and their neural and cognitive correlates. Wolff and O'Driscoll
(1999) arrived at a similar conclusion in a review of motor abnormalities in the
schizophrenia spectrum. These authors suggested the existence of a "triad" (p. 309) of
negative symptoms, cognitive deficits and motor abnormalities including, but not
restricted to, smooth pursuit eye movements. Further evidence for the pervasiveness of
this constellation of signs comes from studies demonstrating a relationship between
SPEM and subclinical negative features of schizotypy in healthy individuals (see Section
2.3.5.5.6).
Somewhat conflicting with the deficit syndrome hypothesis, however, a small number of
studies have observed a relationship between SPEM and the positive symptom category
of thought disorder (Keefe et al 1989; Lee et al 2001; Solomon et al 1987; Tien et al
1996).
Lee et al (2001), in the most comprehensive investigation so far, factor analysed
symptom scores from 78 schizophrenia patients, obtaining factors of Unreality,
Disorganisation and Psychomotor Poverty. A robust relationship with SPEM was
observed only for the Disorganisation dimension. Lee et al (2001) argued that
disorganisation symptoms (tapping thought disorder) might be central to the
pathophysiology of schizophrenia.
Difficulties in reconciling the hypotheses by Ross (2000) and Lee and Williams (2000)
may be at least partly due to methodological reasons. The majority of the studies
reviewed here have used small sample sizes (N<30); large samples are needed to reliably
address individual differences in neurocognitive measures (Detterman 1989). Further,
studies are often difficult to compare due to differences in sample composition, utilising
first-episode, chronic or mixed samples. Additionally, antipsychotic treatment might be
at least partly blamed for inconsistencies as well as systematic failures to observe
relationships. It is well known that typical antipsychotic treatment alleviates positive
symptoms to a greater extent than negative symptoms (Leonard 1997). It is, therefore, a
possibility that relationships between temporally stable measures of SPEM and
temporally fluctuating measures of positive symptoms cannot be detected in samples of
largely typically medicated patients (Anastasi & Urbina 1997). Finally, no previous
study has combined designated measures of the deficit syndrome and of thought
disorder in one investigation, allowing a direct comparison of the magnitude of each
measure's correlations with SPEM.
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A number of other clinical factors merit consideration. First, evidence suggests that
SPEM abnormalities are observed in remitted and asymptomatic as well as acutely ill
patients (Arolt et al 1998; Bartfai et al 1985; Iacono et al 1981; Muir et al 1992;
Salzman et al 1978), suggesting they are not an epiphenomenon of acute symptom
levels. Second, a small number of studies have compared SPEM performance across
different subtypes of schizophrenia, such as paranoid/non-paranoid, hebephrenic and
disorganised, and have obtained no significant differences (Campion et al 1992;
Holzman et al 1974). Third, there appear to be no strong relationships between SPEM
and number and duration of hospitalisations, duration of illness, or age of onset
(Flechtner et al 1997,2002; Katsanis & Iacono 1991; Kelly et al 1990; King et al 1999;
Schlenker et al 1994; Sweeney et al 1994b), although some studies have found worse
SPEM in patients with later age of onset (Bartfai et al 1983; Siever et al 1986; Sweeney
et al 1994a), longer durations of illness (Litman et al 1997) and more frequent or longer
hospitalisations (Bartfai et al 1985; Keefe et al 1989). However, most of these studies
were not designed and powered to detect effects of disease chronicity; large-scale
longitudinal studies are required to systematically address this issue.
Finally, only relatively little evidence has been obtained regarding relationships between
SPEM and neurological soft signs (NSS). NSS constitute motor and neurocognitive
abnormalities detected in a neurological examination and have been shown to be
abundant in schizophrenia patients and their relatives (Wolff& ODriscoll 1999). As
Ross et al (1998b) have pointed out, it is surprising that the two research areas of NSS
and SPEM have been carried out virtually in parallel over the past decades, given the
evidence of general motor deficits in schizophrenia (Wolff& ODriscoll 1999).
Schlenker et al (1994) reported associations between SPEM and 'sensory integration',
'motor coordination', 'sequencing of complex motor acts' and other subcomponents of
NSS. Ross et al (1998b) observed a relationship with 'sensory integration' but not the
other components from the Schlenker et al (1994) study, thus replicating an
observation in healthy individuals (Siever et al 1989). Clearly, more research is needed
to clarify the NSS correlates of SPEM dysfunction in schizophrenia patients.
To summarise the clinical correlates of smooth pursuit dysfunction in schizophrenia,
the most common symptom correlates appear to be those of negative symptoms (or the
deficit syndrome) and thought disorder (or the disorganisation syndrome). At present,
the literature is inconsistent as to which of these symptom dimensions represents the
more reliable correlate. SPEM dysfunction appears not to be a mere epiphenomenon of
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illness state, as studies of acute and remitted patients have demonstrated. It remains to
be investigated whether SPEM impairments become more pronounced with more
frequent hospitalisations, i.e. with a chronic course of the disease. Future studies might
also aim to confirm the link between SPEM and soft neurological motor abnormalities
as well as the negative or disorganised symptom dimensions.
2.3.5.4 Pharmacology
2.3.5.4.1 TREATMENT EFFECTS
Treatment effects in schizophrenia research are ubiquitous and merit careful evaluation
in research (Spohn & Strauss 1989). Given the widespread use of pharmacological
agents in the treatment of schizophrenia, a large number of studies have investigated
the effects of these drugs on clinical symptoms, behaviour, cognition and biological
markers, including the smooth pursuit task.
The very early schizophrenia eye movement studies are sometimes quoted as evidence
that SPEM dysfunction in this patient group "is not merely a motor side effect of
neuroleptic or other antipsychotic medications" (Levin 1983; p. 37). However, patients
in the early studies were treated with other drugs such as tranquillizers and
barbiturates, some of which are known to disrupt SPEM (Holzman et alI975).
Holzman and colleagues as well as others established that short-, medium- and long-
term typical neuroleptic treatment is not associated with SPEM abnormalities in
schizophrenia patients. This conclusion stems from a multitude of designs, including
correlations between drug dose levels and SPEM (Flechtner et al 2002; Schlenker et al
1994; Spohn et al 1985; Thaker et al 1989a), comparisons of treated and untreated
patients (Friedman et al 1992a; Holzman et al 1974; Karson 1979; Litman et al 1989;
Shagass et al 1974; Siever et al 1986; Thaker et al 1999), studies of never-medicated
patients (Campion et al 1992; Hutton et al 1998a; Sweeney et al 1999) and longitudinal
studies of treatment and drug withdrawal effects (Campion et al 1992; Flechtner et al
2002; Gooding et al 1994; Levy et al 1983b; Rosenberg et al 1996; Schlenker & Cohen
1995; Shagass et al1974; Siever et al1986; Spohn et al1988; Sweeney et al 1998a).
However, there are also findings indicating the existence of drug effects. Two studies
using longitudinal designs have found that clozapine (but not typical antipsychotics or
placebo) exacerbates quantitative SPEM measures over treatment intervals of several
weeks (Friedman et al 1992b; Litman et al 1994). Rea et al (1989) found that after one
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month of antipsychotic treatment the number of small saccades during pursuit
increased, while the number of large AS decreased; the magnitude of this decrease was
associated with neuroleptic dosage. Hutton et al (2001a) observed that long- but not
short-term treatment led to reduced pursuit gain. Sweeney et al (1994b) found that
antipsychotic treatment led to improvements in some SPEM measures. Bartfai et al
(1983, 1985) showed that previously treated patients had significantly impaired SPEM
compared to patients without previous treatment. It is, however, possible that in the
Bartfai et al studies previous treatment was confounded with longer duration of illness
or number of psychotic episodes.
It has also been demonstrated that treatment with clinical doses of lithium improves
symptoms of bipolar psychosis patients but impairs their smooth pursuit, leading to
qualitative abnormalities, reduced gain and increased saccadic frequency (Holzman et
al 1991; Iacono et al 1982; Levy et al 1985), although one study did not find this effect
(Gooding et al 1993).
Another drug effect that has received attention concerns tardive dyskinesia (TO).TO is a
syndrome characterised by abnormal, involuntary movements, thought to be caused by
long-term treatment with typical antipsychotic agents (Leonard 1997). As its
pathophysiology is likely to involve dopaminergic neurons in the basal ganglia, TO could
affect the neural control of any motor system.
Worse SPEM in patients with TO was reported by a number of investigators, in line with
the expected disruption of motor systems (Oepen et al 1990; Spohn et al 1988; Thaker
et al 1989a). However, a later replication failed (Ross et alI998a). These authors argued
that earlier studies might have found effects of TO because they employed the EOG
recording technique, allowing for artefacts of face muscle activity to yield an 'abnormal'
pattern of pursuit.
Another important issue concerning the pharmacology of eye movements in
schizophrenia is the role of nicotine. People with schizophrenia have a prevalence rate
of smoking of between 74% and 92% compared to 30% to 35% of the general population
and take in more nicotine from cigarettes than non-schizophrenic individuals (Olincy et
al 1997). Interestingly, the a7 nicotinic receptor subunit has been implicated as a
genetic marker of schizophrenia (Freedman et alI994).
Experimental findings regarding the effects of smoking on SPEM are inconsistent.
Olincy et al (1998) found that cigarette smoking acutely improved SPEM abnormalities
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in schizophrenia patients, but had no effect on healthy controls. Domino et al (1997)
found that smoking slightly improved SPEM in healthy individuals. Two studies (Sibony
et al 1988; Thaker et al 1991) observed increases in square-wave jerk rate during SPEM
after smoking. Additionally, it has been shown that nicotine can induce nystagmus
(Pereira et al 2001); how this is related to SPEM remains to be investigated.
Other agents acting on the cholinergic system have not been explored systematically.
Schizophrenia patients with extrapyramidal side effects are often prescribed
anticholinergic drugs, such as procyclidine (Leonard 1997); the effects of procyclidine
on smooth pursuit in people with schizophrenia have not been addressed.
To conclude, the bulk of the literature suggests that the robust SPEM impairments seen
in schizophrenia are unlikely to be entirely due to medium- or long-term treatment with
typical antipsychotic drugs. While some deleterious effects on SPEM have been
demonstrated, allowing for the possibility of a further exacerbation of SPEM with long-
term treatment, the evidence from studies of never-medicated patients is conclusive.
The question of whether TD contributes to SPEM abnormalities needs to be addressed
further using infrared light oculographic recording techniques. Finally, the effects of
atypical antipsychotics, especially the newer ones, have not been studied intensively.
2.3.5.4.2 EFFECTS OF PHARMACOLOGICAL MANIPULATION IN HEALTHY INDIVIDUALS
A number of pharmacological compounds interfere with the control of smooth pursuit
eye movements when administered to healthy individuals. The most relevant to the
present discussion are drugs frequently administered to schizophrenia patients.
Given the widespread treatment of schizophrenia patients with typical antipsychotics, it
was examined early whether these drugs could affect SPEM in healthy volunteers.
Holzman et al (1975) demonstrated no effect of chlorpromazine (but of barbiturates) on
SPEM; Lynch et al (1997) similarly did not observe significant effects of haloperidol. In
contrast, King (1994) reported that haloperidol dose-dependently impaired SPEM;
Malaspina et al (1994b) similarly showed disrupted SPEM after haloperidol (but not
amphetamine) administration.
These inconsistencies need to be resolved in future studies. However, the relevance of
these studies to the validity of SPEM as a schizophrenia endophenotype has to be
questioned. First, these studies used individuals without schizophrenia; drug effects in
these individuals may be very different from those in patients with schizophrenia.
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Second, effects of acute administration might be significantly different from those of
medium- or long-term treatment with antipsychotics.
More consistent evidence concerns the effects of benzodiazepines, suggesting that SPEM
is reliably interrupted by administration of this sedative (Green et al 2000; Iwata et al
1999; Lynch et al 1997; Masson et al 2000; Norris 1971; Roy-Byrne et al 1993). This
finding suggests the necessity to examine the effects of benzodiazepines in
schizophrenia patients and the role of this compound in between-group differences.
Lithium does not appear to impair pursuit in healthy individuals (Flechtner et al 1992).
2.3.5.5 Validity as Endophenotype
2.3.5.5.1 HERITABILITY
Studies of healthy, reared-together twins have been carried out in order to assess the
heritability of smooth pursuit performance. Given the small number of these studies,
and the importance of demonstrating heritability in the validation of an endophenotype,
these studies will be discussed individually.
Identical (monozygotic) twins are genetically identical; fraternal (dizygotic) twins share
on average 50% of their genes. Therefore, comparing within-twin pair correlations for a
quantitative biobehavioural measure between monozygotic and dizygotic twins will
indicate the amount of variance in the measure accounted for by genetic and (shared or
non-shared) environmental factors (Plomin et al 2000).
In the first investigation of SPEM in healthy twins, Iacono and Lykken (1979a, 1979b)
observed correlations for RMSE in 32 pairs of monozygotic (MZ)twins ranging between
0.49 and 0.65. Iacono (1982) later extended this sample, adding 24 pairs of dizygotic
(DZ) twins. Within-twin pair correlations were higher for MZ than for DZ twins,
indicating substantial heritability.
Bell et al (1994) investigated smooth pursuit gain in eight pairs of MZ twins and found
within-pair intraclass correlations (ICC) ranging from 0.91 and 0.98. However, the
study used a small sample size and no DZ twins. In an extension of this sample
including dizygotic twins Blekher et al (1997) observed low ICC in dizygotic twins,
suggesting that SPEM is under influence of multiple genes and/or common
environmental influences. Litman et a1 (1997) reported ICC in MZ twins for SPEM gain
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and frequency of saccades of 0.60 and 0.68, respectively, but did not include a group of
healthy DZ twins.
In the most comprehensive investigation to date, Katsanis et al (2000) examined global
as well as specific SPEM measures in 64 MZand 48 DZ adolescent (11 and 17 year old)
twin pairs. With two exceptions, correlations between SPEM measures were
substantially higher for MZ twins than DZ twins. In an examination of the specific
influences of genetic and environmental causes of variance it was found that SPEM
variance was accounted for by roughly equal shares of additive genetic and non-shared
environmental factors.
It may be concluded from these studies that SPEM performance is largely heritable,
although environmental factors also influence individual differences in performance. As
most studies have used relatively small sample sizes, and few have compared
monozygotic and dizygotic twins, future studies employing large samples of monozygotic
and dizygotic twin pairs are needed.
2.3.5.5.2 TEMPORAL STABIUTY
A number of studies have investigated the key criterion of temporal stability of SPEM
performance. These studies have indicated that performance is relatively stable in
schizophrenia patients and healthy controls over time intervals ranging from one week
to two years, with most correlation coefficients ranging between about 0.5 and 0.9
(Campion et al 1992; Gooding et al 1994; Holzman et al 1973; Iacono & Lykken 1981;
Kufferle et al 1990; Rea et al 1989; Roy-Byrne et al 1995; Schlenker & Cohen 1995;
Shagass et al 1974; van den Bosch & Rozendaal1988; Yee et al1998).
Importantly, this moderate-to-good temporal stability has been demonstrated using all
available SPEM measures, including global qualitative and quantitative measures,
velocity arrests, gain, as well as frequency of saccades. The magnitude of reliability
coefficients appears to be unaffected by the length of the time interval between test and
retest. Additionally, performance is relatively stable irrespective of sample
characteristics, as studies of first-episode (Gooding et al 1994; Yee et al 1998) as well as
chronic (Campion et al 1992; Schlenker & Cohen 1995) patients have demonstrated.
Importantly, a number of studies have demonstrated reliable performance despite
changes in medication status and levels of symptom severity between first and second
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assessment (Campion et al 1992; Kufferle et al 1990; Rea et al 1989; Schlenker &
Cohen 1995).
Related evidence of the trait nature of SPEM deficits concerns the lack of significant
improvements in SPEM performance levels between first and second assessment,
irrespective of changes in treatment status and reductions in symptom levels (Campion
et al 1992; Gooding et al 1994; Kufferle et al 1990; Levy et al 1983b; Rea et al 1989;
Schlenker & Cohen 1995; Shagass et al 1974).
Taken together, these findings indicate that SPEM performance is relatively stable over
time. Despite the likely influence of state measures (as indexed by the less than perfect
correlations), SPEM deficits in schizophrenia may not be considered a mere
epiphenomenon of clinical state.
2.3.5.5.3 SPECIFICITY TO SCHIZOPHRENIA
Smooth pursuit deficits are not specific to the schizophrenia spectrum. Impaired
smooth pursuit has been observed in a number of neurological and psychiatric
conditions, including cocaine addiction (Rosse et al 1992b), in particular with a
paternal history of alcoholism (Bauer 1997), Pick's disease (Hutton et al 1987), dyslexia
in children (Eden et al 1994), progressive supranuclear palsy (Vidailhet et al 1994),
Alzheimer's disease (Zaccara et al 1992), Parkinson's disease (Lekwuwa et al 1999;
Rottach et al 1996), Huntington's disease (Collewijn et al 1988), anorexia nervosa
(Pallanti et al 1998), in HIV-l seropositive individuals (even before onset of overt
symptoms of the AIDS Dementia Complex) (Sweeney et al 1991) and in university
students with a childhood history of emotional and physical abuse (Irwin et al 1999).
The existence of SPEM impairments in obsessive-compulsive disorder (OCD)is unclear,
with some studies obtaining deficits (Gambini et al 1993a; Pallanti et al 1996; Sweeney
et al 1992b) but others not (Farber et al 1997; Nickoloff et al 1991). It appears that
individuals with OCD have impairments particularly at faster target velocities (Clementz
et al 1996a). Adults or children with ADHDgenerally appear not to have impaired SPEM
(Castellanos et al 2000; Jacobsen et al 1996; Ross et al 2000).
Deficits in these widely different neuropsychiatric conditions have most commonly been
attributed to damage to cortical and subcortical areas involved in smooth pursuit, in
particular FEF and basal ganglia.
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The most relevant patient group in which to examine the proposed specificity of SPEM
dysfunction to schizophrenia, however, is that of affective disorder. This disorder,
particularly in combination with psychotic features, has been argued to be related to
schizophrenia at genetic, biological and clinical levels (Berrettini 2000a, 2000b; Maier et
al 1999). Given the proposed nature of the SPEM task as a schizophrenia
endophenotype, therefore, a number of studies have aimed to examine the putative
specificity of SPEM deficits. Evidence from these studies is mixed. Although some
studies have found SPEM deficits to be relatively specific to schizophrenia (Diefendorf &
Dodge 1908; Friedman et al 1995a; Iacono et al 1992; Muir et al 1992; Tien et al 1996),
others have observed impairments similar in kind and magnitude in (unipolar and
bipolar) affective disorder and schizophrenia (Amador et al 1991, 1995; Couch & Fox
1934; Friedman et al 1992a; Iacono & Koenig 1983; Kufferle et al 1990; Lipton et al
1980b; Shagass et al1974; Sweeney et al1999; van den Bosch 1984).
More positive evidence of specificity, however, has been obtained in some studies
showing similar performance levels of schizophrenia and affective disorder patients on
certain measures (e.g. gain) but worse performance in schizophrenia patients on other
measures (e.g. catch-up saccade rate; Abel et al1991; Flechtner et al1997; Sweeneyet
alI994a).
A number of explanations have been offered for the observation of SPEM impairments
in affective disorder, in particular bipolar patients. First, it has been shown that SPEM
impairments in affective disorder might be state-related and affected by treatment.
Malaspina et al (1994a) showed that SPEM dysfunction in major depression improved
with ECT treatment. Other studies have shown that lithium salts, which are commonly
used in the treatment of bipolar patients, impair SPEM in this patient group (Holzman
et al 1991; Iacono et al 1982; Levy et al 1985). However, a more recent study failed to
observe this effect (Gooding et al 1993). Additionally, there is evidence of SPEM
impairments in affective disorder patients never medicated with lithium (Kufferle et al
1990) or unmedicated at time of assessment (Sweeney et al 1994a). It remains,
therefore, debated whether SPEM impairments in affective disorder represent a state
variable, as some have argued (Levy et alI994).
A second explanation that has been proffered to support the assumed specificity of
SPEM dysfunction to schizophrenia is the failure to observe SPEM impairments in first-
degree relatives of affective disorder patients (Holzman et al 1984; Levy et al 1983c).
This evidence indicates that SPEM deficits may be observed in affective disorder, but
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are not an expression of the genetic liability. However, the two relevant investigations
(Holzman et al 1984; Levy et al 1983c) suffer from poor methodologies, thus requiring
replication. Additionally, more recent studies did observe some levels of SPEM
impairments in relatives of unipolar or bipolar patients (Blackwood et al 1996;
Rosenberg et al 1997c), thereby challenging this argument of specificity.
More research is needed to establish whether SPEM impairments are indeed specific to
schizophrenia. This research could benefit particularly from the use of unmedicated
patients with affective disorders and the inclusion of their unaffected first-degree
relatives. If future studies will indeed demonstrate relative non-specificity for SPEM
impairments across the nosological boundaries of schizophrenia and bipolar affective
disorder, then this might still not, however, present a serious challenge to the SPEM
endophenotype approach. Recent evidence suggests that some of the most promising
genetic susceptibility loci are associated with schizophrenia as well as bipolar affective
disease (Berrettini 2000b). Given the clinical overlap between the two conditions, it may
turn out that SPEM dysfunction is an indicator of general vulnerability to the psychosis
spectrum, rather than to schizophrenia per se.
2.3.5.5.4 FAMILY AND TWIN STUDIES
Studies of first-degree relatives have been the focus of the SPEM research program in
schizophrenia since the mid 1970s (Holzman et al 1974). These studies are based on
the assumption that SPEM dysfunction may serve as an endophenotype, as outlined in
Section 1.8.1. The demonstration of subtle SPEM deficits in first-degree relatives of
schizophrenia patients is, therefore, an important piece of evidence concerning the
validity of this approach.
Historically, the first studies by Holzman and colleagues (Holzman et al 1974, 1976)
demonstrated global SPEM abnormalities in first-degree relatives, including parents,
siblings and offspring. The percentage of relatives with SPEM dysfunction (about 30-
50%) fell between that of patients (50-80%) and healthy controls as well as relatives of
non-psychiatric patients (about 8-10%).
Later studies replicated these findings by employing quantitative global and specific
measures. Relatives' levels of RMSE and In(S/N) were found to fall between those of
patients and healthy controls (Iacono et al 1992; Ross et al 1996c; Schlenker et al
1994).
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The pattern of performance deficits in the first-degree relatives group described by
specific measures is very similar to that observed in the patients, including reduced
gain (Clementz et al 1990; Lencer et al 1999; Ross et al 1996c) and increased frequency
of saccades (Clementz et al 1990; Lencer et al 1999; Rosenberg et al 1997c; Ross et al
1996c, 1998e), although some have failed to find reduced gain (Keefeet al 1997; Thaker
et al 1998). Other, specific, deficits previously observed in the patient group, such as
those in predictive pursuit (Thaker et al 1999; Trillenberg et al 1998) and pursuit
initiation (Sweeney et al 1998a) were similarly replicated in the relatives (Clementz et al
1995; Thaker et al 1998). Chen et al (1999b) demonstrated similar associations between
SPEM deficits and motion/velocity processing in both patients and first-degree
relatives. These similarities further underscore the validity of the assumption that
SPEM performance may be a schizophrenia spectrum marker, transcending the borders
of people with and without a diagnosis of schizophrenia.
In addition to observations of impaired performance levels in first-degree relatives, a
number of other findings merit consideration. First, it has been reported that SPEM
deficits in first-degree relatives are not due to increased levels of psychiatric symptoms
in these individuals (Iacono et al 1992). This finding is of importance, as it indicates
that SPEM dysfunction in relatives is not merely a consequence or an epiphenomenon
of psychiatric symptoms. It has, however, been shown that relatives with subclinical
schizophrenia spectrum symptoms have particularly impaired performance (Clementz et
al 1991; Thaker et al 1996a), similar perhaps to the relationship between schizotypy
and SPEM observed in healthy individuals (Gooding et al2000b; O'Driscoll et al 1998).
Second, a small number of studies have investigated the specificity of SPEM deficits to
first-degree relatives of schizophrenia patients. Given the presumed and observed
overlap between bipolar affective disorder and schizophrenia, it is of importance to
determine whether SPEM dysfunction is a genetic marker specific to schizophrenia
(Levyet al 1994) or non-specific within the wider psychosis spectrum. Evidence to date
appears to indicate that SPEM dysfunction characterises relatives of schizophrenia but
not bipolar disorder patients (Holzman et al 1984; Levy et alI983c). Iacono et al (1992)
observed no significant differences between relatives of bipolar patients and healthy
individuals; however, their Figure 1 clearly indicates that performance levels of these
relatives fell in between those of relatives of schizophrenia patients and healthy
individuals. Blackwood et al (1996) described SPEM abnormalities in a large family of
relatives of bipolar patients. Unfortunately, no control group was used in this study and
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comparisons were based on performance levels of healthy individuals from a previous
study (Muir et al 1992). Rosenberg et al (1997c) observed worse global pursuit in adult
offspring of depressed patients. Therefore, the assumed specificity to relatives of people
with schizophrenia remains debated.
Third, SPEM performance levels appear to be correlated within families, such that
relatives of patients with poor performance tend to have poorer performance than
relatives of patients with good performance (Iacono et al 1992; Rybakowski &
Borkowska 2002). These patterns of within-family correlations complement studies of
healthy twins, indicating a familial, and possibly genetic basis of SPEM dysfunction.
Fourth, first evidence of the neural correlates of SPEM dysfunction in first-degree
relatives of schizophrenia patients points to the FEF. In the above-mentioned study,
ODriscoll et al (1999) demonstrated that relatives with and without global SPEM
dysfunction differed only in FEF activation (but not in activation of posterior areas)
during pursuit. FEF activation levels further correlated with pursuit gain scores.
Fifth, one specific measure of SPEM that has attracted attention as a particularly
promising endophenotype is the increased AS frequency during pursuit (Whicker et al
1985). Ross et al (1996c) demonstrated increased AS (but not CUS) frequency in
children of schizophrenia patients compared to normally developing children. AS
frequency was subsequently shown to be a specific discriminator between adult
offspring of schizophrenia patients and depressed patients (Rosenberg et al 1997c),
were observed in childhood onset schizophrenia patients aged 10-18 (Jacobsen et al
1996), were found to be more frequent in childhood than adult-onset schizophrenia and
associated with bilineal inheritance (Ross et al 1999b) and were found to characterise
the more-likely gene carrier in families multiply affected with schizophrenia (Ross et al
1998e).
However, the validity of AS as a specific oculomotor endophenotype was challenged in
studies showing that differences between schizophrenia spectrum individuals and
healthy controls could be abolished by attention-facilitating target characteristics
(Clementz et al 1990; Rosenberg et al 1997c). Relatedly, Rea et al (1989) found a
decrease in large AS frequency after neuroleptic treatment. One interpretation of these
findings is that AS frequency reflects superficial inattention and is not a 'hardwired'
expression of a genetic deficit (Clementz et al 1990). A more positive interpretation,
however, might be that AS frequency does indeed reflect attentional processes, a
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suggestion that is compatible with propositions that attention may be a useful
schizophrenia endophenotype (Cornblatt & Malhotra 2001).
Sixth, a distinction is sometimes made in the schizophrenia literature between familial
and non-familial schizophrenia. Familial (or multiplex) schizophrenia is observed in
individuals with families characterised by multiple occurrences of the illness; non-
familial (or simplex, or sporadic) schizophrenia is described when the proband does not
have relatives with the disorder. Only a small number of studies have addressed this
distinction with regard to SPEM performance. Schwartz et al (1995b) found that
patients with familial schizophrenia had reduced rightward SPEM gain compared to
controls; non-familial patients performed intermediate. Lencer et al (2000) failed to
obtain differences between simplex and multiplex schizophrenia families, suggesting
that a degree of SPEM abnormalities and, arguably, genetic factors, might be observed
in both.
Finally, probably the best test of the validity of the proposed SPEM dysfunction
endophenotype is the examination of its concordance in twins discordant for
schizophrenia. If variance in SPEM performance was entirely due to genetic influences,
perfect concordance of SPEM dysfunction should be observed in twin pairs despite
discordance in clinical status (i.e. one twin has schizophrenia, the other twin does not).
Such a situation would indicate the influence of non-genetic factors on the clinical
expression of schizophrenia but not SPEM dysfunction and would strengthen the
validity of the SPEM endophenotype. However, as described in Section 2.3.5.5.1, SPEM
variance is only partially accounted for by genetic factors, including substantial
variance from environmental sources.
Holzman et al (1977) were the first to investigate SPEM in twins discordant for
schizophrenia. Eleven sets of MZ twins and 15 sets of DZ twins were selected from
Kringlen's Norwegian twin sample. Of the MZ twins, 7 pairs were discordant and 4 pairs
were concordant or "partially concordant" (i.e. "manifested some behavioural
peculiarity"; Holzman et al 1978a; p. 116). All 7 discordant pairs were concordant for
global SPEM quality ('good', 'bad']. The correlation for velocity arrests between pairs was
0.77 for all MZ twins and 0.40 for all DZ pairs. These findings clearly indicate strong
genetic influence on SPEM performance in discordant twins.
Holzman et al (1980) replicated the twin design using a different sample of slightly
younger twins (10 MZ and 15 DZ pairs). Six of the MZ pairs were discordant and four
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remaining co-twins had psychotic disorders (schizophrenia, schizoaffective condition,
reactive psychosis, manic-depressive illness). DZ twin pairs were discordant. Data were
scored both qualitatively and quantitatively (In SIN). According to Holzman et al (1980),
findings indicated higher concordance of abnormal SPEM in MZ than in DZ, supporting
the genetic hypothesis. Correlations for In(S/N) were 0.80 for MZ and 0.39 for DZ pairs
(across diagnoses), indicating good heritability. Qualitative SPEM concordances were
also higher for MZ than DZ twins.
However, a number of criticisms of this study must be made. First, the probands in the
MZ sample had a number of psychiatric diagnoses. In effect, there were only three pairs
of twins truly discordant for schizophrenia (all of which were concordant for qualitative
SPEM scores). A second apparent anomaly in these data is the finding that only 6 of 20
MZ twins had 'bad' eye-tracking. These individuals all had psychosis and all except 5 of
the remaining twins had a psychiatric diagnosis. Third, the three twin pairs with
concordant 'bad' performance were the oldest pairs (ages: 35, 36, 36), suggesting an age
effect (only one pair with 'good' performance was aged 35).
A recent attempt at replicating the Holzman twin findings failed. Litman et al (1997)
obtained detailed quantitative measures of SPEM performance using thorough
operational definitions and criteria for data scoring amongst 12 pairs of MZ twins
discordant for schizophrenia and 12 pairs of healthy twins. Affected twins showed
decreased gain and increased numbers and amplitudes of total and intrusive saccades
during pursuit. Unaffected twins performed similarly to healthy controls. These findings
imply that SPEM abnormalities seen in schizophrenia are associated with the
phenotype, i.e. the clinical expression of schizophrenia, and not the genotype, casting
serious doubt on the validity of this endophenotype.
In a response to this study, Holzman and colleagues (1997) pointed out a number of
methodological weaknesses in the Litman et al study. First, the small sample size may
have allowed for non-random error to confound the results and generally weaken any
interpretation of the findings. Second, two of the affected twins had also suffered brain
trauma, which may have affected SPEM. These participants possibly increased the
differences between the schizophrenic and the other groups. If the two twin pairs with
brain trauma had been removed from the analyses, Holzman et al (1997) argued, the
performance of the schizophrenic twins would have been in the range of the normal.
The inclusion of these two pairs would have, therefore, masked true differences between
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groups. Third, two of the control twins displayed deviant SPEM and may have,
therefore, blurred differences between this group and the unaffected twins.
Further, Holzman et al mentioned that the data by Litman et al had also been scored by
Holzman and Levy to assign qualitative scores, as done in previous studies by these
researchers. According to Holzman et al the concordance of the qualitative scores in a
subs ample of the discordant twins (8 pairs) was 100%. These data, not reported by
Litman et al, are, of course, in accordance with earlier findings (Holzman et al 1977,
1980), pointing to a genetic basis of SPEM dysfunction in schizophrenia. Holzman et al
also attacked Litman et al's claim that quantitative measures of gain and frequency of
saccades provide a more superior index of eye-tracking dysfunction than the qualitative
measures favoured by Holzman's group.
While this is an ongoing debate (Clementz et al 1997; Ross et al 1997), the claim that
quantitative measurement of SPEM may have masked between-group differences
appears questionable. Holzman et al's criticism of Litman et al's small sample size is, of
course, correct, but likewise concerns their own earlier studies (Holzman et al 1977,
1980), which used very similar sample sizes (N=10-15). Additionally, the Holzman et al
(1977, 1980) studies may themselves be criticised for their methodology, employing
EOG recordings, less than optimal testing conditions (in various hospital settings or
participants' homes) and global qualitative SPEM ('good', 'bad) analysis. Also, as
mentioned, the sample in the 1980 study was very heterogeneous with regard to clinical
status.
Clearly, further studies of discordant twins are needed. Given the advantages of specific
measures (Abel 1986; Abel & Ziegler 1988), future studies should use precisely defined
measures of gain and saccadic frequency. In order to allow comparisons with the
Holzman et al (1977, 1980) studies, however, global measures might also be included.
Future studies should also use large samples of accurately diagnosed twin pairs.
In conclusion, evidence from studies of first-degree relatives of people with
schizophrenia lends support to the hypothesis that SPEM dysfunction may be a genetic
marker of risk for schizophrenia. First-degree relatives consistently show subtle SPEM
impairments when compared to healthy controls; their performance levels tend to fall
between those of the patients and healthy controls. Within-family correlations, evidence
from healthy twin studies (Section 2.3.5.5.1) and similarities in the specific SPEM
deficits between patients and relatives further support the usefulness of the SPEM
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endophenotype. Future studies should a} clarify the specificity of SPEM dysfunction to
schizophrenia by studying families with bipolar disorder, b} further investigate the
neural correlates of SPEM performance in the relatives, and c}replicate observations of
SPEM concordance in MZand DZ twins discordant for schizophrenia.
2.3.5.5.5 FIRST-EPISODE PSYCHOSIS
First-episode psychosis patients constitute an important sample in which to confirm the
validity of a schizophrenia endophenotype. Studies of this patient group have the
advantage of circumventing a number of methodological difficulties encountered in the
study of chronic patients. These include factors possibly influencing, i.e. worsening
performance in samples of chronic patients, such as prolonged antipsychotic drug
treatment, long-term hospitalisation, or functional, social and professional impairment.
An additional advantage of first-episode studies is the improved sample homogeneity
with regard to disease stage and illness duration. Finally, it has been argued that there
might be detrimental, e.g. neurotoxic, effects on the brain of the illness itself, which
could affect performance in chronic patients (Weinberger & McClure 2002). SPEM
abnormalities seen in the first psychotic episode are, therefore, thought to be linked to
the primary disease process and the genetic basis rather than secondary confounds or
the effects of disease chronicity (Copolov et al 2000; Lieberman et al 1993; Lieberman et
al1992; Lieberman et al2001; Spohn & Strauss 1989; Waring 1995).
There are, however, also methodological difficulties of first-episode studies. First, it has
been argued that the subgroup of acutely ill schizophrenia patients who are willing to
and capable of performing psychophysiological assessments may not be representative
of the patient group at large (Clementz 1998). Second, it remains a possibility that the
onset of illness disrupts eye movement performance in an all-or-none fashion.
Longitudinal studies tracking individuals' performance before and after onset of illness
are required to address this issue.
In line with observations of impaired performance on a number of proposed
endophenotypes in first-episode psychosis (Copolov et al 2000; Ettinger et al 2001;
Hirayasu et al 1998; Hutton et al 1998b; Riley et al 2000; Salisbury et al 1998), SPEM
deficits have also been described in this patient group.
Importantly, the types of abnormalities seen in the first episode mirror those seen in
chronic patients, including global qualitative (Levy et al 1992; Yee et al 1998) and
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quantitative (Iacono et al1992; Vee et al1998) abnormalities as well as specific deficits,
such as reduced gain (Hutton et al 1998a; Levy et al 2000; Sweeney et a1 1992a) and
increased saccadic frequency (Levy et al2000; Sweeney et al1992a, 1998a).
In addition to demonstrating performance deficits in the first episode, it is of interest to
compare performance levels in first-episode psychosis with those observed in chronic
schizophrenia. While most of the clinical exacerbation in schizophrenia is observed in
the first five years of the illness (Lieberman et al 1992), studies of cognition have
provided no consistent evidence of deterioration, with some indication of selective
improvements in function following recovery after illness onset (Censits et al 1997; Hoff
et alI999).
Evidence concerning changes in SPEM through the first months of the illness is mixed,
with one study showing no change in global SPEM performance over approximately 9.5
months, despite changes in medication status and clinical improvement (Gooding et al
1994), but another study (Veeet al1998) showing significant deterioration over a period
of one year.
Evidence from cross-sectional studies indicates that SPEM deficits are more
pronounced in chronic than in recent-onset patients (Holzman et a1 1974; Hutton et al
2001a; Sweeney et alI992a). It appears, therefore, that SPEM performance deteriorates
with the occurrence of multiple psychotic episodes; however, this issue needs to be
resolved using longitudinal studiests. The failure to obtain consistent correlations
between SPEM and indirect measures of disease chronicity (e.g. number of
hospitalisations) (Section 2.3.5.3) might be due to methodological reasons, such as
small samples and small range of scores.
What implications would deteriorations in performance over multiple psychotic episodes
have, if observed, for the validity of oculomotor measures as schizophrenia
endophenotypes? First, the observation of SPEM deficits in the first psychotic episode
renders it unlikely that deviant performance in the schizophrenia patient group at large
is entirely due to secondary confounds. Second, it is possible that secondary effects of
schizophrenia, such as social and functional impairments, chronic drug treatment and
disease chronicity do adversely affect performance levels. These factors in the chronic
12 Lieberman et al (1992) report that the first-episode patients in their Hillside Hospital study
have been followedup using SPEM(and other) assessments at 18, 3D, and 60 months after
baseline tests. However,at present these data have not been published.
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group might lead to a systematic overestimation of differences with groups of relatives
or healthy controls, and might have to be considered in genetic studies using
quantitative performance scores (Arolt et al 1999; Rybakowski et al 2001). Finally,
genetic research has shown that levels of expression of a gene may vary over time
(Plomin et al 2000). It remains a possibility that worse SPEM in chronic patients
represents a greater reflection of genetic influence.
2.3.5.5.6 SCHIZOTYPY
Given the hypothesised proximity of schizotypy to clinical schizophrenia, a number of
investigations have combined SPEM and psychometric schizotypy questionnaires in
otherwise healthy individuals, mainly university students. Other studies have examined
individuals with a DSM Axis II diagnosis of schizotypal personality disorder (SPD).
Studying schizotypy in healthy individuals (e.g. university students) is an advantageous
strategy in schizophrenia spectrum research as it overcomes many of the
methodological confounds of patient studies, such as antipsychotic and adjunctive drug
treatment, hospitalisation and social and functional impairments.
Studies of schizotypy in healthy individuals and SPD patients mirror those of clinical
schizophrenia in their methodological approaches. Thus, first evidence of a relationship
between SPEM and schizotypy and SPD was obtained and subsequently replicated
using global qualitative as well as non-specific quantitative measures (Coursey et al
1989; O'Driscoll et al 1998; Siever et al 1982, 1989, 1990). As in the schizophrenia
studies, these deficits were also shown using more refined methods (Gooding et al
2000b), although one study found differences between individuals with SPD and
healthy controls on global qualitative ratings, but not specific quantitative measures
(Siever et al 1994). While most researchers have either compared high and low
schizotypal individuals, or investigated correlations between schizotypy levels and
SPEM, an inverse sampling strategy has also been used successfully. Siever et al (1984)
selected college students with good and poor SPEM; a diagnosis of SPD or
schizophrenia was more common in the poor SPEM group.
Few failures to replicate these findings have been reported. A study by Simons and
Katkin (1985) is often quoted as demonstrating worse SPEM in high schizotypy scorers.
In fact, high and low scorers on the Chapmans' Physical Anhedonia (Chapman et al
1980) scale in this study did not differ on qualitative SPEM ratings, although
performance in the high scorer group was more variable and there were three
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individuals with severely impaired performance. Blackwood et al (1994b) found no
differences on the In(SjN) measure of SPEM between adults who were in childhood
diagnosed as schizoid and control adults (who had other psychiatric disturbances in
childhood). However, the two groups also did not differ on another measure of
susceptibility to schizophrenia, the event-related potentials measure P300, thus
suggesting the finding was not a failure specific to SPEM.
One issue of particular interest is that of the specific relationship between SPEM and
symptom dimensions of schizotypy. As discussed in Section 1.7, the symptom
dimensions of schizotypy appear to somewhat map those of clinical schizophrenia
(Vollema & van den Bosch 1995); as summarised in Section 2.3.5.3, a number of
studies have demonstrated a relationship between SPEM and negative features of full-
blown schizophrenia. Interestingly, a remarkably similar relationship has been obtained
in a number of (but not all) studies of schizotypy.
An association between SPEM and social introversion in healthy individuals has been
found (Siever et al 1982, 1989); Coursey et al (1989) similarly found a correlation
between In(SjN) and interpersonal but not affective symptoms in students. Siever et al
(1994) showed that poor qualitative SPEMwas associated with negative, deficit like, but
not positive, psychotic like symptoms in a group of mixed personality disorder patients;
the association was even stronger amongst individuals with SPD.
While these findings are intriguing, as they appear to demonstrate a continuum
between schizophrenia and schizotypy at the phenomenological as well as the biological
level, other studies have found comparable associations between SPEM and negative as
well as positive symptoms (Gooding et al 2000b; ODriscoll et al 1998).
A second point of interest concerns the relationship between measures of schizotypy
and trait emotionality. A number of studies have demonstrated a correlation between
trait emotionality and schizotypal personality traits (Bentall et al 1989; Braunstein-
Bercovitz et al 2002; Eysenck & Barrett 1993; Lipp et al 1994; Muntaner et al 1988;
ODriscoll et al1998; Rust & Chiu 1988; Tien et al 1992a; Wuthrich & Bates 2001) as
well as increased levels of neuroticism in schizophrenia (Catts et al 2000; Gurrera et al
2000; van den Bosch 1984). The reasons for this association are not well understood.
One possibility is that increased levels of neuroticism are observed as a consequence of
distressing psychosis-like symptoms (Claridge & Broks 1984). Alternatively, it has been
suggested that neuroticism may be a non-specific measure of many different types of
104
Eye Movements in the Schizophrenia Spectrum
psychopathology, not specific to psychosis (Claridge & Davis 2001). Finally, high levels
of neuroticism might produce symptoms typically associated with the schizophrenia
spectrum, such as thought disorder (Vollerna & van den Bosch 1995).
Irrespective of the precise causal relationships at operation, Raine and Lencz (1995)
have argued for the need to examine the specificity of proposed behavioural or biological
markers to schizotypy and schizophrenia, while minimising the risk of statistically - or
through sampling - correcting for comorbid features, such as anhedonia or social
anxiety, which may in fact be essential to the construct under study. No previous study
has examined whether trait emotionality impacts on the relationship observed between
SPEM performance and schizotypal traits in healthy individuals. Such an observation
would be of importance in order to establish the relative specificity of the relationship
between SPEM and schizotypy symptoms.
2.3.5.5.7 THE LATENT TRAIT MODEL
In attempting to explain the pattern of inheritance of SPEM dysfunction, Holzman and
colleagues made an observation that rendered a Mendelian pattern unlikely (Matthysse
et al 1986): A number of schizophrenia patients with normal SPEM had first-degree
relatives with impaired SPEM; the opposite pattern was also observed. This finding
indicates that SPEM dysfunction cannot be a necessary genetic marker in
schizophrenia. In order to explain this finding, as well as the observed frequencies of
SPEM dysfunction in patients (50-80%) and relatives (30-50%), Matthysse et al (1986)
developed the latent trait model.
The latent trait model holds that SPEM dysfunction and clinical schizophrenia are two
expressions of an underlying, hence latent, trait. This trait is transmitted in a quasi-
Mendelian fashion, determined by a single major locus. Matthysse et al (1986) argued
that the disease process linked to the latent trait has a greater probability of
manifesting itself as SPEM dysfunction (which is more common in the general
population) than schizophrenia, thereby explaining the observation of schizophrenia
patients with good SPEM and the increased frequencies of SPEM and schizophrenia in
first-degree relatives, the former being more frequent than the latter.
The expression of a gene as more than one phenotypes is called pleiotropy (Plomin et al
2000). Holzman and colleagues (Holzman 2000; Matthysse & Holzman 1987) have
compared their SPEM model to a similar observation in neurofibromatosis, where
105
Eye Movements in the Schizophrenia Spectrum
benign cafe-au-lait spots represent the more common and less pathological phenotype
(comparable to SPEM dysfunction) than the neurofibromata (comparable to
schizophrenia-related symptoms). Another example is phenylketonuria (PKU),where a
single gene causes light hair and skin colour as well as mental retardation (Plomin et al
2000). In comparison to these conditions, Matthysse and Holzman (1987) argued that
the two expressions of the latent trait (schizophrenia and SPEM dysfunction) "are very
different from each other" (p. 272).
The latent trait model makes a very strong prediction: SPEM performance should be
clearly bimodally distributed, if not dichotomous, in families with multiplex
schizophrenia (allowing for random error of measurement and non-specific sources of
variance). Early studies by Holzman and colleagues, of course, used dichotomous SPEM
scoring methods, thereby artificially creating groups with and without SPEM
dysfunction. Later studies using statistical techniques such as mixture analysis could
demonstrate that the distribution of quantitative SPEM scores is indeed best fit by two
distributions. Mixture of distributions indicates that a sample is more likely to be taken
from two different populations than the same population (one distribution). These
studies indicate that one of the patient subgroups appears to display abnormal pursuit,
underperforming normal controls, while the other, worse performing, group cannot be
easily distinguished from controls.
Mixture distributions were obtained for RMSE (Clementz et al1992; Iacono et al1992;
Ross et al 1988, 1996a, 1997; Sweeney et al 1993), In(S/N) (Gibbons et al 1984) and
gain (Clementz et al 1992) and were demonstrated in schizophrenia patients and their
first-degree relatives but not in healthy controls.
The statistical features of the latent trait model were tested on SPEM data from
schizophrenia patients, their first-degree relatives and discordant twins. In different
datasets Holzman and colleagues found that the genetic transmission of SPEM
dysfunction and schizophrenia could be best explained by a single, autosomal dominant
gene (Holzman et al 1988). However, as Grove et al (1992) pointed out, this study did
not compare the dominant gene model to a polygenic one. Additionally, the study used
qualitative SPEM ratings, thereby losing important between-subject variance. McGue
and Gottesman (1989) have argued further that a shortcoming of the model was not to
consider familial environmental as well as polygenic components.
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Grove et al (1992) provided more evidence of a major gene effect on SPEM deficits in
schizophrenia, but observed polygenic factors as well. Pooling together samples of
schizophrenia patients and their first-degree relatives, they found that a (simulated)
major gene in the presence of residual, polygenic variance accounted for about two
thirds of the variance in RMSE in their sample.
The evidence from the Holzman et al (1988) and Grove et al (1992) studies is promising,
but should be considered preliminary. As outlined below, there is no firm, consistent
evidence of linkage between SPEM dysfunction and a specific genetic locus as yet. Given
Holzman et al's report of a single gene effect in 1988, it may be all the more surprising
that their group has not published a linkage study of the SPEM phenotype.
Additionally, evidence from healthy twin studies appears to indicate a polygenic pattern
of SPEM inheritance. Finally, Matthysse and Holzman's (1987) assumption that SPEM
dysfunction and schizophrenia represent two very different phenotypes may be
challenged. While the most prominent application of the SPEM task in schizophrenia
spectrum research to date has been investigations of its endophenotypic properties (the
'first' stream of research; Section 2.2.1), there is also evidence linking it to
schizophrenia at cognitive and biological levels (the 'second' stream of research; Section
2.2.1). It may be argued that although SPEM and schizophrenia may indeed represent
two pleiotropic manifestations of an underlying trait, their shared putative frontal lobe
correlates may be more than accidental. This speculation requires more research,
combining genetic, cognitive and biological approaches.
2.3.5.5.8 MOLECULAR GENETIC STUDIES
The ultimate purpose of an endophenotype is to be used in genetic linkage studies. It is,
therefore, surprising that despite almost thirty years of family and twin research of
SPEM in schizophrenia, only two linkage studies (with overlapping samples) of this
endophenotype have been reported.
The first study was reported by Arolt et al (1996). These researchers carried out a scan
limited to the 6p21-23 region to test for linkage between chromosomal markers and
SPEM dysfunction as well as schizophrenia. Two lod scores of 3.51 for 06S271 and
3.44 for 06S282 on chromosome 6p21-23 were obtained for SPEM dysfunction (but not
for a diagnosis of schizophrenia) in 8 families with multiplex schizophrenia. These
markers are close to regions previously implicated in linkage studies of the
schizophrenia phenotype (Moises et al 1995).
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A second linkage study by the same group replicated this finding using an extension of
the original sample (Arolt et al 1999). Linkage of SPEM dysfunction - but not
schizophrenia - was found to markers on chromosome 6p21, while there was no
convincing linkage to chromosomes 8, 9, 20 and 22.
Additionally, a recent study demonstrated a link between SPEM impairments and
polymorphisms of the dopamine D3 receptor on chromosome 3q (Rybakowski et al
2001). The serine-serine polymorphism of the D3 receptor gene was found to be
associated with worst SPEM dysfunction in 119 schizophrenia patients and 85 healthy
controls; serine-glycine heterozygotes performed in-between and glycine-glycine
homozygotes performed best. This finding is of considerable interest given the proposed
role of the dopaminergic system in the pathophysiology of schizophrenia (Kapur &
Remington 2001; Leonard 1997).
While the two studies demonstrating linkage of SPEM dysfunction to chromosome 6p21
are very promising, they will need to be replicated. Additionally, the finding by
Rybakowski et al (2001) is difficult to reconcile with these linkage studies. While Arolt et
al (1999) argued that a single gene on the 6p21 locus may account for SPEM
dysfunction in their families, a different gene was implicated by Rybakowski et al
(2001). It is, however, important to note that Arolt et al (1996) restricted their search to
the 6p21-23 region, thus not allowing the detection of other genetic loci. These
contradictory findings are not inconsistent with the notion that more than one gene is
implicated in schizophrenia. Given the heterogeneity of SPEM itself (Levy et al 2000) it
may further be argued, contrary to the latent trait model (Matthysse et al 1986;
Matthysse & Holzman 1987), that this heterogeneity may also be reflected genetically.
2.4 Visual Fixation
2.4.1 Definition
Visual fixation describes the controlled focus of gaze onto a stationary target. Because
of relatively spared visual fixation capacities in people with schizophrenia and the
proposed similarities between fixation and smooth pursuit, this task is often considered
a 'control' condition for the smooth pursuit task rather than a genetic marker in
schizophrenia spectrum research. Visual fixation methods and key findings will,
therefore, be considered only relatively briefly here.
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2.4.2 Visual Fixation Stimulus
2.4.2.1 Hardware
Visual fixation tasks involve the presentation of a stationary stimulus for lengthy
periods of time. The types of stimulus display are similar to those of smooth pursuit
tasks, using computer screens (Clementz et al 1994j Curtis et al 2001 b; Gooding et al
2000aj Kissler & Clementz 1998; Levin et al 1982a; Paus 1991; Rosse et al 1992a;
Rybakowski et al 2001), CRO (Amador et al 1995j Matsue et al 1986; Mialet & Pichot
1981) and laser spots (Ross et al1988).
2.4.2.2 Stimulus Properties
Stimuli usually consist of simple targets, such as dots, crosses, or squares, similar to
those used in smooth pursuit trials. The target stimulus is usually presented in the
centre of the participant's visual field (0°), or in a peripheral horizontal location. The use
of more than one horizontal location allows investigation of laterality and amplitude
effects (Clementz et al 1994; Kissler & Clementz 1998).
Kissler and Clementz (1998) suggested using at least one horizontal stimulus amplitude
that is taxing for the visual fixation system (e.g. ±200), in order to probe effectively for
drift. Regarding the temporal characteristics of visual fixation trials, previous research
has employed stimulus durations of about 10,000-30,000ms per location. Instructions
to participants are usually to keep their eyes on the target at all times.
A variant of this task, the fixation with dis tractors task, has also been used in
schizophrenia spectrum research (Curtis et al 2001 b; Hutton et al 2002). In this task
peripheral targets appear briefly, introducing a challenge for the saccadic inhibitory
component of the fixation system. As the simple fixation task in the present research
serves primarily as a control condition for the SPEM task, the fixation with distractors
and tasks using semantic stimuli (Paus 1991) are not discussed further.
2.4.3 Visual Fixation Scoring
Scoring methods for visual fixation tasks somewhat overlap with those for SPEM and
have ranged from qualitative to quantitative. Leigh and Zee (1999) described a clinical
assessment of fixation stability, which does not involve recording or analysis
equipment. While such a bedside assessment is indicated for gross neurological
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disorders, it is likely to obscure the subtle fixation abnormalities that may be observed
in schizophrenia.
Rosse et al (1992a) published examples of a 5-point qualitative rating scale for visual
fixation performance, based on the SPEM scale of Shagass et al (1974). This scale
ranged from 1 (best) to 5 (worst), presumably based on accuracy and consistency of
ftxation as well as frequency of saccades (Figure 2.9).
Figure 2.9: Example of a 5-point Visual Fixation Rating Scale
1 --J
2~~~:=J
3 I,_____~~ ___'_'V~
4 t......,..,-r .r--/"'v..~----- - ....--,~j
5 Iv~------------------------~
from Rosse et al (1992), p. 413; 1 = best,S = worst
Kissler and Clementz (1998) undertook a detailed quantitative analysis of fixation data
in schizophrenia patients and healthy controls. The frequency of saccades was
assessed. SWJ were defined as pairs of saccades separated by a 100-450ms interval,
with only the first saccade in each pair counted. Single saccades were also observed.
After exclusion of saccades and eye-blinks, fixation stability was further evaluated as
the average and standard deviation of the eye position and eye velocity. Other
researchers (Clementz et al 1994; Curtis et al 2001b; Gooding et al 2000b; Levin et al
1982a; Mialet & Pichot 1981; Silverman & Gaarder 1967) have also assessed saccade
frequency as a measure of fixation stability. Ross et al (1988), following the SPEM
literature, calculated RMSE for fixation. Minimum amplitudes for the identiftcation of
saccades were reported by Gooding et al (2000b: 1°)and Curtis et al (2001b: 0.5°).
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2.4.4 Visual Fixation in the Schizophrenia Spectrum
2.4.4.1 Behavioural Characterisation of Visual Fixation in
Schizophrenia Patients
A number of studies have indicated relatively unimpaired visual fixation in patients
with schizophrenia (Clementz et al 1994; Gooding et al 2000a; Kissler & Clementz 1998;
Mather & Putchat 1982; Radant et al 1997; Ross et al 1988). However, other studies
have indicated the existence of subtle disruptions of fixation (Amador et al 1991, 1995;
Curtis et al 2001 b; Matsue et al 1986; Mialet & Pichot 1981; Rybakowski & Borkowska
2002; Silverman & Gaarder 1967). These abnormalities most commonly consist of
saccades away from and back to the target as well as slow drift away from the target. It
is important to note that the two methodologically most detailed studies (Gooding et al
2000a; Kissler & Clementz 1998) observed no impairments in schizophrenia and that
many of the studies observing impairments used either qualitative ratings of fixation
performance or the electrooculographic recording technique, thereby allowing for
possible bioelectric artefacts.
An intact fixation system in schizophrenia is sometimes postulated as evidence of the
specificity of SPEM impairments across oculomotor functions. The two tasks have been
related to each other, as visually attending to a stationary target may be equivalent to
smooth pursuit eye movements at zero target velocity (Leigh & Zee 1999). However, the
evidence from a number of studies of fixation impairments in schizophrenia argues
against the presumed specificity of SPEM impairments.
2.4.4.2 Cognitive and Neural Basis of Visual Fixation in
Schizophrenia Patients
Gaze-holding of a stationary target is a cognitively relatively undemanding task.
Therefore, deficits seen during this task do not necessarily imply disturbance of higher
cognitive functions. Lesions to a variety of brain areas can induce fixation impairments.
These areas include the cerebellum (in particular the flocculus), frontal cortex (in
particular the FEF, dorsolateral prefrontal cortex [DLPFC] and supplementary motor
area), occipito-parietal cortex (in particular the inferior parietal lobule), the basal
ganglia and the superior colliculus (Anderson et al 1994; Leigh & Zee 1999; Petit et al
1999).
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Neuroimaging studies of healthy humans have shown mainly frontal areas to be
involved in the control of fixation. In particular, activation has been observed in
precentral gyrus, supplementary eye fields, cingulate and ventromedial and
anterolateral prefrontal cortex (Anderson et al 1994; Petit et al 1999).
To probe for fixation deficits in schizophrenia by increasing cognitive load, a commonly
used variation of the task presents peripheral visual distractors (such as flashing
targets) during fixation of the central target. The participant is in this task required to
actively inhibit the initiation of saccades towards the peripheral targets, thereby
increasing the (frontal) cognitive demands (Petit et al 1999). Although a recent study
failed to find differences between first-episode schizophrenia patients and healthy
controls on this task (Hutton et al 2002), a previous study showed that the distractor
condition led to increased impairments in schizophrenia (Curtis et al 2001b).
In an elegant experimental task manipulation, Paus (1991) observed an increased
frequency of saccades away from the fixation stimulus only during fixation of a
semantically inert stimulus, but not during a categorisation task of semantically
meaningful stimuli. This finding somewhat resembles the attentional manipulations of
target characteristics in the SPEM task (Section 2.3.5.2.3) as it demonstrates normal
performance in schizophrenia after focussing patients' attentional (or other cognitive)
processing capacities onto the stimulus.
Malaspina et al (1999) observed that neuroleptic-free schizophrenia patients had
significantly reduced rCBF in the left medial frontal, superior frontal, middle frontal and
anterior cingulate cortex during visual fixation when compared to controls. Increased
rCBF in the patient group was observed in the left and right parahippocampal gyrus
and right fusiform gyrus. The finding of frontal hypoactivity is consistent with the
hypofrontality hypothesis of schizophrenia (Section 1.4.2), but is intriguing given the
low cognitive demands of the task.
More evidence for a frontal involvement in fixation deficits in schizophrenia was
obtained by Paus (1991) who observed a correlation between fixation performance and
neuropsychological tests of frontal lobe function, such as WCST.
Based on the inconsistent evidence of fixation abnormalities in schizophrenia it is
difficult to infer a specific neural abnormality. However, one hypothesis is that fixation
impairments, when seen in this patient group, might be due to frontal lobe dysfunction
(Malaspina et al 1999; Paus 1991). Findings indicating intact visual fixation, conversely,
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might suggest that lower brain areas involved in fixation, such as the nucleus
prepositus hypoglossi or the medial vestibular nucleus (Kissler & Clementz 1998), are
spared by the schizophrenic disease process.
2.4.4.3 Clinical Correlates
Little is known about the clinical correlates of fixation control in schizophrenia. Rosse et
al (1992a) observed a correlation between visual fixation impairments and Mini Mental
State Examination, a measure of dementia, implying effects of general cognitive decline.
Paus (1991) noted a correlation with BPRS thought disorder. Thaker et al (1989c) did
not find differences between patients with and without tardive dyskinesia in fixation
performance.
2.4.4.4 Treatment Effects in Schizophrenia and Pharmacological
Manipulation in Healthy Individuals
Little is known about antipsychotic treatment effects on fixation in schizophrenia.
Amador et al (1995) observed no significant correlation between neuroleptic dose and
fixation quality. Similarly, Gooding et al (2000a) observed no differences between
patients on and off medication.
It has, however, been demonstrated that lorazepam (but not sertraline or
chlorpromazine) administration leads to increased saccades during the fixation with
distractors task in healthy individuals (Green et al 2000; Green & King 1998).
2.4.4.5 Validity as Endophenotype
2.4.4.5.1 HERITABIUTY
No study examining the heritability of fixation performance in healthy monozygotic and
dizygotic twins could be identified.
2.4.4.5.2 TEMPORAL STABIUTY
Fixation performance appears to be stable in healthy individuals over several weeks
(Roy-Byrne et al 1995).
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2.4.4.5.3 SPECIFICITY TO SCHIZOPHRENIA
Due to the basic neural control of visual fixation, the task has been used widely as a
neurological assessment tool. Patients with a number of neurological conditions,
including Friedreich's ataxia, progressive supranuclear palsy and acquired lesions to
the cerebellum have been demonstrated to have poor abilities to maintain fixation
(Leigh & Zee 1999). Bipolar psychotic patients do not appear to have fixation
abnormalities (Amador et al1991, 1995).
2.4.4.5.4 FAMILY AND TWIN STUDIES
Despite the presumed stability of visual Iixation in schizophrenia, there are two reports
showing fixation impairments in first-degree relatives of schizophrenia patients (Amador
et al 1995; Rybakowski & Borkowska 2002). Curtis et al (2001b) observed increased
saccades during fixation in first-degree relatives only on the fixation with dis tractors
but not the simple fixation task.
2.4.4.5.5 FIRST-EPISODE PSYCHOSIS
Hutton et al (2002) did not observe increased saccadic frequency during the fixation
with distractors task in patients within their first psychotic episode.
2.4.4.5.6 SCHIZOTYPY
Fixation performance does not appear to be related to levels of psychometric schizotypy
in healthy individuals (Gooding et al 2000b).
2.4.4.5.7 MOLECULAR GENETIC STUDIES
The study by Rybakowski et al (2001) already mentioned above (Section 2.3.5.5.8) also
included the fixation task. Fixation disturbance (like SPEM)was significantly associated
with the Ser-Ser genotype in schizophrenia patients and healthy controls; weaker
fixation abnormalities were observed in Ser-Gly homozygotes and Gly-Gly homozygotes
had best fixation scores. These findings indicate that, despite many reports to the
contrary, the fixation task may be studied with profit as a schizophrenia spectrum
endophenotype, possibly in conjunction with the SPEM task. However, the finding
awaits replication.
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2.5 Antisaccade Eye Movements
2.5.1 Definition
An antisaccade is a saccadic eye movement in direction opposite to a peripheral target.
The antisaccade task has over the last decade been suggested to be an oculomotor
endophenotype in schizophrenia spectrum research (Calkins & Iacono 2000; Clementz
1998). Due to this promising evidence, methodological considerations as well as
performance patterns and correlates in the schizophrenia spectrum will be described in
detail.
2.5.2 Antisaccade Stimulus
2.5.2.1 Hardware
Most schizophrenia antisaccade studies have used computer monitors (Broerse et al
2001 b; Clementz et al 1994; Curtis et al 2001a; Klein et al 2000b; McDowell et al 1999),
LED arrays (Crawford et al 1995a, 1995b; Fukushima et a1 1990b; Hutton et al 1998a;
Karoumi et al 1998b) or laser targets (Maruff et al 1998) to present target stimuli.
Similar to SPEM studies, computer monitor targets are presented at distances of about
40cm to 60cm from participants. LED arrays are presented at slightly greater distances
(Fukushima et al1990b; Hutton et al 1998a; Karoumi et alI998b). Computer screen-
based antisaccade targets are usually made up of simple shapes, such as dots or
squares, varying in colour and size.
2.5.2.2 Stimulus Properties
An antisaccade trial usually begins with the presentation of a central target (00). After a
brief duration, the target is abruptly moved to a peripheral location. Participants are
required to initiate an eye movement in opposite direction, without first following the
target movement (see Figure 2.10)
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Figure 2.10: Flowchart of the Antisaccade Task
•1
•1
• target •1eye gaze <,
Different peripheral target locations have been used, typically ranging between ±5° and
±25°. McDowell et al (1999) have highlighted the importance of using more than one
amplitude. These researchers found that a 'far' target (±16°) provided patient-control
separations about 2.5 times larger than a 'near' target (±8°).Some researchers (Burke &
Reveley 2002; Crawford et al 1998; Hutton et al 1998a; Karoumi et al 1998b; Larrison
et al 2000) additionally presented participants with an auditory stimulus (buzzer)
coinciding with peripheral target onset.
Of equal importance is the duration of central and peripheral targets. In schizophrenia
spectrum studies no one single protocol of these factors has been established.
Durations of the central and peripheral targets have varied between about 1,000ms and
3,000ms. While some antisaccade tasks have used fixed central target durations
(Crawford et al 1998; Hutton et al 1998a; Ross et al 1998d), others have varied the
duration quasi-randomly across trials (Clementz et al 1994; Curtis et a1 2001a;
Karoumi et al 2001; Katsanis et a11997; Thaker et a1 2000). Quasi-random duration of
central targets may be advantageous, making the peripheral target appearance
temporally unpredictable.
Most previous studies have used the regular, or 'non-overlap' antisaccade task, where
the peripheral target appears immediately as the central target disappears. Two
variations of this task have been studied, i.e. the 'overlap' and the 'gap' anti saccade
tasks (Fischer et al 2000; McDowell & Clementz 1997), following the gap and overlap
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reflexive saccade tasks (Fischer et al 1993). In the gap task, a brief temporal gap of
about 200ms is introduced between central and peripheral target presentation, in
which the screen is blank. In the overlap task, the central and peripheral targets
overlap by about 200ms. Previous studies have shown that the gap condition leads to a
reduction in latency and an increase in error rate. Conversely, the overlap task is
associated with a prolongation of latency and a reduction in error rate (Fischer & Weber
1997; McDowell & Clementz 1997). While these task manipulations have been studied
with profit, the bulk of the literature (including the research conducted as part of this
thesis) has used the regular (non-overlap) task.
The number of trials in an antisaccade assessment is typically about N=20 (Clementz et
al 1994; Crawford et al 1998; Curtis et al 2001a; Hutton et al 1998a; Katsanis et al
1997), although larger numbers have also been used (N=60) (Karoumi et al 2001;
McDowell et al 1999) and Maruff et al (1999) argued for the use of at least 40 trials.
Practice trials are usually given to familiarise participants with the task requirements.
Instructions to participants usually focus on the inhibition of reflexive saccades towards
the peripheral target and the immediate initiation of a saccade in opposite direction.
Most, but not all (Thaker et al 2000), researchers additionally require participants to
match, with their saccade, the peripheral target amplitude.
Some researchers have chosen to provide feedback to participants concerning the
spatially correct saccadic response. This involves a stimulus appearing in the location
where participants were required to look, i.e. opposite to the peripheral target location
(Burke & Reveley 2002; Crawford et al1995a, 1995b; Karoumi et al2001; McDowell et
al 1999; Nieman et al 2000; Ross et al 1998d; Tien et al 1996). This addition may have
the advantage of providing the individual with important information concerning their
performance. However, feedback on cognitive task performance may improve
performance and induce arousal and may, therefore, lead to complex cognitive
processing, affecting performance differences between schizophrenia spectrum
participants and healthy individuals in an unknown way.
2.5.3 Antisaccade Scoring
The antisaccade task, as a competing endophenotype to the SPEM task, has the
advantage of possessing clearly defined analysis criteria. The key measure of
antisaccade performance, and the most promising saccadic endophenotype, is the error
rate. Probably every schizophrenia spectrum study of the antisaccade task has reported
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the average error rate (Allen et al 1996; Broerse et al 2001b; Burke & Reveley 2002;
Clementz et al 1994; Crawford et al 1995a, 1995b, 1996, 1998; Curtis et al 2001a,
2001b; Dursun et al 1999; Fukushima et al 1988, 1990b, 1990c; Gooding 1999;
Gooding & Tallent 2001; Hutton et al1998a, 2001a, 2001b; Karoumi et al1998b, 2001;
Katsanis et al 1997; Klein et al 2000b, 2000c; Maruff et al 1998; McDowell et al 1999,
2002; McDowell & Clementz 1997; Muller et al 1999; Nieman et al 2000; ODriscoll et al
1998; Ross et al 1998d; Rosse et al 1993; Schlenker & Cohen 1995; Sereno & Holzman
1995; Straube et al1999; Thaker et al1989b, 1989c, 1996a, 2000).
Figure 2.11: Example of an Antisaccade Error with Subsequent Corrective Saccade
1.0.0 r1
_nn
-1.0.0
1.0000 1.2000
Legend: x-axis, time (ms); y-axis, degree of visual angle
An antisaccade error is counted - quite unambiguously - when the participant initiates
a saccade towards the peripheral target. Errors may even be counted by visual
inspection (Figure 2.11). The error rate reflects the percentage of error trials over the
total number of correct antisaccade trials, and is calculated as follows:
Nerr 100%
n;
where Nerr is the number of errors, and Ntot is the total number of antisaccades.
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Figure 2.12: Example of a Correct Antisaccade
1.0.0
...
-1.0.0 -~
6000 8000
Legend: x-axis, time (ms); y-axis, degree of visual angle
A correct antisaccade trial is counted when the participant performs a saccade in
opposite direction to the peripheral target (Figure 2.12). Criteria for detection of
saccades in automatic, computer-based analyses of this task have varied across
studies. A saccade is usually defined as a change in eye velocity, with velocity exceeding
about 5°/s (Clementz et al1994) to 300/s (Crawford et al 1998). Most researchers are
likely to have employed criteria of minimum amplitude, although these are rarely
reported (Broerse et al 2001b: 3°; Gooding 1999: 2°; Straube et al 1999: 5°).
Transforming visual input into an eye movement response requires time (Carpenter
1988; Leigh & Zee 1999); therefore, saccades in response to a target are considered
predictive, and subsequently excluded from analysis, if the latency is less than about
70-100ms (Clementz et al1994; Evans & Schwartz 1997; Gooding 1999; Katsanis et a1
1997; Klein et al 2000c; McDowell et al 1999; Nieman et al 2000).
Some - but not all - studies have investigated the antisaccade error correction rate
(Clementz et a1 1994; Crawford et al 1998; McDowell & Clementz 1997). Usually, an
antisaccade error is corrected by the participant through the execution of a saccade in
opposite direction (Figure 2.11). The correction rate is calculated as the percentage of
corrective saccades over error trials. This measure (usually close to 100% in healthy
individuals) can taken as an indication of whether participants understood the task
instructions and were in principle willing and able to perform the task (McDowell&
Clementz 1997).
Most studies have analysed antisaccade latency. Latency is defined as the time, in
milliseconds, from target appearance to saccade initiation. Only a few studies have
provided an index of anti saccade accuracy. The most frequent measure of accuracy is
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that of primary antisaccade gain (Crawford et al 1995a, 1995b, 1998; Karoumi et al
1998b, 2001; Nieman et al2000). Primary anti saccade gain is calculated as follows:
amp1sacc 100%
ampl,rg,
where amplsaccis the primary saccade amplitude in degrees, and ampltrgt is the target
amplitude in degrees.
As the antisaccade amplitude is opposite in valence to that of the target, the resulting
percentage measure of accuracy will be negative for correctly executed antisaccades. A
gain score of -100%, therefore, reflects perfect accuracy of a primary antisaccade. This
measure of gain minimises effects of drift and is, therefore, preferable over a direct
measure of eye position.
As an additional measure of accuracy, some investigators (Crawford et al 1995a, 1995b,
1998; Hutton et a1 1998a) have reported final eye position, reflecting the average fixation
position after primary and subsequent corrective saccades. Ross et al (1998d) measured
antisaccade accuracy as residual error, defined as a percentage of post-saccadic
position error divided by the distance from initiation of saccade to target location.
Accuracy and latency measures are usually reported only for correct antisaccades,
although some investigators have also studied the saccadic metrics of error saccades
(Fischer & Weber 1997).
Only a few studies have reported other antisaccade characteristics, such as peak
velocity (in degree per second) or duration (in milliseconds) (Fukushima et al 1990b,
1994; Nieman et al 2000; Straube et al 1999). However, probably due to the role of the
error rate as the most promising antisaccadic endophenotype, most schizophrenia
spectrum studies have not used these measures.
2.5.4 Antisaccade Eye Movements in the Schizophrenia Spectrum
2.5.4.1 Behavioural Characterisation of Antisaccade Eye Movement
Impairments in Schizophrenia Patients
The most robust observation of antisaccade abnormalities in schizophrenia is
undoubtedly that of an increased error rate on the antisaccade task. No study to date
has failed to replicate this finding. Average error rates in the patient group tend to range
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from about 25% to over 70%; the range in healthy individuals is from just over 0% to
about 30%. Percentages are difficult to compare across studies, however, due to
differences in task design that may affect performance levels.
Most (Fukushima et al 1990c; Karoumi et al 1998b; Klein et al 2000b; Maruff et al
1998; Matsue et al 1994b), but not all (Nieman et al2000), studies have demonstrated
longer latency in schizophrenia. Hutton et al (1998) observed prolonged latency only in
antipsychotic treated, but not untreated, first-episode patients. The third main
measure, spatial saccadic accuracy, has not been studied comprehensively. There is,
however, some evidence of reduced antisaccade gain in schizophrenia (Karoumi et al
1998b; McDowell et alI999).
The correction rate (initiation of antisaccades after the committal of an error) has been
considered by some to indicate whether patients have understood task instructions and
are willing to comply. Correction rates are generally high, reducing the possibility of a
generalised cognitive, motor or motivational deficit underlying poor antisaccade
performance (Crawford et al 1995a, 1995b; McDowell & Clementz 1997).
There are reliable age effects on antisaccade performance: Young children have
difficulty performing the task (Klein & Foerster 2001); amongst adults, older individuals
tend to make more errors and take longer to initiate correct antisaccades (Gooding &
Tallent 2001; Klein et al 2000a; Olincy et al 1997). Some studies have shown that
females make more errors than males (Crawford et al 1998; Tien et al 1996); however,
the majority of studies have not observed this relationship.
2.5.4.2 Neural and Cognitive Basis of Antisaccade Eye Movements
2.5.4.2.1 NEURAL SUBSTRATES OF ANTISACCADE EYE MOVEMENTS
The precise neural correlates of the antisaccade remain debated (Broerse et al 2001a;
Everling & Fischer 1998). It is thought that antisaccades share with simple reflexive
saccades the basic saccadic circuitry, including FEF, parietal eye fields (PEF), superior
colliculus (sq, brainstem reticular formation and cerebellum. In addition, however,
further cortical areas are likely to be required for the successful suppression of reflexive
errors. Early human lesion studies have primarily implicated the FEF (and SEF) in the
suppression of reflexive errors (Guitton et al 1985). However, more recent lesion studies
have found increased error rate after lesions to the DLPFC but not FEF/SEF
(Fukushima et al 1994; Gaymard et al 1990, 1998b, 1999; Pierrot-Deseilligny et al
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1991). Nevertheless, lesions to the FEF lead to increased antisaccade latency (Rivaud et
al 1994), in line with the well-established role of the FEF in the generation of voluntary
saccades (Pierrot-Deseilligny et al 1995).
Increased rates of antisaccade errors have also been observed after lesions to the
superior colliculus and anterior cingulate (Gaymard et al 1998b). Conversely, lesions to
globus pallidus and putamen appear not to result in increased errors (Vermersch et al
1996). Nonhuman primate recording studies have confirmed a role of the frontal lobe, in
particular FEF, during preparation and execution of antisaccades (Everling & Munoz
2000).
Functional neuroimaging studies of healthy humans have essentially replicated these
findings, including the lack of clarity concerning the roles of FEF and DLPFC in error
suppression. Compared to oculomotor control conditions with low inhibitory demand,
activation during antisaccades has been observed most consistently in DLPFC (Miiri et
al 1998; Sweeney et al 1996) and FEF (Cornelissen et al 2002; O'Driscoll et al 1995;
Sweeney et al 1996). Specifically, Cornelissen et al (2002) could show that FEF activity
rose before initiation of correct antisaccades but not error saccades, likely indicating
pre saccadic inhibitory processes. Similarly, increased FEF activation during a (covert)
inhibitory task has been observed (Perry & Zeki 2000). Paus et al (1993) observed
involvement of the anterior cingulate, in agreement with some lesion evidence (Gaymard
et al 1998b).
Although functional imaging techniques have the advantage of providing relatively good
spatial resolution their key disadvantage is probably the low temporal resolution.
Electroencephalography (EEG) shows the inverse pattern of excellent temporal but poor
spatial resolution. This technique has been used to examine cortical brain activity
preceding pro- and antisaccades in healthy individuals. Studies appear to agree on an
increase in electrical (neural) activity observed in the frontal cortex preceding
antisaccades but not prosaccades, possibly due to processes of pre saccadic inhibition
(Evdokimidis et al 1996; Everling et al 1997). However, due to limitations in spatial
resolution these studies have not been able to address the relative involvements of
specific frontal areas.
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2.5.4.2.2 NEUROIMAGING STUDIES IN SCHIZOPHRENIA
The first functional neuroimaging study of the antisaccade in schizophrenia was
reported by Crawford et al (1996).13 In this single photon emission tomography (SPET)
study schizophrenia patients with normal and high antisaccade error rate were
compared during task performance. Patients with high error rate showed decreased
regional cerebral blood flow (rCBF) in anterior cingulate, insula and left striatum. This
design has the advantage of avoiding non-specific differences between groups, such as
patient status, drug treatment or disease severity. In addition to lending support to the
involvement of the anterior cingulate in antisaccade performance (Gaymard et al
1998b), these findings also point to a role of the basal ganglia.
A recent fMRI study provided clear evidence of DLPFC involvement (McDowell et al
2002). During a pro saccade task, schizophrenia patients demonstrated normal FEF,
SEF and PPC activation. Reduced DLPFC activation relative to healthy controls was
observed during antisaccade performance, which according to McDowell et al (2002)
presents "corroborative evidence that pre frontally mediated inhibition is functionally
impaired among schizophrenia subjects" (p. 222).
In contrast, a second fMRI study of the same year (Raemaekers et al 2002) obtained no
evidence of DLPFC deficits in schizophrenia, but observed that reductions in neural
activity associated with saccadic inhibition in patients (relative to controls) were
localised to the striatum. The difference between this study and that by McDowell and
colleagues (2002) is most likely to lie in the type of stimuli that were used. The
McDowell et a1 study used a 'traditional' antisaccade stimulus, similar to those used
previously (Section 2.5.2) and to that used in this thesis (Chapter 3). Thus, central and
peripheral targets alternated with inter-stimulus intervals of about l,OOO-2,OOOms.
Additionally, the antisaccade block used in the McDowell et al study interleaved
prosaccades and antisaccades; the type of eye movement required was indicated to the
participant by a change in colour of the central target (green: prosaccade; red:
antisaccade) at the beginning of each trial. This design, therefore, placed heavy
demands on (prefrontal) attentional and working memory resources, as the participant
13In an earlier study, Nakashima et a1 (1994) observed reduced FEF and DLPFCactivation in
patients relative to controls during an uncommon version of the antisaccade task: Participants
were required to followa spatially (but not temporally) predictable target, while inhibiting a
distractor stimulus at the opposite side. The extent to which this finding generalises to the
antisaccade task used in most other studies and in this thesis thus remains unclear.
123
Eye Movements in the Schizophrenia Spectrum
had to constantly focus on the task, maintain instructions on-line and make the correct
decision concerning which type of eye movement to initiate at the beginning of each
trial.
The Raemaekers et al study, on the other hand, used an event-related fMRI design in
order to study neural activation associated with individual trials. Inter-stimulus
intervals were more than 12,OOOms, thus isolating the inhibitory component in the
relative absence of continuous working memory or sustained attentional processing. It
is likely that these differences in stimulus sequence led to the failure to observe DLPFC
activation in the Raemaeker et al study. Although Raemaeker et al (2002) ruled out
medication effects as a possible explanation for the striatal underactivation in the
patients, the finding does provide a suggestive link to studies showing increased error
rate in patients with tardive dyskinesia (Thaker et al 1989b, 1989c).
The implications of the Raemaeker et al study for the antisaccade error rate as a
(prefrontal) schizophrenia endophenotype (Calkins & Iacono 2000; Clementz 1998) are
not yet clear. What the findings do appear to indicate is that DLPFC underactivation
might not be necessary to explain inhibitory deficits in schizophrenia. The traditional
antisaccade task, on the other hand, does appear to be a good measure of DLPFC
activation in humans (McDowell& Clementz 2001), whether or not this may be due to
saccadic inhibition, sustained attention, or task complexity.
A recent brain activation study using EEG methods observed significantly reduced
cortical activity (the contingent negative variation; CNV) in schizophrenia patients
before antisaccade performance compared to healthy controls (Klein et al 2000b). The
CNV has been argued to be a measure of prefrontal working memory function, thus
providing some support for frontal hypoactivation during antisaccades in schizophrenia.
The only structural neuroimaging studies of the anti saccade in schizophrenia to date
indicated an association between increased errors and frontal lobe atrophy (Fukushima
et al 1988, 1990b). Unfortunately, however, these studies used small sample sizes, a
low-resolution neuroimaging technique (CT) and qualitative interpretation of brain
structure, necessitating further research in this field.
2.5.4.2.3 EXPERIMENTAL COGNmVE STUDIES
Antisaccade performance may be dissected into three cognitive components: first, the
inhibition of a prepotent response to a peripheral visual target; second, covert
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attentional processes to encode target location; and third, initiation of a voluntary
saccade in opposite direction of the target. Since its first administration to brain
damaged patients, the antisaccade task has been argued to be a measure of frontal lobe
integrity (Guitton et al 1985). Prefrontal cortex is critically involved in processes of
working memory, response inhibition and keeping plans and thoughts 'online'
(Goldman-Rakic 1999). The response inhibition component of the antisaccade task may
be related to the visual grasp reflex (Everling et al 1997). A number of experimental
cognitive studies support the hypothesis that response inhibition, or suppression of the
visual grasp reflex, and working memory are interrelated functions and are required for
successful antisaccade performance. Other studies have pointed to the (covert)
attentional requirements of this task.
One of the key functions of prefrontal cortex is the inhibition of reflex-like, prepotent
responses (Roberts et al 1994). By its face validity, therefore, an antisaccade error
reflects a failure to inhibit a prepotent response, that is a reflexive saccade towards the
target. Using up working memory resources increases the probability to respond in a
reflex-like manner to a prepotent stimulus, similar to everyday action errors during
distraction (taking the 'old' route to a new place of work when one's thoughts are
occupied during driving; Roberts et al 1994). Following this rationale, Roberts et al
(1994) experimentally 'impaired' working memory resources in healthy individuals
during pro saccade and antisaccade task performance through simultaneous
performance of arithmetic calculations. This manipulation increased antisaccade error
rate and latency but did not affect prosaccade metrics. Effects were stronger with
increasing working memory load and were not accounted for by non-specific effects of
task performance (such as listening or speech).
Stuyven et al (2000) could demonstrate that another working memory measure
(internally generated, arrhythmic finger taps) but not a control condition (regular finger
taps) increased antisaccade error rate and latency. Similarly, a recent study showed
increased antisaccade errors during a well-known working memory task, the n-back
task (Mitchell et al 2002). These authors observed non-linear increases in antisaccade
errors, which paralleled increases in DLPFC activation observed in previous studies in
response to the increasing working memory loads of this task (O-back, 1-back, 2-back).
The authors concluded that the most likely neural site of interference of the n-back task
with anti saccade performance might be the DLPFC. Further supporting the involvement
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of the frontal lobe in antisaccade performance, Gooding and Tallent (2001) observed a
relationship with a delayed-response working memory test.
A second line of research has implicated attentional processes in the antisaccade.
Maruff and colleagues (1996; 1998) have pointed to the overlap in reflexive saccades
and overt attentional shifts. Likewise, the first phase of the antisaccade is likely to
involve a covert attentional shift (without eye movement) towards the target, in order to
encode target location. It was shown that schizophrenia patients have difficulties
inhibiting both overt and covert reflexive shifts of attention (Maruff et al 1996, 1998).
Given the observation of intact disengagement of attention to cued targets it was argued
that damage in schizophrenia may not be localised to parietal cortex but probably
frontal attentional areas (Maruff et al 1998). More recently, it was observed that
distracting (covert) attention briefly before an antisaccade eye movement increased or
decreased its latency, depending on its timing [Kristjansson et al 2001).
The processes required between the response inhibition and the initiation of a voluntary
saccade in opposite direction were illuminated by Krappmann et al (1998). These
processes may be referred to as sensorimotor coordinate transformations and require
the transforming of spatial representations between sensory input and motor output.
Likely neural correlates of sensorimotor coordinate transformations are frontal and
parietal areas (Krappmann et al 1998; Leigh & Zee 1999).
Taken together, studies of working memory manipulation during task performance
suggest a necessary prefrontal component in the generation and control of
antisaccades, but not prosaccades. Other studies have pointed to the role of covert
attentional processes and internal manipulation of spatial signals in the initiation of a
motor response. It becomes clear from this brief discussion that successful antisaccade
performance is a multivariate, cognitively (and neurally) complex task. The implications
of this complexity for the endophenotype hypothesis will be discussed later (Section
9.3).
2.5.4.2.4 NEUROPSYCHOLOGICAL STUDIES
The notion that the antisaccade might be a 'frontal' task has also been supported by a
number of studies of standardised neuropsychological tests. The most robust finding is
that of a correlation between error rate and WCST (Crawford et al 1995a, 1995b, 1996;
Karoumi et al 1998b; Radant et al 1997; Rosse et al 1993; Tien et al 1996). Less
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consistent evidence was obtained by Broerse et al (2001b), who found no strong
associations of antisaccade errors with 'frontal' neuropsychological tests (e.g. Stroop
test, TMT-B, verbal fluency), but instead with psychomotor speed (e.g. TMT-A).
The extent to which relationships between antisaccade and 'frontal' neuropsychological
tests can be explained by overall intelligence (IQ), remains unclear, although most
studies appear to suggest that antisaccade deficits remain after covarying (or matching)
for IQ (Crawford et al 1995b, 1995a; Gooding & Tallent 2001; Nieman et al 2000; Tien
et alI996).
2.5.4.2.5 NEURAL CORRELATES - CONCLUSION
Researchers have attempted to pinpoint the neural correlates of antisaccade
impairments in schizophrenia on the basis of findings from lesion, neuroimaging,
cognitive and neuropsychological studies. It appears that the pattern of increased
antisaccade error rate and prolonged latency in schizophrenia is most compatible with
DLPFC and/or FEF damage, consistent with evidence from functional neuroimaging
studies. Cognitive and neuropsychological studies of working memory and covert
attention similarly suggest DLPFC and FEF involvement, respectively. However,
functional imaging studies in the patient group, probably the best evidence of the
neural correlates of antisaccade impairments, remain ambiguous, implying deficits in
frontal (anterior cingulate, DLPFC)and subcortical areas (striatum).
2.5.4.3 Clinical Correlates
There is little consistent evidence of clinical symptom correlates of antisaccade
performance; most schizophrenia studies do not report correlations with severity of
symptoms. One study showed an association between increased antisaccade errors and
conceptual disorganisation as well as motor retardation, with 14 other (positive,
negative, cognitive and emotional) symptom scales showing no effect (Fukushima et al
1990c). Some (Crawford et al 1995b; Muller et al 1999; Tien et al 1996) but not other
(Crawford et al 1996; Karoumi et al 1998b; Raemaekers et al 2002; Rosse et al 1993)
authors observed a relationship with negative symptoms (SANS)and thought disorder
(Tien et al 1996). Additionally, one study (Tien et al 1996) found fewer positive
symptoms to be associated with more antisaccade errors.
Due to the relatively small number of studies of the antisaccade task in schizophrenia
(compared to SPEM), the small samples used in some of these studies and the fact that
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several studies did not report relationships with clinical symptom ratings, more
research into the clinical correlates of anti saccade performance in schizophrenia is
required. Given the evidence of an association between motor abnormalities and
negative symptoms (Wolff & O'Driscoll 1999), future studies should focus on
relationships between antisaccade performance and a) robust measures of negative
symptoms and b) neurological soft signs.
2.5.4.4 Pharmacology
2.5.4.4.1 TREATMENT EFFECTS
A small number of cross-sectional as well as longitudinal studies have examined drug
effects on antisaccade performance. In the first systematic investigation of treated and
untreated schizophrenic patients, Crawford et al (1995a, 1995b) demonstrated
increased error rate and reduced gain in both unmedicated (but previously treated) and
(typically) medicated patients. In post-hoc analyses of (lithium, neuroleptic, anti-
parkinson, antidepressant, anxiolytic, anticonvulsant) medication effects, no
relationships with error rate were obtained in a number of studies (Gooding & Tallent
2001; Maruff et al 1998; Sereno & Holzman 1995). No differences between risperidone
and olanzapine treated first-episode patients were observed in one study (Nieman et al
2000). Muller et al (1999) observed that treatment over 1-4 months with a variety of
typical and atypical antipsychotics did not affect antisaccade error rate.
Significant increases in error rate have been observed in patients with TO compared to
patients without TO (Thaker et al 1989b, 1989c). Additionally, it was shown that the
amount of GABAagonist-induced reductions in antisaccade errors were correlated with
the amount of changes in dyskinesia ratings (Cassady et al 1992). The relationship
between anti saccade and TO might be due to the effects of long-term antipsychotic
treatment, possibly mediated by GABAergic neurons in the basal ganglia (Thaker et al
1989b, 1989c).
Two recent studies point to the existence of positive treatment effects on the error rate.
In an elegant cross-over longitudinal design, Burke and Reveley (2002) demonstrated
that patients had lower error rate under risperidone than typical antipsychotic
treatment. This effect was not caused by practice effects as it was observed after
'switching' in both directions (risperidone ~ typical and typical ~ risperidone); it was
also independent of changes in psychotic symptoms. As error rate worsened after a
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switch from risperidone to typical anti psychotics, the improvement effected by
risperidone treatment may be only temporary. Risperidone has previously been shown
to improve core schizophrenic symptoms as well as neurocognitive deficits when
compared to typical antipsychotics (Honey et al 1999), possibly due to its antagonism of
5-HT2 receptors. This hypothesis was supported by a recent study showing beneficial
effects of the 5-HT2 antagonist cyproheptadine on anti saccade error rate and other
'frontal' neuropsychological tests (Chaudhry et al 2002). 5-HT2 antagonism is thought
to activate dopaminergic neurons projecting to the prefrontal cortex, thus increasing OA
turnover in this area (Friedman et al 1999).
It appears, therefore, that typical antipsychotic treatment has little effect on the key
measure of antisaccade error rate but antagonism of 5-HT2 receptors (and, indirectly,
action on prefrontal OA transmission) may improve performance. An alternative
explanation of the findings by Burke and Reveley (2002), however is that reduced OA
occupancy of the basal ganglia (and associated motor side effects) led to the observed
improvements in error rate with risperidone. This finding might be compatible with the
observed association between error rate and TO (Thaker et al 1989b, 1989c) and the
involvement of the striatum in saccadic disinhibition in schizophrenia (Raemaekers et al
2002). The extent to which clinical doses of anticholinergic treatments affect
anti saccade performance is unknown.
2.5.4.4.2 EFFECTS OF PHARMACOLOGICAL MANIPULATION IN HEALTHY INDIVIDUALS
Antisaccade errors are increased dose-dependently in healthy individuals by
administration of a benzodiazepine drug, lorazepam (Green et al 2000; Green & King
1998). These impairments were associated with increased latency and slowed peak
velocity and were specific to lorazepam; chlorpromazine and sertraline had no effect on
error rate. In contrast, McCartan et al (2001) recently observed an increase in error rate
with chlorpromazine.
These studies leave open the question of whether administration of typical
antipsychotics causes antisaccade impairments in schizophrenia, and call for caution in
the interpretation of findings from patient groups receiving benzodiazepines.
Evidence for an involvement of dopaminergic pathways in antisaccade performance was
obtained in further studies. Oursun et al (1999) found that a small number of
amphetamine (a drug of abuse acting on the OA system) users had higher error rates
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than non-users. Duka and Lupp (1997) observed reduced antisaccade error rates in
healthy individuals during monetary incentives (but no effects on other saccadic
paradigms). Additionally, Duka and Lupp (1997) found that the dopaminergic agonist
levodopa led to increased antisaccade errors in healthy volunteers. Error rate was also
increased by overnight withdrawal from smoking in smokers and reduced by smoking
before testing (Powell et al 2002). Due to the action of nicotine on dopaminergic
pathways (Powell et al 2002), and as the same participants also displayed reduced
responsiveness to incentive motivation during abstinence, it is likely that dopamine
mediated motivational stimulus properties affect anti saccade performance. Relatedly,
Klein et al (2002) showed improvements in antisaccade errors during methylphenidate
administration (an indirect dopamine agonist often used in the treatment of ADHD) in
adults with ADHD.
A role of dopamine in antisaccade performance is, of course, also consistent with the
prefrontal neural correlates of this task (Section 2.5.4.2). It has, for example, been
established that disruption of DA projections to prefrontal cortex impairs working
memory performance (Friedman et al 1999); working memory relies on intact prefrontal
cortex and is thought to be a key cognitive component of antisaccade performance.
Similarly, acute administration of amphetamine (a dopamine agonist) improves
prefrontal cortex function during WCSTperformance, a test shown to be correlated with
antisaccade error rate (Daniel et al 1991; Rosse et al 1993).
2.5.4.5 Validity as Endophenotype
2.5.4.5.1 HERITABIUTY
A recent study observed considerable heritability of the antisaccade error rate in
healthy, adolescent twins (Malone & Iacono 2002). Using biometric model-fitting
analysis, additive genetic factors were found to account for more than half of the
variance in antisaccade performance. Amongst non-genetic factors, the largest source of
variance was found to be non-shared environmental factors.
2.5.4.5.2 TEMPORAL STABILITY
Surprisingly few studies have investigated the temporal stability of antisaccade
performance. Roy-Byrne et al (1995) reported non-significant intrac1ass correlations
(ICC) for antisaccade error rate but good reliabilities for latency. Correlations for
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reflexive saccade latency and SPEM measures in the same sample were considerable
and significant. The failure to obtain significant ICC for anti saccade error rate might
have been due to the restricted range of scores (the number of reflexive errors ranged
from 0-2) and the very small sample (N=8). Similarly, Klein and Berg (2001) reported
low reliability of antisaccade error rate, but good reliability of antisaccade latency over a
four-week interval in twenty healthy individuals.
More positive results were obtained by Thaker et al (1989a), who mentioned (but did not
provide detailed data of) test-retest reliabilities for antisaccade latency and error rate of
r>0.75 over periods of one week to one year.
Apart from the parenthetic report by Thaker et al (1989a), no study has, therefore,
demonstrated good antisaccade reliability in healthy individuals or schizophrenia
patients. Such a demonstration is urgently required in order to confirm the
antisaccade's status as a schizophrenia spectrum endophenotype.
2.5.4.5.3 SPECIFICITY TO SCHIZOPHRENIA
Antisaccade impairments are not specific to schizophrenia but are observed in a
number of psychiatric and neurological disorders. Most antisaccade studies in these
disorders may, for the purpose of this review, be classified into two categories: first,
those relating to affective disorder; and second, those relating to disorders of fronto-
striatal networks. In addition to these two disease categories, however, antisaccade
abnormalities have also been discovered in conditions such as Alzheimer's disease (Abel
et al 2002; Currie et al1991) (although no clear evidence of abnormalities was obtained
in dementia by Mulligan et al, 1996), persistent whiplash syndrome (Mosimann et al
2000), neurological impairments after cardiac surgery (BhaskerRao et al 1998) and
autism (Minshew et al 1999).
The evidence from studies of patients with affective disorders is somewhat mixed, but
appears to indicate that antisaccade errors are moderately increased in this disorder.
This has been confirmed for both unipolar depressed, manic and bipolar patients
(Crawford et al1995a; Curtis et al2001a; Gooding & Tallent 2001; Katsanis et al1997;
Sereno & Holzman 1995; Sweeney et al 1998b; Tien et al 1996), although normal
performance has also been reported (Fukushima et al 1990c). Generally, performance
levels of affective disorder patients fall between those of schizophrenia patients and
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healthy controls, similar perhaps to those of first-degree relatives of schizophrenia
patients (Curtis et al2001a).
A number of studies have demonstrated that patients with presumed fronto-striatal
atrophy have difficulties on the antisaccade task, as indexed by increases in error rate
and, less consistently, prolongations of latency. These patient groups include OCO
(Rosenberg et al 1997a, 1997b; Tien et al 1992b; however, see Maruff et al, 1999, for a
failure to replicate increased antisaccade errors), attention deficit/hyperactivity disorder
(Aman et al 1998; Mostofsky et al2001a; Nigg et al 2002), Tourette's syndrome (Oursun
et al 2000b; Farber et al 1999; Straube et al 1997), progressive supranuclear palsy
(Pierrot-Oeseilligny et al 1989; Vidailhet et al 1994) and Huntington's disease (these
deficits appear to be independent of antipsychotic drug treatment; Oursun et al 2000a;
Lasker & Zee 1997).
Antisaccade abnormalities in Tourette's syndrome may be due to co-morbidity with
AOHO (Mostofsky et al 2001 b) and people with cocaine dependence may have increased
error rate if they display foraging behaviours related to drug craving (Rosse et al 1994).
Conversely, Parkinson's disease patients have inconsistent antisaccade performance
(Crevits et al 2000; Fukushima et al 1994; Lueck et al 1990; Vidailhet et al 1994).
These diverse patient groups are thought to have in common structural and functional
neural abnormalities centred on prefrontal cortex and basal ganglia, in particular the
striatum (caudate and putamen). While symptoms and course of illness clearly differs
between these different disorders, findings of antisaccade deficits have most commonly
been attributed to abnormalities in the fronto-striatal network. The precise
abnormalities of fronto-striatal connections and possible overlap with the
pathophysiology of schizophrenia remain to be investigated more closely.
This pattern of findings across a large number of studies clearly challenges the
assumption of specificity relating to the anti saccade error rate as a schizophrenia
endophenotype. However, a number of issues must first be considered before discarding
the antisaccade task on these grounds.
First, little is known about the nature of antisaccade deficits in affective disorder
patients. It remains to be investigated whether heightened antisaccade error rate is a
trait or state measure in this population and whether their first-degree relatives also
share this abnormality. A first hint for differences in the type of antisaccade
impairments in schizophrenia and bipolar disorder comes from studies suggesting
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different neurocognitive correlates of the error rate in bipolar and schizophrenic
patients (Gooding & Tallent 2001; Sereno & Holzman 1995; Tien et al1996).
Second, antisaccade impairments in non-schizophrenic (especially affective disorder)
patient groups appear to be of modest magnitude (performance levels often fall between
those of schizophrenia patients and healthy people) and less consistent, as some
failures to replicate have been observed. These failures to replicate contrast with the
very robust observation of antisaccade impairments in schizophrenia across a large
number of studies.
Third, a shared neural substrate at a macro-level (e.g. 'prefrontal-striatal dysfunction,
between schizophrenia and other disorders may not in itself be damaging to the validity
of the antisaccade endophenotype in schizophrenia research. The precise neural deficits
within these (large) structures remain to be investigated. With regard to schizophrenia
and bipolar disorder in particular, recent views hold that there may be a shared genetic
basis of these two disorders, in addition to common clinical and neurocognitive features
(Maier et al 1999). In contrast, however, antisaccade impairments do not appear to be a
genetic marker for Huntington's disease. Rothlind et al (1993) found no differences
between presumed Huntington's disease gene carriers and non-carriers on antisaccade
performance; this finding, of course, contrasts with the evidence of antisaccade
impairments in the family members of schizophrenia patients (Section 2.5.4.5.4).
2.5.4.5.4 FAMILY AND TWINSTUDIES
Since the first observation of increased antisaccade error rate in first-degree relatives of
schizophrenia patients (Clementz et al 1994), a number of studies have replicated this
finding in parents, siblings and offspring (Curtis et al 2001a, 2001b; Karoumi et al
2001; Katsanis et al1997; Ross et al 1998d; Thaker et al 2000). However, two studies
failed to find statistically significant differences in error rate between relatives and
healthy controls (Crawford et al 1998; Thaker et al 1996a).
A number of additional findings relating to the validity of the antisaccade
endophenotype have emerged from these family studies. First, increased error rate has
been observed in relatives with and without psychiatric symptoms, suggesting an
independence of acute psychiatric symptoms (Curtis et al 2001a; Katsanis et al 1997).
Second, antisaccade errors, like SPEM performance scores, show a familial pattern:
Relatives of patients with high error rate have higher error rate than relatives of patients
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with low error rate (Crawford et al 1998; Curtis et al 2001a). Third, antisaccade latency
is not generally found to be prolonged in first-degree relatives (Clementz et al 1994;
Crawford et al 1998; Karoumi et al 2001; Katsanis et al 1997; McDowell & Clementz
1997; Ross et al 1998d); however, see (McDowellet al1999; Thaker et al 1996a, 2000).
Fourth, deficits appear to be most severe in relatives with schizophrenia spectrum
symptoms (Thaker et al 2000). Fifth, performance may be worse in multiplex than
simplex schizophrenia family members (McDowell et al 1999), suggesting an effect of
increased genetic loading (or familiality).
2.5.4.5.5 FIRST-EPISODE PSYCHOSIS
Antisaccade impairments have been replicated in samples of first-episode patients,
supporting the notion that they might be intrinsic to the disease process or the genetic
disposition. Hutton et al (1998a) observed substantially increased error rates in both
drug-naive and neuroleptic treated patients. Treated but not drug-naive patients had
reduced primary antisaccade gain; final eye position, however, did not differ between
groups. Drug-naive patients had longer latency than treated patients and healthy
controls. Nieman et al (2000) observed similar increases in error rate in the patient
group. Additionally, patients had reduced primary gain.
2.5.4.5.6 $CHIZOTYPY
Increases in error rate, but not latency, have been related to higher scores on
psychometric measures of schizotypy in university students, further supporting the
association between this measure and the schizophrenia spectrum (Gooding 1999;
Larrison et al 2000; O'Driscoll et al 1998).
The scales that were used in these studies focussed on positive schizotypal signs and
symptoms, including the Chapmans' Perceptual Aberration (Chapman et al 1980) and
Magical Ideation (Eckblad & Chapman 1983) scales as well as the Rust Inventory of
Schizotypal Cognitions (Rust 1989), but also the Schizotypal Personality Questionnaire
(Raine 1991) and the Chapmans' Social Anhedonia Scale (Mishlove & Chapman 1985).
This pattern of findings suggests antisaccade errors are associated with both positive
and negative dimensions of schizotypy; however, the negative dimension has not been
explored in great depth.
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A recent study failed to obtain differences between healthy schizotypy high and low
scorers (Klein et al 2000c), possibly due to methodological reasons.!" The only
investigation of the anti saccade in people with schizotypal personality disorder (SPD)
observed no statistically significant differences compared to a control group (Brenner et
al 2001). However, as Brenner et al (2001) claimed, a subgroup of SPD patients had a
significantly increased error rate.
Effects of trait emotionality on the association between antisaccade impairments and
schizotypy have not been explored. O'Driscoll et al (1998) observed that high scorers on
the Chapmans' Perceptual Aberration scale also had higher scores on measures of state
anxiety and depression (Beck Depression Inventory; BOI) and that there was a
correlation between BDI scores and antisaccade errors. Importantly, however, neither of
these measures fully accounted for the relationship between SPEM and antisaccade
dysfunction and positive schizotypal traits.t-
2.5.4.5.7 MOLECULAR GENETIC STUDIES
Only one molecular genetic study to date has used the antisaccade task as an
endophenotype. This study combined the error rate with a measure of sensorimotor
gating (from the P50 event-related potentials paradigm) into a "composite inhibitory
phenotype" (p. 544) and observed linkage to a locus on chromosome 22qll-q12 in eight
multiplex schizophrenia families (Myles-Worsley et al 1999). Importantly, this
chromosomal region has been implicated in schizophrenia linkage as well as other
genetic studies, thus providing suggestive evidence of an important susceptibility locus
(Egan et al2001b; Jorgensen et al2002).
Clearly, given the otherwise promising evidence of the antisaccade error rate as a
schizophrenia endophenotype, further linkage and other molecular genetic studies are
required.
14 For a more detailed discussion of the Klein et al (2000c) study, see Section 7.5.3.
15 Shafiq-Antonacci et al (1999) observed a correlation between heightened trait anxiety and
increased antisaccade errors, however, did not include measures of schizotypy.
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2.6 Prosaccade Eye Movements
2.6.1 Definition
A prosaccade, or reflexive saccade, is a rapid eye movement in response to a (visual)
stimulus of abrupt onset. It serves to bring the image of an object of interest onto the
fovea. As prosaccade performance has been found to be unimpaired in schizophrenia in
a number of studies, and due to the physiological similarity with the antisaccade, this
task is often considered a 'control' condition for the antisaccade task rather than a
genetic marker in schizophrenia spectrum research and will, therefore, be considered
only relatively briefly. The terms prosaccade and reflexive saccade are used
interchangeably in this thesis, as both refer to a reflex-like saccadic eye movements in
response to a visual stimulus. The term prosaccade further underscores the
methodological differences between the antisaccade and prosaccade tasks.
2.6.2 ProsaccadeStimulus
2.6.2.1 Hardware
Stimulus display methods in the prosaccade task mirror those of the antisaccade, using
computer monitors (Curtis et al 2001a; Klein et al 2000c), LEOs (Crawford et al 1998;
Fukushima et al1990a; Hutton et al1998a; Karoumi et al2001; Schwartz et al1995a)
and laser targets (Maruff et al 1998). Physical targets properties are likewise similar to
those of the antisaccade, consisting of common shapes, such as squares or dots.
2.6.2.2 Stimulus Properties
The most commonly used laboratory-based horizontal pro saccade trial begins with the
target in the central location (0°), which then moves abruptly horizontally to one of a
number of peripheral locations. Instructions to participants are to follow the target
movement, with their eyes, as accurately and quickly as possible.
About 20-60 trials are carried out in a standard pro saccade task (Broerse et al 2001 b;
Crawford et al 1998; Karoumi et al 1998b; Klein et al 2000c; Thaker et al 2000). Some
researchers have presented an auditory stimulus (e.g. buzzer) simultaneously with the
peripheral target (Burke & Reveley 2002; Crawford et al 1998; Hutton et al 1998a;
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Karoumi et al 1998b; Larrison et al 2000). Different peripheral target amplitudes have
been used, typically ranging between ±SOand ±30°.
Some researchers have used random rather than fixed horizontal target locations
(Muller et al 1999; Straube et al 1999). This specification has the advantage of making
targets completely spatially unpredictable; however, it makes analysis of specific target
amplitudes difficult. As target amplitude might affect between-group differences
(Schreiber et al 1997) it may be beneficial to use at least two different visual angles on
either side of the central fixation point, possibly dividing each herni-field equally. This
allows the comparison of saccades of small and large amplitude.
Regarding the temporal characteristics of pro saccade targets, a number of studies have
adopted a fixed duration of central fixation point presentation, typically in the range of
SOO-l,OOOms(Broerse et al 2001b; Crawford et al 1998; Hutton et al 1998a). Other
tasks have employed randomised central target durations, most commonly ranging
between 1,000ms and 3,000ms (Fukushima et al 1990c; Karoumi et al 1998b; Levin et
al 1981a; Sweeney et al 1997; Thaker et al 2000), thereby making target appearance
temporally unpredictable. Peripheral target durations are usually fixed for about 1,000-
2,000ms.
A number of variations of the standard pro saccade paradigm have been employed in
schizophrenia spectrum research. The gap task introduces a temporal gap of about
200ms between fixation point and peripheral target appearance (Cavegn & Biscaldi
1996; Fischer 1986; Wenban-Smith & Findlay 1991). This gap has been shown to
reduce saccadic latency, produce an increased number of so-called express saccades
(latency< lOOms) and induce the so-called gap negativity, i.e. a negative electrical brain
wave peaking 200ms after the fixation point has disappeared. Conversely, in the overlap
task the central and peripheral targets overlap by about 200ms, leading to increased
latency (Cavegn & Biscaldi 1996; Fischer 1986; Fischer et al 1997; Klein et al 2000c;
Reuter-Lorenz et al1991; Spantekow et al1999; Wenban-Smith & Findlay 1991).
Some researchers (Clementz et al 1994; Schmid-Burgk et al 1983; Schreiber et al 1995)
have used target movements slightly departing from the regular prosaccade task. In
these studies, the target stepped (quasi-)randomly between a number of horizontal
target locations. Thus, a trial did not consist of a central-peripheral step, but of steps in
either horizontal direction, foveofugal or foveopetal. This task has the advantage of
making the target appearance spatially unpredictable. However, as it has been shown
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that saccadic metrics differ between foveofugal and foveopetal steps (Leigh & Zee 1999),
a (quasi-)random selection of such trials increases the heterogeneity of the task.
2.6.3 Prosaccade Scoring
The two most commonly used measures of prosaccade performance in schizophrenia
spectrum research are those of latency and gain. Criteria of minimum amplitude (2°_5°;
Broerse et al 2001b; Gooding 1999; Straube et al 1999), latency (about 70-100ms;
Fischer et al 1997) and velocity at saccade initiation (5°-300/s; Clementz et al 1994;
Crawford et al 1998; Sweeney et al 1997) have been used in the automatic detection of
saccades.
Primary saccade gain is calculated as outlined above (Section 2.5.3). A gain score of
100%, therefore, reflects perfect primary saccade accuracy. Additionally, final eye
position has been reported, as defined above (Crawford et al 1995a, 1995b, 1998;
Hutton et al 2000). The latency reflects the time, in milliseconds, between target
appearance and saccade initiation.
In addition to gain and latency, some previous studies have reported measures of
average and peak velocity and duration (Clementz et al 1994; Fukushima et al 1994;
Levin et al 1981a, 1982b; Sweeney et al 1997; Thaker et al 2000). Reflexive saccade
peak velocity has been widely studied in pharmacological research, due to its sensitivity
to CNS active pharmacological agents (Griffiths et al 1984). Most studies of
schizophrenia spectrum participants, however, have not included measures of velocity.
2.6.4 Prosaccade Eye Movements in the Schizophrenia Spectrum
2.6.4.1 Behavioural Characterisation of Prosaccade Eye Movements
in Schizophrenia Patients
According to some (e.g. McDowell & Clementz 2001), prosaccade performance is
unimpaired in patients with schizophrenia. This claim is supported by numerous
studies demonstrating normal latency (Clementz et al 1994; Couch & Fox 1934;
Crawford et al 1995a, 1995b, 1998; Curtis et al 2001a; Diefendorf & Dodge 1908;
Karoumi et al 1998b; Klein et al 2000b; Krebs et al 2001; Maruff et al 1998; Matsue et
al 1994b; Muller et al 1999; Schwartz et al 1995a; Sweeney et al 1997), accuracy
(Clementz et al 1994; Crawford et al 1995a, 1995b, 1998; Hommer et al 1991; Karoumi
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et al1998b, 2001; Krebs et al2001; Levin et al1981a, 1982b; Maruffet al1998; Muller
et al 1999; Park & Holzman 1992; Sweeney et al 1997; Vee et al 1987) and velocity
(Clementz et al1994; Levin et al 1981a, 1982b; Mather & Putchat 1982; Sweeney et a1
1997) in this patient group. Additionally, the relationship between saccade amplitude
and duration as well as peak velocity (the main sequence; Leigh & Zee 1999) has been
shown to be comparable to healthy individuals (Clementz et al 1994; Fukushima et al
1990b; Levin et al1981a, 1982b).
Studies of the gap prosaccade task have indicated that schizophrenia patients are able
to display reduced latency and increased frequency of express saccades compared to
non-overlap stimuli similar to healthy individuals (Clementz 1996b; Matsue et al 1994a;
Sereno & Holzman 1993). However, Currie et al (1993) observed fewer express saccades
in the patient group.
Based on these findings it is often claimed that the schizophrenic disease process
spares the basic saccadic neural circuitry and the pro saccade task may, therefore, be
used as a control condition for the cognitively more complex antisaccade task (e.g.
McDowell & Clementz 2001). Unimpaired prosaccade performance has also been
interpreted as indicating, in addition to an intact basic saccadic neural circuitry,
sufficient levels of motivation and compliance, supporting the specificity across
oculomotor tasks of antisaccade (and SPEM) impairments.
While this line of reasoning is important and supported by considerable evidence, there
is also evidence of impaired prosaccades in schizophrenia. Patients with schizophrenia
have been shown to display longer prosaccade latency (Evans & Schwartz 1997;
Mackert & Flechtner 1989), decreased and increased peak velocity (Cegalis et al 1982,
1983; Fukushima et al 1990a, 1990b, 1990c; Mahlberg et al 2001; Schwartz et al
1995a) and reduced accuracy (Cegalis et al 1982; Mather & Putchat 1982; Schmid-
Burgk et al 1982, 1983; Schwartz et al1995a).
The reasons for these discrepancies between studies are unclear, but may involve
treatment factors or stimulus characteristics. One hint concerns stimulus amplitude:
Two independent investigations (Schreiber et al 1997; Schwartz et al 1995a) observed
reduced saccadic gain in schizophrenia spectrum individuals only for large-amplitude
targets, not commonly used in other studies. It is, therefore, a possibility that saccadic
deficits in the schizophrenia spectrum are restricted to large saccades. In concordance
with this assumption, Levin et al (1981a) observed a trend for longer latency to larger
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amplitude targets in schizophrenia. Clearly, the claim of unimpaired prosaccades in
schizophrenia has to be treated with caution.
2.6.4.2 Cognitive and Neural Basis of Prosaccade Eye Movements
in Schizophrenia Patients
Given the inconsistency of prosaccades performance in schizophrenia it is difficult to
deduce a specific neural or cognitive substrate of impairments when seen. Indeed, a
number of writers have argued that, given the behavioural data, the basic saccadic
neural circuitry is likely to be intact (e.g. McDowell & Clementz 2001). Cortical areas
most likely involved in triggering reflexive saccades are FEF and PEF (Gaymard et al
1998a; Pierrot-Deseilligny et al 1995). Patients with FEF lesions have increased latency
of voluntary saccades, but not consistently of simple reflexive saccades. PEF damage,
on the other hand, appears to prolong latency of reflexive saccades (Pierrot-Deseilligny
et al 1991). Neural projections important for the generation of reflexive saccades are
those from PEF to FEF and from both PEF and FEF to the SC; the SC (as well as the
FEF) projects to the brains tern reticular formation. The cerebellar vermis, in concert
with other areas, plays a crucial role in determining saccadic accuracy (Barash et al
1999; Batzel et al 1993; Ettinger et al 2002; Hashimoto & Ohtsuka 1995; Takagi et al
1998; Vahedi et alI995).
Observations of normal prosaccade latency and accuracy in some schizophrenia studies
might thus argue for an intact saccadic neural circuitry, including brainstem, SC,
cerebellum and PPC. This assumption is further supported by a functional
neuroimaging study (McDowell et al 2002) already discussed, which obtained normal
levels of activation in FEF, SEF and PPC during prosaccade performance in
schizophrenia patients. Raemaekers et al (2002), on the other hand, observed slightly
reduced - but not absent - activation in visual cortex, FEF, SEF and PEF in
schizophrenia patients compared to controls.
Findings of impaired saccadic accuracy in some studies (Cegalis et al 1982; Mather &
Putchat 1982; Schmid-Burgk et al 1982, 1983; Schwartz et al 1995a) may at first be
interpreted as indicating subtle impairments of cerebellar vermis. It is, however,
important to note the difference between the hypometric saccades of lesioned humans
(and nonhuman primates) (Barash et aI 1999; Batzel et al 1993; Takagi et al 1998;
Vahedi et al 1995) and people with schizophrenia. Individuals with cerebellar or
brainstem lesions are usually unable to perform spatially accurate saccades (Schmid-
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Burgk et al 1983; Schreiber et al 1997). Patients with schizophrenia, however, tend to
make saccades of variable amplitudes, some of which are hypometric, resulting in
overall between-group differences in some studies. Therefore, the neural substrate of
reduced saccadic accuracy in schizophrenia is unlikely to be found in the brainstem or
cerebellum, but may possibly be localised to cortical areas such as FEF (Schreiber et al
1997) or PEF (Gaymard et al 1998a).
Studies of gap prosaccades have shown that lesions to the FEF, SC and PPC disrupt the
generation of express saccades. Based on observations of normal or increased frequency
of express saccades in schizophrenia patients, McDowell and Clementz (McDowell &
Clementz 2001) argued that these brain areas are, therefore, unlikely to be impaired in
schizophrenia. Additionally, as Clementz (1996b) argued, damage to DLPFC can lead to
an increased generation of express saccades, suggesting DPLFC damage in
schizophrenia. Conflicting with this conclusion is, of course, the observation of fewer
express saccades in schizophrenia by some researchers (Currie et al 1993).
Cognitive interpretations of prolonged prosaccade latency in schizophrenia have drawn
on attentional processes (Mackert & Flechtner 1989), such as impairments in the
disengagement of covert attention from the central fixation target (Evans & Schwartz
1997). Similarly, Schwartz and Evans (1999) could show that reflexive saccade latency
in schizophrenia patients increased during the introduction of a peripheral distractor,
likely due to the interference with overt as well as covert attentional processes.
Attentional hypotheses of problems in saccade initiation are in accord with studies
showing overlap in the neural networks mediating covert and overt shifts of attention
(Beauchamp et al2001; Nobre et al2000).
Taken together, evidence from studies of reflexive saccade control in schizophrenia
patients argues for relatively intact basic saccadic neural circuitry, including brainstem
and cerebellum, with inconsistent evidence concerning the roles of FEF and PPC.
2.6.4.3 Clinical Correlates
Prosaccade metrics are not consistently correlated with clinical symptom ratings in
schizophrenia patients (Clementz 1996b; Evans & Schwartz 1997; Karoumi et al 2001;
Mackert & Flechtner 1989; Mahlberg et al2001).
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2.6.4.4 Treatment Effects in Schizophrenia and Pharmacological
Manipulation in Healthy Individuals
A large variety of pharmacological compounds interfere with saccadic control in healthy
individuals. Indeed, the susceptibility of prosaccades to centrally mediated drug effects
makes this task an ideal tool for the detection of CNS activity of novel compounds
(Griffiths et al 1984). Compounds with relevance to schizophrenia research which
disturb prosaccade control include benzodiazepines, opiates, antipsychotics,
monoamine oxidase inhibitors, alcohol and others (Blekher et al 2002; Griffiths et al
1984; Roy-Byrne et al1993; Schmid-Burgk et alI982).
A longitudinal study of risperidone treatment in schizophrenia patients showed adverse
effects of this drug on latency, peak velocity and accuracy (Sweeney et al 1997), a
finding later partly replicated in a cross-sectional design (Nieman et al 2000). However,
Burke and Reveley (2002) found no differences between risperidone and typical
antipsychotic treated patients. Curtis et al (2001a) observed reduced pro saccade gain in
patients taking anxiolytics, but no effects of antipsychotics or anticholinergics. Other
studies have found no associations between pro saccade metrics and treatment
variables (Clementz 1996b; Crawford et al 1995a; Karoumi et al 2001; Mahlberg et al
2001; Schmid-Burgk et al1982).
Given the effects of pharmacological compounds on prosaccades demonstrated in some
studies, research addressing comparisons between schizophrenia patients and healthy
individuals not adjusting for these effects have to be treated with caution.
2.6.4.5 Validity as Endophenotype
2.6.4.5.1 HERITABILITY
In a study already described (Section 2.3.5.5.1), Bell et al (1994) investigated
prosaccade performance in eight pairs of healthy twins and found ICC between twins of
0.64 (latency) and 0.83 (gain). However, the absence of a group of dizygotic twins makes
the assessment of heritabilities impossible. Blekher, Gale and colleagues (Blekher et al
1998; Gale et al 1996) observed high within-twin pair correlations for prosaccade
latency, accuracy and peak velocity in MZ but not in DZ twins and suggested that
variance might be best accounted for by multiple genes and/or prenatal environmental
factors; the MZ twins were the same as those studied by Bell et al (1994).
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2.6.4.5.2 TEMPORAL STABILITY
Measures of prosaccade latency, accuracy and amplitude-duration as well as
amplitude-velocity relationships are stable over durations ranging from several weeks to
two years (Iacono & Lykken 1979a; Versino et al1993; Wilson et al1993).
2.6.4.5.3 SPECIFICITY TO SCHIZOPHRENIA
Reflexive saccade eye movement abnormalities are observed in a number of neurological
conditions (Leigh & Zee 1999). Patterns of abnormalities in these patient groups include
prolonged latency and reduced accuracy, similar to some schizophrenia patients.
However, many individuals with neurological disorders or acquired brain lesions also
display evidence of main sequence perturbances, not observed in schizophrenia.
Additionally, as outlined above, many individuals with acquired brain damage or
neurological disorders appear to have more severe, and qualitatively different,
abnormalities than people with schizophrenia.
2.6.4.5.4 FAMILY AND TWIN STUDIES
While most studies have found normal pro saccade performance in first-degree relatives
of schizophrenia patients (Crawford et al1998; Curtis et al2001a; Karoumi et al2001;
Thaker et al 2000), there are some reports to the contrary. Hypometric (reduced
accuracy) prosaccades have been observed in a mixed sample of first-degree relatives
(Schreiber et al 1995) as well as adolescent offspring of schizophrenia patients (Mather
1985; Schreiber et al 1997). Interestingly, in the Schreiber et al (1997) study, relatives
showed hypometric saccades most reliably to large amplitude targets (>30°), mirroring
those observed in the patient group (Section 2.6.4.1). Most previous studies have not
used such large amplitudes, possibly explaining the failures to obtain this finding.
2.6.4.5.5 FIRST-EPISODE PSYCHOSIS
Prosaccade metrics appear to be relatively normal in patients in their first psychotic
episode (Hutton et al 1998a, 2002), although Nieman et al (2000) observed prolonged
latency in risperidone treated first-episode patients (suggesting a treatment effect; see
Section 2.6.4.4).
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2.6.4.5.6 SCHIZOTYPY
There is no consistent evidence of an association between levels of schizotypy and
prosaccade metrics in healthy individuals (Gooding 1999; Klein et al 2000c; Larrison et
al 2000), although Iacono and Lykken (1979b) observed an association between longer
latency and higher scores on the psychoticism dimension (Eysenck & Eysenck 1976).
2.6.4.5.7 MOLECULAR GENETIC STUDIES
No study to date has employed the prosaccade task as a phenotype in schizophrenia
linkage studies.
2.7 Other Eye Movement Tasks
In addition to the SPEM, fixation, antisaccade and prosaccade tasks, a number of other
experimental paradigms involving the recording of eye movements have been used in
schizophrenia spectrum research. Some of these (e.g. predictive saccade and memory-
guided saccade tasks) are similar to the tasks discussed above in terms of stimuli and
procedure; others focus on the processing of complex semantic stimuli.
The predictive saccade task involves a spatially as well as temporally predictable visual
target stepping between two peripheral locations (e.g. ±12°). In this task, predictive
saccadic behaviour is usually established in healthy individuals after a few target
oscillations. Predictive behaviour is indicated by reduced saccadic latency and an
increased frequency of 'anticipatory saccades'; these are saccades made not in response
to but in anticipation of the target movement (e.g.latency<100ms).
People with schizophrenia appear to be as able as healthy individuals to make
anticipatory saccades (Litman et al 1994); indeed, some reports observed faster latency
and greater frequency of anticipatory saccades in schizophrenia (Karoumi et al 1998a;
McDowell et al 1996). The second characteristic of predictive saccade performance in
schizophrenia is that of reduced amplitude saccades, or hypometria (Hommer et al
1991; Hutton et al 2001b; Krebs et al 2001; McDowell et al 1996). This finding was
initially thought to be mediated by typical neuroleptic drug treatment (as similar deficits
were observed in Parkinson's disease; Crawford et al 1995b, 1995a; Hommer et al
1991); however, a recent report observed hypometric predictive saccades in never-
medicated patients, suggesting a working memory deficit (Hutton et al 2001 b).
Predictive saccades have not yet been examined closely in first-degree relatives, making
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it difficult to estimate whether this task might constitute an oculomotor endophenotype.
In one investigation, Clementz et al (1994) did not find impairments.
In the memory-guided saccade, or oculomotor delayed response task, participants are
presented with a central fixation point. During fixation of this target a peripheral target
appears briefly (e.g. SOOms); participants are instructed not to saccade towards this
target. Upon disappearance of the central target participants are required to initiate a
saccade to the remembered location of the peripheral target. This task, therefore,
requires the inhibition of a reflexive saccade towards the saccade, the covert encoding
and memorisation of the spatial location of the peripheral target and the initiation of a
voluntary saccade towards the remembered target location.
People with schizophrenia tend to make an increased number of reflexive errors to
target (Crawford et al 1995a, 1995b; McDowell & Clementz 1996), consistent with the
demonstration of reflexive errors on the antisaccade task. Additionally, memory-guided
saccades in schizophrenia tend to be of prolonged latency and reduced accuracy (i.e.
hypometric) (Everling et al 1996; Krappmann & Everling 1998; McDowell & Clementz
1996; Park & Holzman 1992). Similar deficits of reflexive errors and hypometric
saccades were observed in first-degree relatives of schizophrenia patients (McDowell et
al 2001; Park et al 1995). On the basis of these observations, and as memory-guided
saccade task performance appears to rely on DLPFC integrity (Pierrot-Deseilligny et al
1995), it has been suggested that this task might be useful to study both the
pathophysiology and genetics of schizophrenia (McDowellet al 2001; Park et al 1995).
In contrast to the predictive and memory-guided saccade tasks as well as the tasks
studied in this thesis, further paradigms involve the recording of eye movements while
participants are viewing semantically meaningful stimuli, such as pictures, complex
shapes, or faces.
A number of authors have noted visual scan paths of reduced area and fewer but longer
fixation periods in people with schizophrenia when viewing drawings or complex figures
(Kojima et al 1992; Kojima et al 2001; Matsushima et a1 1992). Scan paths are the
records of eye movements made by an individual while freely viewing a stimulus over a
certain period of time. Associations with psychiatric symptoms have been described
(Gaebel 1989; Tsunoda et a1 1992). Gaebel (1989) observed excessive scanning in
patients with predominantly positive symptoms and reduced scanning (with longer
fixation] in patients with predominantly negative symptoms. Tsunoda et al (1992)
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argued that the assessment of scanning eye movements may be a good and objective
measure of symptom severity in schizophrenia. Matsushima et al (1998) observed good
sensitivity and specificity of exploratory eye movement abnormalities to schizophrenia
and argued that these abnormalities point to the existence of pathological visual
information processing in schizophrenia.
Exploratory eye movements to complex stimuli may, therefore, be studied profitably to
detect deficits in schizophrenia. However, the cognitive and neural correlates of
scanning eye movements in response to these artificial and complex stimuli, as well as
their relevance to the genetics of schizophrenia, remain unclear.
Other studies have used images of human faces as stimuli. Unlike artificial geometric
figures, faces have the advantage of being naturally and evolutionarily salient stimuli,
with evidence of specific face-processing areas (Bruce & Young 1998). Studies of visual
scanning of face stimuli in schizophrenia patients have demonstrated reduced fixation
periods, fewer fixations, reduced scan paths and increased processing of extra-facial
features (Gordon et al 1992; Loughland et al 2002; Manor et al 1999; Phillips & David
1997, 1998).
More recently, the neural correlates of impaired face processing in schizophrenia have
been studied. Phillips et al (1999) observed differential neural responses associated with
incorrect classification of facial emotions in paranoid and non-paranoid patients with
schizophrenia. Non-paranoid patients were more likely to categorise faces expressing
disgust as fearful or angry and displayed greater activation of amygdala (typically
associated with fearful stimuli).
To conclude, studies of eye movements during face processing have the advantage of
using graphic representations of naturally occurring stimuli. Due to the importance of
face processing in humans in a variety of social contexts, schizophrenia studies may
build on a large body of knowledge concerning the cognitive and neural mechanisms
underlying face processing (Bruce & Young 1998). As facial stimuli can be manipulated
easily to depict mood states (happiness, sadness, disgust, etc.), these paradigms may
also be used to study affective processing in schizophrenia.
2.8 Relationship between Smooth Pursuit and Antisaccade
One issue that has received relatively little attention is that of the relationship between
SPEM accuracy and antisaccade errors in the schizophrenia spectrum. The majority of
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studies of the SPEM and antisaccade tasks in the schizophrenia spectrum have
focussed on either task, but have rarely combined both. Previous studies addressing
this question remain inconclusive. While some studies (Matsue et al 1994b; Schlenker
& Cohen 1995; Sereno & Holzman 1995) found higher antisaccade error rate to be
associated with worse SPEM performance, others did not (Hutton et al 1998a; Nkam et
al2001; Thaker et al1989c; Tien et alI996).
It thus remains to be investigated conclusively whether SPEM and antisaccade deficits
independently characterise schizophrenia patients or whether the two tasks may be
used interchangeably due to shared variance. Investigating the relationship between
SPEM and antisaccade performance is of interest as it has been suggested that both
measures may be schizophrenia endophenotypes tapping frontal function (Calkins &
Iacono 2000).
If performance on the two measures was indeed unrelated in schizophrenia patients and
healthy individuals, and patients' performance was characterised by deficits on both
tasks, then a combination of the two tasks might improve the statistical separation
between the patient and a control group, with possible implications for the diagnostic
process (Arolt et al 1998; Robins & Guze 1970; Sponheim et al 2001). Statistical overlap
between two conceptually related eye movement measures, on the other hand, would
suggest that these measures might be profitably combined in the development of a
'composite oculomotor endophenotype' for linkage studies (cf. Cadenhead et al 2002;
Myles-Worsley et al 1999). Genetic linkage requires labelling individuals as 'affected' or
'unaffected'. In many diseases this dichotomy is achieved through the combined
observation of a number of diagnostic signs and symptoms (Ott 1991). Similarly, an
endophenotype could consist, not of the dichotomisation of a single variable (e.g.
antisaccade error rate), but of a combination of two or more such variables (e.g.
antisaccade error rate and saccadic frequency during smooth pursuit). A composite
(oculomotor) endophenotype would thus have the advantage of providing a more reliable
identification of individuals as affected or unaffected (Ott 1991).
Given the evidence from some studies (Matsue et al 1994b; Schlenker & Cohen 1995;
Sereno & Holzman 1995) of a relationship between SPEM and antisaccade performance,
and the putative shared frontal involvement in both tasks (Calkins & Iacono 2000;
Clementz 1998; Levin 1984; MacAvoy & Bruce 1995), it may be argued that these two
measures are to some extent related. More research, however, is required to fully
characterise this relationship. In particular, a number of previous studies have used
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non-specific SPEM measures. It is a possibility that the use of specific measures would
facilitate the study of this relationship, in particular if certain specific measures were
more closely related (biologically) to antisaccade errors than overall smooth pursuit
performance.
One particularly interesting lead in the literature stems from research into the
anticipatory saccade during smooth pursuit (Rosenberg et al1997c; Ross et al1998e).
This type of intrusive saccade has been described as a failure of inhibitory processes
due to frontal dysfunction (Sweeney et al 1994a), a feature it shares at face level with
antisaccade errors. This putative shared inhibitory component underlying both types of
saccades suggests that the relationship between these measures in schizophrenia
spectrum populations would deserve to be explored; no study to date has observed an
association. However, there are, of course, phenomenological differences between
anticipatory saccades and antisaccade errors, including the role of the visual target:
Anticipatory saccades during smooth pursuit occur away from and in anticipation of
the physical target, whereas in the antisaccade task errors reflect a reflexive response
towards the target. Therefore, differences in the cognitive and neural substrates may be
observed in addition to a possibly shared inhibitory component.
A similar approach to combining neurocognitive schizophrenia endophenotypes was
adopted recently by Myles-Worsley and colleagues (1999). These researchers combined
antisaccade errors and a measure of inhibitory function derived from an event-related
paradigm, the PSO suppression, into a "composite inhibitory phenotype" (p. 544). This
phenotype showed linkage to a locus on chromosome 22q11-q12, supporting the
validity of combining conceptually related measures in the identification of
schizophrenia genes. The relationship between antisaccade errors and PSOsuppression
(but not prepulse inhibition, another measure of inhibitory function) has subsequently
been confirmed (Cadenhead et al2002).
2.9 Evaluation of the Validity of the Smooth Pursuit and
Antisaccade Tasks as Schizophrenia Endophenotypes
A large body of evidence relating to the endophenotypic nature of oculomotor tasks has
been reviewed. The key conclusions from this body of evidence may be as follows.
~ The most promising oculomotor schizophrenia endophenotypes are those of
reduced smooth pursuit accuracy and increased antisaccade errors. Reduced
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smooth pursuit accuracy in the schizophrenia spectrum appears to be best
characterised by reduced gain and increased frequency of (catch-up and
anticipatory) saccades. Back-up saccades and square-wave jerks during smooth
pursuit as well as antisaccade latency are less promising endophenotypes;
antisaccade gain has not been studied sufficiently.
~ Smooth pursuit and antisaccade deficits are argued by most researchers to be
relatively specific on the background of less consistent impairments in visual
fixation and reflexive saccades, making the existence of a generalised
oculomotor deficit in schizophrenia unlikely.
~ Deficits in the patient group are unlikely to be entirely due to factors such as
typical neuroleptic treatment, hospitalisation, disease chronicity or psychiatric
symptom severity.
~ SPEM and antisaccade deficits in the patient group are at present most
parsimoniously explained by frontal and fronto-striatal dysfunction,
respectively.
~ SPEM and anti saccade deficits in schizophrenia show familial patterns
compatible with genetic influence; both measures have good heritability.
~ Individuals with subclinical levels of schizophrenia spectrum symptoms show
subtle smooth pursuit and antisaccade impairments, similar in kind to those of
patients with schizophrenia.
~ Preliminary evidence links SPEM and antisaccade deficits to genetic loci on
chromosomes 6p21 and 22qll-q12, respectively.
2.10 Plan of Investigations and Hypotheses
This review has identified a number of gaps in the literature concerning the validity of
the SPEM and antisaccade tasks as schizophrenia spectrum endophenotypes. The
empirical investigations of this thesis will attempt to fill some of these gaps.
First, before proceeding to address questions concerning the behavioural characteristics
of the proposed oculomotor endophenotypes in schizophrenia spectrum populations, a
thorough analysis of their reliability is needed. As outlined above, despite reports of
good temporal stability of SPEM performance, evidence concerning the antisaccade task
149
Eye Movements in the Schizophrenia Spectrum
is much less consistent. Thus, one aim of Study I is to investigate the temporal stability
of eye movement tasks used in this thesis (Chapter 4). Additionally, reliability
characteristics of the methods employed here, such as inter- and intra-rater reliability,
as well as internal consistency of performance levels will be considered. Finally, because
two sets of eye movement tasks are used in this research, the concurrent validity of
these will be addressed. On the basis of the assumed temporal stability of
neurocognitive endophenotypes, both SPEM and antisaccade performance is
hypothesised to be reliable within and across assessments.
Second, little evidence of eye movement performance of people in their first psychotic
episode exists. Study II will aim to replicate and extend the existing findings (Chapter
5). An additional aim will be to explore the relationship between SPEM measures and
antisaccade error rate. As outlined above, evidence concerning this relationship is
inconsistent but is needed given the possibility of combining these measures in future
genetic studies of oculomotor endophenotypes. The main hypothesis of this study is
that people in their first episode of psychosis demonstrate SPEM (gain as well as CUS
and AS frequency) and antisaccade (error rate) impairments on the background of
relatively intact fixation and prosaccade performance.
Third, studies of first-degree relatives have generally indicated good validity of the SPEM
and antisaccade tasks as schizophrenia endophenotypes. A sample of siblings
discordant for schizophrenia will be examined in Study III in order to replicate and
extend this evidence (Chapter 6). The design of Study III will have a number of
advantages over previous oculomotor family studies, using tightly matched triplets of
patient, sibling and healthy controls and isolating between groups the variable of
interest, namely the genetic relatedness to an individual with schizophrenia. Following
Study II, the relationship between SPEM performance and antisaccade errors will be
examined in the patient, sibling and control groups. The main hypothesis of Study III is
that SPEM (gain, CUS and AS) and antisaccade (error rate) impairments will be
observed not only in the patient group but also, to a lesser extent, in their healthy
siblings; fixation and prosaccade performance is expected to be unimpaired.
Fourth, although previous studies have provided evidence of an association of SPEM
and anti saccade performance with schizotypy levels in healthy individuals, the precise
relationships of eye movement tasks with specific schizotypal symptom dimensions (e.g.
positive or negative schizotypy) are less clear (in particular concerning the antisaccade
task). Study IV will address the relationship between eye movement performance and
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specific, empirically derived dimensions of schizotypal personality traits (Chapter 7).
Additionally, the impact of trait emotionality on the relationship between eye
movements and schizotypy will be examined. As outlined above (Section 2.3.5.5.6),
there is evidence for an association between trait emotionality and schizotypy; whether
trait emotionality accounts for the eye movement deficits seen in individuals with high
schizotypy scores is not clear. As in Studies II and III, the relationship between SPEM
and antisaccade errors will be addressed. It is hypothesised that individuals with high
levels of schizotypy have SPEM (gain, CUS and AS) and antisaccade (error rate)
impairments; given the assumed specificity of these endophenotypes to the
schizophrenia spectrum, these impairments are hypothesised to be independent of trait
emotionality. No relationships between schizotypy and fixation or prosaccade measures
are hypothesised.
Fifth, despite a substantial body of knowledge concerning the effects of pharmacological
manipulations on eye movements, the effects of anticholinergic drugs in schizophrenia
remain unknown. Anticholinergic drugs are often prescribed to schizophrenia patients
in order to alleviate extrapyramidal side effects of antipsychotic drug treatment. Due to
the role of the cholinergic system in cognition, impairments on neurocognitive tasks
may be observed during treatment with anticholinergics. Study V will examine the
effects of one widely prescribed anticholinergic compound, procyclidine, on eye
movement performance (Chapter 8). The study will address the methodological
implications that such a state influence on eye movements might have for the validity of
the SPEM and anti saccade measures as schizophrenia endophenotypes. Assuming that
measurement of a good endophenotype is resistant to state effects (such as
pharmacological treatment), the main hypothesis of this study is that acute
administration of procyclidine will not confound the assessment of SPEM and
antisaccade function in schizophrenia patients.
Across all studies, therefore, the emphasis lies on the SPEM (gain, CUS and AS) and
antisaccade (error rate) measures as schizophrenia spectrum endophenotypes. In order
to investigate the specificity of these deficits within the functional domain of oculomotor
control, the fixation and prosaccade tasks will also be studied. Following previous
arguments (Levy et al 1994; McDowell & Clementz 2001), these tasks are expected to
represent oculomotor control conditions; fixation and prosaccade performance in
schizophrenia spectrum individuals is thus hypothesised to be relatively unimpaired.
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This hypothesised pattern of performance in the schizophrenia spectrum groups will
allow the assessment of the discriminant validity of the SPEM and antisaccade deficits.
The empirical studies of this thesis will be reported after a thorough description of the
eye movement methods used in these studies (Chapter 3). The findings from Studies I-V
will be discussed and integrated in the General Discussion (Chapter 9).
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Chapter Three
Eye Movement Methods
3.1 Chapter Overview
This chapter describes the eye movement methods adopted in the present
investigations. Wherever possible these methods will be compared to and evaluated
against methods employed in previous schizophrenia spectrum studies, as reviewed in
Chapter 2. Details of other methods employed in this thesis will be discussed in the
relevant experimental chapters (e.g. psychometric questionnaires, Chapter 7;
pharmacology, Chapter 8). As different samples were recruited for each of the studies
reported in this thesis, the relevant recruitment strategies and sample characteristics
will also be outlined in each experimental chapter. Likewise, statistical analyses differ
between studies and will be described in detail in the relevant chapters.
3.2 Hardware and Software for Stimulus Presentation
The research reported in this thesis employed two batteries of eye movement tests.
When the research for this thesis was begun, a set of eye movement tasks was available
in the Section of Cognitive Psychopharmacology, Institute of Psychiatry. This set of eye
movement tasks, referred to hereafter as Battery I, had been piloted and used by
researchers in this group (Kumari et al2000). As data collection on Study II had already
begun at the beginning of this thesis, and data collection on Study III began shortly
thereafter, Battery I was used for these studies (Chapters 5 & 6).
However, during data collection on Studies II and III it was felt that the tasks of Battery
I could be improved upon in terms of stimulus properties. To this end, one aim of this
thesis was to develop a second set of eye movement tasks suitable for schizophrenia
spectrum research. This new set of tests is referred to hereafter as Battery II. A
methodological study addressing the relationship and differences between the two
batteries was conducted (subsequent to data collection on Studies II and III) and is
reported in Chapter 4. Battery II was also used in two further studies reported in this
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thesis (Chapters 7 & 8).16Hardware specifications as well as stimulus properties of all
tasks will be described in detail below.
3.2.1 Battery I
3.2.1.1 Hardware and Laboratory Specifications
Stimuli of Battery I were presented using a commercially available LED array, the
AMTech Digital LED Bar 96 (AMTech GmbH, Weinheim, Germany). This LED bar
consisted of an aluminium case, 160cm wide, Scm deep and Scm high. In this case
were mounted, horizontally aligned, approximately 300 diodes of round shape, each of
about 5mm in diameter. The LED bar was presented at eye level from participants at a
distance of 200cm. The target stimulus (a single LED) thus subtended an amplitude of
approximately 0.15°. similar to previous studies (Crawford et al 1998; Curtis et al
2001a; Klein et al 2000c; ODriscoll et al 1998; Spantekow et al 1999; Sweeney et al
1992a; Thaker et al 1999). A PC was used to run software controlling the LEOs.
Testing took place in a small, quiet room in the Institute of Psychiatry. Lights were
dimmed in order to secure optimal recording conditions for the infrared light
oculographic equipment. The infrared light recording technique (Sections 2.3.3 and 3.3)
demands that ambient infrared light must be eliminated in the recording environment.
Participants were seated in a comfortable, height-adjustable office chair. A vertically
adjustable chin-rest was attached firmly to a desk in front of participants (Troost et al
1974). Participants were instructed to rest their chins on the chin-rest while resting
their arms on the desk, in order to minimise movement artefacts and vestibulo-
optokinetic influences and to maximise comfort.
3.2.1.2 Stimulus Properties
The software used to control stimulus presentation for all tasks of Battery I was
provided by AMTech GmbH (Weinheim, Germany).
16 In order to improve the presentation of the experimental chapters in this thesis, the
methodologicalstudy will be reported first (Chapter 4), followedby the (earlier)studies using
Battery I (Chapters 5 & 6) and the (later)studies using Battery II (Chapters 7 & 8).
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3.2.1.2.1 SMOOTH PURSUIT TASK
The smooth pursuit eye movement (SPEM) task of Battery I employed a trapezoidal,
constant-velocity target waveform. Two different velocities were used. The first target
moved at a velocity of 10°/ s (Figure 3.1) while the second target moved at a velocity of
24° /s (Figure 3.2). Both velocities are comparable to previous studies (Allen 1997;
Hutton et al 1998a; Iacono & Koenig 1983; Levin et al 1982a; O'Driscoll et al 1998;
Roitman et al 1997).
Figure 3.1: Smooth Pursuit Block at 10°/5 (Battery I)
1.0000 20000 30000
Legend: x-axis, time (ms); y-axis, degree of visual angle
Two blocks were run at each velocity. A block of the 10°/s target consisted of 6.5 half-
cycles; a block of 24° /s target consisted of 7 half-cycles. Therefore, the 10°/s SPEM
task consisted of 13 half-cycles and the 24°/s SPEM task consisted of 14 half-cycles. In
both tasks, the target moved horizontally between ±1So, in accord with previous studies
(Litman et al 1991; Nkam et al 2001; Ross et al 1999c).
Figure 3.2: Smooth Pursuit Block at 24°/5 (Battery I)
1.5.0
1.0000 20000
Legend: x-axis, time (ms); y-axis, degree of visual angle
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At each velocity, the target was initially presented in the central location (0°), from
where it moved to the extreme left position (-15°). This first ramp in each block was
treated as a practice trial for participants to become familiar with the task and was thus
not included in the analysis. The target remained stationary between half-cycles for
quasi-random durations between 300ms and 1,ODOms.
Instructions to participants were to follow the target, with their eyes, as closely as
possible, wherever it moved. Instructions were repeated during the task if necessary. In
order to minimise movement artefact, participants were told to keep their head still
while only moving their eyes.
A five-point calibration task was carried out immediately before each SPEM block, using
target eccentricities of 0°, tSO and ±10°. This task, calibrating linearly for a horizontal
range of 20°, is less than optimal for a SPEM task traversing a range of 30°. Due to
practical limitations this was the only calibration task available when the research for
this thesis was initiated. It may, however, be argued on two grounds that the SPEM
data from Battery I can be used despite this calibration. First, measurement of the
frequency of saccades during pursuit is not believed to be influenced by poor calibration
(Abel & Ziegler 1988; p. 752). Second, the SPEM gain measure of pursuit accuracy in
the current investigations was taken from the middle third section of each half-cycle,
thereby minimising effects of poor calibration; these would be expected to be more
pronounced for sections of pursuit outside the calibrated range of t10°.
3.2.1.2.2 FIXATION TASK
The visual fixation task consisted of the target presented subsequently in three different
locations. The target was always presented first in the central location (0°), then at _15°
and finally at +15°, Target duration in each location was IS,OOOms.Instructions were "to
follow the target as closely as possible, wherever it moves", Calibration was based on
the central location (0°)as well as the relevant peripheral target eccentricity (±lSO).
3,2.1.2.3 ANTISACCADE TASK
The antisaccade task of Battery I is depicted in Figure 3.3. Each block consisted of 8
trials. Each trial began with a central target (0°) presentation for 1,000ms. The target
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then moved to a horizontal peripheral location (USO), where it remained for I,OOOms,
before moving back to the centre for the next trial.
Figure 3.3: Antisaccade Block of Battery I
~oooo 20000 30000
Legend: x-axis, time (ms); y-axis, degree of visual angle
Each block used the same, quasi-random sequence of target movements. In Chapters 5
and 6, two blocks were carried out for each participant. In the assessment of the task's
reliability and validity in Chapter 4, three blocks each were carried out.
The task instructions required participants to fixate the target when in the central
location. They were further instructed that, as soon as the target moved to the side,
they should look to the exact opposite location. Participants were instructed in detail
that they should a) avoid looking towards the peripheral target and b) attempt to match
the exact target location on the 'other' side. Participants were asked whether they had
understood the task requirements; these were repeated if necessary until it was felt that
participants sufficiently understood what was required of them.
In order to familiarise participants with the task requirements, four practice trials were
carried out which were repeated if necessary. Performance was monitored by the
experimenter; participants were provided with verbal feedback during and after the
practice trials.
A nine-point calibration task was run between practice trials and the first experimental
block, using the central location and ±20O,±ISo, Uoo and ±so. The target moved from
right to left and remained in each location for I,OOOms.A brief gap intervened between
the calibration task and the first antisaccade block.
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This anti saccade task has a number of disadvantages. First, the number of trials (16 in
Chapters 5 and 6; 24 in Chapter 4) was small. While comparable to previous studies
(Clementz et al 1994; Curtis et al 2001a; Hutton et al 1998a; Nieman et al 2000), a
larger number of trials might ensure more reliable assessment. It has been shown that
the number of items (or trials) in a measurement instrument is related positively to the
reliability of the instrument (Anastasi & Urbina 1997).
Second, the use of a quasi-random sequence of target presentations might have allowed
for procedural, or implicit, learning to occur across repeated presentations of blocks
(Corr et al 1997; Kumari et al 1997a). It is possible that this factor influenced between-
group comparisons of people with schizophrenia (who have difficulties in procedural
learning tasks; Kumari et al 2002) and healthy individuals. However, as only three
blocks were used at most, effects of procedural learning were expected to be small.
Third, using only one target eccentricity in either half of the visual field increased the
spatial predictability of the target movement. Additionally, more than one peripheral
target amplitude might be necessary to estimate reliably spatial accuracy on
antisaccades.
Fourth, fixed central target durations might have led to temporally predictable
peripheral targets. It is unknown how target predictability, which is known to affect
saccadic latency on other tasks (Hutton et al2001b), affected between-group differences
on anti saccade error rate.
3.2.1.2.4 PROSACCADE TASK
Battery I provided two prosaccade tasks. The first task (Figure 3.4) was used in
Chapters 5 and 6; the second task (Figure 3.5) was used in Chapter 4. Ideally, the same
task should have been used in each of these studies, so that the reliability and validity
findings of Chapter 4 could be related to the data from Chapters 5 and 6. The first
pro saccade task was used as most of the data of Chapter 5 had already been collected,
and data collection on the Sibling study (Chapter 6) had been initiated, at the beginning
of this thesis. It was, however, felt that the second prosaccade task, which had not been
used in these studies, might provide an improvement over the previous task, for
reasons outlined below. Therefore, this second task was then employed in the analysis
of reliability and validity reported in Chapter 4.
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Figure 3.4: Prosaccade Block of Battery I (Chapters 5 & 6)
Legend: x-axis, time (ms); y-axis, degree of visual angle
The first pro saccade task consisted of 12 trials. Each trial began with a 500ms central
target presentation. The target then moved to one of three peripheral locations (±5°,
±10°, or ±15°) for durations of 500ms each. Each target location was used twice, with
the sequence of target movement being fixed and quasi-random within each block.
Chapter 5 used one block; Chapter 6 used two blocks.
Figure 3.5: Prosaccade Block of Battery I (Chapter 4)
J.0000 20000
Legend: x-axis, time (ms); y-axis, degree of visual angle
A five-point calibration task was used, presenting the stimulus for 500ms each at 0°,
±5° and ±l0°. This calibration task is less than optimal, as it calibrates accurately for a
range between ±10°, but less accurately for the ±15° targets. Therefore, measurement of
pro saccade gain (but not latency) might have been slightly inaccurate on this task,
calling for caution in the interpretation of these data. The second prosaccade tasks
circumvented this problem of poor calibration by using peripheral target eccentricities
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of ±5° and ±l0° and an appropriate five-point calibration (±OO,±5° and ±100). The target
remained in each location for 500ms. Three blocks of 9 trials each were carried out.
In both tasks, instructions to participants were to follow the target, with their eyes, as
closely as possible, wherever it moved. Participants were told to keep their head still
while only moving their eyes.
These pro saccade tasks suffer two minor weaknesses. First, the number of trials was
relatively small. Second, the quasi-random target sequence might be undesirable due to
aforementioned possibility of procedural learning effects.
3.2.2 Battery II
Given the apparent weaknesses of Battery I, a second set of stimuli was developed
(Battery II). These hardware and software specifications will be described below.
3.2.2.1 Hardware and Laboratory Specifications
A computer screen was chosen for stimulus display to achieve greater flexibility with
regard to the manipulation of stimulus properties. The hardware for stimulus
presentation consisted of a commercially available PC (Gateway 650), comprising of a
midi tower (ATX200 watt tower case) with a 20-GB 7200RPM hard drive. The computer
was a Pentium 3 P600 processor, contained an ATIRAGE 128 16MB graphics card, had
128 MB RAMand was designed to run Microsoft Windows 98. The screen that was used
to display stimuli was a 17-inch Gateway EV700 LG monitor. The equipment was
chosen to be of sufficient capacity for simultaneous stimulus presentation and data
logging. Storage capacity had to be considerable due to the size of the eye movement
data files.
The target stimulus consisted of a white dot of circular shape of approximately 3mm in
diameter, presented against a black background. As the participant's eyes were at a
distance of 57cm from the screen, the target sub tended about 0.3° of visual angle,
similar to previous studies '? (Crawford et al 1998; Curtis et al2001a; Klein et al2000c;
ODriscoll et al1998; Spantekow et al1999; Sweeney et al1992a; Thaker et a11999).
17 Interestingly, however, Fischer and Weber (1997) demonstrated that differences in stimulus
size (0.1°,0.2°, and 0.4°) have little effect on antisaccade performance.
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A number of previous studies (Amador et al 1995; Knox 1998; Levin et al 1982a;
ODriscoll et al 1998) have presented stimuli at a distance from participants of 57cm.
One reason for using this distance is the ease with which a rough estimate of target
amplitudes can be read off from the display. Amplitudes may be calculated using the
formula
a
tan =-
b
where a is the distance between two target locations on the display; b is the distance
between eye and target display; and a is the amplitude of the angle formed by a and b.
If b=57cm then a (in degrees) will be approximately equal to a (in cm) for short
distances of a (Figure 3.6).
Figure 3.6: Relationship Between Target Distance and Amplitude of Visual Angle
a= 6cm
~
b = 57cm
A distance of 57cm between eye and monitor was considered acceptable to participants
and believed not to strain their eyes unnecessarily, as it is similar to standard reading
distances.
The general set-up was identical to that used for Battery 1. Experiments took place in
the same window-less, light-dimmed, quiet room, using the same chin-rest. The PC
monitor was mounted on a small desk in front of participants. Data collection for the
study reported in Chapter 7 took place at Goldsmiths College. Hardware and laboratory
specifications were identical to those described above.
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3.2.2.2 Stimulus Properties
The stimulus properties of the smooth pursuit, fixation and saccadic tasks of Battery II
will be outlined in the following sections. The software used to present the stimuli was
purpose-written in C++ for Windows.
3.2.2.2.1 CALIBRATION TASK
In order to improve the homogeneity of this battery, it was decided to use the same
calibration task for all paradigms. At the beginning of each task a three-point
calibration task was carried out. This task presented the stimulus first in the central
location, then at -12° and finally at +12°. Stimulus duration in each location was
1,000ms. Peripheral target locations in this calibration task (±12°) were equal to the
most eccentric targets used in each task of Battery II, thereby covering the entire range
of target movements across tasks. Three-point calibrations have previously been used
(Lencer et al 1999, 2000).
In the smooth pursuit, fixation and prosaccade tasks, the calibration task immediately
(without gap) preceded the subsequent test. Participants were, therefore, not aware of
the transition from calibration to 'actual' eye movement task, as instructions were
simply to follow the target. In the antisaccade task, the calibration was followed by a
break, in which the subsequent task requirements were explained to participants, as
well as by the practice trials. Therefore, intervals of up to 1-2 minutes intervened
between calibration and antisaccade task. The length of such an interval was deemed
not to pose a problem for the accuracy of the calibration, as participants were requested
to, and usually did, remain still for that duration. If a participant moved considerably
during this gap the task was re-started (including a new calibration).
3.2.2.2.2 SMOOTH PURSUIT TASK
The SPEM task employed a triangular waveform (Figure 3.7). Target velocities were
12°/s, 24°/s, 36°/s and 48°/s, corresponding to frequencies ofO.25Hz, 0.5Hz, 0.75Hz
and 1Hz, respectively.
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Figure 3.7: Smooth Pursuit Task of Battery II
~oooo 20000 30000
Legend: x-axis, time (ms); y-axis, degree of visual angle
The target was initially placed in the central position and then moved horizontally to
one side until it reached the ±12° location, where it reversed abruptly and moved to the
opposite side. The direction of the first ramp was random (right or left). The first ramp
(from the central location to the first eccentric location) was considered practice and
was not analysed. It is known that relatively short tracking durations (within a quarter
cycle of target onset) are sufficient for predictive pursuit to become established (Leigh&
Zee 1999). A total of 16.5 half-cycles were used at each target velocity. Both target
excursion and velocities were comparable to previous studies (Allen et al 1990a; Allen
1997; Bell et a1 1994; Hutton et al 1998a; Iacono & Koenig 1983; Levin et al 1982a;
O'Driscoll et al 1998; Roitman et al 1997; Schwartz et al 1999; Versino et al 1993). Task
instructions were identical to those of Battery I, requiring participants to keep their eyes
on the target wherever it moved.
Although a target velocity of 48°/ s may be considered quite fast for successful foveation
by the smooth pursuit system (Leigh& Zee 1999), it was decided to include this task.
First, previous studies have used similar and faster velocities (Bell et al 1994; Iacono &
Koenig 1983; Levin et al 1982a; Schwartz et al 1999; Versino et al 1993). Similarly,
Leigh and Zee (1999) suggested using target velocities of 5-50° / s for a comprehensive
smooth pursuit system assessment (p. 179). Second, it has been suggested that faster
target velocities discriminate better between schizophrenia patients and healthy
individuals (Abel et al 1991; Lipton et al 1980a; Pivik 1979b). Finally, the reliability
analysis in Chapter 4 indicated good psychometric properties of this task.
This SPEM task may be considered an improvement over the Battery I task on a
number of grounds. First, a slightly larger number of half-cycles (N=16.5 at each
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velocity) were used than in Battery I (N=13 and N=14 at the two velocities). Second, the
problem of poor calibration encountered in Battery I was circumvented through the use
of an appropriate calibration task, covering the entire target range.
3.2.2.2.3 FIXATION TASK
The visual fixation task presented the stationary target stimulus in each of three
locations. First, after a central presentation of 1,OOOms (which served to bring the
participant's attention onto the target and was not included in the analysis) the target
was moved randomly to either of the two most eccentric target locations (±12°). The
target subsequently moved back to the central location, was then presented in the
remaining peripheral location and finally moved back to the centre (Figure 3.8). The
target duration in each location was 20,OOOms. Instructions were identical to those of
Battery I.
Figure 3.8: Fixation Task of Battery II
15.0
0.0
-15.0
20000 40000 60000 BOOOO
Legend: x-axis, time (ms); y-axis, degree of visual angle
It was chosen to examine fixation of central as well as peripheral targets, as these might
require slightly different neural substrates (Kissler & Clementz 1998). Target durations
of 20,OOOms were deemed sufficient to tax the fixation system (Kissler & Clementz
1998) and were comparable to previous studies (Amador et al 1995; Clementz et al
1994; Gooding et al 2000a; Kissler & Clementz 1998; Rosse et al 1992a).
3.2.2.2.4 ANTISACCADE TASK
An anti saccade trial began with the target in the central location for a random duration
of 1,OOO-2,OOOms.The target was then abruptly moved to one of four peripheral
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locations (±6° and ±12°) where it remained for 1,000ms. Each peripheral location was
used 15 times, resulting in a total of 60 trials. The sequence of peripheral target
presentations was random (sampling without replacement). A small sample of
anti saccade trials from this task is given in Figure 3.9. Trials were presented in one
block without break.
Figure 3.9: Saccadic Trials of Battery II (sample)
-1.0.0
1.0000 20000 25000
Legend: x-axis, time (ms); y-axis, degree of visual angle
Four practice trials, using each target location once, were carried out before the
experimental trials, and could be repeated if necessary. It was found, however, that
most participants required only one session of practice trials.
It has previously been argued that the inter-trial interval in saccadic tasks should be
considerably longer than 200ms, which is estimated to be the maximum duration of the
refractory period following the completion of a saccade (Stern & Dunham 1990). The
current task complied with this requirement.
Varying the duration of the central fixation point in saccadic tasks randomly may be
advantageous over using fixed durations as peripheral targets become temporally
unpredictable. Previous studies of the antisaccade task have also used quasi-random
durations (Clementz et al1994; Curtis et al2001a; Karoumi et al1998b, 2001; Nieman
et al 2000; Thaker et al 2000). The temporal characteristics of this task are generally
comparable to previous studies.
The number of trials was expected to be appropriate, i.e. providing sufficient between-
subject variance without affecting participants' levels of alertness and motivation. The
larger number of trials in this task than in Battery I was identical to previous studies
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(Brenner et al 2001; Karoumi et al 2001; McDowell et al 1999) and was hoped to
improve the task's reliability (Anastasi & Urbina 1997).
Another difference between this task and the Battery I antisaccade task concerned
target locations. In order to make target movements spatially less predictable, and to
enable the examination of effects of target eccentricity, two locations in either side of the
visual field were used. Using more than one target amplitude also allows for a more
accurate and reliable assessment of spatial accuracy of saccades. Finally, the task
avoided the possibility of procedural learning effects by using a randomised trial
sequence.
3.2.2.2.5 PROSACCADE TASK
The temporal and spatial properties of the prosaccade task were identical to those of the
antisaccade, except for an absence of practice trials. Instructions required participants
to follow the target as quickly and accurately as possible.
Randomised central target durations have been used in previous prosaccade tasks
(Karoumi et al 1998b; Muri et al 1998; Sweeney et al 1997), serving to make the target
appearance temporally unpredictable. The number of trials is comparable to previous
studies (Clementz et al 1994; Karoumi et al 1998b). Given the larger number of trials,
as well as the more accurate calibration, this task was expected to provide an improved
assessment of reflexive saccades compared to Battery I.
3.2.2.3 Summary
Battery II provides a homogenous set of tasks for the assessment of oculomotor
function in schizophrenia spectrum participants. In developing this battery it was
ensured that a number of validity criteria were met. First, the tasks appear to have face
validity. Second, content validity was maximised through a comprehensive review of the
existing literature on eye movements in schizophrenia. The properties of the stimuli
used here are embedded in the existing literature and aim to provide an optimised
combination of previous tasks. While care was taken to match previous task
characteristics, it has been pointed out that there is no "standard protocol" in the eye
movement literature (Klein & Berg 2001; p. 709). Further issues of validity will be
discussed in Chapter 4.
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Battery II appears to have greater internal homogeneity than Battery I for a number of
reasons. First, the same calibration task was used across different paradigms. This was
thought to ensure that putative performance differences between tasks, e.g. in saccadic
gain between antisaccade and pro saccade tasks, may not be attributable to differences
in calibration. Second, horizontal target range was kept identical across tasks (±12°).
This is of importance for comparisons across tasks, as target eccentricities have been
shown to affect saccadic metrics (McDowellet al 1999; Schreiber et al 1997). Third, the
temporal and spatial characteristics of the pro saccade and antisaccade tasks are
identical, again facilitating comparisons across tasks.
In addition to the improved internal homogeneity, Battery II may be considered an
improvement over Battery I for other reasons. First, the number of trials (or half-cycles
in the SPEM task) was generally larger, possibly leading to better internal consistency
and other reliability criteria (Anastasi & Urbina 1997). Second, Battery II avoided the
calibration problems encountered in Battery I. Third, the SPEM task of Battery II used
four different velocities, thereby allowing a more detailed analysis of the effects of target
velocity on smooth pursuit performance. Finally, saccadic tasks employed sufficient
numbers of trials at four peripheral target locations, thereby allowing the assessment of
effects of target eccentricity.
3.3 Hardware and Software for Recording Eye Movements
Eye movements were recorded using the IRIS eye-tracker, model 6500 (Skalar Medical
BV, Delft, The Netherlands; Reulen et al 1988; Figure 3.10). The IRIS eye-tracker is a
system based on the principles of infrared oculography, as outlined above. Some of the
hardware specifications are as follows (IRIS 6500 Instruction Manual, Skalar Medical
BV; Reulen et al 1988).
Horizontal recordings with the IRIS system may be made within a range of ±30°. Given
this limitation, the maximal target range in the current tasks (±15°) is appropriate. The
linearity of the system lies within 3% between ±25° of horizontal recordings.
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Figure 3.10: IRIS 6500 Eye-tracker and Headset (Skalar Medical BV)
Legend: a = headset; b = eye-tracker
Infrared light is projected onto the participant's eyes using a head-mounted device. This
device, which is akin to a light plastic helmet (weight 0.3kg), contains nine infrared light
emitting diodes (Siemens BPX 269) and nine infrared light detecting photodiodes
(Siemens BPX 69), horizontally aligned in transparent Perspex cases above and below
the eyes, respectively. The low weight of the headset guarantees minimised discomfort
to the participant. The photodiodes are covered by a black infrared filter to reduce
artefacts from ambient light. Each emitter/detector array can be adjusted in three
perpendicular directions in order to maximise recording accuracy. The infrared light
transducers can be rearranged to record vertical eye movements; however, in the
present set-up they are only used for the recording of horizontal eye movements. The
emission of infrared light is chopped in order to minimise interference from ambient
light, resulting in an improved signal-to-noise ratio. Recording is sensitive to artefacts of
eye blinks, head movements and baseline shifts due to excessive tear fluid production.
The IRIS Skalar eye-tracker has been established internationally (mostly in Europe) by
a number of laboratories for its use in schizophrenia spectrum research (Allen 1997;
Broerse et al 2001 b; Crawford et al 1998; Dursun et al 1999; Klein et al 2000c; Knox et
al 1999; Krebs et al 2001; Lencer et al 1999; Maruff et al 1998; Nkam et al 2001; Powell
et al2002).
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Only horizontal eye movements were recorded in the current investigations. The
recording of vertical eye movements was unnecessary, as these are believed to occur
only minimally during horizontal eye movement tasks and can be excluded as artefact,
or noise, from the data (Leigh & Zee 1999). Moreover, in order to minimise calibration
time at the beginning of each test session, recordings were taken from the left eye only.
This was possible as the current experiments only required conjugate eye movements;
error term due to vergence eye movements with the angles applied in this set-up may be
negligible (Leigh & Zee 1999).
Eye position was logged by the eye-tracker and converted from analogue to digital by an
analogue-digital (AD) converter card. For Battery I a commercially available AD
converter card with a sampling frequency of 500Hz was used (BOT 96 Eye Movement
Digitizer, AMTech GmbH, Weinheim, Germany). For Battery II, a purpose-built AD
converter was used. This was a 4 channel AD converter with 12 bits resolution per
channel and a sampling frequency of 500Hz, i.e. a sample of target and eye position was
obtained for every 2ms. This sampling frequency is generally considered adequate for
the study of eye movements (Stem & Dunham 1990). Data from the eye-tracker,
together with target position, were saved onto the hard disk of a PC for further analysis.
3.4 Eye Movement Data Scoring
The following sections will describe the criteria adopted in this thesis for the analysis of
eye movement data from the smooth pursuit, fixation, antisaccade and pro saccade
tasks. Before turning to specific criteria, however, the software that is used in the
analysis will be described.
3.4.1 Software
Eye movement recordings were analysed using a semi-automated procedure in the
EYEMAP software package (Version 2.0; AMTech GmbH, Weinheim, Germany). Semi-
automated, or interactive, analyses are believed to be more accurate and reliable than
fully automated analyses (Leigh & Zee 1999). EYEMAP allows the analysis of eye
movement data from up to eight 'channels' (equivalent to visual presentations of the
data in line graphs). Channels of horizontal left eye position, horizontal target position,
as well as overlapping target and eye traces were displayed simultaneously (see Figure
3.11 for an example of a smooth pursuit trace from Battery II).
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Figure 3.11: Example of an EYEMAP Representation of Eye and Target Trace
Legend: x-axis, time (ms); y-axis, degree of visual angle
Top: eye channel; middle: target channel; bottom: combined traces in double-window;
left: menu bar
Before a data file containing eye movement data can be opened for analysis in EYEMAP
a set-up file must be chosen. The set-up file contains information required by the
software to access the data file, such as data format, path to data as well as output file,
number and kind of channels required and other specifications. Once a data file has
been opened, and eye position has been calibrated based on the relevant calibration
task, EYEMAPprovides a number of options for analysis.
For analysis of all saccadic tasks as well the saccadic analysis of smooth pursuit and
fixation data, EYEMAPsearches the eye movement data trace for certain predefined
changes in position and velocity assumed to reflect saccades. The criteria used for the
detection of saccades will be discussed below (Section 3.4.2.2).
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Figure 3.12: Example of an Interactive Saccade Analysis in EYEMAP
Legend: x-axis, time (ms); y-axis, degree of visual angle
The semi-automated saccadic analysis option in EYEMAPwas used (Figure 3.12). In
this analysis the software places two vertical cursors over each successive change in the
eye movement trace assumed to be a saccade based on predefined criteria, starting at
the beginning of the trace (Oms).The rater then decides for each such event whether to
accept it as a saccade or to reject it (as artefact or eye-blink). If an event is accepted as
saccade, the rater is required to label it appropriately. This is done by choosing one of a
number of saccade labels from a menu. The saccadic labels have to be specified in a
separate file and in the current analyses included: reflexive saccade, antisaccade,
antisaccade error, antisaccade corrective saccade, anticipatory saccade, square-wave
jerk, back-up saccade, catch-up saccade and other.
The results of a saccadic analysis are stored in a tab-delimited (*.dat) output file. This
file contains the saccadic label and metrics of each event that has been accepted. These
data were then further analysed as follows. Output files were opened in Microsoft Excel
2000 and copied into template files designed to extract relevant information. Template
files differed between different types of eye movement paradigms.
The metrics from the antisaccade and prosaccade tasks relevant to the current
investigations (primary saccade gain, latency and antisaccade error rate) were extracted
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from saccadic events by a number of Excel formulae stored in the template file.
Saccadic events that were utilized for the calculation of saccadic metrics were defined
according to criteria outlined below (minimum latency to target, direction, type).
Saccades that did not meet these criteria were omitted from this calculation. Average
measures for each participant (across saccades) were then copied into SPSS for
statistical analysis. Saccades from the SPEM and fixation tasks were counted for
frequency; metrics were not further analysed.
In the assessment of smooth pursuit gain the rater manually places a 100ms cursor
over sections of pursuit in the 'eye channel' (see Section 3.4.2.1). The software stores
gain scores for all sections and writes these into an output file. The SPEM gain output
file is opened in Microsoft Excel 2000; each participant's average gain score is extracted
and then transferred into SPSS for further analyses. Different gain scores were
calculated for different velocities.
The EYEMAPsoftware package was purpose-designed for the analysis of eye movement
data from clinical populations and has been validated by different laboratories in a
number of studies of eye movements in schizophrenia spectrum samples (e.g. Dursun
et al 1999; Hutton et al 2000; Lencer et al 1999; MacCabe et al 2002; Mahlberg et al
2001; Straube et al 1999).
3.4.2 Scoring Criteria
Following the discussion of previous approaches to the analysis of oculomotor data it is
clear that criteria for identifying eye movement parameters have to be chosen and
justified carefully, as there does not appear to be one single, and universally valid,
scoring procedure for any of the tasks discussed here. As with the temporal and spatial
characteristics of stimulus presentation in the experimental paradigms it appears that a
number of different, equally valid, approaches exist. Scoring criteria were identical
across batteries.
3.4.2.1 Smooth Pursuit Task
Given the controversies surrounding SPEM analysis, it was decided to employ a
comprehensive battery of quantitative measures. Scoring criteria were based on
previous studies and were chosen to provide a feasible (in terms of technical and
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temporal restrictions) and valid analysis of SPEM performance. Scoring criteria were
identical across studies and batteries.
The key variables were gain and the frequency of anticipatory and catch-up saccades.
Back-up saccades and square-wave jerks were also observed, but occurred infrequently
and were not included in the statistical analyses. Previous studies have repeatedly
shown that these measures are not consistently impaired in schizophrenia spectrum
samples (Clementz et al 1990; Iacono & Koenig 1983; Lencer et al 1999; Radant &
Hommer 1992). Global qualitative (Benitez 1970; Shagass et al 1974) or quantitative
(Iacono & Lykken 1979a, 1979b; Lindsey et al 1978) measures were not employed.
While these have been shown to provide valid and reliable overall descriptions of
smooth pursuit dysfunction in schizophrenia, specific measures were considered to be
more informative regarding the precise nature of pursuit dysfunction (Abel & Ziegler
1988; Leigh & Zee 1999; Ross et al 1998c).
SPEM gain was measured following previous studies (Gooding et al 2000b; Hutton et al
1998a, 2001a; O'Driscoll et al 1999; Siever et al 1994). Initially, SPEM data was
smoothed twice using a 5-point averaging filter. This procedure averaged five
consecutive eye position data points, thereby reducing noise in the recordings. For gain
analysis in EYEMAP, a cursor covering a time window of lOOms was placed onto
sections of steady-state pursuit, not including saccades or eye-blinks, in the middle
third of each half-cycle (Figure 3.13). Pursuit gain was calculated by EYEMAPfor each
window, dividing eye velocity by target velocity and multiplying the result by 100. A
participant's pursuit gain was thus evaluated for each half-cycle of pursuit and then
averaged across half-cycles for each velocity. The middle third section of each half-cycle
was chosen (Hutton et al 2000, 2001a; O'Driscoll et al 1999) as pursuit may slow in
anticipation of target reversals and in order to overcome problems of calibration on the
Battery I tasks.
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Figure 3.13: Example of Smooth Pursuit Gain Analysis
**
0.0
0.0
-10.0
14000 16000
L~.X:14459.86 V: 2.49 Ri.X:14557.71 V: J
0.0 2)
-10.0
14000 16000
Y: stiMulus hor. X: TiMe [Msec]
3)
Legend: x-axis, time (ms); y-axis, degree of visual angle
** lOOmswindow cursor for gain analysis
1) eye channel; 2) target channel; 3) joint representation of eye and target
Measures of pursuit gain were not taken for half-cycles which consisted entirely of
saccades (Figure 3.14). Such saccadic, or 'cogwheel' pursuit (Levin 1983; Troost et al
1974), occurred infrequently and was deemed unsuitable for the analysis of the pursuit
system (Levin et al 1982a). As Levy et al (1994) argued, "average gain calculations that
include epochs with AS, in which gain is reduced to or near zero, should not be
included in an assessment of the integrity of the pursuit system because the eye is not
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engaged in pursuit" (p. 49; italics in original). Saccades were also not included if they
occurred within the peripheral fixation period of the trapezoidal target in Battery I.
Figure 3.14: Example of Saccadic Pursuit
20.0
17000 18000
Legend: x-axis, time (ms); y-axis, degree of visual angle
The automatic detection of saccades during pursuit was based on criteria of minimum
amplitude (1.5°) and minimum velocity (30°Is), similar to previous investigations (Abel
et al 1991; Cegalis et al 1983; Cegalis & Sweeney 1979; Hutton et al 2001a; Matsue et
al 1986; Mialet & Pichot 1981; Ross et al 1999c). Once a saccade was identified by
EYEMAP, it was classified by the rater according to visual appearance into the
categories of anticipatory saccade (AS), catch-up saccade (CUS), back-up saccade
(BUS), square-wave jerk (SWJ), or other (if it did not fit any of these criteria).
Anticipatory saccades were defined as saccades in target direction that took the eye
ahead of the target (Figure 3.15). AS were typically followed by slowing or cessation of
pursuit for the target to 'catch up' with the eye. Observations were also made of AS
which were followed by a second saccade in opposite target direction, returning the eye
to the target (Figure 3.15). These could be distinguished from SWJ, as pursuit typically
slowed, or cessated, during the intersaccadic interval. It is a hallmark feature of SWJ
that pursuit continues between saccades (see below). The second saccade, returning the
eye to the target following an AS, was classified as BUS.
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Figure 3.15: Example of an Anticipatory Saccade (Arrow) during Smooth Pursuit,
with Subsequent Back-up Saccade
15.0
1.6000 1.8000
Legend: x-axis, time (ms); y-axis, degree of visual angle
Following Ross et al (1999c) it was decided to include anticipatory saccades with a
small minimum amplitude criterion (1.5°). This amplitude criterion, smaller than
suggested by others (Whicker et al 1985), was believed to maximise patient-control
separations (Ross et al 1999c).
Catch-up saccades were defined as saccades in target direction that served to reduce
position error, i.e. to bring the eye closer to the target (Abel et al 1991; Flechtner et al
1997; Levy et al 2000). CUS always began with the eye behind the target. A CUS of
perfect accuracy would, therefore, end on the target. Frequently, however, CUS moved
the target close to, but slightly off the target, either behind or ahead of it (Figure 3.16).
Figure 3.16: Example of Catch-up Saccades during Smooth Pursuit
-20.0
11.000 12000
Legend: x-axis, time (ms); y-axis, degree of visual angle
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An important criterion for the classification of anticipatory and catch-up saccades was
the increase or decrease in position error (Abel et al 1991; Flechtner et al 1997; Levy et
al 2000). While not quantified, such a change could be observed visually. If a saccade
initiated behind the target and ended ahead of it, it was classified as an AS if more than
half of the amplitude served to move the eye ahead of the target. If more than half of the
amplitude was spent behind the target, i.e. reducing position error, the saccade was
considered a CUS (Clementz et al 1990; Ross et al 1999a).
Back-up saccades were defined as saccades that were executed in direction opposite to
target movement (Figure 3.17; Flechtner et al 1997; Lencer et al 2000). Like CUS they
were corrective, i.e. served to reduce position error. BUS could be identified relatively
unambiguously, usually occurring after segments of hypermetric gain (Figure 3.17) or a
large anticipatory saccade (Figure 3.15).
Figure 3.17: Example of a Back-up Saccade during Smooth Pursuit
0.0
5.0
5000 5250
Legend: x-axis, time (ms); y-axis , degree of visual angle
Square-wave jerks were defined as a complex of two saccades of roughly similar size
(Figure 3.18). These saccades were performed in opposite directions, with the first
saccade moving the eye ahead, i.e. in target direction, and the second saccade bringing
the eye back to the target, i.e. in opposite direction. Typically, these saccades were
separated by SO-SOOms,although a precise evaluation of inter-saccadic duration was
not carried out. Importantly, pursuit typically continues during the pair of saccades in
SWJ (Leigh & Zee 1999; Ross et al 2001); this feature served to distinguish them from
AS.
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Figure 3.18: Example of a Square-wave Jerk during Smooth Pursuit
1.0.0
-1.0.024000 26000 28000
Legend: x-axis, time (ms); y-axis, degree of visual angle
Eye-blinks also occurred during pursuit and could in most cases be identified
unambiguously (Figure 3.19). Eye-blinks were not counted or included in further
analyses.
Figure 3.19: Example of an Eye-blink during Smooth Pursuit
-1.5.0
26000
Legend: x-axis, time (ms); y-axis, degree of visual angle
Frequencies were calculated for all types of saccades. First, the number of saccades in
each category was established. Then, this number was divided by the duration of each
block of pursuit (in seconds), yielding the frequency of saccades per second.
3.4.2.2 Fixation Task
The measure of visual fixation performance was the frequency of saccades. This
measure was based on previous studies (Curtis et al 2001 b; Gooding et al 2000a,
2000b; Kissler & Clementz 1998; Levin et al 1982a; Mialet & Pichot 1981; Silverman &
Gaarder 1967) and was believed to provide a reliable assessment of the integrity of the
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fixation system (Leigh & Zee 1999), aiming to yield more accurate information than
qualitative ratings (Amador et al 1995; Rosse et al 1992a).
Criteria for the automatic detection of saccades in EYEMAPwere as in Section 3.4.2.1.
The number of saccades during fixation was counted and divided by the time (in
seconds) of task duration. Eye-blinks were not counted or included in analyses. A
number of different types of saccades were typically observed during fixation. These
were similar to those occurring during smooth pursuit and have been described
elsewhere (Kissler & Clementz 1998; Leigh & Zee 1999; Levin et al 1982a).
Figure 3.20: Saccades Occurring during Fixation
J.O.O
b)
-J.O.O
22000 23000 24000
Legend: x-axis, time (ms); y-axis, degree of visual angle
a = BUS after period of drift; b = SWJ
SWJ (Figure 3.20) were defined as in Section 3.4.2.1, following Kissler and Clementz
(Kissler & Clementz 1998) and Leigh and Zee (1999). During fixation the eye
occasionally drifts off the target and subsequently restores eye position through a
corrective BUS (Leigh & Zee 1999) (Figure 3.20). The third category of saccades that
were observed regularly consisted of saccades away from the target. These were either
followed by a slow drift back towards the target or a second saccade. Only if the second
saccade was not part of a SWJ it was counted as a separate saccade. Saccades were
then added (irrespective of subtype) for the calculation of saccadic frequency.
3.4.2.3 Antisaccade Task
The antisaccade performance measures used in the present research were chosen to be
in agreement with those of previous studies (Section 2.5.3), assessing reaction time
(latency), accuracy (gain), direction errors (error rate) and correction rate.
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Detection of saccades was based on criteria of minimum amplitude (1.5°), minimum
velocity (300/ s) and minimum latency to target (1OOms)(Broerse et al 2001 b; Crawford
et al 1998; Gooding 1999; Katsanis et al 1997; Klein et al 2000c; McDowell et al 1999;
Nieman et al 2000). Antisaccade trials were excluded from the analysis if an eye-blink
occurred immediately before, during, or after target presentation, or if the participant
failed to initiate a saccade. Eye-blinks were identified quite clearly in the current IRO
records, although a combination of vertical and horizontal recordings would have been
advantageous in a more reliable detection of eye-blinks (Troost et al 1974).
Antisaccade error rate, correction rate, latency and primary saccade gain were measured
precisely as described in Section 3.4.1.3.1. Velocity was not calculated, as it was not
considered an important schizophrenia spectrum endophenotype.
3.4.2.4 Prosaccade Task
In agreement with previous studies, prosaccade performance was measured using
primary saccade gain and latency. These measures were calculated as described in
Section 3.4.1.3.2. Criteria for detection of saccades (minimum amplitude=1.5°;
minimum latency=100ms; minimum velocity=30° Is) resembled previous studies of
similar populations. Eye-blink trials were excluded. Human primary prosaccade gain is
often slightly hypometric, i.e. undershoots the target (Batzel et al 1993), although
hypennetric, or overshooting, saccades were also observed (Figure 3.21).
Figure 3.21: Example of Prosaccades
f-n 1.0.0
I I \ \
\ \ } J La) b)
-1.0.0
1.0500 1.2000 1.3500 1.5000
Legend: x-axis, time (ms); y-axis, degree of visual angle
a = hypometric primary saccade; b = hypennetric primary saccade
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Saccadic velocity was not investigated in order to focus the discussion of this thesis on
the key measures, the putative endophenotypes of SPEM performance and antisaccade
error rate.
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Chapter Four
Study I - Reliability and
Concurrent Validity of Eye Movement Measures
4.1 Chapter Overview
This chapter examines a number of issues relating to the reliability and concurrent
validity of the eye movement paradigms employed in this thesis. In order to draw firm
conclusions regarding effects on oculomotor function of psychotic illness, genetic
liability to schizophrenia, schizotypal personality traits and pharmacological
manipulation, the reliability and validity of the methods should first be established.
Reliability is defined as the extent to which measurement is free of error (relating to
human rater bias, technical faults, variability over time, etc.); validity is defined as the
extent to which the measurement captures the property it purports to capture.
A potential source of error in the assessment of eye movements concerns the effects of
rater, or scorer, variability. To this end, Section 4.2 reports on the intra- and inter-rater
reliability of the scoring procedures used for oculomotor data in the studies reported in
this thesis. As outlined in Chapter 3, due to practical reasons, two oculomotor batteries
- differing in stimulus display specifications, but not recording or scoring techniques -
were used in the work reported here. The second point of attention, therefore, concerns
the concurrent validity of these two sets of measures, i.e. the relationship of Battery II
to Battery I (Section 4.3). Section 4.4 addresses another aspect of reliability, i.e. internal
consistency, reporting Cronbach's coefficient alpha for each oculomotor measure.
Finally, an important requirement of a putative biological marker in psychiatry research
is its temporal stability, or test-retest reliability. To establish the temporal stability of
the proposed oculomotor endophenotypes, the current eye movement batteries were
subjected to follow-up assessment in a sample of healthy individuals over an interval of
several weeks. The reliabilities of these measures and performance changes over time
are described in Section 4.5.
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4.2 Intra- and Inter-rater Reliability of Scoring Procedures
4.2.1 Introduction
Good intra- and inter-rater reliabilities are important properties of any assessment tool
(Anastasi & Urbina 1997; Rust & Golombok 1999). With fully automated scoring
procedures, as they may be used in psychophysiological and psychophysical studies,
the involvement of the human rater is minimal and unlikely to introduce variability into
the data. Therefore, intra-rater reliability is assumed to be perfect, indicating that two
analyses of the same dataset by the same rater would produce identical results on both
occasions. Likewise, agreement between two (or more) raters, called inter-rater
reliability, would be expected to be perfect under these circumstances.
In the field of eye movement research, a number of different scoring routines have been
developed to analyse raw data, ranging from purely manual/visual (Benitez 1970; Rosse
et al 1992a; Shagass et al 1974) to fully automated (Powell et al 2002). As described in
Chapter 3, eye movement data scoring in the research reported here is carried out using
the software package EYEMAP.Analysis in EYEMAPis semi-automated and interactive,
thereby possibly generating error due to examiner variance. Therefore, less than perfect
reliabilities may be expected.
Both saccadic analysis (of smooth pursuit, fixation, antisaccade and pro saccade
paradigms) and smooth pursuit eye movement (SPEM) gain analysis involve subjective
decisions by the human rater. In the saccadic analysis the rater accepts (and
subsequently classifies), rejects (as eye-blink or artefact), or manually adjusts a saccade
captured by automated routines in the software. In SPEM gain the rater manually
places a cursor onto a trace of pursuit in each half-cycle.
These small subjective elements are utilised in the interactive analysis procedure in
order to maximise scoring accuracy; however, they allow for human error, thereby
possibly reducing reliability.
4.2.1.1 Aims
The present study aimed to establish the intra- and inter-rater reliabilities of the eye
movement scoring procedures used in this thesis, by subjecting SPEM, fixation and
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saccadic variables to repeated EYEMAP analysis by the same rater, as well as the
fixation, antisaccade and prosaccade tasks to analysis by two raters.w Given the
relatively small subjective element of the semi-automated scoring procedures, and the
precision of the operational criteria outlined in Chapter 3, correlation coefficients were
hypothesised to be high (>0.8).
4.2.2 Method
4.2.2.1 Participants
For intra-rater reliability, eye movement data of twelve participants (7 males, 5 females;
mean age=28.33 years; SO=6.27) was used. Data of these participants was drawn from
the study of siblings discordant for schizophrenia (Chapter 6). Four schizophrenia
patients, four participants from the sibling group (not related to the patients in this
sample) and four healthy controls were chosen quasi-randomly from the entire sample
for inclusion in the re-analysis. For inter-rater reliability, eye movement data of ten
participants (5 males, 5 females; mean age=34.70, SO=12.26) was used. This sample of
four patients and six controls was drawn quasi-randomly from an unrelated study not
reported in this thesis but using identical task specifications as those described in
Chapter 3.
4.2.2.2 Eye Movement Assessment
Participants for the analysis of intra-rater reliability were tested on oculomotor Battery
I; participants for inter-rater reliability were tested on Battery II (Chapter 3). For intra-
rater reliability, SPEM, fixation, prosaccade and anti saccade data were re-analysed 1-2
weeks after first analysis. Identical scoring procedures and software settings were used
on both occasions. The dependent oculomotor variables were as described in Chapter 3
and included SPEM gain and frequency of anticipatory (AS) and catch-up saccades
(CUS) at each velocity; frequency of saccades during fixation; antisaccade gain, latency
and error rate; and prosaccade gain and latency. For inter-rater reliability, frequency of
saccades during fixation; antisaccade gain, latency and error rate; and pro saccade gain
and latency were measured using identical EYEMAPsettings by the author of the thesis
18 Due to practical limitations it was not possible to determine inter-rater reliability on SPEM
measures.
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and a placement student trained in EYEMAPanalysis by the author, based on the
criteria outlined in Chapter 3.
As some error concerning the correct discrimination between AS and CUS during
smooth pursuit was expected due to similarity in appearance (Ross et al 2001; also cf.
Chapter 3), the frequencies of these two types of saccades were subsequently added into
a combined saccadic frequency measure at each velocity (not including square-wave
jerks and back-up saccades). This measure was expected to produce slightly better
agreement than either of the individual measures.
4.2.2.3 Statistical Analysis
In order to assess the consistency of the scoring procedure (by the same rater over two
occasions, or by two raters), intraclass correlations (ICC)were computed between pairs
of variables (e.g. antisaccade error rate at Scoring I and antisaccade error rate at
Scoring II; Bartko 1991). As Bartko (1991) pointed out, ICC is the appropriate statistical
method for assessing agreement (between raters, or within one rater over time) in
reliability analysis. Correlations (Pearson or Spearman) fail to take account of
systematic differences between raters (or over time), or within-subject variance.
Therefore, if all subjects obtain the same score on two occasions (or from two raters),
both (Pearson or Spearman) correlation and ICC will indicate unity, i.e. perfect
association and agreement, respectively (r=l; ICC=l). However, if scores differ
systematically (over time or between raters), ICC will be a more realistic estimate of
agreement, i.e. of within-subjects variance (over time or between raters). The data in
Table 4.1 illustrate this example. This dataset represents two assessments (at two time
points, or by two raters) of a given behaviour in five participants (Var1 and Var2).
Pearson or Spearman correlations between the two variables in the original dataset
(N=S; participants aI-aS, until the dotted line) result in coefficients of 1, indicating
perfect association (between-subject variance). ICC between the two variables in this
dataset, however, is -0.06, indicating poor agreement (over time or between raters).
Generally, ICC tend to be somewhat lower than Pearson or Spearman correlations, and
may be considerably lower if within-subjects variance is large.
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Table 4.1: Example of Spreadsheet Prepa red for Intraclass Correlation
Subject Varl Var2
a1 1.00 4.00
a2 2.00 5.00
a3 3.00 6.00
a4 4.00 7.00
_~? ?_.~9.. . _?_.~9.. .
a1 4.00 1.00
a2 5.00 2.00
a3 6.00 3.00
a4 7.00 4.00
as 8.00 5.00
In order to calculate intraclass correlations the dataset was prepared in the following
way (see Table 4.1; Dunn 1989). For any given variable, data from Scoring I was
replicated in the corresponding column of that variable at Scoring II by copying these
data below the data points from Scoring II (in the same order). Likewise, for the same
variable the data points from Scoring II were copied below the data points in the
corresponding variable at Scoring I. This procedure yields a 'doubled-up' data file with
twice the original sample size. ICC were then computed using Pearson's correlation
coefficients between the pair of variables. Coefficients were tested for statistical
significance based on the original sample size N. Although exact p-values are stated
throughout the thesis, testing for significance (two-tailed) of ICC based on a Pearson's r
table (Gravetter & Wallnau 1996) means that significance is given only relative to the
nearest landmark (i.e. < or> 0.01, 0.02, 0.05 and 0.10). In order to provide an estimate
of how Pearson and ICC coefficients differ in this dataset both coefficients are reported.
All statistical analyses were carried out using the Statistical Package for the Social
Sciences (SPSS), Release 10.0.7 (SPSS Inc., Chicago, Ill).
4.2.3 Results
4.2.3.1 Correlations between Scoring I and Scoring II
As can be seen from Table 4.2, all Pearson correlations and ICC were of considerable
magnitude and highly significant. Pearson correlations and ICC were the same or very
similar for most variables, and Pearson coefficients were never smaller than ICC.
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Table 4.2: Pearson and Intraclass Correlations for Intra-rater Reliability of Battery I
Pearson Intraclass
SPEM gain 10°/ s (%)
SPEM gain 24°/s (%)
Anticipatory saccades 10°/s (N/sec)
Anticipatory saccades 24° /s (N/sec)
Catch-up saccades 100/s (N/sec)
Catch-up saccades 24° /s (N/sec)
Saccades total 10°/ s (N/ sec)
Saccades total 24° (N/sec)
Fixation (Nsaccadesj sec]
Antisaccade gain (%)
Antisaccade latency (ms)
Antisaccade error rate (%)
Prosaccade gain (%)
Prosaccade latency (ms)
r=0.85; p<0.00 1
r=0.89; p<0.001
r=0.95; p<0.001
r=0.89; p<0.00 1
r=0.97; p<0.001
r=0.98; p<0.001
r=0.99; p<0.001
r=0.98; p<0.001
r=0.98; p<0.001
r=0.93; p<0.001
r=0.92; p<0.001
r=0.94; p<0.001
r=0.91; p<0.001
r=0.91; p<0.001
r-0.82; p<O.O 1
r=0.82; p<0.0 1
r=0.92; p<0.01
r=0.86; p<0.0 1
r=0.97; p<0.01
r=0.96; p<0.01
r=0.99; p<0.01
r=0.98; p<0.01
r=0.90; p<0.01
r=0.92; p<0.01
r=0.89; p<0.0 1
r=0.93; p<0.01
r=0.91; p<0.01
r=0.91; p<0.01
For frequencies of saccades during SPEM, all ICC~0.86. As expected, agreement for
combined frequencies of saccades (adding AS and CUS) at the two velocities was better
(ICC=0.99 and ICC=0.98) than for AS and CUS considered separately. ICC for SPEM
gain were slightly lower (r=0.82), but still highly significant. ICC for fixation as well as
prosaccade and antisaccade variables were all highly significant and ~0.89.
4.2.3.2 Correlations between Rater 1and Rater 2
Pearson and intrac1ass correlations are given in Table 4.3. Inter-rater reliabilities for all
variables were high, with ICC ranging from 0.77 to 0.98 and Pearson correlations
ranging from 0.86 to 0.99. As above, Pearson correlations tended to be larger than ICC.
Table 4.3: Pearson and Intraclass Correlations for Inter-rater Reliability of Battery II
Pearson Intraclass
Fixation (N saccadesj sec]
Antisaccade gain (%)
Antisaccade latency (ms)
Antisaccade error rate (%)
Prosaccade gain (%)
Prosaccade latency (ms)
r=0.86; p=0.003
r=0.89; p=0.001
r=0.97; p<0.001
r=0.99; p<0.001
r=0.96; p<0.001
r=0.91; p<0.001
r=0.83; p<O.O 1
r=0.85; p<0.0 1
r=0.94; p<0.01
r"'0.98; p<0.01
r=0.95; p<0.01
r"'0.77; p<0.01
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4.2.4 Discussion
These findings show that the current eye movement scoring procedures have high intra-
and inter-rater reliability, comparable to those of previous quantitative (Clementz et al
1990; Sweeney et al 1994b) and qualitative (O'Driscoll et al 1998; Rosse et al 1992a;
Siever et al 1994; Spohn et al 1988) assessments of SPEM and fixation data as well as
those of standardised neuropsychological tests used in schizophrenia research (Heaton
et al 1993). Both types of reliability are important and necessary, but not sufficient,
criteria in the process of establishing the validity of the current methods. As the
EYEMAP scoring procedures are identical across eye movement batteries, intra-rater
reliability coefficients of Battery I are assumed to generalise to Battery II and inter-rater
reliability coefficients of Battery II are assumed to generalise to Battery I.
Identification of saccades (including antisaccade and prosaccade paradigms, as well as
saccades occurring during smooth pursuit and fixation) and saccadic metrics (of the
antisaccade and prosaccade tasks) was highly reliable (all ICC~0.86). As expected,
adding the frequencies of AS and CUS during pursuit into a combined saccadic
frequency measure improved agreement. This indicates that some variability occurred
between assessments in the identification of these two types of saccades, but that the
overall quantification of saccades during SPEMwas highly consistent. Variability in the
identification of AS and CUS may stem from the fact that these two types of saccades
are sometimes difficult to distinguish (see Chapter 3). Error term remaining in the
analysis of the combined measure may stem from the incorrect inclusion of eye-blinks
or artefacts (Calkins et al 2001), the rejection of saccades as artefacts or eye-blinks, or
the incorrect categorisation of square-wave jerks.
SPEM gain measures had slightly lower intra-rater reliabilities, indicating the presence
of greater examiner variance. This variability may be inherent in the choice of SPEM
gain analysis method in this thesis. SPEM gain was evaluated using a 100ms window
for each half-cycle of pursuit. Although placement of this window by the examiner was
restricted to sections of clear pursuit in the middle third of each half-cycle, there was
some scope for SUbjective choice and variability, thereby reducing scorer reliability.
An additional point of concern is that of the SPEM calibration task. As described in
Chapter 3, a five-point calibration with target eccentricities of 0°, ±5° and ±10° was
used. However, the range of target movement in the SPEM task was between ±15°. This
might have led to poor calibration of SPEM data, especially data points exceeding ±10°.
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While the gain measure was taken from the middle third of each half-cycle (between
stimulus eccentricities of ±5°), it remains a possibility that poor calibration may have
introduced additional error term, thereby adversely affecting the intra-rater agreement.
Any effects of poor calibration should affect the SPEM gain measure more than the
frequency of saccades during pursuit (Abel& Ziegler 1988).
Inter-rater agreement was generally very good. This indicates that error due to the
subjective component of interactive EYEMAPanalysis may be kept to a minimum if
strict operational criteria are used. Establishing the consistency of scoring across two
individuals from the same laboratory of course does not preclude the possibility of
systematic error in the approach adopted. Further validation through scoring by
experienced raters from an unrelated laboratory is required. Finally, due to practical
limitations, SPEM data were not subjected to inter-rater analysis. Given the high intra-
rater reliabilities of these variables the SPEM scoring procedures may be expected to be
of acceptable validity; however, further analysis is required.
To conclude, interactive scoring procedures in EYEMAPhave high intra- and inter-rater
reliabilities, indicating that scoring is highly consistent over time within the same rater
as well as across raters. High intra- and inter-rater reliabilities are necessary, albeit not
sufficient, criteria for the validity of the scoring methods used in this thesis.
4.3 Concurrent Validity of the Oculomotor Test Batteries
4.3.1 Introduction
An important criterion in the development of a psychological measurement instrument
is its concurrent validity (Anastasi & Urbina 1997; Rust & Golombok 1999). Concurrent
validity is defined as the extent to which a new measurement tool is similar to, i.e.
correlates with, an existing, conceptually related tool.
Factors leading to less than perfect concurrent validity (r<1) principally concern content
sampling. Although a novel instrument may be partly based on, or developed out of, an
existing instrument, it is almost certainly an aim of the researcher to provide an
improvement over the existing tool. Therefore, deliberate differences in content (i.e.
questionnaire items, stimulus specifications, etc.) are introduced, thought to improve
the statistical or theoretical properties of the instrument. These factors may reduce the
correlation between the two measures. In fact, it is argued that an extremely high
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correlation between two measures (e.g. r>0.9) may indicate the redundancy of one of
them (Anastasi & Urbina 1997; Rust & Golombok 1999).
There are reports confirming the concurrent validity of eye movement tasks across
different stimulus display methods. Studies of smooth pursuit and saccadic eye
movements in schizophrenia have employed different ways of displaying target stimuli,
including pendulum, cathode ray oscilloscope (CRO), laser projector, light emitting
diodes and video and computer monitors (Chapter 3). Shagass et al (1974) were the first
to establish that SPEM dysfunction in schizophrenia could be observed using different
ways of displaying target stimuli, with correlations between pendulum and CRO
tracking ranging between r=0.51 and r=0.66. Levin et al (1981b) used a traditional
pendulum device as well as an electronically driven rear-projection target. The
correlation for SPEM performance between the two displays was r=O.91 (p=O.001).
In addition to correlations for performance measures across different display types, it is
important to establish whether average performance levels are comparable. Smooth
pursuit performance is affected by a number of stimulus properties, such as target
velocity (Leigh & Zee 1999), attentional salience of the stimulus (Sweeney et al 1994b)
and physical background of the target display (Hutton et al 2000). However, using
comparable target velocities, Levin et al (1981b) observed that there were no significant
differences in SPEM performance across the pendulum and rear-projection methods.
These findings indicate that mere hardware specifications (unlike changes in the
'cognitive' properties of the stimulus) are unlikely to affect smooth pursuit performance,
or to lead to the observation of pursuit dysfunction in the schizophrenia patient group.
Little is known regarding the differences or correlations between saccadic and fixation
performance measures across different stimulus display methods. Given the findings
from SPEM studies it may be reasonable to expect moderate to high correlations
between saccadic metrics across different stimulus displays. Again, performance
differences may be observed depending on factors known to influence performance,
such as presence or absence of a temporal gap between central and peripheral target,
the amplitude of the peripheral target, or semantic properties of the stimulus (Klein et
al2000c; McDowell et al1999; Paus 1991).
4.3.1.1 Aims
The present study had the following aims. 1) To establish the correspondence between
the two oculomotor batteries used here. It was hypothesised that corresponding
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performance measures from the two display methods would be correlated with each
other. 2) To examine performance differences between the two batteries. No a priori
hypotheses were formulated.
4.3.2 Method
4.3.2.1 Participants
Thirty participants (19 males, 11 females; age range 19-44 years, mean=27 .17,
SD=6.88) underwent assessment. Participants were recruited from amongst staff and
students at Goldsmiths College and the Institute of Psychiatry. All participants were
free of major psychiatric disorder by self-report. All participants provided written
consent after the study details had been fully explained to them. The study was
approved by the Ethics Committee of the Department of Psychology, Goldsmiths
College, University of London.
4.3.2.2 Eye Movement Assessment
Participants underwent assessment on Battery I and Battery II. Order of administration
was counterbalanced, such that 13 participants were tested on Battery I first and
Battery II second and 17 participants were tested in the opposite order.
The oculomotor variables that were used in this analysis were SPEM gain and
anticipatory saccade (AS) and catch-up saccade (CUS) frequency at each velocity;
frequency of saccades during fixation; antisaccade error rate, gain and latency; and
prosaccade gain and latency. In order to provide additional information on how
performance measures were related across studies, SPEM gain and frequencies of
saccades during pursuit were averaged across target velocities.
One participant's SPEM data from Battery IIat O.25Hz and one participant's SPEM data
from Battery II at O.75Hz were unusable due to fatigue. One participant's fixation data
from Battery II was unavailable because of data storage error and one participant's
fixation data from Battery IIwas unusable due to fatigue.
4.3.2.3 Statistical Analysis
Skewness of all oculomotor variables was assessed. Variables were transformed using
square or square root transformations if skewness values were less than -1 or exceeded
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1, respectively. All statistical analyses reported below were carried out using SPSS
Release 10.0.7 (SPSS Inc., Chicago, Ill).
4.3.2.3.1 EFFECTS OF AGE AND SEX
Pearson correlations were carried out between age and oculomotor variables. Males and
females were compared on oculomotor performance using multivariate analysis of
variance (MANOVA);separate analyses were carried out for Battery I and II.
4.3.2.3.2 INTERCORRELATIONS BETWEEN OCULOMOTOR MEASURES FROM BATTERIES I AND II
For SPEM variables, Pearson correlations were carried out between batteries on
averaged measures of gain, AS frequency and CUS frequency. Further, as each battery
used a SPEM stimulus velocity of 24° Is, Pearson correlations were carried out between
gain, AS frequency and CUS frequency at this velocity. For visual fixation and saccadic
variables, Pearson correlations were carried out for corresponding variables across
batteries.
4.3.2.3.3 DIFFERENCES BETWEEN OCULOMOTOR MEASURES FROM BATTERIES I AND II
Repeated-measures t-tests were carried out between corresponding saccadic and
fixation variables in order to assess differences between stimulus displays. For SPEM
variables, t-tests were carried out comparing SPEM gain, AS and CUS at 24° /s across
batteries. Averaged SPEM measures were not included in the repeated-measures
analysis, as the average target velocities of the two batteries did not correspond.
4.3.3 Results
A number of variables were skewed and were transformed accordingly, normalising all
distributions (-1<skewness< 1). However, results of analyses using untransformed
variables are reported below, as these were very similar to those using transformed
variables, with the exception of frequency of saccades during fixation, as noted below.
Descriptive statistics of oculomotor measures are given in Table 4.4. These are generally
comparable to performance data reported in previous studies of healthy individuals.
Average antisaccade correction rates for Battery I (100%) and Battery II (99.36%;
SD=2.09) were very high, indicating that participants were willing and able to follow
instructions and perform the task (McDowell & Clementz 1997).
192
..... If) 00 .....
V V 0 00000 .....00 VO~~ .....~V N 9c 9 9 . '99 '099 Q,Q,9:§ Q, Q, Q, Q, Q, .~ .~ Q, .- 0'1 .~ .~ 0'1 0'1 .~ 0'1~ 0'1 0'1 N ~O'I('.1NO'I('.I..... N N J!. ~~J!.J!.~J!.c J!. J!. 't:I ~~~~~~~~
~
't:I 't:I
Ocf M .~ .~0 If) .~ Lf)+I ..... ~ Lf)\0""'00 v 0'1• ~ N 000 •• \0 .c::: ~ 0 M ....... ('.1 'Ma +I ..... I OM I I ..... II II II II II II II II II II
"tl
+I I +' I I +' I I +' I I ....... ~ ............ ~ .......
c:::
IQ
C ..... ..... +- ~::: 00 \0 0 0 ..... vMMO'IOMLf)
.Q ..... M 0 0 0 00000 .....0
~ 9 9 0 0 9 9999999v
~QJ Q, Q, c, Q, Q,Q,Q,Q,Q,Q,Q::: c:I
0 Lf) i-~ M ('.I If) i-~:..:0;'N0;' a.~0e N ..... \0 ~ ~ MvMMvNMIII 0 0 0 0 0 0000000~ II II II I!. I!. II I!. II I!. II I!. I!.Do. I ~ I I ~ I I ~ I I I ~ ~ ~-0
M
II
Z-' '-'.... I/)IXS ...II)- Q)...I/) I
Q) ...·c I/)
Q) Q)... L.... ::J
It] I/)co It]
E
Q)
0
~
L. "06- Q)II) ...
Q) It]
:0 Q)0.
It] Q)·c 0::
It]
">L. C
0 It]... >:0
E ~
.2 "::J It]
U >0 ...
06- C
0 Q)
I/)
L.
L.
U ::J;:; U
I/) C
;:; 0
It] u...
(f) L.
Q) .E
> I/);:; ca. 0·c ;:;
u ~I/)
Q) Q)
L.a L.
0
~ uv c0
~ ~
.0 It]
It] Q)r Q.
=
VM~ 0'1
\0 ..... 000 v .....0 ~ Mlf)OO .....OO.....O
fa 0'1 ..... \0 ..... M N ..... M .....0 .........~ \Cio 0 00 0 • ...... v..... • Lf)I 00 I I I I I I I I OONM .....O'I.....
....
~
0'1 If) vOO vO
G M ..... ~ °M~lf)('t)('t)
t M ..... '\0 0 ~ ..... v .....('t) • • \0 • •:S 00 0 ..... Lf) N ..... ~ MONO'I·MVIII 0 O. . 'O'I~VO~eQ ..... I 0'1 I I .....0 I 0 I I 00 I 0 I 00 IN""''''''''''' s.....
193
Reliability and Concurrent Validity
4.3.3.1 Effects of Age and Sex
For Battery I, age was correlated significantly with prosaccade gain (r=-0.37; p=O.045).
For Battery II, age was correlated significantly with antisaccade gain (r=0.41; p=O.03),
antisaccade latency (r=0.42; p=O.02), prosaccade gain (r=-0.48; p=O.07) and CUS
frequency at 36° /s (r=0.44; p=O.02) and at trend level with SPEM gain at 48° /s (r=-
0.35; p=O.06). Noother correlations were significant (all r<0.31; all p>0.10).
For Battery II, females had longer pro saccade latency (F[1,26]=4.29; p=O.049). For
Battery II, males had higher antisaccade error rate (F[1,26]=4.73; p=O.04). No other
analyses were significant (all p>0.06).
Analyses of age and sex indicate that effects on oculomotor performance were very small
and inconsistent. These variables are thus not further considered in the following
analyses of Chapter 4.
4.3.3.2 Intercorrelations between Oculomotor Measures from
Batteries I and II
Pearson correlation coefficients and levels of statistical significance for pairs of related
variables are presented in Table 4.4. Correlations between SPEM gain measures (at
24° /s and averaged) across batteries did not attain statistical significance (both
p>0.18). Correlations between AS frequencies across tasks were significant for the 24° / s
target (r=0.63; p<0.001) and averaged velocities (r=0.72; p<0.001). Rates of CUS were
significantly correlated across batteries for the 24°/s target (r=0.45; p=O.Ol) as well as
averaged velocities (r=0.37; p=O.04). Frequency of saccades per second during visual
fixation were significantly correlated across batteries (r=0.41; p=O.03). However, as
noted above, frequencies of saccades during fixation from both batteries were positively
skewed (Battery I: 2.12; Battery II: 1.74). The correlation across tasks using
transformed variables was slightly lower and failed to reach statistical significance
(r=0.32; p=O.10).
For antisaccade gain and error rate as well as pro saccade latency, correlations across
batteries were significant (all p<0.05). There was a trend for a correlation between
anti saccade latencies (r=0.32; p=O.09). Prosaccade gain was not significantly correlated
(r=0.29; p=O.13). Inspection of the scatter plot, however, indicated that there was a
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general pattern of a positive association between the two variables in the presence of a
single case falling outside this pattern. Spearman rank correlation+? was rho=O.39
(p=O.03). Pearson correlation excluding this case was r=O.35 (p=O.06), further
confirming the outlier status and disproportionate influence on the result of this
participant.
4.3.3.3
and II
Differences between Oculomotor Measures from Batteries I
The results of repeated measures t-tests between pairs of variables across tasks are
summarised in Table 4.4. Fixation performance, SPEM gain at 24°/s and AS rate at
24°/ s did not differ across batteries (all p>O.24). Battery II elicited significantly more
CUS during pursuit at 24°/s than Battery I (t=-3.73; df=29; p=O.OOI).
There were no differences between batteries for antisaccade latency and prosaccade
gain. Performance on Battery II was characterised by higher antisaccade error rate (t=-
2.85; df=29; p=O.008), larger antisaccade gain (t=3.06; df=29; p=O.005) and longer
prosaccade latency (t=-3.95; df=29; p<O.OOI).
4.3.4 Discussion
4.3.4.1 Key Findings
The key findings from this study are as follows. 1) SPEM (frequency of saccades),
fixation and saccadic eye movement performance measures were largely correlated
across Batteries I and II; smooth pursuit gain and prosaccade gain were not
significantly correlated. This finding indicates that the two target displays largely
correspond in their measurement of oculomotor function in healthy individuals,
furnishing evidence of the tests' concurrent validity. 2) Specific differences across tasks
were obtained, primarily for saccadic variables. Possible explanations for these
differences will be put forward below.
19 Parametric tests, such as Pearson correlation, have low power if a variable's distribution
departs from normality (Tabachnick & Fidell 2001).
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4.3.4.2 Intercorrelations between Batteries
Validation is an important step in the development of a novel measurement instrument.
The set of oculomotor tasks specifically developed for research reported in this thesis
(Battery II) meets a number of validity criteria. First, the stimulus display and eye
movement recording methods have high face validity, as their purpose of eliciting and
recording eye movements is unmistakable and the tasks were generally found to be
acceptable to participants. Second, content validity was ensured by making the
stimulus properties comparable to previously published tasks through an extensive
review of the literature (see Chapter 3). Finally, this study provides evidence of
concurrent validity, i.e. the correspondence of the new set of tasks (Battery II) with an
existing one (Battery I).
Rates of AS and CUS were correlated significantly across batteries. This correlation,
which also includes error term from the brief temporal gap between tasks (see Section
4.5) and examiner variance (see Section 4.2), suggests that individual differences in the
control of these saccades are not strongly influenced by the physical properties of the
two stimulus displays used here. This assumption is further bolstered by the lack of
differences inAS rate between the two tasks, although the reason for an increased CUS
rate in Battery II is unclear. The reliable identification of AS is particularly important
given the role of this measure as a putative schizophrenia endophenotype (Ross et al
1998e, 1999b, 1999c, 2001).
SPEM gain scores were not significantly correlated across display methods, posing a
problem for the validity of this task. One possible source of error might be the slightly
lower intra-rater reliability of the SPEM gain measure (Section 4.2). Additionally, poor
calibration may partly account for the low correlations. Of the SPEM measures used
here, gain is more likely to be affected by problems with calibration than saccades
during pursuit (Abel& Ziegler 1988). Another possibility is, as before, the limited width
of the window used in the SPEM gain analysis (lOOms). This factor might have lowered
the reliability of SPEM gain assessment. The possibility remains that systematic
differences in stimulus properties between the two tasks adversely affected the
correlation. However, this possibility may be discounted for the following reasons. First,
there were no differences in SPEM gain for the 24°/ s target across display methods.
Second, systematic differences between tasks may occur without affecting the (Pearson)
correlation (Bartko 1991).
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Despite the relative infrequency of saccades during fixation, this measure was
comparable across tasks; rates of saccades were correlated and did not differ between
display methods. However, using transformed variables somewhat lowered the
correlation between the two, probably due to the skewed distributions of the variables,
as most participants emitted only very few saccades during fixation.
Saccadic performance measures, with the exception of pro saccade gain, were also
correlated across display methods. The correlation for prosaccade gain between tasks
was in the expected direction, approached statistical significance after exclusion of an
outlier and was significant using an ordinal level correlation, which is less sensitive to
the effects of outliers.
4.3.4.3 Differences between Batteries
Significant differences between batteries were obtained for prosaccade latency,
antisaccade gain and antisaccade error rate. These are discussed in the following.
Battery II was associated with significantly longer prosaccade latency and non-
significantly longer antisaccade latency than Battery I. The reason for this may have
been the duration of central fixation target presentation, which varied randomly
between I,OOOms and 2,OOOms in the saccade tasks of Battery II, but was fixed at
SOOmsand I,OOOms in the pro- and antisaccade tasks, respectively, of Battery I.Quasi-
random variation in central fixation point duration means that peripheral target
presentation is temporally unpredictable. Temporally predictable targets have been
shown to lead to faster latency than temporally unpredictable targets (Zahn et al 1998).
Indeed, the fastest saccadic latencies are obtained when target presentation is both
temporally and spatially predictable (Hutton et al 2001a; Karoumi et al 1998b). The
present findings are compatible with these effects.
Battery II was also associated with a higher antisaccade error rate. One possible
explanation for this finding is the greater variability in target locations in Battery II. In
this task the target appeared in two possible locations on either side of the central
fixation point, whereas in the antisaccade task of Battery I only one location was used
on either side. As participants were instructed to perform eye movements in opposite
direction and equal distance to the peripheral target, it is possible that some errors
occurred during attempts to encode target location in order to execute spatially
accurate antisaccades. Greater choice in target locations would, therefore, require
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increased covert attentional processing and might be associated with a greater
probability to commit errors.
Another possible explanation for the difference in antisaccade error rate comes from a
study by McDowell et al (1999). These researchers reported greater statistical
separation between schizophrenia patients and healthy participants for a far (±16°) than
a near (±8°) antisaccade target. It was found that healthy individuals made more
reflexive errors when the antisaccade target was presented closer to the central ftxation
point. In the current study the antisaccade task of Battery II used target eccentricities
of ±6° and ±12° while the Battery I task used ±15° targets. It may be hypothesised that
target occurrences closer to the central ftxation point led to greater average error rate in
the Battery II antisaccade task.
Finally, while antisaccade gain scores were correlated across stimulus displays,
differences were observed between tasks. The Battery I antisaccade task led to slightly
hypometric antisaccades and the Battery II task led to slightly hypermetric
antisaccades. It is more common for a primary saccade to slightly undershoot the target
(Leigh& Zee 1999). The reason for the slight overshoot in the Battery II task is unclear,
but may reflect spatial inaccuracies due to greater variability in stimulus locations.
4.3.4.4 Conclusions
To conclude, the two oculomotor batteries employed here demonstrated reasonable
concurrent validity for measures of SPEM saccadic frequency, ftxation and saccadic
performance. Correlations for SPEM gain across tasks, however, were disappointing,
pointing to low correspondence of the two batteries for this measure. Speciftc
performance differences between methods occurred. The antisaccade task of Battery II
was shown to be more difftcult than that of Battery I (as indexed by higher error rate
and slightly longer latency). Increased prosaccade (and, non-signiftcantly, antisaccade)
latency of Battery II might be due to characteristics of stimulus durations.
4.4 Internal Consistency of Eye Movement Performance
4.4.1 Introduction
An important reliability criterion is an instrument's internal consistency (Anastasi &
Urbina 1997; Rust & Golombok 1999). Internal consistency is a measure of the
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reliability of content sampling, or homogeneity of items. A test consisting of a set of
highly homogenous items (in terms of content, difficulty, or format) will be associated
with consistent within-test performance. A heterogeneous selection of items, however,
may pose a threat to internal consistency, leading to variable performance across items
within the same test.
Only one previous study on internal consistency of SPEM performance could be
identified (Cegalis & Sweeney 1979); these authors reported high consistencies of
saccadic frequency and spatial error for different intervals of smooth pursuit tracking.
No further reports of internal consistencies of eye movement variables could be
identified through performing a comprehensive literature search of the Medline and
PsycINFO databases, reading of relevant publications and consulting an eye movement
mailing list (http://www.jiscmail.ac. uk/lists /EYE-MOVEMENT.html).
Stimulus properties of oculomotor paradigms used here do not vary within one
assessment, with the exception of randomised central target presentation in the
saccadic tasks of Battery II. Therefore, high internal consistency may be expected.
However, variability of human performance over time, due to effects of fatigue,
motivation and learning, may affect the internal consistency of oculomotor paradigms.
Additionally, these effects may lead to systematic improvement or deterioration in
performance within a test session.
4.4.1.1 Aims
The aims of this study were, therefore, as follows. 1) To assess the internal consistency
of the current eye movement paradigms by calculating Cronbach's coefficient alpha
(Cronbach 1951). 2) To examine whether there were any significant within-session
changes in performance levels, using consecutive time segments of performance within
each task.
4.4.2 Method
4.4.2.1 Participants and Eye Movement Data Scoring
Eye movement data of participants from study 4.3 (N=30)was used in this analysis.
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4.4.2.2 Statistical Analysis
All statistical analyses were carried out using SPSS Release 10.0.7 (SPSS Inc., Chicago,
Ill). Oculomotor variables were assessed for normality of distributions and transformed
accordingly if positively (skewness> 1) or negatively (skewness<-1) skewed. Transforming
variables did not noticeably affect internal consistencies or within-session changes;
therefore, results reported below are based on untransformed variables.
4.4.2.2.1 INTERNAL CONSISTENCY
Cronbach's coefficient alpha (Cronbach 1951) was used as an estimate of internal
consistency (cf. Lund et al 1995). Coefficient alpha is the most appropriate measure of
internal consistency for scales (or tests) with items that depart from a binary response
format (e.g. 1=correct; O=incorrect) (Anastasi & Urbina 1997).
In order to compute Cronbach's alpha, sub-scores for SPEM and saccadic performance
measures were calculated. Data at the item level (i.e. one SPEM half-cycle, one saccade
trial) could not be used for the following reasons: First, regarding SPEM gain, due to
eye-blinks or other artefacts, gain measures could occasionally not be obtained for
individual half-cycles. Second, AS and CUS during smooth pursuit and saccades during
fixation do not occur as a function of fixed trials, vary in frequency between people and
can, therefore, not be used in an analysis at the item level. Third, similar problems of
missing trials prevented the use of single trial data on the saccadic tasks.
Therefore, sub-scores were obtained for segments (time sections) of pursuit or saccadic
eye movement recordings. For Battery I, each of the two blocks of SPEM traces at each
velocity was divided into two equally long sections. Gain and frequencies of AS and CUS
were obtained for the resulting four subsections at each velocity. For the antisaccade
task, each of the three blocks of 8 trials was divided into two equally long sections.
Likewise, regarding the pro saccade task, each of the three blocks of 12 trials was
divided into two equally long sections. Both antisaccade and prosaccade tasks,
therefore, yielded six segments each. Saccadic metrics were then obtained for each
segment. For visual fixation, internal consistency was calculated for three segments
consisting of the central as well as the two peripheral target presentations.
For Battery II, SPEM traces for each velocity were divided into four sections of equal
temporal duration each. Gain and frequencies of AS and CUS were then obtained for
each section at each velocity. For antisaccade and pro saccade tasks, four sections of
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equal duration were obtained each. Saccadic metrics were then obtained for each
section. For visual fixation, internal consistency was calculated for four segments
consisting of the two peripheral and two central target presentations.
Cronbach's coefftcient alpha was thus calculated for each variable on the basis of the
scores from three to six time segments. Larger alpha coefftcients indicate better internal
consistency, i.e. higher intercorrelations between subscores. Cronbach's alpha has been
shown to increase with the number of items in the scale (Anastasi & Urbina 1997).
Therefore, it may be criticised that failing to use individual item (or trial) data might
adversely affect the internal consistencies reported here. However, using segments of
performance data as 'items' is believed to be a robust approach, as each segment
already represents an average performance score of a number of trials. That this
segmentation does indeed provide an appropriate, and robust, item pool for computing
Cronbach's coefftcient alpha will briefly be demonstrated using a dataset of
psychophysical data collected and published by the author (Ettinger & Corr 2001).
Data from a psychophysical decision task were collected, consisting of 200 identical
trials per participant. Each trial required the participant to make a decision (as to the
occurrence of a stimulus) and was scored as 1 ('correct1 or 0 (wrong}. Data were
gathered amongst 57 participants (mean number of correct trials=140.19; SD==16.74).
Cronbach's alpha for this scale of 200 items at the item level was 0.85; for 20 segments
of 10 consecutive trials each it was 0.86; and for 4 segments of 50 consecutive trials
each Cronbach's alpha was 0.87. This finding demonstrates that truncating multi-trial
performance data into segments of consecutive trials does not present a severe threat to
the assessment of internal consistency using Cronbach's coefftcient alpha.
4.4.2.2.2 WITHIN-SESSION CHANGES
In order to examine whether performance levels changed over sections of consecutive
trials, repeated measures analyses of variance (ANOVA) were carried out for each
variable. Due to the large number of analyses statistical signiftcance was considered at
the level ofp<0.0 1 and statistical trends were considered at the level of 0.05>p~0.0 1.
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4.4.3 Results
4.4.3.1 Internal Consistency
Cronbach's alpha for SPEM and saccadic variables of both Batteries I and II are given in
Table 4.5. As can be seen, most coefficients were high, indicating good internal
consistency. Coefficients were larger than 0.70 for all but two variables of Battery I,
with five coefficients ~ 0.80. Cronbach's alpha for antisaccade error rate of Battery I was
relatively low (0.57). When this analysis of error rate was rerun combining consecutive
pairs of segments to yield three performance scores, coefficient alpha increased to 0.65.
All but three coefficients for variables from Battery II indicated very high internal
consistency (alph~0.73). Coefficients for AS at 48° /s and CUS at 12°/s were 0.43 and
0.34, respectively. Coefficients for fixation data from both batteries were moderate.
4.4.3.2 Within-session Changes
For Battery I, there was a trend for a linear improvement in SPEM gain scores at 24° /s
(F(3,87]=2.95; p=O.04). There was a significant linear reduction in CUS frequency at
24° / s (F(3,87)=27.34; p<O.OO 1). There was a trend for a significant change in AS
frequency at 24° /s over time, with greatest frequencies observed in the first and third
segments (F(3,87]=27.34; p<0.001). Within-subjects contrasts revealed that this was not
a linear (F(I,29]=O.61; p=O.44) but a cubic effect (F(I,29)=9.32; p=O.005).
A trend for a significant change in antisaccade gain over time was observed, with
smallest gain scores observed for segments 3-5 (F(5,125=2.60; p=O.03). Within-subjects
contrasts indicated that this was not a linear (F(I,25]=0.11; p=O.74) but a quadratic
effect (F(I,25]=6.68; p=O.02). There was a significant linear reduction in prosaccade
latency over time (F(5,115]=6.64; p<O.OOI).
For Battery II, CUS frequency at 12°/ s dropped significantly and linearly over time
(F(3,84]=6.09; p=O.OOI). There was a trend for a linear reduction of CUS frequency at
36° / s (F[3,81)=3.39; p=O.02). AS frequency at 36°1 s increased significantly and linearly
(F[3,83)=8.48; p<O.OOl). There were no other within-session performance changes for
Battery II.
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4.4.4 Discussion
4.4.4.1 Key Findings
This study has the following findings. 1) Internal consistencies of oculomotor variables
investigated in this thesis were generally very good. With a few exceptions, coefficients
were larger than 0.70. 2) Some within-session changes in performance levels were
observed; however, these were fairly inconsistent.
4.4.4.2 Internal Consistency
This is the first study to thoroughly investigate the internal consistency of a
comprehensive set of oculomotor tasks used in schizophrenia spectrum research. Most
of the key measures demonstrated very good internal consistency. Internal
consistencies for both fixation tasks were relatively low, probably due to the small
number of saccades occurring during fixation in this healthy sample. Possibly the
greatest challenge to the validity of endophenotypic markers in this thesis is the slightly
disappointing coefficient alpha for antisaccade error rate of Battery I.
The reason for this low reliability might lie in the stimulus properties of the Battery I
antisaccade task. As this task involves only three blocks of a total of 24 trials, each time
segment in the reliability analysis included a maximum of only four trials. This means
that for each segment only four different error scores (25, 50, 75 and 100%) may have
occurred. Due to missed trials (e.g. eye-blinks) other values were in fact also observed
(e.g. 33.33 or 66.67%), however the overall between-subject variation of scores was
small. This statistical problem, rather than the neurophysiological correlates of
anti saccade performance per se, probably led to the task's unsatisfactory internal
consistency. Evidence for this hypothesis comes from the finding that antisaccade error
rate from Battery II was highly consistent. Additionally, combing the six time sections of
the Battery I task into three consecutive segments, thereby allowing for greater within-
segment variability of scores, improved Cronbach's alpha to 0.65.
Internal consistencies reported here are largely comparable to those reported by Cegalis
and Sweeney (1979) and those of neuropsychological (Wechsler 1981; Wechsler 1987),
clinical (Moniz-Cook et al 2001) and psychometric schizotypy (Eysenck & Eysenck
1991; Vollerna & van den Bosch 1995) measures used in schizophrenia spectrum
research, although highly homogenous tests tend to possess better reliabilities (Nelson
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1991). Lund et al (1995) reported Cronbach's alpha coefficients for EEG power spectra;
these were somewhat higher than the current reliabilities, with most coefficients above
0.9.
Internal consistency of psychophysiological measures is a non-trivial matter. Most
assessments of brain function using psychological or psychophysiological tasks rely on
obtaining and subsequently averaging multiple performance samples (e.g. trials).
Calculating averages is often necessary for further statistical analysis. However, the
validity of this approach assumes that measures of brain function obtained across an
extended period of time, or several trials, are consistent. With a few exceptions (Lund et
al 1995) this consistency has not been demonstrated. The present study demonstrates
consistent oculomotor control and a relative absence of consistent significant within-
session practice effects in healthy individuals (with the exception of some improvement
on the SPEM task), thereby validating the subsequent averaging of performance data for
each participant. The absence of significant within-session deterioration of performance
is of importance given the influence of fatigue or loss of motivation, which may ensue
after a large number of trials. This finding suggests that tasks from both batteries were
of acceptable length for healthy individuals. The extent to which these reliability
findings generalise to schizophrenia patients remains to be investigated.
4.4.4.3 Within-session Changes
Some within-session changes were observed. These were fairly patchy, but appeared to
be most consistent for SPEM. Improvements in smooth pursuit performance were
observed for SPEM gain and CUS frequency, consistent with the notion that the eye
requires some time to optimally follow a moving target (Leigh & Zee 1999). However, an
increase in AS frequency over time was also observed at one velocity; the reason for this
is unclear. Additionally, there was some evidence for faster reaction times of
prosaccades over time in Battery I, pointing to effects of learning. As the order of
stimulus presentation of a Battery I prosaccade block is quasi-random but employs
fixed inter-stimulus durations and three blocks of identical trials were presented, this
pattern of learning is compatible with effects of procedural learning commonly observed
on psychomotor tasks with such characteristics (Corr et al 1997; Kumari et al 1997a;
Kumari et al 2002). The spatial and temporal random sequence of target movements on
the Battery II task is most likely to have prevented this effect. Interestingly, no
significant linear within-session changes in antisaccade performance were obtained (see
Section 4.4 for between-session effects).
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4.4.4.4 Conclusions
To conclude, the current oculomotor test batteries demonstrate good internal
consistency. Antisaccade error rate of Battery I showed slightly disappointing reliability,
most likely due to the small number of trials. Internal consistencies of Battery II were
equal to or higher than those of Battery I, but never lower. Within-session practice
effects were inconsistent across tasks and batteries, but point to small improvements in
smooth pursuit performance, as indexed by increases in gain and reductions in CUS
frequency over time.
4.5 Test-retest Reliability of Oculomotor Measures in
Healthy Individuals
4.5.1 Introduction
An important characteristic of a putative endophenotype is its trait, rather than state,
nature (Clementz 1998; Leboyer et al 1998; Ott 1991). Accordingly, a number of studies
have investigated the temporal stability of eye movement performance in samples of
healthy individuals as well as people with schizophrenia. As outlined above (Section
2.3.5.5.2), previous research indicates that both global and specific SPEM measures are
relatively stable in schizophrenia patients and healthy controls over time intervals
ranging from one week to two years, with correlation coefficients between about 0.5 and
0.9 (Campion et al 1992; Gooding et al 1994; Holzman et al 1973; Iacono & Lykken
1981; Rea et al1989; Roy-Byrne et al 1995; Schlenker & Cohen 1995; Yee et al 1998).
There are relatively few studies of the temporal stability of saccadic eye movements.
Good reliabilities of prosaccade velocity, accuracy, latency, as well as amplitude-
duration and amplitude-peak velocity relationships have been observed (Iacono &
Lykken 1979a; Versino et al 1993; Wilson et al 1993). Even fewer studies have
addressed the antisaccade task, with two studies failing to show significant test-retest
reliability (Klein & Berg 2001; Roy-Byrne et al 1995) and one study (Thaker et al 1989a)
reporting test-retest reliabilities for antisaccade latency and error rate of r>0.75 periods
from one week to one year.
These studies suggest that the duration of interval between test and retest is not
systematically related to the magnitude of reliability coefficients. Therefore, any error
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term that reduces the reliability of performance is unlikely to be accumulating over time
(at least over periods of up to 1-2 years). Less than perfect test-retest reliability is,
therefore, likely to be due to two separate sources of variance: error of measurement
(methods) and effects of state measures on the neural circuitry of oculomotor control.
First, an individual's observed score on a behavioural (psychometric or
psychophysiological) measure is assumed to reflect their true score plus error of
measurement (Anastasi & Urbina 1997; Rust & Golombok 1999). Thus, to the extent
that an individual's score on an eye movement task is invariant to state-related changes
in the neural system of oculomotor control, less than perfect reliability will reflect error
of measurement, which, in the case of oculomotor research, stems from eye movement
recording (Reulen et al 1988) and data scoring (Section 4.1).
Second, however, a number of state variables are known to affect eye movement
performance, thereby reducing reliability, irrespective of error associated with
methodological issues. These variables include time of day (Roy-Byrne et al 1995;
Schalen et al 1984), fatigue (Bahill & Stark 1975; Schalen et al 1984), caffeine intake
(Litman et al 1989), smoking (Olincy et al 1998; Powell et al 2002; Thaker et al 1991),
states of influenza or cold (Smith et al 1999) and motivational factors (Duka & Lupp
1997).
Another topic with relevance to studies investigating the temporal stability of
oculomotor performance concerns that of practice effects. Significant practice effects on
cognitive tests have been demonstrated in healthy individuals (Lezak 1983; Wechsler
1981; Wechsler 1987). These improvements in performance from first to second
assessment (usually over periods of several days or weeks) are likely to be due to effects
of learning, but might also reflect reduced anxiety levels due to increased familiarity
with the task and laboratory setting. Healthy people generally do not show significant
improvements on SPEM measures at retest (Campion et al 1992; Gooding et al 1994;
Versino et al 1993). Regarding the antisaccade error rate, however, there is some
evidence of practice effects (Green et al 2000; Klein et al 2002).
4.5.1.1 Aims
The present study had the following aims. 1)To investigate the temporal stability of the
oculomotor Batteries I and II in a sample of healthy individuals over a period of about
two months. Based on previous studies, moderate to good reliabilities were
hypothesised. 2) To assess whether performance levels changed over time. Given
207
Reliability and Concurrent Validity
previous reports, no improvements on SPEM measures, but reductions in anti saccade
error rate were hypothesised.
4.5.2 Method
4.5.2.1 Participants
The sample comprised a subgroup of the participants of study 4.3. Participants of study
4.3 had been informed in advance and agreed that they would be contacted for retest.
Due to practical reasons (e.g. unwillingness or unavailability of participants), however,
only twenty of these participants could be followed up. The sample consisted of fourteen
males and six females. Ages ranged between 19-43 years (mean=26.15, SO=6.48).
Participants repeated oculomotor assessments of study 4.2, with an average test-retest
interval of 58.35 days (SO=19.40; range=38-105 days).
Participants who volunteered for retest did not differ from other participants on sex
(X2=1.15; p=O.28), age (F[I,27]=2.51; p=O.13), or any oculomotor variables (all F<4.09;
p>0.05), with the exception of lower saccadic frequency during fixation on Battery II
(F[I,27]=5.73; p=O.03). It is thus assumed that the subsample used in the retest
analysis did not differ consistently from participants who could not be recruited for
retest.
4.5.2.2 Eye Movement Assessment
Batteries I and II were administered at assessment I and assessment II. Order of testing
was counterbalanced as described in Section 4.3. Additionally, participants who were
tested in order 1 at assessment I were tested in order 2 at assessment II and vice versa.
Three participants were not tested on Battery I at follow-up due to limitations of time.
One participant's SPEM data for Battery I was not available due to data storage error.
4.5.2.3 Statistical Analysis
All statistical analyses were carried out using SPSS Release 10.0.7 (SPSS Inc., Chicago,
Ill). Skewness was assessed for all oculomotor variables. If variables were positively (> 1)
or negatively «-1) skewed, variables were transformed accordingly.
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4.5.2.3.1 TEST-RETEST RELIABILITY
In order to assess the test-retest reliability of oculomotor measures, intraclass
correlations (ICC) were used (Bartko 1991; Roy-Byrne et al 1995). The data file was
prepared as described above (Section 4.1). ICC were then computed using Pearson's
correlation coefficients and tested for statistical significance based on the original
sample size N. In order to provide an estimate of the differences in magnitude between
the ICC and Pearson correlations, and to allow comparisons with previous studies
(Campion et al 1992; Gooding et al1994; Klein & Berg 2001; Schlenker & Cohen 1995),
both coefficients are reported here.
Interestingly, Klein and Berg (2001) imply that Pearson's correlation coefficient is a
more appropriate measure of test-retest stability of psychophysiological measure, as
ICC assumes that "identical scores are obtained during the first and second
measurement" (p. 706). This appears to be not so much an assumption, but a strength,
of ICC, as it is sensitive to departures from this assumption. Therefore, ICC is believed
to be the better measure oftest-retest reliability (Bartko 1991).
4.5.2.3.2 BETWEEN-SESSION CHANGES
In order to probe for effects of repeated exposure on eye movement performance,
repeated measures t-tests were calculated between pairs of oculomotor variables across
assessments (Rosmark et al 1999). Due to the large number of analyses statistical
significance for all below analyses was considered at the level of p<0.01 and statistical
trends were considered at the level of 0.05>p~0.0 1.
4.5.3 Results
A number of variables were positively or negatively skewed; transformations normalised
distributions of all variables. As results based on untransformed variables were very
similar to those of transformed variables, except where stated (Battery I anti saccade
error rate), those from untransformed data are reported below.
Table 4.6 summarises descriptive statistics for oculomotor variables of Battery I from
both assessments, Pearson correlations and ICC for each variable and the results of the
repeated measures t-tests for each variable. Table 4.7 represents the same information
for Battery II.
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4.5.3.1 Test-retest Reliability
For all variables, Pearson correlations were the same or larger than ICC, but never
smaller. For Battery I, significant or trend level ICC (and Pearson) were obtained for AS
at 24° /s and total AS, CUS at 24° /s and total CUS, antisaccade gain and pro saccade
and antisaccade latency.
SPEM gain, CUS at 10°/ s, frequency of saccades during fixation, antisaccade error rate
and pro saccade gain were not stable over time, although the direction of coefficients
was as expected. As mentioned above, antisaccade error rate was positively skewed;
using the transformed variable yielded a Pearson correlation of r=0.46 (p=O.06) and
ICC=0.35 (p=O.04).
For Battery II, all but four ICC and all but three Pearson correlations were significant or
reached trend level. Non-significant ICC and Pearson correlations were obtained for
SPEM gain at 12°/s and 24°/s, CUS frequency at 12°/s (which approached trend level
for Pearson correlation), frequency of saccades during fixation (which was significant for
Pearson correlation) and antisaccade gain (which reached trend level for Pearson
correlation).
4.5.3.2 Between-session Changes
For variables in Battery I, only antisaccade error rate changed at trend level (t=2.35;
df=17; p=O.03). Participants tended to make fewer errors at assessment II (7.80%) than
at assessment I (15.31%). Participants also made slightly faster latency antisaccades at
assessment II, however this did not reach statistical significance (t=1.76; df= 17;
p=O.10). No other variables differed significantly over time (all p>0.22).
A significant reduction in antisaccade error rate was found for Battery II (t=3.16; df=19;
p=O.005), with average rate dropping from 20.76% to 15.75%. Saccadic performance at
assessment II was also characterised by more accurate antisaccade gain (t=-2.59;
df=19; p=O.02) and slightly reduced prosaccade gain (t=2.28; df=19; p=O.04). For SPEM
and fixation variables of Battery IIno comparisons yielded significant changes, although
participants made slightly fewer AS at 36°/ s at second assessment (t= 1.95; df= 18;
p=O.07).
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4.5.4 Discussion
4.5.4.1 Key Findings
The key findings from this study are as follows. 1) With some exceptions, oculomotor
performance was stable over time. As Becser et al (1998) pointed out, ICC>0.75 indicate
excellent reliability and ICC>0.40 indicate good reliability. 2) Effects of practice were
most consistently observed on the antisaccade task, indicated by reduced error rate
(both batteries), improved accuracy (Battery II) and slightly faster latency (both
batteries) at retest.
4.5.4.2 Test-retest Reliability
Previous studies have pointed to good temporal stability of global quantitative and
qualitative, as well as specific, measures of smooth pursuit. This study only partially
replicates these findings. Good Pearson correlations and ICC were obtained for
frequency of CUS and AS for both batteries, confirming previous reports (Roy-Byrne et
al 1995). However, reliabilities for SPEM gain were more variable, with ICC ranging from
-0.06 to 0.77. None of the correlations for the three SPEM gain measures of Battery I
but three of five SPEM gain measures of Battery II reached statistical significance. The
reason why SPEM gain measures for the two slower velocities of Battery IIwere non-
significant might be the fixed width of the window used to measure gain in EYEMAP.
The width of this window is lOOms, which represents a smaller proportion of
performance within each half-cycle at slower than at faster target velocities. From this it
follows that sampling of a greater proportion of data points due to prolonged
measurements would lead to more reliable data at the two faster velocities. As target
velocities of the SPEM task from Battery Iwere comparable to the two slower velocities
of Battery II, the same reason might explain the low reliabilities of Battery I SPEM gain.
The high reliability for frequency of AS is particularly important given the proposed role
of this measure as an inhibitory schizophrenia spectrum endophenotype (Friedman et
al 1992a; Rosenberg et al1997c; Ross et al 1998e, 1999b, 1999c, 2001).
Test-retest reliabilities of saccadic measures were heterogeneous. The key measure in
schizophrenia spectrum research, antisaccade error rate, was highly stable over time
when assessed with Battery II, but somewhat less reliable when assessed with Battery I.
Probably due to the skewed nature of the Battery I error rate distribution (most
participants made very few errors), reliability was improved after data transformation.
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Given this finding, and the high reliability of antisaccade error rate from Battery II, it
may be argued that actual performance on this measure is stable over time and the
somewhat lower reliability of Battery I may be due to methodological issues, as
discussed in the following.
Battery I used only 24 trials, compared to 60 trials in Battery II. A critical review of the
literature (Chapter 3) indicated that 60 trials might be an appropriate number of trials,
making assessment sensitive by avoiding bottom and ceiling effects and allowing for
sufficient between-subjects variance. Indeed, Maruff et al (1999) argued that "at least
40 antisaccade trials are required to obtain reliable estimates of error rate" (p. 1383). To
provide an indication of the difference in variance between the two tasks, at baseline
(N=30; Section 4.3) there were 16 different scores for Battery I antisaccade error rate
(with five scores 'shared' by two or more participants) and 29 different scores for Battery
II antisaccade error rate (with only one score 'shared' by two participants). The skewed
distribution of the data and the subsequent improvement in reliability after
transformation further underscores the poor statistical properties of the Battery I task.
It is, therefore, likely that the low between-subjects target variance (Bartko 1991) of
antisaccade error rate in Battery I adversely affected the task's reliability (Anastasi &
Urbina 1997).
The reliability of the Battery II antisaccade error rate is the best reliability reported to
date for this measure and contrasts with a recent study by Klein and Berg (2001), who
reported a non-significant correlation. The reason for Klein and Berg's (2001) failure to
obtain significant reliability might lie in the type of antisaccade task they used, the
overlap version. In the overlap version of the antisaccade task, the central target
remains 'on' when the peripheral target appears. This version of the antisaccade task is
associated with lower error rates (Fischer & Weber 1997), thereby arguably reducing
between-subjects variability in healthy individuals. A possible implication of this finding
is that the non-overlap task might represent a psychometrically improved measure of
saccadic inhibition amongst healthy individuals.
Saccadic latency measures were temporally stable. Prosaccade gain of Battery II, but
not of Battery I, was stable over time. The reasons for this divergence in reliability are
unclear, as both batteries used comparable stimulus eccentricities (±SOand ±10° for
Battery I; ±6° and ±12° for Battery II) and adequate calibration procedures. However,
the prosaccade task of Battery II had more trials than that of Battery I. Antisaccade
gain was stable over time for both batteries.
214
Reliability and Concurrent Validity
The use of Pearson correlation and ICC coefficients allowed the comparison between
these two measures of association and agreement, respectively (Bartko 1991). As
expected, ICC coefficients tended to be lower, thereby providing a more conservative
estimate of temporal stability (Mathalon et al 2000). Despite this, ICC coefficients
reported here were comparable in magnitude to (Pearson and ICC) coefficients reported
in previous studies. The global quantitative and qualitative SPEM measures employed
in previous studies of test-retest reliability may be related to the measures in this
study, as global measures are likely to reflect pursuit gain and frequency of saccades
(Levy et al 2000; Ross et al 1998c).
It is instructive to compare the obtained temporal stability coefficients of oculomotor
performance with those reported for other psychophysiological, neuropsychological and
personality trait measures used in schizophrenia spectrum research. Mathalon et al
(2000) observed ICC for the electrophysiological measure of P300 amplitude of between
0.84 and 0.93. Fein et al (1984) obtained similar coefficients for electroencephalography
spectra over 1-3 years. Cadenhead et al (1999) reported somewhat higher ICC for
prepulse inhibition, a measure of sensorimotor gating. Most of the coefficients reported
by Cadenhead et al (1999) were above 0.80 and many were above 0.90, although very
low coefficients (0.12 - 0.31) were also observed. Test-retest reliability coefficients for
neuropsychological and psychometric schizotypy tests commonly used in schizophrenia
spectrum research tend to be comparable to those obtained for measures of Battery II
and slightly higher than those of Battery I (Vollema & van den Bosch 1995; Wechsler
1981; Wechsler 1987), although even higher reliabilities have been reported for more
homogenous tests (Nelson 1991; Trenerry et al 1989). Taken together, temporal
stabilities of most measures from Battery II and some measures from Battery I are
comparable to other tasks used as endophenotypes in schizophrenia spectrum
research.
4.5.4.3 Between-session Changes
Regarding the effects of repeated exposure on oculomotor performance, the most
systematic changes over time were observed for the antisaccade task. Average
antisaccade error rates from both Battery I and II significantly and considerably
dropped from assessment I to assessment II. Additionally, there was some evidence for
improved accuracy (Battery II) and slightly faster latency (Batteries I and II).
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This pattern of practice effects is compatible with previous research (Klein et al 2002).
Green et al (2000) demonstrated significant practice effects in healthy participants
undergoing multiple assessments of the antisaccade task. Interestingly, the reduction
in error rate from first to second assessment observed by Green et al (from 21.1% to
14.5%) is very similar to that observed on Battery II (from 20.8% to 15.8%).
As no within-session practice effects on antisaccade error rate were observed (Section
4.4), it might be argued that between-session improvements are not due to "fast
learning gains" (p. 314) akin to priming, but due to slow, time-dependent (skill) learning
processes (Hauptmann & Karni 2002). These processes may include effects of memory
and motor consolidation (Shadmehr & Holcomb 1997) as well as increased familiarity
with the laboratory environment and consequently reduced anxiety levels (DeRosa &
Patalano 1991; Lister & Hilakivi 1988).
Lezak (1983) pointed out that practice effects in neuropsychological assessment are
observed particularly on tests that "require an unfamiliar or infrequently practiced
mode of response" (p. 115). Regarding the antisaccade task, it may be argued that this
measure, due to its artificial nature as a laboratory task, is both unfamiliar and
infrequently practised, and that these properties make the task particularly susceptible
to practice effects. Interestingly, practice effects have also been observed on the Stroop
test (Trenerry et al 1989). The Stroop test resembles the antisaccade task in its
assessment of the integrity of (prefrontal) inhibitory function and its nature as an
unpractised, infrequently used and artificial laboratory procedure. As Ahonniska et al
(2001) noted, practice effects are not commonly observed on tests related to steadiness
of motor control, perhaps explaining the absence of consistent practice effects on the
SPEM and fixation tasks in the present study as well as previous studies.
Practice effects on the antisaccade task have to be taken into consideration in studies
using parallel (between-group) designs involving repeated assessments (within-
subjects). These designs are commonly used in clinical studies of treatment effects.
Rate and magnitude of learning across sessions may vary between groups and,
therefore, confound interaction effects of group and treatment. Practice effects on
cognitive measures are particularly likely to occur in samples of young or middle aged
individuals of high IQ (Ahonniska et al 2001) and schizophrenia patients treated with
atypical rather than typical antipsychotics, presumably due to the existence of
maximum learning capacities (Harvey et al 2000). These factors need to be considered
in longitudinal studies of group comparisons.
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4.5.4.4 Conclusions
To conclude, with some exceptions, oculomotor performance in this sample of healthy
individuals was stable over time. Measures of Battery II tended to have higher temporal
stabilities than those of Battery I. The disappointing test-retest reliabilities of some
measures of Battery I were most likely due to methodological problems. Consistent
practice effects were observed on the antisaccade task; these may have to be taken into
consideration in longitudinal studies.
4.6 Overall Discussion
The oculomotor test batteries used in this thesis were assessed in this chapter on a
number of criteria regarding reliability and validity. The conclusions that may be drawn
on the basis of these analyses are as follows.
First, the scoring procedures of the current oculomotor tasks show excellent
consistency within the same rater as well as across raters. Second, with the exception
of prosaccade gain and SPEM gain, eye movement performance scores were correlated
across the two display methods, indicating reasonable concurrent validity. The
antisaccade task of Battery II was found to be more difficult than that of Battery I and
both saccadic tasks of Battery II were associated with slightly longer latencies than
those of Battery I. Third, internal consistencies of the current oculomotor tasks were
generally high, with the most notable exception of antisaccade error rate from Battery I.
Finally, performance on Battery II was stable over time, with the exception of two SPEM
gain measures. Temporal stability of performance on Battery I was less consistent, with
low reliabilities observed for measures of smooth pursuit gain and pro saccade gain.
Consistent improvements between - but not within - sessions were observed on the
antisaccade error rate.
These findings suggest that the thesis may progress using the current eye movement
tasks to address the effects of psychotic illness, genetic liability, schizotypal personality
traits and pharmacological manipulation, on oculomotor function. A number of caveats,
however, have to be borne in mind.
First, the two batteries, in particular the saccadic paradigms, are not identical.
Therefore, direct comparisons between studies using Battery I (Chapters 5 & 6) and
studies using Battery II (Chapters 7 & 8) have to be treated with caution. As pointed out
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in Section 4.2, the saccadic tasks of Battery II are associated with longer latencies and
the antisaccade task of Battery II may be described as more difficult.
Second, there was some divergence in reliability (internal as well as temporal) between
the two batteries. The antisaccade task of Battery II was somewhat more reliable than
that of Battery I, both in terms of temporal stability and internal consistency.
Taken together, it may be argued that the development of an oculomotor test battery
specifically adapted for research in this thesis (Battery II) was successful, as judged by
this investigation of reliability and concurrent validity. Most measures of Battery II were
correlated with the established measures of Battery I. Additionally, implementation of
specific differences in stimulus specifications may have led to improvements in the
statistical properties of these tasks.
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Chapter Five
Study II - Eye Movements
in First-episode Psychosis
5.1 Chapter Overview
Patients in their first episode of psychosis constitute an important test for the validity of
an endophenotypic marker of genetic liability to schizophrenia. The recent onset of
illness in this patient group allows one to study the severity of impairment on a marker
in the relative absence of the secondary confounds encountered in chronic
schizophrenia patients. Given the established reliability of the current eye movement
tasks, this chapter investigates eye movements (using Battery I) in a sample of first-
episode psychosis patients, in order to explore the extent of impairment of the smooth
pursuit and anti saccade tasks compared to healthy controls, as well as the
interrelationship between these two measures in the patient and the healthy control
samples.
5.2 Introduction
Most studies of eye movement function in schizophrenia have used samples of chronic
patients or combinations of first-episode (or recent-onset) and chronic patients.
Studying patients in their first episode of schizophrenia, however, has a number of
advantages over studying chronic patients. First-episode patients have not experienced
prolonged antipsychotic drug treatment, long-term hospitalisation, or functional, social
and professional impairment, as it is commonly encountered in chronic schizophrenia.
Further, studying patients in their first episode reduces sample heterogeneity with
regard to disease stage and illness duration. Finally, it has been argued that there
might be detrimental, e.g. neurotoxic, effects on the brain of the illness itself as well as
neurodegenerative processes (although this remains controversial; see Weinberger &
McClure 2002). Therefore, neurobehavioural abnormalities seen in the first psychotic
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episode are often thought to be linked to the primary disease process rather than
secondary confounds or the effects of disease chronicity (Copolovet al 2000; Lieberman
et al1993; Lieberman et al1992; Lieberman et al2001; Spohn & Strauss 1989; Waring
1995).
From the perspective of research into biological schizophrenia spectrum markers, the
observation of deficits in first-episode patients is, therefore, a crucial test of the validity
of these measures. Deficits in recent-onset psychosis patients have been observed on a
number of proposed endophenotypes, including neuropsychology (Bilder et al 2000;
Hoff et al 1992; Hutton et al 1998b; Riley et al 2000; Saykin et al 1994; Sweeney et al
1992a), brain structure (Copolov et al 2000; Ettinger et al 2001; Fannon et al 2000;
Hirayasu et al 2001; Lim et al 1996; Sumich et al 2002; Zipursky et al 1998) and
psychophysiology (Hirayasu et al 1998; Papageorgiou et al 2001; Salisbury et al 1998).
Previous studies of oculomotor function in first-episode psychosis patients have
obtained evidence of smooth pursuit eye movement (SPEM)(Hutton et al 1998a; Iacono
et al 1992; Levy et al 1992; Sweeney et al 1992a, 1998a; Vee et al 1998) and
antisaccade (Hutton et al 1998a; Nieman et al 2000) deficits. Importantly, deficits have
been observed in untreated and never-medicated patients, further supporting the
notion that these deficits are intrinsic to the disease process and not due to the effects
of antipsychotic drug treatment (Hutton et al 1998a; Sweeney et al 1998a). Taken
together, these studies consolidate the validity of the SPEM and antisaccade tasks as
possible genetic markers by ruling out the possibility that deviant performance in the
schizophrenia patient group is entirely due to secondary confounds listed above.
Two measures that have not been investigated comprehensively in first-episode
psychosis patients are those of visual fixation accuracy and antisaccade gain. Hutton et
al (2002) found no evidence of increased saccadic frequency during fixation with
distractors; this study, however, did not include a simple fixation task. Antisaccade
gain was found to be reduced in one study (Nieman et al 2000); Hutton et al (1998a)
observed reduced gain only in antipsychotic treated but not drug-naive patients.
As outlined in Section 2.8, the relationship between SPEM and antisaccade
performance in schizophrenia has not been investigated conclusively, with inconsistent
evidence to date (Matsue et al 1994b; Nkam et al 2001; Schlenker & Cohen 1995;
Sereno & Holzman 1995; Thaker et al 1989c; Tien et al 1996). Only one first-episode
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study has combined these tasks; this study did not find a significant relationship
(Hutton et al 1998a).
5.2.1 Aims
The aims of the current study were, therefore, as follows. 1)To replicate and extend the
findings of oculomotor impairments in first-episode psychosis patients, including a
visual fixation task and investigating antisaccade gain. Selective deficits on the SPEM
and antisaccade, but not fixation and pro saccade tasks were hypothesised. 2) To
investigate the relationship between SPEM measures and anti saccade error rate in the
patient and control groups.
5.3 Method
5.3.1 Participants
The patient sample used in this study was part of a larger investigation of first-episode
psychosis (Ettinger et al 2001; Fannon et al 2000; Riley et al 2000; Sumich et al 2002;
Tennakoon et al 2000). Due to logistic reasons, not all patients recruited into this first-
episode study could be tested on eye movements (assessment of which began after the
overall study had been initiated).
The patient group consisted of twenty individuals with DSM-IV diagnoses of
schizophrenia (N=10), schizophreniform disorder (N=9) or schizoaffective disorder
(N=I).20 Patients were recruited as inpatients or outpatients from a catchment area
including inner and outer London. Diagnoses were ascertained by experienced
psychiatrists using the Structured Clinical Interview for DSM-IV Axis I Disorders
Research Version (SCID-I; First et al 1996b). Patients were matched on the variables of
sex, handedness (Oldfield 1971), parental socio-economic status (SES), ethnicity (white
vs. other) and age to a group of eighteen healthy control participants, recruited by
newspaper advertisement from a similar geographical area. Ethnicity and SES were
based on UK standard classifications (Officeof Population Censuses and Surveys 1991).
20As there were no differences between the schizophrenia and schizophreniform disorder groups
(excluding the patient with schizoaffective disorder) on any demographic, clinical or oculomotor
variables (all p>O.13), patients were combined for all following analyses into one first-episode
psychosis group.
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Controls were free of OSM-IV Axis I and II disorders (First et al 1996a). Additionally,
controls were required to have no history of schizophrenia in their first-degree relatives,
as ascertained using the Family Interview for Genetic Studies (FIGS; Gershon & Guroff
1984).
Exclusion criteria for all participants were substance abuse or dependence, neurological
disorder, or a medical condition with possible effects on brain structure and function.
Patients'symptom levels were rated using the Positive and Negative Syndrome Scale
(PANSS; Kay et al 1987). This rating scale is based on a semi-structured interview
schedule conducted by a psychiatrist and yields a total negative, total positive, general
psychopathology and an overall symptom score. Higher PANSS scores indicate greater
symptom severity. Ratings were undertaken by experienced research psychiatrists with
high inter- and intra-rater (over a period of 1 year) reliability (r>0.90). Duration of
treatment for treated patients and duration of psychotic illness (calculated from time of
onset of first psychotic symptoms, based on patient interview, corroborative history
from family members and medical records where available) for all patients was recorded
in weeks. Seven patients were treated with typical antipsychotics, four were treated with
atypical antipsychotics and nine were medication-naive. Demographic and clinical data
of the two groups are summarised in Table 5.1.
Table 5.1: Demographic and Clinical Characteristics
Age (mean [SO)years}
Sex (%males)
SES (median) *
Handedness (% right-handed)
Ethnicity (%white)
Age of onset (mean [SO)years)
Illness duration (mean [SD)weeks}
Treatment duration (mean [SO)weeks}
PANSS neg. symptoms (mean [SO)) **
PANSS pos. symptoms (mean [SO))
PANSS gen. psych. (mean [SO))
PANSS total score (mean [SO))
Patients
(N=20)
24.90 [6.19)
80.00%
3.00
90.00%
65.00%
25.37 [6.55)
7.06 (6.75)
5.18 [3.52) t
20.47 [5.83)
21.42 [4.93)
42.89 17.57)
84.79 [13.871
Controls
(N=18)
Statistical Analysis
24.61 [5.00)
66.70
2.00
83.30%
77.20%
t=0.16; df=36; p=0.88
X2=O.87;df=1; p=0.35
z--0.64; p=0.57
X2=0.37; df=L; p=0.54
X2=O.23;df=1;p=0.63
Legend:
* SES, socio-economic status
** PANSS, Positive and Negative Syndrome Scale
t medicated patients only (N=l1)
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All participants provided written consent after the study details had been fully
explained to them. The study was approved by the Ethics Committee of the Bethlem
and Maudsley National Health Service Trust.
5.3.2 Eye Movement Assessment
All participants underwent oculomotor assessment of the SPEM, anti saccade and
prosaccade tasks of Battery I.The first prosaccade of Battery I (peripheral targets of ±5°,
±10°, or ±15°) was used. In the visual fixation task, only the central fixation target was
used consistently throughout this study; data from peripheral trials were discarded due
to a large number of unavailable trials (mainly because of fatigue or movement artefacts
in the acutely ill first-episode patients). Other oculomotor dependent variables were as
described in Chapter 3, including SPEM gain, frequency of anticipatory saccades (AS)
and catch-up saccades (CUS); antisaccade gain, latency and error rate; and prosaccade
gain and latency.
Due to computer storage errors as well as participant fatigue and movement artefacts
there were missing data for SPEM (patients, N=2; controls, N=3), prosaccade (patients,
N=4; controls, N=l) and fixation (patients, N=2; controls, N=l).
5.3.3 Statistical Analysis
All statistical analyses reported below were carried out using SPSS Release 10.0.7
(SPSS Inc., Chicago, Ill). Distributions of oculomotor variables were assessed for
normality using the skewness index. If positively (skewness> 1) or negatively
(skewness<-1) skewed, variables were transformed using square root or square
transformations, respectively.
5.3.3.1 Effects of Age and Sex
Interactions of sex and group on oculomotor variables were investigated using analysis
of variance (ANOVA).Effects of age were examined using Pearson correlations between
age and oculomotor variables.
5.3.3.2 Group Comparisons
Due to the large number of missing values, group differences on oculomotor variables
were investigated using univariate analysis of variance (ANOVA)with each oculomotor
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variable as dependent variable and group (patient, control) as independent variable.P!
Effect sizes of oculomotor variables were calculated according to the formula
(/11 - /12)
SD{pooled)
where PI = mean of group 1, P2 = mean of group 2 and SD(pooled)= pooled standard
deviation of the two groups (Cohen 1988). The pooled standard deviation was calculated
as follows:
(Na -l)SDa
2 + (Nb -l)SD/
Na +Nb-2
where Na is the sample size of Group Awith its SD; and Nb is the sample size of Group
B with its SD.
5.3.3.3 Effects of Target Velocity and Velocity-by-Group
Interactions for SPEM Variables
In order to investigate effects of target velocity on SPEM variables and velocity-by-group
interactions, repeated measures ANOVAwere carried out with group (patient, control)
as between-subjects factor and velocity (100/s, 24°Is) as within-subjects factor.
5.3.3.4
Error Rate
Relationship between SPEM Measures and Antisaccade
Interrelationships between SPEM variables and antisaccade error rate in the combined
group as well as the patient and control groups separately were investigated using
Pearson correlations. Error rate was correlated with each SPEM measure at each
velocity; additional correlations were carried out between antisaccade error rate and
average SPEM measures (across velocities) in order to provide a more detailed and
robust investigation of this relationship.
21 Multivariate analysis of variance (MANOVA)was additionally carried out in order to explore
similarities and differences to univariate ANOVAresults. MANOVAyielded an overall effect of
group on oculomotor variables (F[12,15]=3.28; p=O.02). The pattern of between-group
differences and significance levels for individual variables were very similar to those observed
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5.3.3.5 Associations of Oculomotor Measures with Clinical Variables
and Antipsychotic Drug Treatment
Interrelationships between oculomotor and clinical variables (duration of treatment,
duration of illness and age of onset) in the patient group were investigated using
Pearson correlations. Medicated and unmedicated patients were compared on
oculomotor variables using ANOVA. Differential effects of typical and atypical
antipsychotic treatment were not investigated due to the small sample sizes of these
groups of patients.
5.4 Results
A number of variables were skewed and transformed accordingly, normalising skewness
(-I<skewness<l). Using transformed variables yielded virtually identical results to using
untransformed variables; therefore, and for reasons of clarity, descriptive statistics and
below results are based on raw (untransformed) data.
S.4.1 Effects of Age and Sex
Age was not correlated significantly with any oculomotor variables (all r<0.21; all
p>0.25). Significant sex-by-group interactions were observed for AS at 10°/s
(F[I,32]=4.67; p=O.04) and CUS at 10°/s (F[I,32]=4.55; p=O.04). Therefore, sex was
used as covariate only in analyses involving these variables.
5.4.2 Group Comparisons
Descriptive statistics and effect sizes of oculomotor measures are summarised in Table
5.2. Average rate of correction in the antisaccade task was 100% for controls and
96.93% (SD=9.30) for patients, indicating that participants appeared to be, in principle,
willing and able to perform this task (McDowell& Clementz 1997).
using ANOVA,supporting the validity of using univariate ANOVAin the analysis of between-
group differences.
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Table 5.2: Descriptive Statistics and Effect Sizes (d) of Oculomotor Measures
SPEM gain 10°/ s *
SPEM gain 24° /s
Anticipatory saccades 10°/ s
Anticipatory saccades 24° /s
Catch-up saccades 10° /s
Catch-up saccades 24° /s
Fixation saccadic frequency
Antisaccade error rate
Antisaccade gain
Antisaccade latency
Prosaccade gain
Prosaccadelatency
91.91 (13.52) t
85.38 (16.70) t
0.37 (0.33) t
0.66 (0.37) t
0.44 (0.17) t
0.46 (0.23) t
1.83 (3.33) t
28.39 (17.67)
-90.20 (19.65)
339.05 (116.78)
88.84 (11.40) t
180.65 (32.66) *
d
-0.60
-1.09
0.75
0.52
0.84
-0.02
0.74
0.92
0.94
0.47
-0.70
0.22
98.42 (6.20)
99.41 (5.48) I
0.15 (0.27) I
0.48 (0.34) I
0.30 (0.15) I
0.4 7 (0.13) I
0.06 (0.24) *
14.45 (11.95)
-105.39 (11.22)
292.32 (74.82)
95.82 (8.50) *
174.00 (28.24) *
Legend: tN=18; tN=16; *N=17; IN=15
Significant between-group differences were obtained for SPEM gain at 24° /s
(F[1,31)=9.67; p=0.004), AS at 10° /s (F[1,31)=4.56; p=0.04), CUS at 10° /s
(F[1,31)=5.73; p=0.02), frequency of saccades during fixation (F[1,33)=4.80; p=0.04),
anti saccade gain (F[1,36]=8.30; p=0.007), antisaccade error rate (F[I,36j=7.93; p=0.008)
and prosaccade gain (F[I,31]=4.00; p=0.05). Differences at trend level were observed for
SPEM gain at 10°/s (F[1,31]=2.95; p=0.096). All other comparisons were non-significant
(allp>0.14).
These differences indicate reduced SPEM gain, increased saccadic frequency during
SPEM and fixation, reduced antisaccade and pro saccade gain and increased
antisaccade error rate in the patients compared to controls. Using sex as covariate for
analyses of AS at 10°/s and CUS at 10°/s did not change the significance of between-
group differences.
S.4.3 Effects of Target Velocity and Velocity-by-Group Interactions for
SPEMVariables
Repeated measures ANOVAshowed that SPEM gain was non-significantly reduced at
24°/s compared to 100/s (F[I,31]=2.71; p=0.11). There was a significant group-by-
velocity interaction (F[1,31]=5.00; p=0.03), indicating that patients had more severely
reduced gain at the faster than the slower target velocity (see Figure 5.1).
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Figure 5.1: Effects of Target Velocity on Smooth Pursuit Gain (by Group)
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Figure 5.2: Effects of Target Velocity on Anticipatory Saccade Frequency (by Group)
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Figure 5.3: Effects of Target Velocity on Catch-up Saccade Frequency (by Group)
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There was a significant main effect of velocity on AS frequency (FI1,31]=58.64; p<O.OOl),
indicating that AS were more frequent at the faster velocity (see Figure 5.2), but no
velocity-by-group interaction (F[1,31]=0.24; p=O.63).
There was a significant main effect of target velocity on CUS frequency (F[1,31]=7.15;
p=O.01) and a trend for a velocity-by-group interaction (F[1,31)=3.76; p=O.06). This
interaction indicates that during slow but not fast velocity SPEM patients had higher
CUS rate than controls (see Figure 5.3).
5.4.4 Relationship between SPEM Measures and Antisaccade Error
Rate
In the combined group, higher antisaccade error rate was associated with reduced
SPEM gain at 10°/s (r=-0.34; p=O.OS), at 24° /s (r=-OAO; p=0.02) and averaged across
velocities (r=-OAO; p=0.02) as well as increased AS rate at 100/s (r:cO.S3;p=O.OOl), at
24° / s (r=OAO; p=0.02) and averaged across velocities (r=OA9; p=0.004), but not
consistently with CUS at 100/s (r'"'O.06;p=0.76), 24°/s (r=-O.33; p=0.06) or averaged
across velocities (r=-O.18;p=0.33).
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In the patient group, higher anti saccade error rate was associated significantly with
greater AS frequency at 10°/s (r=O.57; p=O.Ol) and averaged across velocities (r=O.54;
p=O.02), and at trend level with AS frequency at 24° /s (r=O.44; p=O.07), but not with
gain or eus (all p>O.19).
In the control group, antisaccade error rate was correlated at trend level with SPEM
gain at 24° /s (r=O.50; p=O.06) and averaged across velocities (r=0.49; p=O.06) but not at
10°/s (r=0.36; p=0.19); antisaccade error rate was also correlated significantly with eus
at 24° /s (r=-0.68; p=0.005) and averaged across velocities (r--0.62; p=O.Ol) but not at
24°/5 (r=-0.34; p=0.22). These correlations indicated that better anti saccade
performance was associated with worse SPEM performance in the control group. Error
rate was not correlated with AS frequency (all p>0.80).
The correlations between antisaccade error rate and AS frequency for the two groups
(averaged across velocities) are depicted in Figures 5.4 and 5.5.
Figure 5.4: Relationship between Antisaccade Error Rate and Anticipatory Saccade
Frequency (Averaged across Velocities) in the Patient Group
70
60 *
*
~
50
S 40!!!...g
CD 30
CD
"Q
8 20
<II.~
*c * * *<II 10
*
0 *
-10
0.0 .2 .4 .6 .8 1.0 1.2
anticipatory saccade frequency (N/sec)
229
First-episode Psychosis
Figure 5.5: Relationship between Antisaccade Error Rate and Anticipatory Saccade
Frequency (Averaged across Velocities) in the Control Group
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S.4.S Associations of Oculomotor Measures with Clinical Variables and
Antipsychotic Drug Treatment
There was a trend for a correlation between SPEM gain at 10°/s and duration of illness
(r=-0.48; p=O.07), indicating that longer duration of illness was associated with reduced
SPEM gain, as well as a trend for a correlation between antisaccade latency and
duration of treatment (r=0.40; p=O.08), indicating that longer duration of treatment was
associated with longer latency. There were no other correlations between oculomotor
variables and age of onset (all p>0.20l, duration of treatment (all p>0.14l, or duration of
illness (all p>0.10).
Higher levels of PANSS negative symptoms were associated with increases in
antisaccade error rate (r=0.58; p=0.009), reduced SPEM gain at 10°/s (r--0.52; p=O.03),
increased AS frequency at 10°/s (r=0.65; p=O.005) and non-significantly reduced
pro saccade gain (r=-0.48; p=O.07). Higher levels of PANSS positive symptoms were
associated with increased CUS frequency at 24°/s (r-0.51; p=0.04). Higher levels of
PANSS general psychopathology scores were associated with reduced SPEM gain at
100/s (r=-0.49; p=0.05) and non-significantly increased AS frequency at 100/s (r=0.47;
230
First-episode Psychosis
p=0.06). Higher PANSS total scores were significantly associated with reduced SPEM
gain at 10°/s (r=-0.49; p=O.OS), non-significantly increased anti saccade error rate
(r=0.40; p=0.09) and non-significantly increased AS frequency at 10°/s (r=0.46; p=0.07).
There were no further significant or trend level correlations between PANSS and
oculomotor variables (all p>0.10). No significant correlations emerged for prosaccade
latency or anti saccade gain when covarying for sex.
Treated and untreated patients did not differ from each other on any oculomotor
variables (all p>0.13).
5.5 Discussion
5.5.1 Key Findings
The key findings from this study are as follows. 1) The observation of SPEM and
antisaccade impairments in this sample of first-episode psychosis patients replicates
and extends previous findings, and points to the presence of oculomotor deficits early in
the psychotic disease process. Significant impairments were also observed on visual
fixation and antisaccade gain. 2) There were associations between SPEM and
antisaccade measures, the most consistent of which was observed between AS
frequency and antisaccade error rate.
5.5.2 Oculomotor Abnormalities in First-Episode Psychosis
The replication of smooth pursuit and antisaccade deficits in first-episode psychosis
patients is an important piece of evidence in establishing the validity of these
oculomotor schizophrenia spectrum endophenotypes. The importance of first-episode
studies lies primarily in the fact that these patients are relatively free of secondary
confounds, such as prolonged drug treatment, institutionalisation, social isolation and
functional impairments, as well as putative toxic effects of the disease process. Eye
movement deficits observed in this patient group may, therefore, be argued to be linked
to the primary schizophrenic disease process or the genetic predisposition to
schizophrenia (Copolov et al 2000; Hutton et al 1998a; Iacono et al 1992; Lieberman et
al 1992, 2001; Sweeney et al 1992a; Waring 1995).
The patient group had reduced SPEM gain and increased rates of AS and CUS. Reduced
gain and increased CUS frequency confirm previous first-episode studies (Hutton et al
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1998a; Sweeney et al 1992a, 1998a). This is the first study to demonstrate increased AS
frequency in this patient group.
The group-by-velocity interaction for SPEM gain indicated that patients showed reduced
pursuit gain particularly at the faster velocity (Abel et al 1991; Lipton et al 1980a; Pivik
1979b). The group-by-velocity interaction for CUS indicated that patients had increased
CUS frequency only at the slower, but not the faster, velocity. A relationship between
SPEM gain and CUS frequency has been put forward earlier (Friedman et al 1991).
Friedman et al (1991) proposed an analogue of a machine that has two systems, a
pursuit and a saccadic correction system. Given slow pursuit and limited tolerance for
position error, once a certain threshold has been passed, the saccadic system will
execute a CUS to restore gain. This model can explain why segments of low pursuit may
be associated with increased numbers of corrective saccades in schizophrenia and other
conditions. While data from a number of SPEM studies of schizophrenia patients appear
consistent with this hypothesis (Friedman et al 1991; Levy et al 2000; Ross et al 1998c),
the present findings are not compatible with this hypothesis. It appears instead that at
the slow target velocity patients performed increased rates of CUS despite only
moderately impaired SPEM gain (relative to the controls). It is also unclear why there
was an increase in AS frequency at the slower (but not the faster) velocity in the patient
group.
At the faster target velocity patients displayed reduced gain; however, they failed to
produce a corresponding increase in CUS frequency to compensate this reduced gain.
As CUS are thought to restore reduced gain (Friedman et al 1991) they are dependent
on information concerning position error, i.e. a mismatch of target and eye velocity. This
finding suggests that position error detection mechanisms, which may function
relatively well at a slower target velocity in this patient sample, were impaired at the
faster velocity.
Patients made more saccades away from the target during fixation of a central,
stationary target. Studies of visual fixation in schizophrenia have obtained conflicting
evidence. While some studies have shown abnormal fixation (Amador et al199S; Curtis
et al2001b; Silverman & Gaarder 1967) others have found stable fixation (Gooding et al
2000a; Kissler & Clementz 1998). This inconsistency may partly be due to differences in
analysis of fixation data as well as sample composition, but challenges the notion that
fixation performance is unimpaired in schizophrenia.
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The patient group also had significantly increased antisaccade error rate. This finding is
compatible with previous studies of recent-onset (Hutton et al 1998a; Nieman et al
2000) and chronic schizophrenic patients (Crawford et al 1995a, 1995b; Fukushima et
al1988) and may indicate prefrontal abnormalities (McDowell& Clementz 2001; Muri et
al1998; Roberts et al 1994; Rosse et alI993). The effect size for error rate of 0.92 may
be considered large (Cohen 1988). This confirms that an increase in antisaccade errors
robustly characterises the oculomotor performance pattern of patients with
schizophrenia and that this deficit is present in the early stages of the disease. As most
(96.93%) of antisaccade errors were subsequently corrected by patients, failure to
comprehend or lack of compliance with task instructions can be ruled out.
A noteworthy finding was that of reduced anti saccade gain in patients (with a large
effect size). While many previous studies of the antisaccade in schizophrenia have not
included measures of accuracy, there is evidence of reduced accuracy in schizophrenia
patients (Crawford et al 1995a, 1995b; Maruff et al 1998; McDowell et al 1999). Hutton
et al (1998a) obtained reduced antisaccade gain in treated but not untreated first-
episode patients, suggesting a treatment effect. Antisaccade accuracy is believed to be a
measure of sensorimotor coordinate transformations and spatial working memory
(Krappmann et al 1998). This process requires the covert encoding of the spatial
location of the target and the translation of this sensory signal into a motor output
signal, which serves to initiate a saccade to a contralateral location. Sensorimotor
coordinate transformations are likely to require prefrontal and parietal cortex integrity
(Doricchi et al 1997; Leigh & Zee 1999; Pierrot-Deseilligny et al 1995) and might
deserve further attention in the field of schizophrenia research.
Other studies have demonstrated hypometric saccades on other paradigms likely to
involve sensorimotor coordinate transformations or spatial working memory, such as
the predictive saccade task (Crawford et al 1995b, 1995a; Hommer et al 1991; Hutton
et al 2001 b; Karoumi et al 1998b; Krebs et al 2001; McDowell et al 1996) or the
memory-guided saccade task (Everling et al 1996; Karoumi et al 1998b; McDowell &
Clementz 1996; Park & Holzman 1992). Given the role of working memory in the
pathophysiology of schizophrenia (Goldman-Rakic 1999; Goldman-Rakic & Selemon
1997), accuracy measures on saccadic tasks (including antisaccade, predictive saccade
and memory-guided saccade paradigms) might prove a useful window to studying this
process in schizophrenia.
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It should be noted, however, that antisaccade accuracy might be partly influenced by
task instructions or strategy use. If participants (or the experimenter) emphasise the
inhibition of reflexive saccades then this might improve the rate of correct antisaccades
whilst compromising the accuracy criterion. Conversely, stressing the importance of
spatially accurate antisaccades may lead to greater recruitment of covert attentional
resources necessary to encode the spatial location of the target, and consequently to
greater numbers of antisaccade errors.
A limitation of this study is that the present study utilised one antisaccade target
amplitude only (±15°). The finding of reduced accuracy must, therefore, be considered
preliminary, as assessment of saccadic accuracy may most reliably be achieved by
using more than one target amplitude.
Symptom correlates of eye movements in this study partly replicated previous findings.
An association between negative symptoms and antisaccade errors as well as SPEM
impairments has been reported previously (Crawford et al 1995b; Muller et al 1999;
Tien et al 1996), possibly implicating frontal lobe dysfunction (Ross 2000; Wolff &
O'Driscoll 1999). No treatment effects were observed, probably due to the short duration
of treatment and the relatively small sample sizes of treated and untreated patients.
Interestingly, a correlation emerged between SPEM gain at 100/s and duration of
illness, suggesting a small effect of prolonged illness duration on eye movement
impairments. This relationship, although of only moderate magnitude and not
consistent across tasks, points to the importance of testing patients early in the course
of illness.
In order to further elucidate the pathophysiology of schizophrenia and the role of
oculomotor deficits in this condition, more research using first-episode patients might
be beneficial. Given the already mentioned advantages of first-episode research, as well
as the suggested generalisability of findings from this population to other schizophrenia
patient groups (Ganguli & Brar 1992), it may be expected that research using this
patient group can shed more light on the nature of the association between eye
movement abnormalities and the schizophrenia phenotype. Remaining questions
concern whether eye movement deficits seen at, or shortly after, onset of illness
deteriorate further, remain stable, or improve. It would be of additional interest in this
context to investigate whether the patients with schizophrenia and schizophreniform
disorder in this study differ in eye movement function at a later stage of the illness.
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5.5.3 Relationship between SPEM Measures and Antisaccade Error
Rate
Previous studies have provided inconsistent evidence of an association between SPEM
and antisaccade error rate (Section 2.8). The present findings suggest an association
between antisaccade error rate and SPEM gain in the combined group of patients and
controls. However, this relationship was not found in the patient group alone and was
reversed in the control group. The inverse association in the control group is very
difficult to explain, but could be a chance finding.
The association between frequency of AS during smooth pursuit and antisaccade error
rate in the patient group as well as the combined group is intriguing.22 This statistical
relationship between these two putative markers of genetic liability (Clementz 1998;
Ross et al 1998e, 1999b; Whicker et al 1985) is consistent with the notion that both
measures tap frontal inhibitory oculomotor function (Calkins & Iacono 2000; Friedman
et al 1992a; Levin 1984; Milri et al 1998). The key measure of antisaccade performance,
the error rate, is a measure of the successful inhibition of reflexive saccadic responses
to a prepotent stimulus (Section 2.5.4.2). The occurrence of AS during smooth pursuit
may similarly involve breakdown of inhibitory processes, as this type of saccades
typically intrudes on otherwise normal pursuit and, unlike CUS, serves no obvious
compensatory function.
Inhibitory mechanisms are believed to play an important role in the pathophysiology of
schizophrenia (Braff 1993). A recent study (Myles-Worsley et al 1999) combined the
antisaccade error rate with an event-related potentials measure of inhibitory function
(P50 gating) and demonstrated linkage of this "composite inhibitory phenotype" (p. 544)
to a chromosome 22q11-q12 locus in multiple schizophrenia families.
The correlations between antisaccade error rate and SPEM gain as well as AS frequency
open up the issue of whether these measures might be profitably combined in genetic
schizophrenia spectrum research. Combinations of uncorrelated measures, which are
both affected in the patient group, might improve the statistical separation between the
patient and control groups (Arolt et al 1998; Robins & Guze 1970; Sponheim et al
2001). The use of multiple neurobehavioural or cognitive measures might also have
22 The reason why this relationship was not obtained in the control group could be the relatively
lowrange ofantisaccade errors in this group (seeFigure 5.5).
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advantages over individual measures or diagnostic manuals in identifying clinically and
aetiologically homogenous patient groups (Arolt et al1998; Sponheim et al2001).
On the other hand. combining conceptually related and statistically correlated
neurobehavioural measures might be useful in the development of a composite
endophenotype (Myles-Worsley et al 1999). e.g. a combined 'inhibitory' measure of AS
frequency and antisaccade error rate. Following Myles-Worsley et al (1999) one could
label participants as poor or good performers based not on either but both measures;
these labels might then be used in linkage analysis. The moderate magnitude of the
correlation between AS frequency and antisaccade error rate prevents complete overlap
and redundancy.
However. more research is needed before such a combination of measures may be used
as phenotype in schizophrenia linkage studies. First. the correlation has to be
replicated using a larger sample. Second. there was no correlation between AS
frequency and antisaccade errors in the control group; the reasons for this are unclear,
but probably include the reduced range of antisaccade errors in this group (Figure 5.5).
Third. it remains to be investigated whether the relationship is also observed in other
schizophrenia spectrum populations, such as first-degree relatives of schizophrenia
patients, or schizotypal individuals.
5.6 Conclusions
» The present study replicated previous findings of SPEM and antisaccade deficits
in first-episode psychosis patients. These deficits are, therefore, thought to be
intrinsic to the schizophrenic disease process or the genetic predisposition and
not entirely due to secondary, disease-related confounds.
» The finding of reduced antisaccade gain in the patient group may deserve
further attention in schizophrenia spectrum research.
» Antisaccade error rate was associated with the frequency of anticipatory
saccades during smooth pursuit in patients and in the combined group,
pointing to a link between these two putative measures of inhibitory function.
236
First-episode Psychosis
5.7 Limitations
~ Due to the acutely ill state of the patient sample and because of technical
failures there were a number of missing values on eye movement data.
~ The visual fixation task utilised only a central target.
~ The sample size is too small to conclusively address the issue of the relationship
between SPEM and anti saccade performance and the possible application of a
combination of these measures in genetic linkage studies.
~ Antisaccade gain was measured using one target amplitude only. Therefore, the
finding of reduced gain in the patient group needs to be extended using an
antisaccade task with multiple peripheral amplitudes.
~ The study was not sufficiently powered to examine treatment effects or clinical
correlates in the patient group.
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Chapter Six
Study III - Eye Movements
in Siblings Discordant for Schizophrenia
6.1 Chapter Overview
Probably one of the best behavioural tests of the validity of a proposed endophenotypic
marker is its assessment in unaffected first-degree relatives of members of the patient
group under study. Given the observation of smooth pursuit and antisaccade deficits in
the crucial group of first-episode psychosis patients, this chapter addresses smooth
pursuit and antisaccade performance (using Battery I) in another important
schizophrenia spectrum group, namely pairs of full biological siblings discordant for
schizophrenia. Following the finding of a relationship between antisaccade error rate
and anticipatory saccade frequency during pursuit in Study II (Chapter 5), one focus of
this chapter will be on the relationship between smooth pursuit measures and
antisaccade error rate.
6.2 Introduction
A considerable number of studies have observed smooth pursuit eye movement (SPEM)
and anti saccade deficits in first-degree relatives of schizophrenia patients (Clementz et
a11994; Curtis et al2001a; Holzman et a11974; Iacono et al1992; Katsanis et al1997;
Lencer et al 1999). These observations constitute important evidence of the validity of
these measures as schizophrenia endophenotypes. However, a number of questions still
remain regarding the precise pattern of behavioural oculomotor performance amongst
unaffected first-degree relatives of schizophrenia patients.
First, little is known about the interrelationship between the SPEM and antisaccade
measures in first-degree relatives. Previous studies have observed moderate
associations (Karoumi et al 2001; Thaker et a1 2000). As argued above (Section 2.8),
knowledge of a relationship between SPEM and antisaccade measures might be useful
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not only in further characterising the behavioural, cognitive and possibly neural
correlates of these deficits, but also in the development of an improved oculomotor
endophenotype for linkage studies.
A second point of interest in schizophrenia family studies of oculomotor performance
concerns the sample composition. Most previous eye movement studies have utilised
mixed samples of first-degree relatives, including siblings, offspring and parents, based
on the assumption that these relatives all share, on average, 50% of their genes with
the proband. However, Ross et al (1998d, 1998e) demonstrated differences in both
SPEM and antisaccade performance between parents who were assumed to be likely
gene carriers (i.e. with a family history of schizophrenia) and less likely gene carriers
[i.e, without a family history of schizophrenia). Therefore, recruiting parents as first-
degree relatives increases sample heterogeneity and might lead to sampling bias if both
parents of each proband are not included, due to the possibility of differences in
willingness to volunteer between likely and less-likely gene carriers. Additionally, given
that oculomotor control deteriorates with age (Olincy et al 1997; Ross et al 1999a) a
sample of older first-degree relatives might underestimate differences compared to a
younger patient group.
A third point of attention concerns the genetic relatedness of the patients and their
first-degree relatives, which is likely to lead to correlated performance on biological and
behavioural measures (Plomin et al 2000). Therefore, the use of analysis of variance
may be inappropriate in the analysis of group differences, as the assumption of
independence of observations is violated by the genetic relatedness (Ott 1991). To
overcome this problem, a random effects linear regression model has been developed
that controls for effects of relatedness in family studies (Rabe-Hesketh et al 2001).
Additionally, it may be advantageous to use samples of patients and relatives including
only one individual from each family per group. This removes correlations between
individuals in the same group, which would lead to a reduction in statistical power.
6.2.1 Aims
Following this overview of the shortcomings of previous oculomotor family studies, the
present study had the following aims: 1)To replicate the SPEM and antisaccade deficits
observed in unaffected first-degree relatives of schizophrenia patients. Both
schizophrenia patients and their siblings were hypothesised to have impaired SPEM
and antisaccade, but normal fixation and pro saccade performance relative to a sample
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of healthy individuals. 2) To investigate the relationship between SPEM measures and
antisaccade error rate in the combined as well as individual groups (patients, relatives,
controls). On the basis of the observation in Study II, a relationship between
anticipatory saccades during pursuit and antisaccade error rate was hypothesised. 3)
To explore whether SPEM and antisaccade performance levels are correlated within
family members, thereby justifying the use of statistical techniques taking into account
effects of genetic relatedness. It was hypothesised that oculomotor performance levels
would be similar, i.e. correlated, within family members.
6.3 Method
6.3.1 Participants
Twenty-four inpatients and outpatients with a DSM-IV diagnosis of schizophrenia
(mean age=30.71; SD=S.84; 13 males), 24 of their full siblings (one sibling for every
patient) (mean age=28.63; SD=6.41; 7 males) and 24 healthy control participants (mean
age=28.S0; SD=S.99; 7 males) completed the study. All participants were drawn from
similar geographical areas (East, Southeast and Southwest London and West Kent). The
non-significantly increased number of males in the patient group when compared to
siblings and controls (Pearson x2=4.27; df=2; p=0.12) was likely due to a higher
incidence of schizophrenia amongst younger males (Egan et al 2000; Iacono & Beiser
1992) and a greater willingness of females to participate.
Initially, thirty-four patients underwent preliminary screening for participation in the
study; of these, thirty patients consented for their siblings to be contacted (two patients
had no eligible siblings and two patients refused for siblings to be contacted). These
thirty patients had a total of fifty-three eligible siblings. Siblings were contacted over the
telephone for an initial interview with the objective of recruiting only one sibling per
patient for the study. A total of twenty-eight patients and twenty-eight of their siblings
agreed to come for assessments. However only twenty-four patients and their siblings
completed assessments; the remaining patient-sibling pairs did not participate because
of logistic problems, e.g. lack of availability or childcare issues (N'"'3)or because of
refusal to take part in the eye movement assessment (N=1).
In each final group, sixteen participants were Caucasian, six were of Afro-Caribbean
origin and two were of Asian origin. The study was approved by the Bethlem and
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Maudsley Ethical Committee (Research). All participants provided written informed
consent after the study procedures had been fully explained to them.
The patients' diagnoses were established by experienced psychiatrists using the
Structured Clinical interview for DSM-IV Axis I disorders (SCID I; First et al 1996b).
Patients and siblings with a history of alcohol or drug dependence in the last year or a
lifetime history of five years of alcohol or drug abuse/dependence, head injury with
cognitive sequelae or loss of consciousness exceeding five minutes, epilepsy, history of
neurological disorder or medical illness associated with significant neurocognitive
impairment were excluded from the study. Patients' duration of illness (defined as
duration from first onset of psychotic symptoms) ranged from 2 to 20 years (mean=7.08;
SD=5.36; median=5; interquartile range=3-10). Nineteen patients were treated with
atypical antipsychotics, four were on typical antipsychotics and one patient was
untreated. Additionally, three patients were treated with anticholinergic compounds.
Additionally, siblings had to be within five years of age of the patient, between 16 and
40 years of age (patients between 16 and 45 years of age). Siblings were excluded if they
had a DSM-IVAxis I disorder, or Axis II schizotypal personality disorder (SCID II; First
et al 1996a).
Healthy controls were recruited through advertisements in the local press and screened
according to the same criteria as siblings, with the additional requirement that they did
not have a first-degree relative with a history of psychosis. Family history of mental
illness was recorded using the Family Interview for Genetic Studies (FIGS; Gershon &
Guroff 1984). Controls were individually matched to siblings on age (±5 years), sex,
years of education (±2years), ethnicity and handedness.
Current symptoms of the patients were rated with high reliability using the Positive and
Negative Syndrome Scales (PANSS; Kay et al 1987). Schizotypal symptoms were
assessed in the siblings and controls with high reliability using the Structured Interview
for Schizotypy (SIS; Kendler et a1 1989).
6.3.2 Eye Movement Assessment
Eye movements were assessed using Battery I. The first of the two prosaccade tasks
(with target eccentricities of ±5°, ±l0° and ±15°) was used. Due to computer storage
errors smooth pursuit data at both velocities from one patient and one sibling, as well
241
Siblings Discordant for Schizophrenia
as smooth pursuit data at 100/ sand pro saccade data from one patient were
unavailable.
The oculomotor dependent variables were as described in Chapter 3 and included SPEM
gain, frequency of anticipatory saccades (AS)and catch-up saccades (CUS);frequency of
saccades during fixation; antisaccade gain, latency and error rate; and prosaccade gain
and latency.
6.3.3 Statistical Analysis
The random effects regression model (Section 6.3.3.2) was carried out using Stata
Release 7 (Stata Corporation, College Station, TX). All other analyses were carried out
using SPSS Release 10.0.7 (SPSS Inc., Chicago, Ill). Distributions of oculomotor
variables were assessed for skewness. If variables were positively (>1) or negatively «-1)
skewed, square root or square transformations were applied.
6.3.3.1 Effects of Age and Sex
Sex differences for oculomotor variables were investigated in each group using
multivariate analysis of variance (MANOVA).Pearson correlations were obtained
between age and oculomotor variables in each group.
6.3.3.2 Group Comparisons and Effects of SPEM Target Velocity
The genetic relatedness between patients and siblings and the likely within-family
correlations violate the ANOVA assumption of independent observations. Therefore,
group differences on oculomotor variables, age and years of education were analysed
using a random effects regression model (Rabe-Hesketh et al 2001). The model uses
group membership (patient, sibling, control) as independent variable and each
oculomotor variable as dependent variable. A random effect is introduced into the
regression equation, which takes on a different value for each patient-sibling-control
triplet, thereby allowing for correlations within triplets due to relatedness and individual
matching.
Velocity-by-group interactions for SPEM variables were tested using the patient-sibling-
control triplets as 'subjects' in repeated measures ANOVAs; group and velocity were
used as within-triplet factors.
Effect sizes were calculated according to the formula
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CUI -,u2)
SD(difJ)
where PI = mean of group 1, P2 -= mean of group 2 and SOldiff)'" standard deviation of
the difference scores (Cohen 1988).
6.3.3.3
Error Rate
Relationship between sPEM Measures and Antisaccade
The relationship between SPEM and antisaccade measures was assessed using Pearson
correlations. SPEM measures at each velocity as well as averaged measures were used
in this analysis. For reasons of clarity, scatter plots between antisaccade error rate and
SPEM measures are displayed only for averaged measures; these relationships were
mostly very similar to those with SPEM measures at individual velocities.
6.3.3.4 Effects of Relatedness on sPEM and Antisaccade
Performance
A cut-off criterion was used to explore effects of relatedness for patients and siblings,
i.e. whether siblings of patients with deviant performance also had deviant performance
themselves (Crawford et al1998; Curtis et al 2001a; Iacono et alI992). Patients were
classified as 'impaired' if scores fell more than ISO below the control group mean for
SPEM gain and more than ISO above the control group mean for SPEM saccadic
frequency and antisaccade error rate. Independent samples t-tests were carried out
comparing siblings of patients with 'impaired' performance and siblings of patients with
less impaired performance on relevant oculomotor measures.
6.3.3.5 Interrelationships between Oculomotor Variables and
PANSs, Duration of Illness and SIS; and Effects of Antipsychotic Drug
Treatment
MANOVAwas used to compare patients on typical and atypical antipsychotics on all
oculomotor variables. Pearson correlations were run between all oculomotor variables
and PANSS ratings and illness duration in patients and total schizotypy scores in the
sibling and control groups.
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6.4 Results
Prosaccade latency was still positively skewed after square root transformation and was,
therefore, transformed using the natural logarithm. The distribution of the transformed
variable was roughly normal (skewness= 1.09). Antisaccade latency was heavily skewed
(skewness=5.61), due to the presence of an outlier. When this case was excluded the
distribution became normal (skewness=0.98). Statistical analyses involving this variable
were carried out with and without this case. With the exception of the comparison
between patients and siblings results were unaffected by the exclusion of the outlier.
Therefore, results based on the entire sample are reported below unless stated
otherwise (see Table 6.2). Distributions of other skewed variables were normalised after
data transformation. As there were no major differences between results using
transformed and untransformed data, for reasons of clarity descriptive statistics and
results based on untransformed data are reported below.
Average antisaccade correction rate for patients (79.23%; SD=4.38), siblings (97.10%;
SD=4.38) and controls (96.37%; SD=4.58) were similar to those reported previously and
suggest that participants understood and were willing and able to follow the task
instructions (McDowell& Clementz 1997).
6.4.1 Effects of Age and Sex
Female patients had slightly longer pro saccade latency (F[1,22)=4.66; p=O.04) than male
patients, but no further sex differences emerged (all remaining p>0.06). Males and
females were, therefore, combined in each group and sex was used as covariate only for
prosaccade latency. Groups did not differ in years of education (Wald X2=2.79; df=2;
p=O.25) but differed in age (Wald X2=15.87; df=2; p=O.0004): patients were significantly
older than siblings (z=-3.34; p=O.001) and controls (z=-3.34; p<0.001), who did not
differ from each other (z=0.20; p=O.84). Significant correlations between age and
oculomotor variables emerged in the patient group with pro saccade latency (r"0.45,
p=O.03) and in the control group with CUS frequency at 10°/s pursuit (r=-0.55,
p=O.005), showing longer pro saccade latency and fewer CUS in older people. Therefore,
age was included as a covariate in group comparisons involving these variables.
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6.4.2 Group Comparisons and Effects of SPEM Target Velocity
Descriptive statistics and effect sizes for group differences in oculomotor measures are
presented in Table 6.1; individual scores for SPEM gain at 10°/ sand 24°/ s as well as
antisaccade error rate are presented in Figures 6.1 and 6.2. Results of the random
effects regression group comparisons are summarised in Table 6.2.
There was a trend for a main effect of target velocity on SPEM gain (F[1,21]=4.08;
p=O.06) and a highly significant effect on CUS (F[1,21]=258.82; p<O.OOl) and AS
frequency (F[1,21]=67.03; p<0.001), indicating reduced gain and increased saccadic
frequency at the faster velocity. There was a trend for a significant velocity-by-group
interaction for pursuit gain (F[2,42]=2.95; p=O.06) but not saccadic frequencies (F<1.26;
p>0.29). The interaction indicated that while patients and controls showed reduced
pursuit gain on the faster target, siblings showed no difference between velocities
(Figure 6.1).
6.4.3 Relationship between SPEM Measures and Antisaccade Error
Rate
In the combined group, antisaccade error rate was correlated with SPEM gain at 10°/s
(r=-0.30; p=O.Ol) and 24°/s (r=-0.29; p=O.02) as well as averaged SPEM gain (r=-0.31;
p=O.009). Error rate was correlated with CUS frequency at 10°/s (r=0.39; p=O.OOl) and
24°/s (r=0.38; p=O.OOl) as well as averaged CUS frequency (r=0.42; p<0.001) but not AS
frequency (all r<0.18; all p>0.15). Inspection of the scatterplot for the latter
relationships indicated the presence of three outliers; after removal of these cases the
correlation became significant for AS at 10°/s (r=0.40; p=O.OOl) and at 24°/s (r=0.26;
p=O.04) as well as averaged AS (r=0.38; p=O.002). Spearman correlation including
outliers was rho=0.26 (p=O.03) for AS at 100/s, rho=0.21 (p=O.09) for AS at 24°/s and
rho=0.31 (p=O.009) for averaged AS, further supporting the disproportionate influence
of outliers in the parametric analyses.
The correlations between antisaccade error rate and AS frequency in the patients were
non-significant (all r<0.18; all p>0.42) arguably due to the existence of three outliers
(two of whom were the same as above; see Figure 6.3). After removal of these cases, the
correlation approached significance for AS at 10°/ s (r=0.41; p=O.08) as well as averaged
AS (r=0.44; p=O.05) but not at 10°/ s (r=0.34; p=O.15). Spearman rank correlations
including outliers were non-significant (all rho<-0.07; all p>0.75). The correlations were
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not significant in the siblings (all r<-O.24; all p>O.29) (Figure 6.4). In the controls, error
rate was correlated significantly with averaged AS (r=0.42; p=O.04) (Figure 6.5) and, at
trend level, with AS at 10°/s (r=O.3S;p=O.09) and at 24°/s (r=O.38;p=O.07).
Figure 6.1: Smooth Pursuit Gain by Group
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Figure 6.2: Antisaccade Error Rate by Group
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Figure 6.1: Smooth Pursuit Gain by Group
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Figure 6.2: Antisaccade Error Rate by Group
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Figure 6.3: Relationship between Antisaccade Error Rate and Anticipatory Saccade
Frequency (Averaged across Velocities) in the Patient Group
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Figure 6.4: Relationship between Antisaccade Error Rate and Anticipatory Saccade
Frequency (Averaged across Velocities) in the Sibling Group
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Figure 6.5: Relationship between Antisaccade Error Rate and Anticipatory Saccade
Frequency (Averaged across Velocities) in the Control Group
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Error rate was significantly correlated with CUS frequency only in the sibling group
(100/s: r=0.45; p=O.03; 24°/s: r=0.37; p=O.09; averaged: r=0.47; p=O.03); after removal
of an outlier these correlations became non-significant (all r<0.20; all p>0.38) (Figure
6.6). Correlations between error rate and SPEM gain were not significant at individual
group level (all r<-0.21; all p>0.37).
251
Siblings Discordant for Schizophrenia
Figure 6.6: Relationship between Antisaccade Error Rate and Catch-up Saccade
Frequency (Averaged across Velocities) in the Sibling Group
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6.4.4 Effects of Relatedness on SPEM and Antisaccade Performance
Siblings of patients with reduced pursuit gain (N=15) had reduced pursuit gain (t=-2.65;
df=20; p=0.02) compared to other siblings (N=7). Siblings of patients with increased AS
frequency (N=II) had increased AS frequency (t=2.04; df=20; p=0.05) compared to other
siblings (N=l1). Siblings of patients with increased CUS frequency (N-=10)had similar
CUS frequency (t=0.27; df=20; p=0.79) to other siblings (N=12). Siblings of patients with
increased antisaccade error rate (N=18) did not differ from other siblings (N=6) on
antisaccade error rate [t= 1.02; df=22; p=0.32). Samples sizes of less than 24 are due to
missing values as described above (Section 6.2.2).
6.4.5 Interrelationships between Oculomotor Variables and PANSS,
Duration of Illness and SIS; and Effects of Antipsychotic Drug
Treatment
In the patient group, increased positive symptoms were associated with reduced SPEM
gain at 24° /s (r"'-0.43; p=O.04). Higher levels of general psychopathology were
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associated with greater CUS frequency at 10°/s (r=0.6S; p=O.OOI) and at 24°/s (r=0.43;
p=O.04) as well as reduced SPEM gain at 24° /s (r=-0.47; p=O.02). Reduced pro saccade
gain was associated with increased positive (r=-0.44; p=O.03) and negative (r=-0.44;
p=O.03) symptoms. There was a trend for a correlation between saccade frequency
during fixation and PANSSgeneral psychopathology score (r=0.39; p=O.06). Duration of
illness was correlated with pro saccade latency (r=0.S2; p=O.OI), indicating that longer
duration of illness was associated with longer latency. When this correlation was rerun
covarying for age (r=0.33; p=O.13) or age and sex (r=0.34; p=O.13), it became non-
significant, suggesting a likely influence of age on this relationship.
No significant correlations between oculomotor measures and total schizotypy score
were found in the siblings (all p>0.10) or in the controls (all p>0.10). MANOVArevealed
no effect of antipsychotic drug status on oculomotor variables (F[I,21)=1.92; p=O.18).
Excluding patients who were treated with anticholinergic drugs did not noticeably affect
the pattern of differences between patients and controls as displayed in Table 6.2.
6.5 Discussion
6.5.1 Key Findings
The key findings of this study are as follows. 1) The observation of SPEM and
antisaccade deficits in schizophrenia patients and their unaffected siblings largely
replicates previous studies. 2) There were correlations between SPEM measures and
antisaccade error rate in the combined group as well as in individual groups. The most
consistent correlation was that between AS frequency and anti saccade error rate. 3)
SPEMmeasures demonstrated an effect of relatedness, as siblings of 'impaired' patients
also displayed somewhat 'impaired' performance. This effect was not statistically
significant for antisaccade error rate.
6.5.2 Group Comparisons
The first finding of this study concerns the comparisons between patients, siblings and
controls, which largely replicated previous studies. The patient group had significantly
reduced smooth pursuit gain (Clementz & McDowell 1994; Ross et al 1988; Sweeney et
al 1998a) and increased AS (Ross et al 1999b) and CUS frequency (Radant & Hommer
1992) at both target velocities. On the antisaccade task patients had significant
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difficulties suppressing reflexive saccades to the target (Crawford et al 1995a, 1995b;
Fukushima et al 1988), increased latency (Fukushima et al 1988; Karoumi et al 1998b)
and reduced accuracy (Karoumi et al 1998b; McDowell et al 1999). Patients also had
slightly reduced prosaccade gain (Curtis et al 2001a; Nieman et al 2000; Ross et al
1988; Schmid-Burgk et al 1983) and increased prosaccade latency (Mackert &
Flechtner 1989). No visual fixation impairments were found (Gooding et al 2000a;
Kissler & Clementz 1998; Ross et al 1988).
Siblings performed intermediate, i.e. between patients and controls on most measures.
Significant differences between siblings and controls were found on SPEM gain at 10°/s
and AS frequency at 100/s. Siblings also made more AS at 24°/s and CUS at 100/s,
although these comparisons failed to reach statistical significance.
The finding of subtle SPEM deficits in the siblings can be reconciled with previous
studies (Clementz et al 1990; Lencer et al 1999), although two studies (Keefeet al 1997;
Thaker et al 1998) failed to find reduced pursuit gain in first-degree relatives. The
finding of increased AS frequency also agrees with previous studies (Lencer et al 1999;
Rosenberg et al 1997c; Ross et al 1998e; Whicker et al 1985). SPEM gain scores of the
three groups interacted non-significantly with target velocity, indicating that while
patients and controls showed the usual effect of reduced eye tracking accuracy at faster
target velocities (Leigh & Zee 1999), siblings showed the opposite pattern.
Siblings had normal prosaccade and visual fixation performance. Despite some previous
findings of reduced pro saccade accuracy and fixation impairments in first-degree
relatives (Amador et al 1995; Schreiber et al 1995, 1997), the bulk of the literature
suggests that these basic eye movements are unimpaired in this population as well as
the patient group (Clementz et al 1994; Crawford et al 1998; Curtis et al2001a, 2001b;
Gooding et al 2000a; Karoumi et al 2001; Kissler & Clementz 1998; Ross et al 1988,
1998d; Thaker et al 1996a). Interestingly, however, Rybakowski et al (2001) recently
reported an association between fixation (and SPEM) impairments and D3 dopamine
receptor gene polymorphism. As SPEM and fixation were correlated in the Rybakowski
et al study, and SPEM and fixation are thought to be related at a neurophysiological
level (Leigh & Zee 1999), it remains to be investigated further whether fixation
performance might not be a useful schizophrenia spectrum measure, perhaps in
conjunction with SPEM.
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Siblings' performance on the antisaccade task was characterised by reduced accuracy
and increased error rate. The observed effect size of 0.49 for the error rate may be
described as medium (Cohen 1988) and was very similar to previous studies (Clementz
et al 1994; Thaker et al 2000). The relatively small sample size could be the reason why
this difference fell short of conventional statistical significance.
A noteworthy finding is that of reduced antisaccade accuracy (Karoumi et al 2001; cf.
Chapter 5). Most previous studies of the antisaccade task in first-degree relatives have
not included an accuracy measure (Clementz et al1994; Curtis et al2001a; Katsanis et
al 1997; Thaker et al 2000). While some investigations failed to find differences between
relatives and healthy individuals (Crawford et al 1998; McDowell et al 1999), one study
showed that a subgroup of relatives (without a family history of schizophrenia) had
reduced accuracy (Ross et al 1998d). Other authors have noted reduced antisaccade
accuracy in schizophrenia patients (Karoumi et al 1998b; McDowell et al 1999).
Antisaccade accuracy is a measure of sensorimotor coordinate transformations that
occur between sensory input and motor output, requiring internal manipulation of
spatial information (Krappmann et al 1998). Possible neural substrates for these
processes include parietal and prefrontal cortex (Doricchi et al 1997; Leigh & Zee 1999;
Pierrot-Deseilligny et al 1995). It remains to be investigated whether saccadic accuracy
measures of sensorimotor coordinate transformations may serve as a useful genetic
marker in schizophrenia research. The finding of unimpaired pro saccade accuracy of
relatives in this and previous studies (Crawford et al 1998; Curtis et a12001a; Karoumi
et al 2001) provides an adequate control condition for the programming and execution
of saccadic motor commands in the presence of visual targets.
However, as the present study included only one antisaccade target amplitude (tIS·),
the finding of reduced accuracy must be considered preliminary and should be
replicated in future studies utilising several amplitudes for a more reliable estimation of
spatial accuracy. Also, as in Chapter 5 it has to be pointed out that antisaccade
accuracy might in part reflect effects of task instructions or strategy use. It is unknown
to what extent the participants' emphasis on inhibition of error saccade or antisaccadic
accuracy influenced performance and performance differences between groups. Future
research is needed to clarify exactly how strategy use may interact with stimulus
amplitude to influence antisaccade error rate, latency and accuracy.
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6.5.3 Effects of Relatedness
The choice of statistical analysis of between-group differences was based on an
important assumption. The genetic relatedness between the patient and sibling pairs
violated the assumptions of analysis of variance concerning independence of groups
(Egan et al2000; Ott 1991). In particular, first-degree relatives were expected to attract
similar, i.e, statistically correlated, scores across groups (Rabe-Hesketh et al 2001).
Evidence of this effect of relatedness was obtained in this study for two of three SPEM
measures. Siblings of patients with 'impaired' smooth pursuit gain (defined relative to
the control group mean) had themselves reduced gain compared to siblings of patients
who performed above the cut-off point. The same pattern was observed for AS
frequency. This finding is of interest as it highlights the familial contribution to variance
in SPEM gain and AS frequency and underscores the need to consider effects of familial
relatedness in the statistical analysis of between-group differences.
Similar findings were obtained previously for SPEM (Iacono et al 1992) and antisaccade
performance (Crawford et al 1998) as well as other proposed neurocognitive
endophenotypes (Chen et al 1998). No effect of relatedness was obtained for antisaccade
error rate in the present investigation, possibly due to the small and unequal sample
sizes used in this analysis. The two groups in the Crawford et al study consisted of 19
and 25 participants, whereas in the present study there were 18 siblings of 'impaired'
antisaccade patients and only 6 siblings of 'unimpaired' patients. The error rates for
these two groups were 26.36% and 18.01%, respectively, compared to a control mean of
15.04%. This difference was, therefore, in the expected direction and might have
achieved statistical significance given larger and more equal group sizes.
In the present design it is impossible to dissect this familial contribution to SPEM and
antisaccade variance into genetic and non-genetic components. Familial patterns of
schizophrenia related phenotypes may not necessarily indicate the operation of genes,
but could also reflect non-genetic familial factors, such as viruses, diet, teratogens, or
psychosocial factors (Torrey & Yolken 2000). Based on estimated heritabilities of SPEM
and antisaccade measures, however, it may be argued that the main source of within-
family correlations consists of genetic factors (Katsanis et al 2000; Malone & Iacono
2002).
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6.5.4 Relationship between SPEM Measures and Antisaccade Error
Rate
A number of correlations were obtained between SPEM and antisaccade variables. In
the combined group, SPEM gain and AS and CUS frequency were correlated with
antisaccade error rate (after the removal of outliers, or using non-parametric statistics).
The only correlation that held across individual groups was that between AS frequency
and error rate (in the patient and control groups), supporting the robustness of this
relationship.
The association between AS frequency and anti saccade error rate mirrors that of
Chapter 5. Previous research has suggested that both tasks may tap (frontal) inhibitory
function (Calkins & Iacono 2000; Friedman et al 1992a; Levin 1984; Muri et al 1998). It
may be speculated that a combination of AS and error rate might provide an improved
composite oculomotor phenotype, given its moderate statistical association in this and
the previous sample (Chapter 5). The finding has to be treated with caution, however,
due to the relatively small sample sizes and the existence of cases whose scores did not
conform to this relationship. This heterogeneity regarding the relationship between
these two measures, however, could be compatible with the clinical and biological
heterogeneity of schizophrenia and its biological correlates and suggests that a
combination of AS and antisaccade errors might identify only a subgroup of individuals
(possibly with a certain genotype).
It is also somewhat puzzling that AS and error rate were not correlated significantly in
the sibling group. While the absence of this relationship in this crucial schizophrenia
spectrum group might represent a disappointing failure of the hypothesis linking AS
and error rate, it is a possibility that these measures follow the pattern of a two-hit
model proposed by Freedman and colleagues (Waldo et al 2000). These researchers
have shown that the deficits of P50 suppression and reduced hippocampal volume co-
occur in schizophrenia patients, but are inversely associated in first-degree relatives.
While AS and antisaccade errors were not inversely correlated in this sample of first-
degree relatives, it remains a possibility that these measures represent two facets of
inhibitory control, likely to co-occur in full-blown schizophrenia, but unrelated in first-
degree relatives, possibly due to protective mechanisms.
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6.5.5 Clinical Considerations
The current sample of relatives may be described as relatively homogeneous as only full
biological siblings were used and no more than one sibling from any family was
included. Ross et al (1998d, 1998e) have shown that schizophrenic patients' parents
with a family history of schizophrenia differed on eye movements from parents without
family history. Therefore, including parents into studies of first-degree relatives
increases the genetic heterogeneity of the sample, in addition to introducing cohort
effects (Egan et al 2000).
Both siblings and controls in the present study were free of DSM-IVAxis I and Axis II
schizophrenia spectrum symptoms. These exclusion criteria represent a strength of the
design as it allows the isolation of the variable of interest, i.e. the genetic relationship
with a schizophrenia patient, in the absence of other, possibly confounding effects of
symptoms or treatment. The current findings agree with previous studies (Curtis et al
2001a; Katsanis et al 1997), which have reported that anti saccade deficits in first-
degree relatives are not due to the presence of psychiatric symptoms. However, as one
study found anti saccade abnormalities only in relatives with schizophrenia spectrum
personality symptoms (Thaker et al 2000), and antisaccade performance has been
linked to schizotypy levels in healthy individuals (Gooding 1999; O'Driscoll et al 1998),
it is possible that the magnitude of the observed differences in error rate in the current
study would have been greater if relatives with higher levels of such symptoms had
been included. The low levels and small range of sub-clinical schizotypy personality
traits in the sibling and control groups might also explain why there were no
relationships between eye movement measures and schizotypy scores.
Another feature of the present sample worth discussing is that the majority (87.5%) of
siblings came from sporadic schizophrenia families, as established through patient
interviews. As there have been previous reports of worse SPEM and antisaccade
performance in multiplex compared to simplex schizophrenia family members
(McDowell et al 1999; Schwartz et al 1995b) it is possible that the inclusion of more
relatives from multiplex families would have provided larger group separations.
Interestingly, Ross et a1 (1998d) observed reduced antisaccade accuracy only in family
history negative but not positive relatives, somewhat consistent with the present
findings. Regarding SPEM, however, Lencer et a1 (2000) found equal impairments in
familial and non-familial relatives.
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No effects of antipsychotic or anticholinergic drug treatment on oculomotor performance
were observed. The present study was not designed to investigate the effects of atypical
antipsychotic treatment on oculomotor function. There were a number of PANSS
symptom correlates of oculomotor measures, in particular those of general
psychopathology and positive symptoms.
6.6 Conclusions
~ The study confirms that SPEM and antisaccade performance may be useful
markers of genetic liability to schizophrenia by demonstrating subtle deficits in
a genetically and clinically homogenous sample of siblings of schizophrenia
patients.
~ Antisaccade gain may prove to be an important oculomotor endophenotype,
possibly involving working memory or visuospatial sensorimotor transformation
processes.
~ AS frequency and antisaccade error rate were correlated in the combined group
as well as the patient and control groups (but not in the siblings). Future
research will need to establish whether these measures might be profitably
combined as a composite inhibitory oculomotor endophenotype in genetic
linkage studies.
~ The effects of familial relatedness on eye movement performance further
underscore the validity of oculomotor measures as endophenotypic markers and
highlight the need to use statistical techniques that take into account between-
group relatedness.
6.7 Limitations
~ The small and unequal sample sizes throw doubt over the findings concerning
the effects of relatedness.
~ The finding of reduced antisaccade gain in the siblings and patients has to be
confirmed using more than one target amplitude before this task can be
considered a putative endophenotype.
~ Additionally, between-group differences in antisaccade gain may partly reflect
differences in strategy use.
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~ The reasons for the absence of a relationship between AS frequency and
antisaccade error rate in the sibling group remain unclear.
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Chapter Seven
Study IV - Relationship between
Eye Movements and Schizotypy
7.1 Chapter Overview
Given the evidence of impaired smooth pursuit and antisaccade eye movements in first-
episode patients as well as healthy siblings of schizophrenia patients, this chapter
investigates another population from the schizophrenia spectrum, individuals with high
scores on psychometric measures of schizotypy. On the basis of the continuum
hypothesis (Claridge 1990), an individual differences approach will be adopted, relating
eye movement performance (Battery II) to continuous scores from self-report
questionnaires of schizotypal personality traits. The study focuses on the relationship
between eye movements and empirically defined schizotypy symptom dimensions, as
well as the role of trait emotionality in this relationship. Following the finding of an
association between antisaccade error rate and anticipatory saccade frequency in
Chapters 5 and 6, this relationship will also be examined.
7.2 Introduction
The hypothesised proximity of schizotypal personality traits and schizotypal personality
disorder (SPD) to schizophrenia is thought to be reflected at clinical, biological and
genetic levels (Cadenhead & Braff 2002; Cannon et al 2002; Fanous et al 2001;
Gruzelier 1996; Gunderson & Siever 1985; van Os et al 2000). Therefore, the role of
oculomotor tasks as putative schizophrenia endophenotypes has to be explored in
relation to schizotypal personality features. Confirming this assumed proximity, a
number of studies have observed a relationship between schizotypal personality traits
and smooth pursuit eye movement (SPEM) and antisaccade error rate (Gooding 1999;
Gooding et al 2000b; Larrison et al 2000; O'Driscoll et al 1998; Siever et al 1984, 1989),
despite some failures to replicate (Klein et al 2000c; Simons & Katkin 1985). Deficits
261
Schizotypy
have also been observed in individuals with SPD (Brenner et al 2001; Keefe et al 1989;
Lencz et al 1993; Siever et al 1994).
As noted in Chapter 1, schizotypy is a multifaceted construct, comprising positive,
negative and possibly other symptom dimensions (Vollema & van den Bosch 1995).
Consequently, some studies have aimed to investigate the relationships between specific
schizotypal traits and eye movement performance. The most commonly used traits in
these studies were those relating to positive and negative features. As summarised
above (Section 2.3.5.5.6), SPEM deficits in SPD patients as well as in healthy
individuals tend to be associated more strongly with negative than positive signs and
symptoms (Coursey et al 1989; Siever et al 1982, 1989, 1994). This pattern somewhat
agrees with findings from schizophrenia studies (Section 2.3.5.3) and suggests a
continuum of pathological schizophrenic and SPD symptoms and 'normal' schizotypal
traits at clinical and psychophysiological levels. Evidence of clinical correlates of
antisaccade errors from studies of schizophrenia and schizotypy is much less
consistent, implicating positive as well as negative symptom correlates (Section 2.5.4.3).
No previous study has combined the SPEM and antisaccade tasks with a comprehensive
set of schizotypy measures, including both positive and negative features. Given the
multifactorial nature of schizotypy, it might valuable to empirically derive dimensions of
schizotypy from a range of psychometric questionnaires to explore their relationships
with oculomotor performance.
A second point of interest concerns the relationship between measures of schizotypy
and trait emotionality. A number of studies have demonstrated an association between
trait emotionality and schizotypy / schizophrenia (Bentall et a1 1989; Braunstein-
Bercovitz et a1 2002; Catts et al 2000; Eysenck & Barrett 1993; Gurrera et al 2000; Lipp
et al 1994; Muntaner et al 1988; O'Driscoll et al 1998; Rust & Chiu 1988; Tien et a1
1992a; van den Bosch 1984; Wuthrich & Bates 2001).
Therefore, in order to establish the specificity of relationships between
schizotypy / schizophrenia and neurocognitive or behavioural measures, the possibly
confounding effects of trait emotionality have to be considered (Raine & Lencz 1995). To
establish this specificity is important, if a given endophenotypic marker is assumed to
reflect the action of a specific, schizophrenia-related disease gene.
Following this argument, Braunstein-Bercovitz and colleagues (Braunstein-Bercovitz
2000; Braunstein-Bercovitz et al 2002; Braunstein-Bercovitz & Lubow 1998) have
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demonstrated that the statistical relationship between schizotypy and one such
behavioural measure, latent inhibition (LI), can be accounted for by measures of trait
anxiety. LI is a phenomenon in which preexposure of a stimulus slows subsequent
learning about that stimulus. The LI paradigm has been widely used in schizophrenia
spectrum and pharmacological studies due to its susceptibility to dopaminergic
manipulation and its proposed role in the pathophysiology of schizophrenia (Gray et al
1995; Lubow & Gewirtz 1995; Moser et al 2000). Given the proposed attentional
underpinnings of this task (Braunstein-Bercovitz et al 2002) and the role of anxiety in
attentional processing (Clark & McManus 2002), the lack of specificity of this deficit to
schizotypy (and possibly, by extension, to schizophrenia) may not be surprising, yet
warrants serious reconsideration of the usefulness of LI as a schizophrenia spectrum
marker.
Similarly, Corr et al (2002) recently observed an association between trait emotionality
and a psychophysiological measure of sensorimotor gating known to be impaired in
schizophrenia, prepulse inhibition (PPI). PPI has been studied as an endophenotype in
schizophrenia genetics as well as to elucidate the pathophysiology of schizophrenia and
the pharmacology of antipsychotic drugs (Braff et al 2001; Cadenhead & Braff 2002;
Kumari 2000; Swerdlow & Geyer 1998). An association between impaired PPI and
increased levels of neuroticism might suggest reduced specificity of this measure to
schizophrenia spectrum symptoms.
Whether trait emotionality affects the relationship between eye movement performance
and schizotypy / schizophrenia has not been explored. O'Driscoll et al (1998) observed
that high scorers on the Chapmans' Perceptual Aberration scale (a measure of positive
schizotypy) also had higher scores on state measures of anxiety and depression and
that there was a correlation between state depression scores and antisaccade errors.
Importantly, neither of these measures fully accounted for the relationship between
SPEM and antisaccade dysfunction and positive schizotypal traits. O'Driscoll et al's
(1998) choice of state emotionality measures, however, leaves open the question of
whether trait emotionality impacts on the relationship between error rate and
schizotypy.
7.2.1 Aims
The aims of the present study were, therefore, as follows. 1) To confirm the
multifactorial nature of schizotypy. Based on previous evidence, a multivariate factor
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structure, possibly comprising positive and negative dimensions, was hypothesised. 2)
To investigate the relationships between empirically derived sub factors of schizotypy
and eye movements. Higher levels of schizotypy were hypothesised to be related to
greater impairments on the SPEM and antisaccade, but not the fixation and prosaccade
tasks. Given the evidence from schizophrenia studies, SPEM impairments were
hypothesised to be associated with negative symptoms. No clear a priori hypotheses
could be made regarding the schizotypy dimension correlates of anti saccade errors, due
to the inconsistent findings from schizophrenia studies. 3) To investigate whether the
relationship between schizotypy and eye movements can be accounted for by trait
emotionality. Assuming specificity of oculomotor endophenotypes to the schizophrenia
spectrum, trait emotionality was hypothesised to be unrelated to SPEM and antisaccade
measures.
7.3 Method
7.3.1 Participants
One-hundred and fifteen participants took part in this study. Participants were
recruited from amongst psychology undergraduate students at Goldsmiths College
(N=68; 59.1%) and postgraduate students and university staff (N=47; 40.9%). There
were 40 (34.8%) males and 75 (65.3%) females. Ages ranged from 18 to 44
(mean=23.88; SD=5.95). All participants provided written informed consent, after the
study details had been fully explained to them. The study was approved by the Ethics
Committee of the Department of Psychology, Goldsmiths College.
No full psychiatric screening was carried out, in keeping with other investigations of
schizotypy in non-clinical samples (Braunstein-Bercovitz 2000; Sharpley & Peters 1999;
Suhr & Spitznagel 2001; Wuthrich & Bates 2001). Instead, participants filled in a self-
report questionnaire probing for demographic data as well as information on drug use
and clinical history. Participants indicated whether they or a family member had a
history of mental illness, and if so what kind (open-ended question). The questionnaire
also asked for the number of units of alcohol consumed per week, whether participants
consumed psychoactive drugs, and if so what kind (open-ended question). No
participant had a history of psychosis, as assessed by this questionnaire. Ninety-eight
participants (85.2%) denied any psychiatric history, but twelve individuals (10.4%)
reported a history of depression and five participants (4.3%) provided no information.
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Eighty-seven individuals (75.7%) reported no psychiatric family history, fifteen
individuals (13%) reported a family history of depression, one person (0.9%) reported a
family history of anxiety disorder, three participants (2.6%) indicated a family history of
schizophrenia and nine participants (7.8%) provided no answer. These data were
dichotomised for further analyses, yielding groups of individuals with or without any
psychiatric history, with or without any family history and with or without a family
history of schizophrenia (excluding those who failed to provide an answer).
Sixty-five individuals (56.5%) denied any drug use, twenty-four (20.9%) admitted to
cannabis use, one individual (0.9%) used cocaine and nineteen (16.5%) reported using
more than one type of drug. Six participants (5.2%) supplied no information. These data
were dichotomised to create separate variables of individuals who did or did not use any
drugs, did or did not use cannabis and did or did not use more than one type of drug
(excluding those who failed to provide an answer).
7.3.2 Eye Movement Assessment
Eye Movement Battery II was used. Prosaccade data from five participants was
unusable. SPEM data was unusable for four participants at 12°/ and 48° Is, for six
participants at 24°/ s and for eight participants at 36°/ s. Fixation data was unavailable
for nine participants. Reasons for missing data included fatigue or movement artefact,
computer storage error and calibration error.
The dependent oculomotor variables were, as before, SPEM gain and frequencies of
catch-up saccades (CUS) and anticipatory saccades (AS);frequency of saccades during
fixation; antisaccade gain, latency and error rate; and prosaccade gain and latency.
7.3.3 Psychometric Assessment
The choice of psychometric self-report schizotypy questionnaires reflects the well-
established observation that in non-psychiatric individuals the expression of
schizophreniaj schizotypy traits is attenuated; therefore, less pathological items, such
as psychometric questionnaires rather than clinical interviews, should be used (Johns
& van Os 2001).
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Missing data occurred for the Eysenck Personality Questionnaire (N=I), the Rust
inventory (N=6) and the Personality Syndrome Questionnaire (N=7). Therefore, factor
scores could be calculated for all but nine participants. Sample items of all
questionnaire scales are given in Table 7.1.
7.3.3.1
LIFE)
Oxford-Liverpool Inventory of Feelings and Experiences (0-
The Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE;Mason et al 1995)
was developed from the Combined Schizotypal Traits Questionnaire (CSTQ;Bentall et al
1989). Factor analysis of the CSTQ yielded four factors, labelled Unusual Experiences,
Cognitive Disorganisation, Introvertive Anhedonia and Impulsive Nonconformity. The 0-
LIFE has 159 items with a binary (yES/NO) response format.
Unusual Experiences (UE; 30 items) has been related to positive schizotypy, containing
perceptual, hallucinatory and magical thinking items. Cognitive Disorganisation (CD; 24
items) also relates to positive schizotypy, describing cognitive aberrations, manifested in
decision-making, attention and concentration difficulties. CD also includes items
relating to emotional deficits, such as a sense of purposelessness, moodiness and social
anxiety. Items from the Eysenck Personality Questionnaire-Revised (EPQ-R; see Section
7.2.3.4) neuroticism scale are included in CD. Introvertive Anhedonia (IA; 27 items)
describes social independence, solitude, introversion, reduced experience of pleasure
from social interactions and a range of other activities, as well as a dislike of emotional
and physical intimacy. IA contains some EPQ-R extraversion items. Impulsive
Nonconformity (IN; 22 items) bears some resemblance to the Eysencks' (Eysenck &
Eysenck 1991) psychoticism scale, containing items relating to disinhibited, impulsive,
violent, self-abusive and reckless behaviours. IN includes EPQ-R psychoticism scale
items.
UE, CD and IN scores were shown to decrease with age while IA increase with age;
males score higher on IA and IN, females score higher on UE and CD (Mason et al
1995). The scale has good reliability characteristics (Burch et al 1998; Mason et al
1995) and is probably one of the most widely used questionnaires in experimental and
psychophysiological studies of schizotypal personality (Mason et al1997; Nunn & Peters
2001; O'Reilly et al 2001; Rawlings & Goldberg 2001; Startup 1999; Steel et al 1996).
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In order to reduce statistical overlap (collinearity) between O-LIFE and EPQ-R, items
from the EPQ-R E, N and P scales contained in the O-LIFE scales lA, CD and IN,
respectively, were excluded from O-LIFE scale scores.
7.3.3.2 Rust Inventory of Schizo typal Cognitions (RISe)
The Rust Inventory of Schizotypal Cognitions (RISC; Rust 1987, 1988, 1989) is a
psychometrically constructed, cognitively based. questionnaire of 26 items. Its response
format is a four-point forced choice set ("strongly agree", "agree", "disagree", "strongly
disagree"). The RISC is a unitary scale (no subscales). Total scores range between 0-78,
with higher scores indicating greater incidence of schizotypal cognitions. In order to
eliminate an acquiescent response bias, thirteen items are positively and thirteen items
are negatively scored. Items were designed so as to be acceptable in content to the
general public, i.e. obviously pathological ("mad"; Rust 1988) items were avoided. As an
example, the item "Sometimes my thoughts seem so loud I can almost hear them" was
preferred over the more pathological "I sometimes hear imaginary voices" (Rust et al
1988).
In contrast to other, related instruments the RISC was developed and standardised to
yield approximately normally distributed scores in the general population. The test was
developed primarily on students, so can be used easily in the present sample.
Validation studies demonstrated an absence of sex differences, but younger individuals
tend to have higher scores (Rust et al 1988; Rust 1987, 1988, 1989).
The RISC was validated in acute schizophrenia patients who had higher scores than
healthy controls. RISC scores were also correlated with psychiatrist ratings of
schizotypal symptoms in chronic schizophrenia patients. Chronic patients had lower
RISC scores than acute patients, reflecting the positive rather than negative schizotypal
nature of the test (Rust 1987, 1988, 1989). Interestingly, no difference was found
between relatives of schizophrenia patients and healthy individuals. Rust (1989) argued
that this might reflect the expression of denial or defensiveness of schizophrenia related
content in the relatives (see also Catts et al 2000; Claridge et al 1983; Katsanis et al
1990).
Further evidence of validity was obtained through correlational studies, which showed
associations between RISC and the Minnesota Counselling Inventory (MCI)in university
students, in particular with MCI subscales of emotional stability (r=0.4S), low mood
(r=0.27), nonconformity (r=0.40) and poor social relations (r=0.26) (Rust & Chiu 1988).
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Larrison et al (2000) reported the highest correlations between RISe and PSQ subscales
with unusual perceptual experiences, constricted affect and odd beliefs/magical
thinking. RISe scores were almost uncorrelated (r=0.12) with the Eysencks'
psychoticism but significantly correlated (r=0.38) with neuroticism in students (Rust et
al 1988). As the RISe was designed at least partly with the aim to provide an
improvement over the then predominant measure of psychosis-proneness, the
Eysencks' P scale (see Section 7.2.3.4), its low statistical relation with P is not
surprising and, according to Rust (1987, 1988, 1989), reflects the independence of the
positive schizo typal dimension (RISC) from the psychopathy or (antisocial) personality
disorder spectrum (P scale). MacDonald et al (2001) observed correlations between RISe
and the Chapman Perceptual Aberration and Magical Ideation scales.
Balogh et al (1991) observed correlations between RISe and subscales of the Chapman
scales, such as perceptual aberration, magical ideation, impulsivity-nonconformity and
social anhedonia, but not physical anhedonia. Additionally, RISe was correlated with
subscales of the widely used clinical assessment tool Minnesota Multiphasic Personality
Inventory (MMPI),such as paranoia, psychasthenia, schizophrenia and hypomania. The
RISe has been used in experimental schizotypy research (Larrison et al2000).
7.3.3.3 Personality Syndrome Questionnaire (PSQ-BO)
The Personality Syndrome Questionnaire (PSQ-80) is based on a three-factor model of
schizotypy, originating in psychophysiological observations and mirroring hypothesised
syndromes of schizophrenia (Gruzelier 1996, 1999, 2002). The questionnaire contains
78 items, scored using a binary response format (true/false), of three schizotypy
measures, relating to the hypothesised Unreality, Withdrawn and Active syndromes.
PSQ-80 also contains two validity measures, the Social Desirability and Inattentiveness
scales.
The Unreality syndrome (UR) scale (24 items) is a measure of positive schizotypy,
tapping perceptual anomalies and magical ideation. The Active syndrome (AC)scale (18
items) provides a measure of increased mental and physical activation, similar perhaps
to certain aspects of thought disorder observed in schizophrenia and mania. The
Withdrawn syndrome (WD; 25 items) scale is a measure of negative schizotypy,
describing social and emotional withdrawal, constricted affect and social anxiety. The
Social Desirability (SO; 8 items) and Inattentiveness (IT; 3 items) scales provide
estimates of the honesty and validity of a participant's responses. Elevated scores on
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these scales would suggest questionable validity of the data, although no precise cut-off
criteria are provided for the exclusion of 'dishonest' or 'inattentive' participants. The
PSQ-BO (or previous versions of it) has been used in psychophysiological and
experimental studies (Croft et al 2001; Gruzelier & Kaiser 1996; Kaiser & Gruzelier
1999).
7.3.3.4 Eysenck Personality Questionnaire - Revised (EPQ-R)
The EPQ-R (Eysenck & Eysenck 1991) is the widely used and well-established
psychometric instrument for the assessment of the Eysenckian personality variables of
extraversion (E), neuroticism (N) and psychoticism (P). It contains 106 items, which
make up the three main scales, a Lie (L) scale and Criminality and Addiction scales.
These latter two scales are not utilised in the present investigation. Items are scored
using a binary response format (yES/NO). While E, P and L scales have both positively
and negatively scored items, all N items are positively scored.
The EPQ-R is the final product of a series of questionnaires, originating in the 1952
Maudsley Medical Questionnaire (MMQ), a brief measure of neuroticism. The
extraversion and neuroticism dimensions, which are at the heart of Eysenck's theory,
were captured in subsequent versions of the 1959 Maudsley Personality Inventory
(MPI), the 1964 Eysenck Personality Inventory (EPI), the 1975 Eysenck Personality
Questionnaire (EPQ) and its 1991 revision, the EPQ-R. The psychoticism scale (Eysenck
& Eysenck 1976; Eysenck 1992) was first included in the EPQ and considerably revised
in the EPQ-R.
Extraversion (23 items) is primarily intended to be a measure of sociability. According to
Eysenck and Eysenck (1991), a high-scorer on the E scale is sociable, enjoys and craves
social interaction, has many friends, is an optimist and gets bored and restless in
situations of solitude and lack of excitement. E, however, also has a second component,
relating to impulsivity. This component describes spontaneous and carefree behaviour,
lack of planning, control and reliability (Eysenck & Eysenck 1991).
Neuroticism (24 items) is a measure of trait emotionality. High levels of N describe
excessive worrying, unstable mood, high reactivity to emotional stimuli, high levels of
anxiety and depression and consequent physical symptoms of sleeplessness, pain
sensitivity and psychosomatic disorders (Claridge & Davis 2001; Eysenck & Eysenck
1991). Neuroticism and extraversion are amongst the most widely accepted 'normal'
personality dimensions (Costa & McCrae 1997).
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Psychoticism (32 items) was proposed as a measure of the liability (or diathesis) to
disorders from the psychosis spectrum (Eysenck & Eysenck 1976; Eysenck 1992).
However, the spectrum of psychosis defined here also includes impulsive, antisocial and
criminal tendencies, in short psychopathy-related behaviours (Zuckerman et al 1988).
The term tough-mindedness is often used to describe this dimension. Despite a
proposed link between psychopathy and psychosis (Corr 2000), items from the P scale
have a somewhat different flavour compared to positive schizotypy scales and
correlations tend to be moderate (Chapman et al 1982; Raine 1991; Rust 1989). A
longitudinal study confirmed the association between P and psychotic-like symptoms
and personality disorder, but not an increased rate of psychosis per se (Chapman et al
1994a).
The Lie scale (21 items) is a measure of social desirability and tendency to 'fake good',
Eysenck and Eysenck (1991) suggested correlating L scores with other measures,
excluding high scorers, and then repeating the analyses. In this manner the effects of L
can be investigated.
A plethora of experimental, psychometric, biological and psychophysiological studies
have used the E, Nand P scales (for review see Eysenck & Eysenck 1976, 1991;
Eysenck 1992; also see special issue of Personality and Individual Differences, 2001,
Volume 31, Number 1).
7.3.4 Statistical Analysis
All statistical analyses were carried out using SPSS Release 10.0.7 (SPSS Inc., Chicago,
Ill). O-LIFE UE (skewness=1.02) and IA [skewness=Lza), prosaccade latency
(skewness=1.09) and AS at 12°/s (skewness=1.35) were slightly positively skewed.
Square root transformation normalised skew for all variables (-0.06, 0.57, 0.84 and
0.22, respectively) and yielded results virtually identical to those reported below, which
are based on untransformed variables.
7.3.4.1 Effects of Age and Sex
Pearson correlations were carried out between age and oculomotor and psychometric
variables. Multivariate analyses of variance (MANOVA)were used comparing males and
females on schizotypy questionnaires, saccadic and smooth pursuit and fixation
variables.
271
Schizotypy
7.3.4.2 Schizotypy Factor Structure
The Pearson correlation matrix of questionnaire scales was factor analysed using
principal components analysis (PCA) with oblique rotation (direct oblimin). Oblique
rotation was chosen as it was deemed phenomenologically unlikely that different facets
of the schizotypy construct would be statistically unrelated to each other. As
Tabachnick and Fidell (2001) pointed out, orthogonal (i.e. uncorrelated) factor solutions
"strain reality unless the researcher is convinced that underlying processes are almost
independent" (p. 614). Factors+' were extracted if their eigenvalues exceeded 1. To
confirm factorability of the correlation matrix, the Kaiser-Meyer-Olkin (KMO)measure of
sampling adequacy was used. Bartlett's test of sphericity was not used as it is likely to
be significant with large sample sizes even if correlations are zero (Tabachnick & Fidell
2001). KMO indicates the proportion of variance in the variables that are shared, i.e.
might be caused by underlying factors. In order to explore the specific role of N (see
below), PCAwas repeated excluding this variable.
Participants' factor scores were obtained using linear regression of questionnaire scales
onto factors. This approach takes into account the loading of each variable onto a factor
and produces factor scores with mean=O and SD=-1. Higher scores on a factor reflect
higher scores on questionnaire scales loading positively onto that factor. As Tabachnick
and Fidell (2001) argue, factor scores are ideally suited for further statistical analyses
and may be more reliable than scores on individual variables. Individual questionnaire
variables were not used in correlations with oculomotor measures due to the probability
of Type I errors with multiple analyses.
7.3.4.3 Relationship between Schizotypy and Eye Movements
Factor scores were then used in multiple regression models as predictor (or
independent) variables, with oculomotor measures as dependent variables. Factor
scores were entered using the stepwise method (probability to enter set at 0.05).
Regression analyses were repeated with N as covariate and factor scores from the PCA
excluding N as predictors using the stepwise method. Further regression analyses were
carried out with antisaccade error rate as dependent variable, factor scores as
23 Following Tabachnick and Fidell (2001), the term factor is used to describe the components
from PCA, as the processes underlying the extraction of factors and components are similar,
and the term factor is used widely and unambiguously by others in this context.
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independent variables and a number of other variables (age, sex, drug and alcohol use,
psychiatric history, family history, lie scales) as covariates. Antisaccade error scores
were then combined, separately, with SPEM gain, AS, or CUS frequency by averaging z-
scores of these variables. For the combination of error rate with SPEM gain, the
percentage of correct antisaccades (100 - error rate) was used, so that lower scores on
both variables indicated greater error. Likewise, SPEM measures were combined with
each other, with SPEM gain multiplied by -1 for that purpose. These combined
variables were then used as dependent variables in regression models with factor scores
as independent variables.
7.3.4.4 Comparisons of Extreme Groups and Relationship between
SPEM Measures and Antisaccade Error Rate
Then, t-tests were carried out, comparing factor score top and bottom scorers on eye
movements. This analysis was carried out in order to make the results of this study
comparable to previous studies (Gooding 1999; Gooding et al 2000b; O'Driscoll et al
1998). Finally, Pearson correlations were carried out between antisaccade error rate and
SPEM gain, CUS and AS for each velocity as well as for averaged velocities.
7.4 Results
Descriptive statistics of oculomotor variables are given in Table 7.2 and psychometric
questionnaires in Table 7.3. Antisaccade correction rate was high (mean=96.86%;
SD=10.59), indicating that participants were, in principle, able and willing to perform
the task (McDowell& Clementz 1997).
7.4.1 Effects of Age and Sex
Females had slightly higher antisaccade error rate than males (FI1,1l0]=3.67; p=O.06)
and reduced pursuit gain at 12°/s (F11,98]=3.56; p=O.06), 24°/s (F11,98]s7.96;
p=O.006), 36° /s (F11,98]=13.18; p<O.OOl) and 48° /s (Fll,98]=16.46; p<O.OOl), as well as
a higher frequency ofCUS at 48°/s (Fll,98]=5.50; p=O.02).
Males scored higher on EPQ-R P (Fll,107]=6.31; p=O.Ol) and females scored higher on
EPQ-R N (F11,107]=3.49; p=O.06), EPQ-R L (F11,107]=6.56; p=O.Ol), PSQ-80 UR
(Fll,107]=6.40; p=O.Ol) and PSQ-80 SD (F11,107]=4.80; p=O.03).
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Table 7.2: Descriptive Statistics of Oculomotor Variables
Mean SD
SPEM gain 12°1 s
SPEM gain 24° Is
SPEM gain 36° Is
SPEM gain 48° Is
Anticipatory saccades 12°1 s
Anticipatory saccades 24°1 s
Anticipatory saccades 36°1 s
Anticipatory saccades 48°1 s
Catch-up saccades 12°Is
Catch-up saccades 24° Is
Catch-up saccades 36° Is
Catch-up saccades 48° Is
Fixation saccadic frequency
Antisaccade gain
Antisaccade latency
Antisaccade error rate
Prosaccade gain
Prosaccade latency
95.75
91.19
81.63
63.96
0.17
0.50
0.57
0.49
0.38
1.13
1.86
2.54
0.02
-109.14
275.48
29.23
98.76
173.82
7.75
10.98
15.75
17.40
0.16
0.32
0.33
0.37
0.13
0.41
0.72
0.79
0.03
33.10
39.54
18.83
11.33
22.84
Table 7.3: Descriptive Statistics of Psychometric Questionnaire Scales
Mean SD
O-LIFE UE
O-LIFE IA
O-LIFE IN
O-LIFE CD
RISC
PSQ-80 AC
PSQ-80WD
PSQ-80 UR
PSQ-80 SD
PSQ-80 IT
EPQ-RE
EPQ-RN
EPQ-RP
EPQ-RL
7.72
4.35
7.98
7.03
32.20
8.44
7.86
7.66
1.59
0.12
15.57
11.83
8.14
6.35
6.70
2.87
3.01
4.48
9.17
3.97
4.32
4.92
1.30
0.35
4.72
5.92
3.84
4.05
For legend see Section 11
Age was not significantly correlated with any oculomotor variables. Older individuals
tended to have lower scores on EPQ-R E (r=-0.28; p=O.003), PSQ-80 AC (r=-0.36;
p<0.001), PSQ-80 UR (r=-0.26; p=O.008), RISC (r=-0.20; p=O.04), O-LIFE UE (r"'-0.30;
p=O.OOI) and IN (r=-0.22; p=O.02).
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7.4.2 Schizotypy Factor Structure
The communalities (Table 7.4) represent the squared multiple correlation for each
variable using the factors as predictors in linear regression and are, therefore, the
proportion of variance accounted for by the factors extracted. All communalities were
substantial (>0.62), indicating that variables were accounted for well by the final factor
solution. The KMOstatistic was 0.82, indicating excellent factorability of the correlation
matrix.
Table 7.4: Communalities of Personality Measures
Variable Communality
O-LIFE UE
O-LIFE CD
O-LIFE IA
O-LIFE IN
EPQ-RE
EPQ-RN
EPQ-RP
RISe
PSQ-80 AC
PSQ-80WD
PSQ-80 UR
0.78
0.80
0.66
0.66
0.78
0.76
0.84
0.62
0.63
0.78
0.70
For legend see Section 11
Three factors were extracted, accounting for 72.44% of the variance (Figure 7.1; Table
7.5). Interpretation of the pattern matrix (Table 7.6) led to the labelling of these factors
as Positive Schizotypy (factor 1), Negative Schizotypy (factor 2) and Psychoticism (factor
3). The pattern matrix summarises the unique relationships between factor and
variables, uncontaminated by factor intercorrelations and is preferable to the structure
matrix, which simply gives the correlation between factor and variable (Tabachnick &
Fide1l2001).24
24 In many datasets, including the present one, differences between pattern and structure matrix
are small.
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Figure 7.1: Scree Plot for Factor Solution
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The Positive Schizotypy factor included O-LIFE UE, CD and IN, RISC, PSQ-80 AC and
UR and EPQ-R N. This factor was, therefore, made up mainly of positive schizotypal
features, such as schizotypal cognitions and experiences (UE, UR, AC, RISC, CD), but
also contained items relating to emotional reactivity (N, CD) and impulsiveness (IN).The
Negative Schizotypy factor was defined by a positive loading of EPQ-R E and negative
loadings of PSQ-80 WD and O-LIFE lA, pointing to an extraversion component. In order
to increase the semantic proximity to the schizotypy construct, however, the best label
for this factor might be the inverse of extraversion, such as introversion, withdrawal,
anhedonia, or negative schizotypy. The Psychoticism factor was defined by EPQ-R P.
Table 7.S: Eigenvalues, Percentages of Variance, and Squared Multiple Correlations
of the Three Factors
Factor
1 2 3
Eigenvalue 4.66 2.17 1.14
Percent of variance 42.36 19.74 10.34
SMC 0.99 0.96 0.71
Legend:
SMC denotes squared multiple correlation of scales onto factor scores
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As Tabachnick and Fidell (2001) pointed out, factor loadings in excess of 0.71 may be
considered 'excellent', those in excess of 0.63 'very good' and those in excess of 0.55
'good'. As can be seen from Table 7.6, factor loadings were good to excellent, indicating
a good description of the factors by the variables. Squared multiple correlations (SMC)
of variables onto their respective factor scores confirmed this finding (Table 7.5).
Table 7.6: Factor Structure of Personality Measures (Pattern Matrix)
Factor
1 2 3
O-LIFEUE
PSQ-BO UR
PSQ-BOAC
O-LIFE IN
RISC
O-LIFE CD
EPQ-RN
EPQ-RE
PSQ-BOWD
O-LIFE IA
EPQ-R P
0.B6
0.B4
O.BO
0.7B
0.75
0.61
0.61
-0.51
0.B7
-0.B4
-0.70
0.B3
For legend see Section 11
Factor intercorrelations were non-significant between factor 1 and factor 3 (r=0.07;
p=O.51) and factor 2 and factor 3 (r=0.03; p=O.75). The correlation between factor 1 and
factor 2 approached formal levels of statistical significance (r=-O.IB; p=O.06), indicating
that higher scores on factor 1 were weakly associated with lower scores on factor 2.
To confirm the stability of the solution, combinations of a variety of extraction (principal
components, alpha factoring, principal axis factoring, image factoring) and rotation
(varimax and direct oblimin) methods were employed. Identical factor structures were
obtained each time, with only small differences in the size of loadings. As Tabachnick
and Fidell (2001) argued, if a factor solution from a 'good' dataset is stable then it is
likely to be obtained across a number of different methods of extraction and rotation.
peA was then repeated excluding N. The factor structure that emerged differed from
that described above as P now loaded onto the first factor. Therefore, two factors were
extracted (eigenvalues: 4.21, 2.13) accounting for 63.39% of the variance. Otherwise,
distribution of variables across factors was identical to the factor solution above, with
very similar sizes of loadings.
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7.4.3 Relationship between Schizotypy and Eye Movements
Predicting SPEM variables from factor scores yielded a significant model for CUS
frequency at 12°/ s: F(1,10 1)=4.68; p=O.03. Psychoticism factor score was the only
variable accepted by the model, resulting in a 4.4% increase in the percentage of
variance explained. Higher psychoticism factor scores were associated with greater CUS
frequency, with a standardised regression coefficient of 0.21 (p=O.03). No other
regression models with SPEM variables as DVyielded any significant predictors. Given
the sex differences on SPEM gain (Section 7.3.1) regression analyses were carried out
for males and females separately using gain as dependent variable and for the
combined group using sex as covariate. No significant predictors emerged.
Predicting saccadic variables from factor scores yielded no significant models for
antisaccade gain, pro saccade latency and antisaccade latency. Positive schizotypy factor
score was the only significant predictor of antisaccade error rate, resulting in a 6.1%
increase in variance explained: F(l,105)=6.85; p=O.Ol. Higher factor scores were
associated with more antisaccade errors (Figure 7.2), with a standardised regression
coefficient of 0.25 (p=O.Ol).
Figure 7.2: Relationship between Antisaccade Error Rate and Positive Schizotypy
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positive schizotypy factor score
A significant model was also obtained for prosaccade gain: F(l,100)'"'4.46; p=O.04.
Psychoticism factor score was the only variable accepted by the model, resulting in a
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4.3% increase in variance explained. Higher psychoticism factor scores were associated
with reduced prosaccade gain, with a standardised regression coefficient of -0.21
(p=O.04).
The stability of the most interesting of these relationships, that between antisaccade
errors and positive schizotypy factor scores, was then explored further. Using the
positive schizotypy factor score from the PCA without N in a multiple regression
analysis predicting antisaccade error rate from factor scores yielded identical R2,Beta, F
and p values as above. In a second analysis, entering N as covariate explained 2.2% of
the variance, indicating a non-significant change from zero: F(1,104)=1.95; p=O.17.
Positive schizotypy was still accepted into the model, predicting significantly over and
above N, with an increase in 4.5% of the variance explained and a standardised
coefficient of 0.25 (p=O.03).
Similarly, covarying in separate analyses for age, sex, cannabis use (yes, no), use of any
drugs (yes, no), units of alcohol per week, psychiatric history (yes, no), psychiatric
family history (yes, no), family history of schizophrenia (yes, no), or EPQ-R L, PSQ-80
SD or IT scales did not alter the relationship between anti saccade error rate and
positive schizotypy. Excluding participants with EPQ-R lie scores of 10 or higher (N""25),
participants with PSQ-80 social desirability scores of 4 or higher (N=19), or PSQ-80
inattentiveness scores of 2 (N=l) in separate analyses did not affect this finding.
Standardised questionnaire variables from each factor were then averaged to yield an
approximation of the factor scores based solely on test scores, i.e. irrespective of factor
loadings (E scores were multiplied by -1 for that purpose). The averaged z-score of
variables making up the positive factor again emerged as sole significant predictor
(Beta=0.23; p=O.02; R2=0.05), further underscoring the robustness of this finding.
Using the combined smooth pursuit (gain, AS, CUS) performance score as dependent
variable yielded no significant psychometric predictor. Similarly, combining antisaccade
errors with either SPEM variable or the combined SPEM measure demonstrated no
significant relationship.
7.4.4 Comparisons of Extreme Groups
Comparing ten participants with the highest positive schizotypy factor score with ten
participants with the lowest score on antisaccade error rate (Figure 7.3) yielded a
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significant difference (t=-4.03; df=18; p=O.OOl); the high scorers had higher average
error rate (31.07%) than the low scorers (10.99%).
Figure 7.3: Antisaccade Error Rates for High and Low Positive Schizotypy Groups
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7.4.5 Relationship between SPEM Measures and Antisaccade Error
Rate
Antisaccade error rate was correlated with SPEM gain at 24° /s (r"'-0.32; p=O.OOI),
36°/s (r"-0.32; p=O.OOl), 48°/s (r=-0.23; p=O.02) and at averaged velocities (r=-0.30;
p=O.OOI), indicating that higher error rates were associated with reduced SPEM gain,
but not at 12°/s (rcO.Ol; p=O.94). There was a trend for a correlation between error rate
and CUS at 12°/s (r=0.18; p=O.06), indicating that higher error rates were associated
with more CUS. No other correlations between error rate and CUS or AS were
significant (all p>0.13). Covarying for positive schizotypy factor score did not increase
the magnitude of the correlations between antisaccade error rate and AS frequency.
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7.5 Discussion
7.5.1 Key Findings
The key findings of this study are as follows. 1) A three-dimensional factor structure
emerged from schizotypy questionnaires subscales, consisting of positive schizotypy,
negative schizotypy and psychoticism. 2) There was a relationship between levels of
positive schizotypy and antisaccade error rate; prosaccade gain was correlated with
scores from the psychoticism dimension. 3) The relationship between antisaccade error
rate and positive schizotypy was not accounted for by individual differences in trait
emotionality, suggesting specificity to the schizophrenia spectrum phenotype.
7.5.2 Schizotypy Factor Structure
Consistent with a plethora of previous investigations, the factorial structure of self-
report schizotypy scales in this study was not unitary (Vollema& van den Bosch 1995).
It is a truism that the factor solution that one obtains depends on the number and kind
of variables that are factor analysed (Gould 1981; Stuart et al 1999; Tabachnick &
Fidell 2001). As has been noted in the context of schizophrenia syndrome research
(Stuart et a1 1999), factor analysis does not reveal whether the symptom variables being
analysed are a balanced and adequate representation of the syndrome(s) under
investigation. For example, if a particular type of symptom (e.g. positive symptoms) is
over-represented it will dominate the factor solution. Therefore, comparisons with
previous factor analytic studies are only of moderate interest, as the particular
combination of items (e.g. questionnaire subscales) is virtually unique to each
investigation.
Despite these caveats, the factor structure obtained here somewhat resembled those
obtained in previous studies. Lipp et a1 (1994) found a positive (with high N), a negative
(with low E) and a psychoticism/physical anhedonia (with high P) factor; N additionally
loaded on the negative factor. Muntaner et a1 (1988) obtained a positive factor, an
impulsivity factor and an introversion factor. In their study, the positive factor was
characterised by perceptual aberrations, magical ideation, as well as the O-LIFE and its
precursor questionnaire. As in the present study, N loaded on this factor. Impulsivity
contained, in addition to P, lie scale and borderline personality scales. The introversion
factor included E as well as physical and social anhedonia. Kelley and Coursey (1992)
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obtained a general (positive) schizotypy and a physical anhedonia factor; the
psychoticism scale was not used. The positive factor observed here resembles that of a
previous study (Venables & Rector 2000), as symptoms of delusions and unusual
experiences as well as those of cognitive disorganisation loaded on the same factor.
Some studies obtained evidence of negative and psychoticism factors but more than one
positive factor, or an additional emotionality factor. Bentall et al (1989) found a positive,
a social anxiety/cognitive disorganisation (including N), a negative and a psychoticism
factor. Kendler and Hewitt (1992) obtained a positive, neuroticism, nonconformity and a
social schizotypy factor. In the development of the O-LIFE questionnaire, Mason et al
(1995) observed two factors relating to positive schizotypy (UE and CD), a negative
factor (IA)and a psychoticism/impulsivity factor (IN). These studies, therefore, partly
match the present solution, with the exception of a unitary positive factor including
neuroticism.
Besides this confirmatory evidence, however, a number of studies have obtained
schizotypy factor structures considerably departing from the present one (Hewitt &
Claridge 1989; Raine & Allbutt 1989; Vollema & van den Bosch 1995). The reasons for
this most probably include the choice of questionnaires that were factor analysed, as
well as sample issues.
With some discrepancies, therefore, the present factor structure may be reconciled with
previous research. In particular, the relationship between N and positive schizotypal
items has been observed previously [Bentall et al 1989; Kendler & Hewitt 1992; Lipp et
al 1994; Muntaner et al 1988).
As has been pointed out (Johns & van Os 2001; Vollema & van den Bosch 1995), the
factor structure of schizotypy bears remarkable resemblance to the syndromes of
schizophrenia. While this could be due to artefacts such as item selection (Stuart et al
1999), the possibility of genetic and clinical continuity is intriguing (Fanous et al 2001).
The present factor structure resembles the syndromes of schizophrenia in so far as
there are distinguishable positive and negative features (Crow 1980a, 1980b). It has
been shown, however, that 'positive symptoms' in schizophrenia may represent two
independent statistical clusters (Liddle 1987a, 1987b). The current study did not
observe two such factors.
The present study was not designed to address comprehensively the factorial nature of
schizotypy. To resolve this longstanding issue, larger sample sizes and possibly a larger
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number of questionnaire scales should be used. Alternatively, a factor analysis at the
item (rather than scale) level of questionnaire data might be instructive. The present
study did not factor analyse item level data due to the relatively small sample size. Sex
and age effects on trait measures were largely consistent with previous studies (Eysenck
& Eysenck 1991; Mason et al1995; Rust 1989).
7.S.3 Relationship with Eye Movements
The most interesting relationship, in terms of oculomotor schizophrenia spectrum
endophenotypes, was that between increased antisaccade errors and increased levels of
positive schizotypy. This finding is compatible with previous studies that observed
increases in error rate in students scoring high on the Perceptual Aberration (Gooding
1999; O'Driscoll et al 1998), Magical Ideation (Gooding 1999), or RISe (Larrison et al
2000) scales. In contrast to Gooding (1999), however, there was no relationship between
negative symptoms and antisaccade error rate.
Klein et al (2000c) failed to find a relationship between schizotypy and antisaccade
errors in a student sample. The reason for this might have been, apart from sampling
issues, the use of an overall schizotypy score (Schizotypal Personality Questionnaire
ISPQ) total score) rather than positive or negative subscores. Vollema and van den
Bosch (1995) have pointed to the importance of using schizotypy subscales, as a total
score (or global measure) might give "one-sided results" (p. 25) or mask important
effects.
Most eye movement studies have used an 'extreme groups' approach to the study of
schizotypy, following the medical dichotomy of affected vs. unaffected, by comparing
high and low schizotypy scorers on eye movement parameters. However, dichotomising
continuous data results in a loss of statistical power (Cohen 1988). It may be desirable
to conserve the wide range of individual differences in this measure, which also better
reflects the assumed continuous nature of the schizotypy construct (Claridge 1990).
The present study achieved this through the use of (normally distributed) factor scores,
however, and replicated the association between antisaccade errors and positive
schizotypy by demonstrating significantly higher error rate in positive schizotypy high
scorers than low scorers.
The observation of a relationship between antisaccade error rate and positive but not
negative schizotypal features is intriguing. The schizophrenia literature is inconsistent
283
Schizotypy
with regard to the symptom correlates of antisaccade errors, with findings of
associations with positive and negative symptoms, or absence of statistical associations.
However, a relationship between antisaccade errors and negative symptoms might have
been expected on the basis of previous findings. These findings include (1) the role of
the frontal cortex in both antisaccade performance (Everling & Fischer 1998; McDowell
& Clementz 2001; Muri et al 1998) and negative symptoms (Carpenter et al 1999), (2)
the association between negative symptoms and motor abnormalities in the
schizophrenia spectrum (Ross 2000; Wolff & O'Driscoll 1999) and (3) the generally
stronger correlation between (frontal) cognitive deficits and negative rather than positive
symptoms (Addington et al 1991). A number of explanations may be drawn upon in
order to account for the observed finding.
First, it was recently conjectured that although the defining subclinical features in first-
degree relatives of schizophrenia patients are negative schizotypal symptoms, the
hallmark features of schizotypy in healthy individuals without a family history of
schizophrenia are positive symptoms (Faraone et al 2001). The present results are in
agreement with this hypothesis, linking the defining features of schizotypy with a
proposed marker of risk for schizophrenia. A replication of the current design using a
sample of first-degree relatives would provide a crucial test of the hypothesis of a
predominant role of negative symptoms in these individuals.
A second explanation might lie in the nature of the positive and negative schizotypy
scales typically used in this type of research. Items from positive scales, probing for
unusual perceptions and experiences as well as delusional and magical thinking,
generally appear to be more pathological in their content than those of negative scales,
relating to social withdrawal and anhedonia (Table 7.1). It is possible, therefore, that
high scores on the positive factor index greater subclinical abnormality, i.e. proximity to
the schizophrenia spectrum, than high scores on the negative factor. This suggests that
positive schizotypal features might be a more sensitive index of schizophrenia-related
psychopathology in non-clinical populations (Faraone et al 2001).
Third, if a 'true' relationship existed between antisaccade errors and positive features, it
could be masked in studies of schizophrenia patients. Positive symptoms in
schizophrenia are known to fluctuate, in particular in the early stages of the illness and
with change in antipsychotic medication (Kapur & Remington 2001; Leonard 1997).
Given the relative stability of antisaccade performance over time (Chapter 4), a
statistical relationship between antisaccade errors and symptom scores could easily be
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abolished by low temporal reliability of one of the measures, namely that of symptom
severity (Anastasi & Urbina 1997).
In contrast to antisaccade errors, SPEM performance was not consistently associated
with schizotypy measures. CUS frequency at 12°/s was associated with psychoticism
factor scores. However, this relationship was not observed for CUS frequency at faster
velocities, or other SPEM measures at the same or other velocities, indicating that the
finding was not consistent and might have been a chance observation due to multiple
analyses.
The absence of a consistent relationship between SPEM and schizotypy scores in this
sample is somewhat disappointing and unexpected given the previous literature
(Gooding et al 2000b; O'Driscoll et al 1998; Siever et al 1984, 1989). The above finding
of a relationship between antisaccade errors and schizotypy levels provides important
evidence of the validity of the choice of psychometric, sampling and statistical methods
used here, suggesting that the failure to obtain a relationship with SPEM may not be
attributed to mere methodological weaknesses. This finding contrasts with the studies
by O'Driscoll et al (1998) and Gooding (1999; Gooding et al 2000b), who obtained
similar patterns of findings for the SPEM and antisaccade tasks in each sample. A
possible reason for this lies in the choice of psychometric questionnaire. Previous
studies have used the physical and social anhedonia measures from the Chapman
scales (Chapman et al 1980; Mishlove & Chapman 1985), which might provide better
measures of negative schizotypy.
Reduced prosaccade gain was associated with higher psychoticism scores. This finding,
although unexpected and in contrast to previous research (Gooding 1999), might be
compatible with the schizophrenia literature. There is evidence, albeit inconsistent, of
reduced saccadic gain in schizophrenia patients (Curtis et al 2001a; Schmid-Burgk et al
1983) and first-degree relatives (Schreiber et al 1995, 1997). Given the proposed
proximity of psychoticism to schizophrenia, reduced prosaccade gain might be another
trait marker of the schizophrenia spectrum, possibly related to dopaminergic processes
(Gray et al 1994). The inconsistent evidence of this finding in schizophrenia, first-degree
relative and schizotypal samples, however, somewhat weakens this conclusion.
285
Schizotypy
7.5.4 Effects of Trait Emotionality
The most promising of the current findings, the relationship between antisaccade error
rate and positive schizotypy, was tested for the influence of trait emotionality using the
Eysencks' neuroticism (N)scale. N failed to predict antisaccade errors and covarying for
N did not significantly reduce the predictive power of positive schizotypy. This indicates
that positive schizotypy scores, in this sample, significantly predicted antisaccade error
rate, over and above the contribution of a general index of psychopathology and trait
emotionality, or N.
The importance of this finding lies in the assumed specificity of antisaccade deficits to
the schizophrenia spectrum. As argued above, neuroticism is a general indicator of
psychopathology and associated somatic complaints. Therefore, a strong influence of
this variable on antisaccade errors would have undermined the claim of this oculomotor
task being a specific schizophrenia spectrum endophenotype. This observation is in
accord with O'Driscoll et al's (1998) finding of a lack of significant effect of state
emotionality on the relationship between antisaccade performance and schizotypy.
Given the evidence of a relationship between neuroticism and schizophrenia/ schizotypy
(Bentall et al 1989; Braunstein-Bercovitz et al 2002; Claridge & Davis 2001; Eysenck &
Barrett 1993; Lipp et al 1994; Muntaner et al 1988; O'Driscoll et al 1998; Rust & Chiu
1988; Tien et al 1992a; Wuthrich & Bates 2001), it may be argued that neuroticism and
antisaccade impairments represent two independent sources of variance, both
associated with the schizophrenia phenotype. The antisaccade endophenotype might,
therefore, tap genetic sources independent of affective disturbance. However, given the
evidence of an association between schizophrenia and affective disorder at a genetic
level (Berrettini 2000a; Maier et al 1999), the observation of antisaccade errors in
people with affective disorders (Crawford et al 1995a; Curtis et at 2001 a; Gooding &
Tallent 2001; Katsanis et al 1997; Sereno & Holzman 1995; Sweeney et al 1998b; Tien
et al 1996) and the use of only one self-report measure of trait emotionality in the
present study, this evidence of specificity should be considered preliminary.
The Eysencks' N scale is a general measure of trait emotionality, encompassing the two
related but dissociable components of anxiety and depression (Claridge & Davis 2001;
Eysenck & Eysenck 1991). Future research should replicate the present design,
replacing N with separate trait measures of anxiety and depression. Such an
investigation might be useful given the link between anxiety and attention and the
presumed attentional demands of the antisaccade task (Kristjansson et at 2001).
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O'Driscoll et al (1998) failed to find an effect of state anxiety; however, a trait measure
might be more useful in this context. It is instructive to note that Wuthrich and Bates
(2001) failed to obtain a correlation between latent inhibition and neuroticism,
suggesting a specific influence of anxiety on the relationship between latent inhibition
and schizotypy (Braunstein-Bercovitz 2000; Braunstein-Bercovitz et al 2002;
Braunstein-Bercovitz & Lubow 1998). Whether a similar effect exists with regard to the
anti saccade task remains to be investigated.
7.5.5 Relationship between SPEM Measures and Antisaccade Error
Rate
Antisaccade error rate was negatively correlated with SPEM gain, indicating that worse
performance on the anti saccade task (higher percentage of errors) was associated with
worse performance on the SPEM task (reduced gain). This finding replicates previous
schizophrenia spectrum research (Thaker et al 2000). However, the expected
relationship between antisaccade errors and anticipatory saccade (AS) frequency
(Chapters 5 & 6) was not observed. This negative finding, given the large sample size,
represents a disappointing failure of the hypothesis linking the two measures on the
basis of their inhibitory requirements (Calkins & Iacono 2000; Friedman et al 1992a;
Levin 1984; Muri et al1998).
A combination of antisaccade error rate and AS frequency (or any SPEM measure) did
not result in improved associations with schizotypy levels. This finding is probably due
to the lack of correlation between error rate and AS frequency and the absence of
consistent correlations between SPEM measures and schizotypy.
The reasons for the failure to replicate the previous findings of an association between
antisaccade error rate and AS frequency are unclear. One possibility could be
differences in stimulus presentation methods (Battery II in this study; Battery I in
Chapters 5 and 6). However, both measures of antisaccade error rate and AS frequency
were previously found to be significantly correlated across batteries (Chapter 4). Given
the finding of higher error rate on Battery II compared to Battery I, the question arises
of whether task difficulty produced spurious correlations in Chapters 5 and 6, possibly
through a floor effect on antisaccade error rate. However, inspection of the scatter plots
(Chapters 5 & 6) suggested that this was not the case. Additionally, given the better
psychometric properties (greater range and variability) of antisaccade scores of Battery
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II (Chapter 4), a stronger correlation might have been expected in the present study
(Anastasi & Urbina 1997). Sampling issues might have affected the results. The control
group of Chapter 6, in which a significant correlation was demonstrated, consisted
largely of members of the general public recruited through newspaper advertisements,
whereas the present sample consisted largely of university students and staff. This
suggests that a restricted range in the more homogenous sample of this study might
account for the failure to obtain a correlation. However, the range of antisaccade errors
in this study (0%-86.44%) was much greater than that of the control group in Chapter 6
(0%-45%).
It remains to suggest that future studies attempt to address this question in order to
clarify whether the relationship between increased antisaccade error rate and AS
frequency, which appears attractive at a theoretical level, was a chance finding, or
whether the failure to replicate in the present study represents a false negative.
7.6 Conclusions
» The factor structure of schizotypy replicates previous studies, suggesting a
positive, a negative and a psychoticism dimension.
» Increased levels of positive schizotypy were related to increased antisaccade
errors.
» Increased levels of psychoticism were related to reduced prosaccade gain.
» SPEM performance was not consistently related to schizotypy scores.
» Trait emotionality was not related to antisaccade errors and did not account for
the relationship between antisaccade errors and positive schizotypy.
» Antisaccade errors were related to SPEM gain but not anticipatory saccade
frequency. Combining error rate with SPEM measures did not result in stronger
correlations with schizotypy measures.
7.7 Limitations
» Information regarding the psychiatric history of participants and their first-
degree relatives was derived from a self-report questionnaire and was not
ascertained through thorough clinical examination.
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~ The measures of schizotypy employed here were based on self-report, thereby
arguably allowing for the presence of bias in responding.
~ Trait emotionality was assessed using the very general measure of neuroticism,
thus possibly masking or underestimating specific contributions of the anxiety
or depression components.
~ The proposed continuity between schizotypal features and schizophrenic
symptoms is tenuous, given the nature of the positive factor extracted in the
present study, which might not mirror schizophrenic symptoms very closely
(Fanous et al 2001).
~ The relationship between antisaccade errors and schizotypy was of moderate
magnitude, suggesting the operation of many other factors in explaining
antisaccade variance.
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Chapter Eight
Study V - State Influences on Eye Movements:
Effects of Procyclidine in Schizophrenia
8.1 Chapter Overview
This chapter examines state effects on eye movements (Battery II) of an anticholinergic
drug, procyclidine, which is commonly administered to patients with schizophrenia in
the treatment of extrapyramidal side effects. Given the role of the cholinergic system in
cognition, and the role of cognitive processes in smooth pursuit and antisaccade eye
movements, it is of interest to examine whether performance on these tasks is affected
by acute administration of procyc1idine. The implications of this putative effect concern
both the pharmacology of oculomotor control and the need to consider anticholinergic
conjunctive treatment when comparisons are made between schizophrenia patients and
healthy individuals.
8.2 Introduction
Procyclidine (1-cyc1ohexyl-1-phenyl-3-(pyrrolidin-1-yl)-propan-1-01 hydrochloride) is a
synthetic anticholinergic agent (Whiteman et al 1985). While previously used in the
treatment of Parkinson's disease (Brocks 1999) it is now most commonly administered
to schizophrenia patients in order to alleviate antipsychotic-induced side effects
(Mindham et al 1977; Spohn & Strauss 1989). The most common side effects of typical
antipsychotic drug treatment in schizophrenia are akathisia (restlessness), dystonia
(muscle cramps), akinesia (motor slowing), tremor and muscle rigidity (Leonard 1997).
Some of these side effects, in particular those with resemblance to Parkinsonian
symptoms (e.g. tremor, rigidity), can be treated successfully with anticholinergic drugs,
such as procyc1idine (Leonard 1997; Spohn & Strauss 1989).
Central cholinergic projections are extremely diffuse. The key pathways arise from
cholinergic neurons in the mid- and hindbrain, such as the nucleus basalis
290
Procyclidine
magnocellularis of Meynert, and project on to cortical neurons (Deutch & Roth 1999).
Procyclidine primarily antagonises muscarinic (M) receptors Ml, M2 and M4, of which
M1 and M4 are diffusely distributed throughout the brain; M2 is the heart isoform of
the receptor and is not widely found in other organs (Waxham 1999). Procyclidine also
acts, less strongly, on N-methyl-D-aspartate (NMDA) glutamine and nicotinic
acetylcholine receptors (Whiteman et al 1985).
The neurotransmitter acetylcholine has been implicated in cognition. Both animal and
human studies have demonstrated a role of the central cholinergic system in processes
of memory, attention and learning (Everitt & Robbins 1997; Francis et al 1999;
McGaughy et al 2000). The role of acetylcholine in cognition is also compatible with the
cognitive degeneration observed in Alzheimer's disease, a neurological condition with
known pathology of basal forebrain cholinergic neurons (Francis et al 1999). Given this
evidence, as well as the evidence of cognitive dysfunction in schizophrenia (Sharma &
Harvey 2000), it is of particular interest to study the effects of clinical doses of
procyclidine on cognition.
Recently, Kumari et al (2001) observed disrupted prepulse inhibition in healthy
individuals after administration of 15mg (but not 10mg) of procyclidine. Prepulse
inhibition (PPI) is an operational measure of sensorimotor gating that has been shown
to be impaired in schizophrenia (Braff et al 2001; Kumari 2000; Swerdlow et al 2000).
Zachariah et al (2002) observed impairments on a variety of cognitive tests in healthy
individuals after procyclidine administration. Sharma et al (2002) found reduced heart
rate and alertness (assessed using the critical flicker fusion threshold paradigm) after
15mg (but not 10mg) of procyclidine in healthy individuals. Taken together, these
reports suggest that procyc1idine dose-dependently impairs cognitive function and leads
to sedation in healthy individuals. Relatedly, Mori et al (2002) observed improvements
in schizophrenia patients in memory and psychopathology and increases in regional
cerebral blood flow after withdrawal from anticholinergics.
Given the role of the cholinergic system in cognition and the use of anticholinergic
drugs such as procyc1idine as adjunctive treatment in schizophrenia patients, it is an
important question to investigate the effects of anticholinergic agents on neurocognitive
endophenotypes, such as the smooth pursuit eye movement (SPEM) and antisaccade
tasks, in this patient group. Studies of the cognitive component processes of smooth
pursuit and antisaccade performance have suggested that successful task performance
relies on recruitment of overt and covert attention [Kristjansson et al 2001; Roitman et
291
Procyclidine
al 1997; Schwartz et al 2001; Sweeney et al 1994a) and response inhibition and
working memory (Mitchell et al 2002; Roberts et al 1994; Stuyven et al 2000), all of
which are likely to be at least partly mediated by central cholinergic pathways
(McGaughy et al 2000). If deleterious effects of procyc1idine on SPEM and antisaccade
performance were obtained, statistical differences on these measures between
schizophrenia patients taking this drug and unmedicated individuals might be inflated
and should be treated with caution (Spohn & Strauss 1989).
8.2.1 Aims
The present study, therefore, had the following aims. 1) To quantify the effects of
procyc1idine on SPEM and anti saccade performance in a sample of schizophrenia
patients using a double-blind placebo-controlled crossover design. 2) Given the
observation of practice effects on antisaccades in previous pharmacological studies
(Green et al 2000; Klein et al 2002), to investigate further whether oculomotor
performance was affected by procyclidine as a function of drug administration order.
8.3 Method
8.3.1 PartiCipants
Fifteen schizophrenia patients were recruited into the study. Two of these refused
second assessment, thus leaving a final sample size of thirteen patients (7 males, 6
females; mean age=35.54; SD=11.59). All patients were treated with one of two atypical
drugs with low intrinsic anticholinergic properties, risperidone or quetiapine. Five
patients were on quetiapine (dose range: 100-300mg daily) and eight were on
risperidone (dose range: 2-6mg daily). Patients were not on any anticholinergic
medication for at least six months prior to taking part in the study, although six
patients had in the past been prescribed procyclidine. All patients were required to have
stable symptoms for at least one month before taking part in the study and reported to
be free from drug abuse. Diagnoses were established using the Structured Clinical
Interview for DSM (First et al 1996b) and current symptoms were rated using the
Positive and Negative Syndrome Scale (PANSS;Kay et al1987).
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All patients provided written consent after detailed explanations of the study procedures
had been given to them. The study was approved by the Ethics Committee of the
Institute of Psychiatry, University of London.
8.3.2 Eye Movement Assessment
Battery II was used in the assessment of eye movements. Antisaccade and fixation data
from one patient (on procyclidine) could not be collected due to lack of compliance.
Fixation data from one patient (on placebo) was not usable due to data storage error.
The dependent oculomotor variables were, as before, SPEM gain and frequencies of
catch-up saccades (CUS) and anticipatory saccades (AS);frequency of saccades during
fixation; antisaccade gain, latency and error rate; and prosaccade gain and latency.
8.3.3 Drug Dose and Administration
Participants were administered oral 15mg procyclidine or a placebo (200mg ascorbic
acid) of identical appearance on two occasions under double-blind conditions. Intervals
between assessments ranged between 10-14 days. Participants were quasi-randomly
assigned to one of two orders of drug administration: seven participants received
procyclidine first and placebo second, six participants were assessed in the reverse
order. All patients received placebo or procyclidine between 9.00 and 11.45am (kept
constant for each participant within ± 30min across both sessions) to control for effects
of time of day on drug metabolism. A dose of 15mg procyclidine was deemed
appropriate as it is clinically relevant and has been shown to affect central nervous
system processing in healthy individuals in the absence of severe side effects (Kumari et
al2001; Sharma et al2002; Zachariah et al2002).
Eye movements were assessed between 4 and 5 hours post drug administration. A self-
rating measure of sedation was taken shortly before drug administration and shortly
before or after eye movement assessment. This measure consisted of a 100mm visual
analogue scale, ranging to "alert" to "drowsy" (Bond & Lader 1974).
8.3.4 Statistical Analysis
Statistical analyses were carried out using SPSS Release 10.0.7 (SPSS Inc., Chicago, Ill).
A number of oculomotor variables were slightly skewed. As both positive « 1.63) and
negative (>-1.37) skewness values were only moderate and no obvious outliers were
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observed, these distributions were not considered to be a significant challenge to the
normality assumption of the parametric statistical analyses reported below.
Each SPEM variable (gain, AS, CUS) was analysed using a 2x4x2 repeated measures
analysis of variance (ANOVA) with drug (procyclidine, placebo) and velocity (12°/s,
24°/s, 36°/s, 48°/s) as within-subjects factors and order (procyc1idine first, placebo
first) as between-subjects factor. Each saccadic and fixation variable was analysed
using a 2x2 repeated measures ANOVAwith drug (procyc1idine, placebo) as within-
subjects factor and order (procyclidine first, placebo first) as between-subjects factor.
To assess effects of drug on mood state (alertness) at time of eye movement assessment,
a 2x2x2 repeated measures ANOVAwas carried out with time (baseline, eye movement
assessment) and drug (procyclidine, placebo) as within-subjects factors and order
(procyc1idine first, placebo first) as between-subjects factor.
8.4 Results
Descriptive statistics of oculomotor variables are given in Table 8.1; ANOVAresults are
given in Table 8.2. Antisaccade correction rates after administration of both
procyc1idine (mean=92.48; SO=10.56) and placebo (mean=90.43; SO=16.48) were high,
indicating that participants were willing and able to follow task instructions (McDowell
& Clementz 1997). There were no between-group effects of order (all p>0.10), indicating
that the quasi-random allocation of participants resulted in two groups matched on eye
movement performance levels. For SPEM, there were significant effects of target velocity
on gain (F[3,33]=49.20; p<0.001), CUS (F[3,33]=107.73; p<0.001) and AS frequency
(F[3,33]=8.90; p<0.001), indicating worse performance at faster velocities (Leigh & Zee
1999). There were no velocity x order (all p>0.08) or velocity x order x drug interactions
(all p>0.14), indicating that drug effects on SPEM variables were similar across
velocities.
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8.4.1 Effects of Procyclidine on SPEM and Fixation
SPEM gain was reduced by procyclidine compared to placebo at trend level (Table 8.2);
there was no effect of order or order x drug interaction on this variable. AS frequency
was increased by procyclidine compared to placebo at trend level. Additionally, there
was a drug x order interaction but no effect of order. The interaction indicates that AS
frequency was increased by procyc1idine if administered second; if procyc1idine was
administered first, the reverse pattern was observed. There were no significant main or
interaction effects on CUS frequency or frequency of saccades during fixation.
8.4.2 Effects of Procyclidine on Antisaccade and Prosaccade
Antisaccade gain scores were increased by procyc1idine compared to placebo at trend
level (Table 8.2); there was no effect of order or drug x order interaction. There was a
significant drug x order interaction on antisaccade latency but no main effects of drug
or order; procyclidine was associated with faster latency if administered second. There
was a significant drug x order interaction but no main effects of drug or order on
antisaccade error rate; procyc1idine increased error rate only when administered first.
There was a significant drug x order interaction but no main effects of drug or order on
prosaccade latency. Procyc1idine was associated with shorter latency when
administered second; the reverse pattern was observed when procyclidine was
administered first. There were no main or interaction effects on prosaccade gain.
8.4.3 Effects of Procyclidine on Alertness
There were no effects of drug, time or order, or drug x order, drug x time, time x order
or drug x time x order interactions on mood ratings (all p~O.09).
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8.5 Discussion
8.5.1 Key Findings
The findings from this study are as follows. 1)Acute administration of procyclidine non-
significantly worsened both smooth pursuit and antisaccade performance in patients
with schizophrenia, pointing to the importance of considering these drug-related state
effects in studies of oculomotor schizophrenia endophenotypes. 2) The effects of
procyclidine on some variables were affected by the order in which procyclidine and
placebo were administered, suggesting the need to consider order effects in drug
administration studies.
8.5.2 Effects of Procyclidine
Procyclidine non-significantly reduced the key smooth pursuit measure of velocity gain.
Similarly, procyclidine non-significantly increased AS frequency during pursuit. It is
possible that these effects could have reached statistical significance if a larger sample
had been used. A possible explanation for the impairments in smooth pursuit
performance during procyc1idine administration is the role of the cholinergic system in
attention (Everitt & Robbins 1997). Previous studies have suggested that successful
generation of smooth pursuit eye movements requires attentional processes (Roitman et
al 1997; Schwartz et al 2001; Sweeney et al 1994a). A likely consequence of the
anatomically non-specific antagonistic action of procyc1idine at the M1 and M4
receptors across the entire brain is a reduction in levels of alertness and, possibly,
attention (Coull 1998; Sharma et al 2002). The lack of an effect of procyc1idine on self-
reported alertness/drowsiness suggests that this effect was centrally mediated.
The effect of procyclidine on AS frequency was mediated by order of drug
administration. Procyclidine led to an increase in AS frequency when administered
second, but the reverse pattern was observed when procyclidine was administered first.
The reasons for this interaction are unclear. Importantly, however, the main effects of
procyclidine on AS frequency were adverse, leading to a non-significant overall increase.
On the anti saccade task, procyc1idine increased antisaccade error rate when
administered first. When administered second, procyclidine appeared to have no
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significant effect on error rate. To explain this pattern of performance, both placebo and
practice effects have to be considered.
It is a possibility that in the group receiving placebo first, performance at first
assessment was slightly impaired due to psychological factors, such as the expectancy
to receive a performance-impairing compound (Beecher 1959). Participants were aware
that they would on one occasion receive a compound that could have detrimental effects
on their cognitive function. At second assessment (during procyclidine in this group),
practice effects on antisaccade error rate might be expected (Green et al 2000; Klein et
al 2002; Chapter 4). Indeed, the overall pattern of reductions in error rate from first to
second assessment (irrespective of drug administration) in Table 8.1 is compatible with
the operation of practice effects. However, participants receiving placebo first would be
expected to have experienced only small practice-related reductions in error rate as, at
second assessment, procyclidine could be expected to have negatively influenced
performance through its anticholinergic action. This hypothesised pattern of effects
might explain the observation of a small reduction in error rate from first to second
assessment in this group.
In participants receiving procyclidine at first assessment, the same factors (of
pharmacological effects and practice) may be drawn upon to explain the observed
change in error rate across the two assessments. First, the adverse effects of
procyclidine at first assessment (in the possible presence of expectancy effects) might
have led to a substantially increased error rate in this group (56.49%), the highest
observed in this study. Second, practice effects can be expected to have led to
reductions in error rate at second assessment. These expected improvements were
likely to have been further strengthened by the absence of performance-impairing
pharmacological effects at second assessment. In other words, the reductions in error
rate from first to second assessment expected due to the switch from procyclidine to
placebo were overlaid by practice effects on this measure.
A notable feature of the current study in the context of practice effects is that all
patients were treated with atypical antipsychotic drugs. Previous research has
demonstrated that practice effects on cognitive tasks may be observed in patients
treated with atypical, but to a lesser extent typical, antipsychotics. This finding is most
likely to be due to the effects of atypical antipsychotics on restoring patients' capacity to
learn (Harvey et al 2000).
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A similar interaction between drug and order of administration, probably due to
practice effects, was observed by Klein et al (2002). In their study of individuals with
ADHD, methylphenidate improved anti saccade errors only when administered second,
with the improvement overlaid by practice effects. When administered first, the
operation of practice effects at second assessment probably masked improvements
effected by this compound at first assessment. In order to investigate effects of practice
more comprehensively, Klein et al (2002) as well as the present study should have
included a third group of participants, given placebo on both occasions. In such a
design the magnitude of practice effects could have been assessed without the influence
of pharmacological agents.
The finding of increased anti saccade error rate due to procyclidine administration
accords well with the putative role of a variety of cognitive processes in task
performance and the role of the cholinergic system in these processes. Previous studies
have shown that successful antisaccade performance requires intact response
inhibition and working memory capacities (Mitchell et al 2002; Roberts et al 1994;
Stuyven et al 2000). Conversely, animal studies have shown disrupted performance on
memory-sensitive tasks after inactivation of cholinergic projections (Everitt & Robbins
1997; McGaughy et al 2000). Antisaccade performance and working memory both
involve a cortical network including, but not restricted to, the dorsolateral prefrontal
cortex (DLPFC)(Mitchell et al 2002; Muri et al 1998), suggesting that this area might be
a possible locus for the action of procyclidine and its effects on task performance.
However, neuroanatomic localisation of procyclidine effects on antisaccade errors in
this study is made difficult by the widespread nature of central cholinergic projections
and the widely distributed occurrence of muscarinic acetylcholine receptors in the
human brain.
Procyclidine also led to non-significantly increased, or hypermetric, antisaccade gain
irrespective of order of administration. Reduced, or hypo metric, saccadic gain has been
observed in schizophrenia patients treated with typical antipsychotic drugs as well as in
patients with Parkinson's disease, suggesting a common influence of the parkinsonian
effects of dopamine antagonism (Crawford et al 1989, 1995b, 1995a; Hutton et al
1998a). It is a possibility that procyclidine administration led to the opposite pattern of
increased saccadic amplitudes in this sample through its antagonist action on
Parkinsonian side effects.
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Effects of procyclidine on saccadic latency were moderated by order of drug
administration. Both prosaccade and antisaccade latencies were shorter only when
procyclidine was administered second. Conversely, procyclidine led to prolonged latency
when administered first. Aizawa et al (1999) observed shortened latency and increased
frequency of 'express saccades' (saccades with latencies ofless than 120ms) in monkeys
after injection of the cholinergic agonist nicotine into the superior colliculus, a midbrain
region involved in the control of saccades. The finding of prolonged latency after
administration of the cholinergic antagonist procyclidine under some conditions are
compatible with this finding and with observations of the sedative effects of this drug
(Sharma et al 2002). However, it remains unclear why prosaccade and antisaccade
latencies were shortened by procyclidine under some conditions. Also, comparisons
between the present findings and those of Aizawa et al (1999) are tenuous as
procyclidine and nicotine act on different acetylcholine receptor subtypes and due to
the localised action of nicotine in the Aizawa et al study.
An alternative explanation for these paradoxical effects of procyclidine and placebo on
saccadic latency is the operation of practice effects. As Table 8.1 reveals, both
antisaccade and prosaccade latencies were consistently shorter at second compared
with first assessment. These improvements in performance are similar to those reported
by Klein et al (2002) over a comparable time interval (see also Chapter 4).
8.5.3 Implications
The present findings have research as well as clinical implications; both are discussed
below.
With regard to schizophrenia research, impaired performance of patients taking
procyclidine might lead to inflated between-group differences when compared to groups
of unmedicated individuals. Procyclidine treatment might also represent a confound in
studies assessing the effects of different types of antipsychotics on oculomotor function.
As procyclidine is more likely to be prescribed to patients on typical anti psychotics due
to the extrapyramidal side effects of these drugs (Kapur & Remington 2001; Leonard
1997), comparisons with patients on atypical antipsychotics might be selectively
affected. Finally, the measures of SPEM gain, AS frequency and antisaccade error rate
are particularly promising oculomotor schizophrenia endophenotypes. The present
findings suggest that procyclidine treatment might have to be considered as a possible
confound in genetic schizophrenia studies using these endophenotypes. In genetic
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linkage studies, procyclidine treatment of some but not all patients might lead to the
spurious identification of gene carriers (false positives). As Ott (1991) pointed out, false
positives may have serious effects in linkage studies, far more than false negatives.
Spohn and Strauss (1989) similarly pointed out the methodological implications for
experimental psychology and psychophysiology research of anticholinergic treatment in
schizophrenia.
Clinically, cognitive dysfunction is a pervasive feature of schizophrenia (Sharma &
Harvey 2000), possibly the most debilitating (Friedman et al 1999; Green 2001).
Research has highlighted the importance of cognition in psychosocial function of
schizophrenia patients (Beiser et al 1994; Katsanis et al 1996; Kurtz et al 2001;
Spaulding et al 1999). Adjunctive treatment with anticholinergic agents will have to be
evaluated in the light of these cognitive impairments, as it may have further deleterious
effects on patients with this disorder.
The second main finding of this study, the interactive effects of drug and order of
administration, highlights the need to consider these factors in pharmacological
research. Administration of pharmacologically inert placebos may have pronounced
effects on cognition and emotion (Beecher 1959). Additionally, practice effects have been
demonstrated for some of the eye movement parameters measured here and may have
overlaid drug effects. A methodological implication of the present finding is that future
pharmacological studies should consider the effects of practice as well as order of drug
administration.
The present study has a number of limitations. First, the sample size, although
comparable to previous studies, was relatively small. Replication using a larger,
independent sample is, therefore, required. However, the fact that even in this small
sample effects of procyclidine on oculomotor function were observed indicates they are
likely to be clinically meaningfu1. Second, there was no control group of healthy
individuals. While the main focus of this investigation was to examine the effects of a
clinical dose of procyclidine on eye movements in schizophrenia patients, who are often
prescribed this drug, it might have been valuable to compare performance levels of the
patient group to healthy individuals. Third, a group of patients administered placebo on
both occasions might have been valuable to study the effects of practice on performance
measures. Finally, the extent to which these findings generalise to longitudinal
treatment of schizophrenia patients with procyclidine remains open. It has to be
investigated how clinically relevant procyclidine treatment over durations of several
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weeks or months affects smooth pursuit and antisaccade eye movements in
schizophrenia patients.
8.6 Conclusions
» Acute administration of procyc1idine non-significantly impaired smooth pursuit
and antisaccade performance in schizophrenia patients. This finding points to
the importance of considering this drug in studies of oculomotor
endophenotypes in samples of schizophrenia patients.
» The effects of procyclidine on a number of variables were mediated by the order
in which drug and placebo were administered and were partly overlaid by
practice effects. These effects have methodological implications, suggesting the
need to consider order and practice in drug administration studies of
oculomotor performance.
8.7 Limitations
» The sample size used in the present study, although comparable to previous
studies, was small.
» There was no control group of healthy individuals.
» A third group of patient participants given placebo on both occasions would
have been desirable in order to investigate practice effects more thoroughly.
» The extent to which these findings generalise to longitudinal treatment of
schizophrenia patients with procyc1idine remains to be investigated.
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Chapter Nine
General Discussion
9.1 Chapter Overview
This chapter will attempt to integrate the findings obtained in the empirical
investigations of this thesis and place them into the context of previous research. The
research problem, the aims of the thesis and the theoretical underpinnings of the
current investigations will first be reviewed. Methodological criticisms and implications
will be made. Finally, suggestions for future research in the field of oculomotor
schizophrenia spectrum endophenotypes will be made.
9.2 The Endophenotype Approach Revisited
The present thesis investigated the validity and reliability of smooth pursuit and
antisaccade deficits as endophenotypes in schizophrenia spectrum research. The
endophenotype approach to the study of schizophrenia genetics was argued to
circumvent a number of difficulties associated with genetic schizophrenia research,
such as the biological and clinical heterogeneity of schizophrenia, the complexity of
genetic influence on this condition and methodological problems associated with
focussing on the patient group.
An endophenotype was defined as a specific biological or behavioural deficit thought to
be a more direct expression of a disease-related gene than the disease phenotype
(Section 1.8.1). Endophenotypes were argued to be objective, reliable and phenotypically
homogenous deficits. Due to their assumed genetic control, endophenotypes were
expected to be observed not only in the schizophrenia patient group but also in
clinically unaffected individuals with a genetic predisposition to the illness
(schizophrenia spectrum populations). An endophenotype was argued to reflect the
action of a disease-related gene, or the action of a gene in linkage disequilibrium with a
disease-related gene. Oculomotor endophenotypes, i.e. smooth pursuit eye movement
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(SPEM) and antisaccade deficits, were argued to be particularly promising
schizophrenia spectrum endophenotypes.
The present thesis aimed to investigate a number of issues concerning the reliability
and validity of the SPEM and antisaccade endophenotypes in the schizophrenia
spectrum. Specifically, the present thesis addressed some of the key criteria required in
the process of establishing the validity of a schizophrenia spectrum endophenotype.
These criteria were temporal (and internal) reliability of measurement; observation of
the deficit in people in their first-episode of psychosis; observation of the deficit in
healthy first-degree relatives of people with schizophrenia; association with schizotypy;
and susceptibility to secondary state effects, such as pharmacological treatment. Other
important criteria, such as heritability or specificity to schizophrenia, could not be
addressed in this thesis due to practical limitations.
The hypotheses that were investigated in this thesis were the following.
~ On the basis of the assumed temporal stability of neurocognitive
endophenotypes, both SPEM and antisaccade performance levels were
hypothesised to be reliable within and across assessments.
~ It was hypothesised that people in their first episode of psychosis would
demonstrate SPEM and antisaccade impairments.
~ SPEM and antisaccade impairments were hypothesised to be observed not only
in schizophrenia patients but also in their healthy siblings.
~ Individuals with high levels of schizotypy were hypothesised to have impaired
SPEM and antisaccade performance. Given the assumed specificity of these
endophenotypes to the schizophrenia spectrum, these impairments were further
hypothesised to be independent of trait emotionality.
~ Assuming robustness and reliability of assessment of a useful endophenotype,
possible pharmacological state effects, such as procyc1idine administration, were
hypothesised not to interfere with SPEM and antisaccade performance.
~ Additionally, it was explored (across studies) whether SPEM performance was
correlated with antisaccade error rate.
~ Finally, following previous studies, the visual fixation and prosaccade tasks
were included as oculomotor control conditions in order to demonstrate
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specificity across oculomotor functions of the SPEM and antisaccade
impairments (discriminant validity). Across all studies, therefore, fixation and
prosaccade performance levels were hypothesised to be relatively unimpaired in
schizophrenia spectrum individuals.
9.3 Discussion and Evaluation of Findings
9.3.1 Key Findings in Relation to Hypotheses
The key findings from the current thesis in relation to the above hypotheses are as
follows. First, SPEM and antisaccade performance was largely stable amongst healthy
individuals both within and between assessments over a period of several weeks.
Second, SPEM and antisaccade impairments were observed in individuals in their first
episode of psychosis. Third, subtle SPEM and antisaccade impairments were observed
in the healthy siblings of schizophrenia patients. Fourth, antisaccade (but not SPEM)
deficits were observed in individuals with high levels of schizotypy; these deficits were
independent of trait emotionality. Fifth, procyc1idine disrupted SPEM and antisaccade
performance. Sixth, there was inconsistent evidence of an association between SPEM
performance and antisaccade error rate; the most consistent relationship concerned the
frequency of anticipatory saccades during pursuit and antisaccade errors. Finally, there
was inconsistent evidence relating to the visual fixation and pro saccade tasks.
9.3.1.1 Validity of SPEMand Antisaccade Deficits as Schizophrenia
Spectrum Endophenotypes
The main findings of studies I-N largely support the hypothesised validity of the SPEM
and antisaccade tasks as schizophrenia spectrum endophenotypes. In agreement with
the hypotheses, deficits were observed in a number of crucial samples from the
schizophrenia spectrum (with the exception of a failure to observe SPEM deficits in
schizotypal individuals). These findings thus provide important evidence of the validity
of the SPEM and antisaccade endophenotypes.
Although some of these findings represent replications of previous observations at a
general level (e.g. the observation of 'oculomotor performance impairments in first-
degree relatives of schizophrenia patients" a number of novel observations were made.
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First, despite previous observations of temporal stability of SPEM performance, Study I
is the first investigation to provide detailed evidence of the good temporal stability of the
antisaccade error rate. Additionally, Study I represents the first thorough investigation
of the internal consistency of oculomotor performance across a number of tasks. The
importance of this type of reliability in psychophysiology research has been discussed
(Section 4.4.4). Likewise, despite the previous observation of practice effects on
antisaccade errors, no study to date has shown that these improvements are due to
between-session effects (of motor consolidation, slow learning gains or reduced anxiety)
and not due to within-session learning. These practice effects, which were also
demonstrated in Study V, have to be taken into consideration in longitudinal studies.
Additionally, this pattern of performance changes, and the relative absence of practice
effects on the SPEM task, may shed light on the cognitive nature of the antisaccade
task. As discussed, practice effects do not occur on all cognitive or motor tasks, but
tend to be specific to unpractised and infrequently used tasks.
Second, the investigation of first-episode psychosis patients yielded the first observation
of increased anticipatory saccade frequency in this crucial schizophrenia spectrum
population, thus confirming the validity of this proposed endophenotype. Additionally,
this study was the first to demonstrate visual fixation and antisaccade gain
abnormalities in the first episode of psychosis.
Third, Study III made a contribution to the literature of oculomotor family studies
beyond replicating the observation of SPEM and antisaccade deficits in first-degree
relatives. The design and statistical analysis of this study was unique amongst this
literature as it utilised tightly matched triplets of patients, siblings and healthy controls
and chose a statistical analysis that acknowledged and accommodated the genetic
relatedness between patients and siblings. Additionally, the crucial comparison between
the sibling and control groups allowed the isolation of the key variable of interest, the
genetic relatedness to someone with schizophrenia. Finally, SPEM (and, non-
significantly, antisaccade) performance showed familial patterns. These findings thus
represent strong evidence of the validity of the SPEM and antisaccade endophenotypes.
Fourth, Study IV was the first to address the schizotypy correlates of SPEM and
anti saccade performance using empirically derived schizotypy dimensions based on
psychometric questionnaire subscales. This analysis demonstrated that positive, but
not negative, schizotypy was related to anti saccade errors. SPEM performance was not
associated with schizotypy; the reasons for this are unclear. An important, and novel,
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finding of this study was that the relationship between anti saccade errors and
schizotypy was not accounted for by a general measure of trait emotionality and
psychopathology. The relationship between antisaccade error rate and schizotypy thus
showed specificity to schizophrenia-related traits.
Finally, the observation of adverse effects of procyc1idine on SPEM and antisaccade
performance represents a methodological challenge to future studies of these
oculomotor endophenotypes in people with schizophrenia. State effects of
pharmacological treatments, such as procyclidine, will have to be considered in genetic
linkage studies involving the SPEM and antisaccade phenotypes in schizophrenia
patients. The administration of compounds that interfere with eye movement
performance, such as procyc1idine, might lead to the false positive detection of 'gene
carriers' (if identified on the basis of oculomotor data), which has serious consequences
for the investigation of genetic linkage (Ott 1991). Strategies to surround this potential
problem in future studies might be 1) the exclusion of patients on anticholinergic drugs
or 2) the withdrawal of anticholinergic treatment for a sufficient period of time before
oculomotor assessment.
9.3.1.2
Error Rate
Relationship between SPEM Measures and Antisaccade
The relationship between SPEM and antisaccade was found to be inconsistent. This
inconsistency, ironically, is consistent with previous research, which has provided
mixed evidence of a relationship between various measures of smooth pursuit and
antisaccade error rate. An a priori focus of interest in this thesis concerned the
relationship between frequency of anticipatory saccades during pursuit and anti saccade
error rate. Ameaningful relationship between these two putative measures of inhibitory
oculomotor function was indeed observed in two studies; however a later study failed to
replicate this observation. Sample characteristics (such as the failure to thoroughly
screen for psychiatric illness or drug consumption) might account for the failure to
replicate in this study. Antisaccade error rate was, however, correlated with SPEM gain
in this sample.
On the basis of the arguments outlined in Section 2.8, a moderate relationship between
these two conceptually related measures might have suggested that they can be used
with profit as a composite oculomotor endophenotype in linkage studies. Whether or not
this does indeed represent a useful approach will have to be tested further, possibly
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using linkage studies. These studies might explore the power of a combined oculomotor
endophenotype. Participants with 'impaired' performance (e.g. ~2S0 of the mean) on
both anticipatory saccade frequency and anti saccade error rate might be labelled
'affected'; participants with impairments on either of the measures might be labelled
'unknown'; and participants with impairments on neither measure might be labelled
'unaffected'. Itwill then be crucial to determine whether linkage occurs between genetic
loci and this composite endophenotype, a single oculomotor endophenotype or the
schizophrenia phenotype.
Figure 9.1 illustrates the identification of 'affected' individuals using the antisaccade
and anticipatory saccade measures. This illustration is based on the combined patient
and control groups from Study II; due to the small sample size a cut-off criterion of ISO
is used here.
Figure 9.1: Illustration of the Identification of 'Affected' Individuals Using a
Combination of Antisaccade Error Rate and Anticipatory Saccade Frequency
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9.3.1.3 Visual Fixation and Prosaccade Performance
The previously held assumption that the visual fixation and prosaccade tasks are
unimpaired in schizophrenia spectrum individuals and may thus represent convenient
control tasks for oculomotor performance may be challenged on the basis of the present
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findings. Prosaccade impairments were observed in patients from studies II (reduced
accuracy) and III (reduced accuracy and increased latency). The impairments observed
in Study II are unlikely to be due to secondary confounds due to the recent onset of
psychosis in this patient group. Additionally, fixation impairments were observed in the
first-episode patients of Study II. Finally, pro saccade accuracy was reduced in
individuals with high psychoticism scores (Study IV).
These findings, in conjunction with previous research, indicate that the notion of
unimpaired visual fixation and pro saccade performance in schizophrenia spectrum
individuals is untenable. Instead, the present and previous findings suggest that the
evidence regarding these tasks is mixed. Given the inconsistencies of findings regarding
fixation and prosaccades, however, it would be equally untenable to propose these two
measures as particularly promising schizophrenia spectrum endophenotypes (however,
see Rybakowski et al 2001). The reason for the inconsistencies in evidence regarding
fixation and prosaccade performance is unclear, but sample and task characteristics
may playa role (Section 2.6.4.1). It should be pointed out, however, that the pro saccade
task of studies II and III suffered some methodological weaknesses, as outlined before
(Section 3.2.1.2.4). The findings concerning saccadic accuracy from these studies, but
not saccadic accuracy from Study IV or saccadic latency, thus have to be treated with
caution.
9.3.2 Additional Findings
In addition to the positive evidence of the reliability and validity of the SPEM and
antisaccade endophenotypes, however, a number of other, less expected findings
emerged from this research.
9.3.2.1 Between-group Comparisons
A striking feature of the between-group comparisons on SPEM and antisaccade
variables between first-episode patients and healthy controls (Study II), between
schizophrenia patients as well as their siblings and healthy controls (Study III) and
between high and low schizotypy individuals (Study IV) was the overlap in variance
within these pairs of groups. This overlap in variance (see, for example, Figures 6.1, 6.2
and 7.3) has a number of implications.
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First, there are (in the present as well as in previous studies; see, for example, Figure 2
of Curtis et al 2001a) healthy, unaffected, low-schizotypy individuals with worse
oculomotor performance than members of putative schizophrenia spectrum
populations. A clear implication of this observation is that it will not be possible to use
any single SPEM or anti saccade measure as a diagnostic tool (although a combination
of psychophysiological and clinical measures might be more successful; Arolt et al
1998; Robins & Guze 1970). Eye movement deficits are thus not pathognomic of
schizophrenia.
Second, the observation of differences in group means with overlapping variance
suggests that the 'deficits' seen in the schizophrenia spectrum groups are subtle. A
similar argument has been made for the observation of structural brain changes in
schizophrenia (Wright et al 2000). Indeed, the differences in oculomotor performance
between the patient groups and healthy individuals observed in this thesis are
comparable to deficits observed on many other neurocognitive measures used in
schizophrenia spectrum research.
A variety of explanations might be drawn upon to account for the magnitude of the
observed between-group differences. People with schizophrenia or other schizophrenia
spectrum characteristics are clearly not qualitatively different from healthy, non-
schizophrenia spectrum individuals in their performance patterns and average
performance levels. Indeed, the 'deficits' seen in the patient group and other spectrum
individuals are also observed, to a lesser extent, in healthy non-spectrum controls (e.g.
CUS and AS during pursuit, segments of less than perfect pursuit gain and reflexive
errors in the antisaccade paradigm).25
These performance patterns, in conjunction with the normality of data distributions,
which were observed for the vast majority of oculomotor variables in the present
research (see Sections 5.4, 6.4, 7.4), have an important implication. It may be argued
that several, genetic and non-genetic, factors influence individual and between-group
differences in task performance (see also Section 9.5). Normality of distribution is, in
statistical terms, typically thought to come about through the combined effects of a
number of variables of small-to-moderate effect each as well as random error of
25Very few healthy individuals, for instance, make no antisaccade errors during an assessment
involving more than 20 trials.
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measurement (Mood & Graybill 1963); in biological variables these factors are likely to
be genetic and non-genetic.
This inferred action of several factors on task performance is consistent with the
involvement of several cognitive and neural components in SPEM and antisaccade
performance. Although assumed to be phenotypically and biologically more
homogenous than the schizophrenia phenotype, it becomes clear from the delineation of
their cognitive and neural components (Sections 2.3.5.2 and 2.5.4.2) that the SPEM
and antisaccade tasks are, in fact, complex and multivariate tasks (Levy et al 2000;
Section 2.3.4). It has been argued that both tasks involve a number of cognitive
processes and a widespread network of cortical and subcortical brain structures. This
assumed cognitive and neural complexity can be argued to be reflected at the statistical
level, such as in approximately normal distributions and overlap in variance between
groups.26
On the basis of this task heterogeneity and the observed patterns of data distributions
and between-group differences it may be speculated that it is unlikely that a single gene
can explain all (or a vast majority) of the variance of any oculomotor endophenotype.
Consequently, a single gene is unlikely to produce the average 'impairments' in
performance that are observed in the schizophrenia spectrum groups. A more likely
scenario is that a number of genes influence task performance and underlying neural
activity, with each gene having a small but significant contribution. The average
performance deficits in schizophrenia spectrum groups may thus be explained by a
number of factors, which might differ in severity and frequency between individuals.
This complex pattern of effects might be able to explain why some schizophrenia
spectrum members show better oculomotor performance than non-spectrum controls.
A first indication for the action of more than one gene in oculomotor performance
deficits comes from molecular genetic studies of the SPEM endophenotype. While one
study (Arolt et al 1999) showed linkage of SPEM dysfunction to a locus on chromosome
6p21, another study (Rybakowski et a1 2001) showed an effect of a gene located on a
different chromosome, i.e. chromosome 3q. Unless one or both of the studies represent
26However,error of measurement alone, in the absence of further variables of small-to-moderate
effect, can cause statistical normality. Thus, the observation of normal distributions of
variables in the current research is merely consistent with the operation of multiple causal
factors and not necessary evidence of it. More convincing evidence for this assumption comes
fromthe known cognitive,genetic and neural correlates of task performance.
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a false positive finding, there are already two promising genetic loci implied in the
behavioural SPEM deficit in schizophrenia.
Additional evidence of the action of several genes in SPEM and antisaccade performance
comes from biometric model-fitting analyses of data from healthy monozygotic and
dizygotic twins (Katsanis et al 2000; Malone & Iacono 2002). These studies (from the
same laboratory) have shown that additive genetic influences and non-shared
environmental factors account for the majority of variance in performance. It is thus
likely that the SPEM and antisaccade tasks face similar issues of genetic complexity
and phenotypic heterogeneity to the schizophrenia phenotype, albeit to a much lesser
extent.
To put these speculations concerning the genetic influence on oculomotor performance
into context, a recent study has investigated the effects of a schizophrenia candidate
gene, the catechol-O-methyltransferase (COMT) gene, on neuropsychological
performance (Egan et al 2001 b). These researchers found that COMT genotype
accounted for 4.1% of variance in WCST performance. The effect of COMTwas thus very
small but statistically (and theoretically) significant.
The present findings of subtle oculomotor impairments and overlapping variance
between schizophrenia spectrum and control groups should be viewed in this context.
The effects of schizophrenia spectrum group status on SPEM and antisaccade
performance are clearly observable and often reach conventional thresholds of
statistical significance, yet are small in overall terms. There is thus likely to be a
number of factors accounting for variance in performance.
The latent trait model outlined in Section 2.3.5.5.7 argues that a major gene with
pleiotropic effects produces schizophrenia and/or SPEM impairments (Matthysse &
Holzman 1987). This model is consistent with the present findings of overlapping
variance in SPEM measures between schizophrenia spectrum and control groups, as it
postulates that a proportion of schizophrenia spectrum individuals with the
SPEM/schizophrenia genotype will not possess the phenotype of SPEM impairments.
The normal performance scores of these individuals would thus overlap with those of
non-spectrum controls.
While the above speculations are consistent with the action of more than one gene with
small-to-moderate effect, a direct test of the latent trait hypothesis was not carried out.
Testing for bimodality was not undertaken as the sample sizes used here were deemed
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too small to produce reliable results. It thus remains a possibility that a pleiotropic
model could account for the overlap in SPEM variance observed between schizophrenia
spectrum and control groups. (Bimodality and pleiotropy has not been postulated
regarding the antisaccade error rate; this issue requires clarification.)
9.3.2.2 Antisaccade Gain
Primary antisaccade accuracy (gain) was found to be impaired in first-episode psychosis
and schizophrenia patients as well as in healthy siblings of schizophrenia patients.
Although reduced antisaccade gain has been observed in previous studies, the
consistency with which these deficits were observed in the present investigations is
suggestive. The status of this measure as a putative schizophrenia spectrum
endophenotype remains to be further characterised. It is particularly intriguing,
however, that one study (Ross et al 1998d) observed reduced antisaccade accuracy in
individuals without, but not with, a family history of schizophrenia. This finding might
be compatible with the observation of strongly reduced antisaccade gain in the siblings
of schizophrenia patients (Study III), most of whom were from simplex schizophrenia
families. The antisaccade gain reduction of the first-episode psychosis group suggests
that it was not due to the long list of secondary confounds discussed above (Section
2.3.5.5.5).
As outlined before, antisaccade accuracy is likely to be a good measure of sensorimotor
coordinate transformation processes and working memory. Sensorimotor coordinate
transformations require the encoding of the spatial location of a target and the
transformation of this stored information into a motor output in the absence of a
physical target. These processes are also likely to be involved in other saccadic
paradigms known to be impaired in schizophrenia spectrum individuals, such as the
memory-guided and predictive saccade tasks (Section 2.7). The present findings, and
the hypothesised prefrontal and parietal neural correlates of antisaccade accuracy,
suggest that this measure might be added to the list of potential schizophrenia
spectrum endophenotypes of neurocognitive function. Importantly, antisaccade gain
meets a number of reliability criteria: antisaccade gain scores in this research had high
intra- and inter-rater reliability; were correlated across two stimulus display methods;
had high within-session consistency; and had good test-retest reliability (but reaching
only trend level using one stimulus display method). Before considering this measure as
a schizophrenia spectrum endophenotype, however, a number of caveats must be
addressed.
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First, the assessment of antisaccade gain in studies II and II is open to methodological
criticism. As argued before, only one antisaccade target amplitude was used in each
visual hemifield. More reliable assessment of spatial accuracy would have been
obtained using more than one amplitude in each hemifield. Future studies should use
improved methods, such as those of eye movement Battery II.
Second, there was no relationship between antisaccade gain and schizotypy in Study IV.
It remains a possibility that sample characteristics particular to this study were
responsible for the failure to observe this relationship; future studies are needed to
clarify this issue. However, given the positive evidence of a relationship between
schizotypy and antisaccade error rate, this finding represents preliminary negative
evidence in the attempt to establish antisaccade gain as a useful schizophrenia
spectrum endophenotype.
Third, on a methodological note, the effects of procyclidine on anti saccade gain warrant
consideration of anticholinergic treatment in future studies of anti saccade accuracy.
Given the effects of antipsychotic drug treatment on accuracy of other saccadic
measures (Crawford et al1995a, 1995b), studies of un medicated schizophrenia patients
are needed.
9.3.3 Conclusions
To conclude, the importance of the main findings of the present research lies in
providing supportive evidence of the SPEM gain, anticipatory and catch-up saccade and
antisaccade error rate measures as schizophrenia spectrum endophenotypes;
suggesting the possibility of combining key measures in genetic studies; questioning the
notion of unimpaired performance on fixation and pro saccade tasks in the
schizophrenia spectrum (and thus the discriminant validity of the SPEM and
antisaccade deficits); demonstrating the subtlety of group differences and making
implications concerning their neural and behavioural sources; proposing the measure of
antisaccade gain as a preliminary schizophrenia spectrum endophenotype; and pointing
to an important pharmacological state effect that needs to be taken into consideration
in future studies.
Although a formal comparison of the relative effect sizes of SPEM and anti saccade
impairments in schizophrenia spectrum individuals was not made, impairments of
similar magnitude were observed across the schizophrenia spectrum on both tasks. The
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only notable exception to this pattern was the failure to observe a relationship between
SPEM and schizotypy. The present findings thus suggest that the SPEM and
antisaccade tasks have passed a number of reliability and validity criteria of
schizophrenia spectrum endophenotypes at the behavioural level and may thus be
studied with profit in molecular genetic schizophrenia spectrum investigations.
9.4 Methodological Criticisms and Implications
The eye movement tasks used in this thesis served to elicit specific oculomotor
behaviours in the laboratory. While most types of eye movement under investigation
here (SPEM, fixation, and reflexive saccade) may be observed in the natural human
environment, the experimental tasks that served to study these behaviours in the
laboratory (in this thesis as well as in previous studies) are highly operationalised and
somewhat artificial. Additionally, the antisaccade - although physiologically similar to
the prosaccade - is unlikely to occur frequently in the natural human habitat. The
ecological validity of these measures may, therefore, be questioned (Stern & Dunham
1990).
However, given the specificity of the hypotheses addressed in this thesis, and to
increase compatibility with previous research, operationalisation and laboratory-based
assessment of eye movements was inevitable, and indeed desirable. It should also be
pointed out that the SPEM, fixation and prosaccade tasks are reasonably adequate
measures of naturally occurring behaviours. Additionally, the difficulties in ecological
validity of the oculomotor tasks used in this thesis are comparable to (or smaller than)
some of the even more operationalised, artificial and indirect measures of cognition
often used in neuropsychological assessment (Lezak 1983).
Due to practical reasons, two sets of eye movement tasks were used in the research
reported here. This fact alone represents a methodological weakness of the current
thesis, as differences between tasks made the direct comparison of findings across
studies difficult.
The utilisation of two sets of tasks, however, also offered the unique opportunity to
compare and contrast these different measures. As argued in the methodological review
(Section 3.2.2.3), the tasks that were specifically developed by the author for the
research of this thesis were held to possess a number of advantages over the previously
used tasks, such as better psychometric properties and greater homogeneity and
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compatibility across measures. These advantages were achieved through careful design
and selection of criteria on the basis of previous studies. Although it is difficult to
isolate specific factors contributing to the better psychometric properties (such as
internal and temporal reliability) of the new tasks, reasons are likely to concern the
number of trials (or duration of trials in the SPEM task), quasi-randomisation of trials
(in the saccade tasks) and adequate calibration.
The optimal number of trials in saccade tasks was discussed by Maruff et al (1999).
These authors suggested the use of at least 40 trials in an antisaccade task. The
present findings agree with this suggestion, as an antisaccade task with a larger
number of trials (N=60) yielded better reliability, probably due to greater between-
subject variance, than a task with fewer trials (N=24). As argued in Chapter 4, using a
random sequence of target movements in saccade tasks makes the target spatially
unpredictable, thus avoiding the confounding effects of procedural motor learning. This
feature may also be advantageous, as it isolates the cognitive component of interest in
the absence of secondary learning effects. Finally, adequate calibration (over the entire
range of target excursions) is, of course, a necessary step in the development of any eye
movement task. Future studies would benefit by taking these issues into consideration.
Another methodological criticism that should be made of the current research concerns
the measures of schizotypy employed in Study IV. As others have argued (Johns & van
Os 2001), psychometric self-report questionnaires are probably the most appropriate
measure of schizotypy in non-clinical samples, such as members of the general
population or university students. This argument is based on the assumption (and
empirical observation) that levels of schizotypal and schizophrenic symptoms are
relatively low in these populations compared to people with schizophrenia. Therefore,
clinical interview schedules designed to ascertain symptom severity and diagnosis of
related disorders in clinical samples (i.e. individuals in a hospital setting) might be
insensitive to the small individual differences in schizotypy observed in non-clinical
samples.s? An indication of this effect may be the failure to observe any relationships
between SPEM or antisaccade measures and scores on the Structured Interview for
Schizotypy (SIS; Kendler et al 1989) amongst healthy controls of Study III. Psychometric
27 Another advantage of psychometric self-report questionnaires is, of course, the ease with which
these can be administered and scored amongst large samples, as was the case in Study IV.
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self-report questionnaires are thus designed to provide a 'magnifying glass' for
individual differences in schizotypal traits in non-clinical samples (Rust 1987, 1988).
These measures may, however, be criticised on other grounds. First, it is difficult to
estimate the truthfulness with which participants provided information given the self-
report nature of these scales. It is, in this context, however, important to note that
exclusion of participants who attracted high scores on measures of social desirability
and truthfulness of responding (e.g. 'lie' scales) did not change the key finding of Study
IV, that is the relationship between positive schizotypy and antisaccade error rate.
Second, it has been shown by several researchers that assessment of schizotypy with
psychometric self-report and clinical measures diverges in the relatives of schizophrenia
patients. While first-degree relatives have reliably elevated levels of schizotypal and
schizophrenic symptoms as well as increased rates of SPD when assessed using clinical
(one-to-one) interview schedules, their scores on psychometric self-report measures of
schizotypy are the same or lower than in healthy control groups. This finding has been
explained in terms of defensive response bias in first-degree relatives, but nevertheless
casts doubt on the validity of these measures. Finally, it has been argued that positive
schizotypy in the general population might not be a good reflection of positive
schizophrenic symptoms (Fanous et al 2001). It thus remains unclear whether the
relationship between positive schizotypy and antisaccade errors observed in Study IV
has relevance for research into the clinical symptom correlates of antisaccade
performance amongst people with schizophrenia.
9.S Outlook
The present thesis has identified a number of avenues for future research. First, the
observation of good internal consistency of oculomotor performance in healthy
individuals needs to be extended to schizophrenia patients and other schizophrenia
spectrum groups. Given the generally more variable performance in the patient group,
somewhat lower internal consistency may be expected.
Second, despite the relatively established observation of oculomotor deficits in people in
their first psychotic episode, longitudinal studies are needed to further chart the course
of these deficits. As discussed in Chapter 5, despite the clinical exacerbation often
observed in the first few years of the illness, neurocognitive performance appears to
remain stable. This putative stability in the early phase contrasts with the evidence of
significantly greater impairments in patients with chronic schizophrenia, as established
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through cross-sectional studies. Future studies are required facing the logistically
difficult task of tracking the change in oculomotor performance over several years of
illness, from first episode to chronic schizophrenia.
Third, clarification of the symptom correlates of antisaccade performance is required. As
discussed (Chapter 2), the schizophrenic symptom correlates of antisaccade error rate
in the patient group are not clear. Similarly, both positive and negative schizotypal
symptoms have been shown to be associated with elevated antisaccade error rate
(Gooding 1999; O'Driscoll et al 1998). The findings from Study IVpoint to a relationship
between anti saccade errors and positive, but not negative symptoms. This relationship
might be partly due to the more pathological nature of positive than negative symptoms,
but requires clarification.
Relatedly, the theoretically intriguing but methodologically problematic finding of
normal or reduced levels of schizotypy in first-degree relatives of schizophrenia patients
when assessed with self-administered schizotypy questionnaires has implications for
oculomotor schizotypy research. Future studies might use clinical assessments in
samples of individuals selected for high and low psychometric self-report scores of
schizotypy to confirm the validity of these measures, such as the participants used in
the analysis of Section 7.4.4. (The use of clinical interviews in samples as large as that
of Study IV is probably impractical.)
Fourth, the deleterious effects of procyclidine on oculomotor function observed in Study
V need to be replicated and extended to longitudinal treatment of people with
schizophrenia. Additionally, related pharmacological side-treatments used in
schizophrenia should be investigated. Only then will it be possible to reliably estimate
the potential confound that state effects of such treatments represent in linkage studies
involving schizophrenia patients.
Fifth, in addition to the criteria of a valid endophenotype listed in Section 1.8.1, it has
been argued that such a deficit should not only precede, but predict, the diagnosis of
the disease (Gottesman & Erlenmeyer-Kimling 2001; Iacono 1998). No study to date has
addressed this question using oculomotor endophenotypes in schizophrenia research.
Studies are needed to track high-risk groups, e.g. individuals with elevated scores of
schizotypy (cf. Chapman et al 1994b), or off-spring of schizophrenia parents, from
adolescence into adulthood, through the period most critical for the development of
schizophrenia.
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Sixth, as argued in Chapter 1, the ultimate aim of the endophenotype approach is to
provide a better, or quantifiable, objective and phenotypically and biologically
homogenous phenotype for linkage studies. Clearly, therefore, this is an area where
future research is much needed. Preliminary linkage evidence exists, linking SPEM and
antisaccade deficits to genetic loci on chromosomes 6p21 and 22q11-q12, respectively
(Arolt et al 1999; Myles-Worsley et al 1999). Given the large amount of work at the level
of behavioural genetics, such as oculomotor family studies, it is perhaps surprising that
more linkage studies of oculomotor endophenotypes have not been carried out.
Seventh, the cognitive and neural complexity of the SPEM and antisaccade tasks has
already been discussed. This complexity indicates that the SPEM and anti saccade
measures might suffer some of the problems that the endophenotype approach aims to
circumvent, such as phenotypic heterogeneity. One strategy around this problem might
be to study more closely the cognitive and neural component processes of these
measures. This research, exemplified by studies of the motion processing component of
SPEM (Chen et al 1999a, 1999b, 1999c), might focus on a cognitive candidate process
thought to underlie the performance deficits in the schizophrenia spectrum groups.
Once such a process has been identified, e.g. response inhibition (for antisaccade) or
motion processing (for smooth pursuit), it could be assessed using a number of different
neurocognitive tasks and might thus be phenotypically more homogenous than each
task itself. Utilising several measures of the same function but from different modalities
(e.g. eye movements, neuropsychology, electrophysiology, etc.) would have the
advantage of partia1ling out random or nuisance variance due to other cognitive or
motivational processes (or error of measurement) unique to each task. An example of
this approach is the combination of the antisaccade and PSOsensorimotor gating tasks
in an investigation of the component of inhibitory function (Cadenhead et a1 2002;
Myles-Worsley et a1 1999). The exploration in this thesis of the relationship between
anticipatory saccades during smooth pursuit and antisaccade errors represents a
related approach. It remains to be investigated further whether the combination of
these two measures provides a useful assessment of the assumed common component
of inhibitory function.
Finally, molecular genetic studies are needed. For example, candidate gene studies
investigate genes whose protein products are thought to play a role in the
pathophysiology of the disorder under study. A number of schizophrenia candidate
genes have been put forward. To date, only one study has investigated the relationship
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between such a gene (the 03 dopamine receptor gene) and oculomotor performance
(Rybakowski et al 2001). Future candidate gene studies of oculomotor endophenotypes
should examine the relationship between genes likely involved not only in
schizophrenia, but also eye movement control. One such gene is the eOMT gene (Egan
et al 2001b). This gene has a common polymorphism resulting in variations of the
eOMT protein's efficiency of frontal dopamine metabolism. Given the role of frontal lobe
dopamine in the pathophysiology and treatment of schizophrenia and the evidence of
impairments on frontal lobe tests, such as the WeST, in people with schizophrenia, a
recent study examined the effect of eOMT genotype on WeST performance (Egan et al
2001 b). Additionally, these researchers studied the effects of eOMT genotype on
prefrontal activation during performance of a working memory task. It was
demonstrated that the disease-related COMT genotype (Val-Val homozygosity) was
associated with poorer weST performance and prefrontal neural inefficiency.
A replication and extension of this design to the field of oculomotor endophenotypes
might be useful. Specifically, antisaccade error rate has been associated with 1)WeST
performance, 2) prefrontal neural activity, 3) dopaminergic manipulation and 4) a
chromosomal region including the locus of the eOMT gene (22q11-12). It is likely that
future studies combining molecular approaches (such as the study of candidate genes)
and functional neuroimaging techniques will provide the strictest tests so far of the
validity of the proposed oculomotor endophenotypes.
321
References
References
Abel LA (1986): Measuring smooth pursuit eye movement in psychiatric populations.
Am J Psychiatry 143: 111-112.
Abel LA (1999): What gives rise to impaired smooth pursuit in the relatives of patients
with schizophrenia? Arch Ophthalmol117:522-523.
Abel LA, Friedman L, Jesberger J, Malki A, Meltzer HY (1991): Quantitative assessment
of smooth pursuit gain and catch-up saccades in schizophrenia and affective
disorders. Biol Psychiatry 29: 1063-1072.
Abel LA, Levin S, Holzman PS (1992): Abnormalities of smooth pursuit and saccadic
control in schizophrenia and affective disorders. Vision Res 32: 1009-1 0 14.
Abel LA, Unverzagt F, Vee RD (2002): Effects of stimulus predictability and
interstimulus gap on saccades in Alzheimer's disease. Dement Geriatr Cogn Disord
13:235-243.
Abel LA, Ziegler AS (1988): Smooth pursuit eye movements in schizophrenics--what
constitutes quantitative assessment? Biol Psychiatry 24:747-761.
Acker W, Toone B (1978): Attention, eye tracking and schizophrenia. Br J Soc Clin
Psychol17: 173-181.
Addington J, Addington D, Maticka-Tyndale E (1991): Cognitive functioning and
positive and negative symptoms in schizophrenia. Schizophr Res 5:123-134.
Ahearn EP, Speer MC, Chen IT, Steffens DC, Cassidy F, Van Meter S, Provenzale JM,
Weisler RH, Rama Krishnan KR (2002): Investigation of Notch3 as a candidate gene
for bipolar disorder using brain hyperintensities as an endophenotype. Am J Med
Genet 114:652-658.
322
References
Ahonniska J, Ahonen T, Aro T, Tolvanen A, Lyytinen H (2001): Practice effects on
visuomotor and problem-solving tests by children. Percept Mot Skills 92:479-494.
Aizawa H, Kobayashi Y, Yamamoto M, Isa T (1999): Injection of nicotine into the
superior colliculus facilitates occurrence of express saccades in monkeys. J
Neurophysiol82: 1642-1646.
Allen JS (1997): Smooth pursuit eye movements in schizophrenia in New Zealand. Aust
N Z JPsychiatry 31:582-591.
Allen JS, Johnson FY (1995): Eye movements and schizophrenia in Papua New Guinea:
qualitative analyses with case histories. P N GMed J38: 106-126.
Allen JS, Lambert AJ, Johnson FY, Schmidt K, Nero KL (1996): Antisaccadic eye
movements and attentional asymmetry in schizophrenia in three Pacific populations.
Acta Psychiatr Scand 94:258-265.
Allen JS, Matsunaga K, Hacisalihzade S, Stark L (1990a): Smooth pursuit eye
movements of normal and schizophrenic subjects tracking an unpredictable target.
Biol Psychiatry 28:705-720.
Allen JS, Matsunaga K, Nakamura T, Kitamura F, Furukawa T, Hacisalihzade SS,
Sarich VM, Stark L (1990b): Schizophrenia, eye movements, and biocultural
heterogeneity. Hum Biol62:337-352.
Allin M, Murray RM (2002): Schizophrenia: A neurodevelopmental or neurodegenerative
disorder? Current Opinion in Psychiatry 15:9-15.
Amador XF, Malaspina D, Sackeim HA, Coleman EA, Kaufmann CA, Hasan A, Gorman
JM (1995): Visual fixation and smooth pursuit eye movement abnormalities in
patients with schizophrenia and their relatives. J Neuropsychiatry Clin Neurosci
7:197-206.
Amador XF, Sackeim HA, Mukherjee S, Halperin R, Neeley P, Maclin E, Schnur D
(1991): Specificity of smooth pursuit eye movement and visual fixation abnormalities
323
References
in schizophrenia. Comparison to mania and normal controls. Schizophr Res 5:135-
144.
Aman CJ, Roberts RJ, Pennington BF (1998): A neuropsychological examination of the
underlying deficit in attention deficit hyperactivity disorder: frontal lobe versus right
parietal lobe theories. Dev PsychoI34:956-969.
American Psychiatric Association (1994): Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition (DSM-W). Washington, DC: American Psychiatric
Association.
Anastasi A, Urbina S (1997): Psychological testing. Upper Saddle River, New Jersey:
Prentice Hall.
Anderson TJ, Jenkins IH, Brooks OJ, Hawken MB, Frackowiak RS, Kennard C (1994):
Cortical control of saccades and fixation in man. A PET study. Brain 117 (Pt 5):1073-
1084.
Andreasen NC (1984): Scale for the assessment of negative symptoms. Iowa City:
University of Iowa Press.
Andreasen NC, Nopoulos P, O'Leary OS, Miller DO, Wassink T, Flaum M (1999):
Defining the phenotype of schizophrenia: cognitive dysmetria and its neural
mechanisms. BioI Psychiatry 46:908-920.
Andreassi JL (1995): Psychophysiology: human behavior and physiological response.
Hillsdale, New Jersey: Lawrence Erlbaum Associates.
Arolt V, Lencer R, Nolte A, Muller-Myhsok B, Purmann S, Schurmann M, Leutelt J,
Pinnow M, Schwinger E (1996): Eye tracking dysfunction is a putative phenotypic
susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in
families with multiple occurrence ofthe disease. Am JMed Genet 67:564-579.
Arolt V, Lencer R, Purmann S, Schurmann M, Muller-Myhsok B, Krecker K, Schwinger
E (1999): Testing for linkage of eye tracking dysfunction and schizophrenia to
324
References
markers on chromosomes 6, 8, 9, 20, and 22 in families multiply affected with
schizophrenia. Am J Med Genet 88:603-606.
Arolt V, Steege D, Nolte A (1993): [Disorders of eye movements in schizophrenia--a
critical review and future perspectives]. Fortschr Neurol Psychiatr 61:90-105.
Arolt V, Teichert HM, Steege D, Lencer R, Heide W (1998): Distinguishing schizophrenic
patients from healthy controls by quantitative measurement of eye movement
parameters. Biol Psychiatry 44:448-458.
Bahill AT, Stark L (1975): Overlapping saccades and glissades are produced by fatigue
in the saccadic eye movement system. Exp Neurol 48:95-106.
Balogh DW, Merritt RD, Steuerwald BL (1991): Concurrent validity for the Rust
Inventory of Schizotypal Cognitions. BrJ Clin Psychol30 (Pt 4):378-380.
Barash S, Melikyan A, Sivakov A, Zhang M, Glickstein M, Thier P (1999): Saccadic
dysmetria and adaptation after lesions of the cerebellar cortex. J Neurosci 19: 10931-
10939.
Bartfai A, Levander SE, Nyback H, Berggren BM, Schalling D (1985): Smooth pursuit
eye tracking, neuropsychological test performance, and computed tomography in
schizophrenia. Psychiatry Res 15:49-62.
Bartfai A, Levander SE, Sedvall G (1983): Smooth pursuit eye movements, clinical
symptoms, CSF metabolites, and skin conductance habituation in schizophrenic
patients. Biol Psychiatry 18:971-987.
Bartko JJ (1991): Measurement and reliability: statistical thinking considerations.
Schizophr Bull 17:483-489.
Bauer LO (1997): Smooth pursuit eye movement dysfunction in abstinent cocaine
abusers: effects of a paternal history of alcoholism. Alcohol Clin Exp Res 21 :910-915.
325
References
Beauchamp MS, Petit L, Ellmore TM, Ingeholm J, Haxby JV (2001): A parametric fMRI
study of overt and covert shifts of visuospatial attention. Neuroimage 14:310-321.
Becser N, Sand T, Zwart JA (1998): Reliability of cephalic thermal thresholds in healthy
subjects. Cephalalgia 18:574-582.
Beecher HK (1959): Measurement of subjective responses: quantitative effects of drugs.
New York: Oxford University Press.
Beiser M, Bean G, Erickson D, Zhang J, Iacono WG, Rector NA (1994): Biological and
psychosocial predictors of job performance following a first episode of psychosis. Am
J Psychiatry 151:857-863.
Bell BB, Abel LA, Li W, Christian JC, Yee RD (1994): Concordance of smooth pursuit
and saccadic measures in normal monozygotic twin pairs. Biol Psychiatry 36:522-
526.
Benitez JT (1970): Eye-tracking and optokinetic tests: diagnostic significance in
peripheral and central vestibular disorders. Laryngoscope 80:834-848.
Bentall RP, Claridge GS, Slade PD (1989): The multidimensional nature of schizotypal
traits: a factor analytic study with normal subjects. Br J Clin Psychol 28 (Pt 4):363-
375.
Berman RA, Colby CL, Genovese CR, Voyvodic JT, Luna B, Thulborn KR, Sweeney JA
(1999): Cortical networks subserving pursuit and saccadic eye movements in
humans: an FMRI study. Hum Brain Mapp 8:209-225.
Berrettini WH (2000a): Are schizophrenic and bipolar disorders related? A review of
family and molecular studies. Biol Psychiatry 48:531-538.
Berrettini WH (2000b): Susceptibility loci for bipolar disorder: overlap with inherited
vulnerability to schizophrenia. Biol Psychiatry 47:245-251.
326
References
Bertram L, Tanzi RE (2001): Of replications and refutations: the status of Alzheimer's
disease genetic research. Curr Neurol Neurosci Rep 1:442-450.
BhaskerRao B, VanHimbergen D, Edmonds HL, Jaber S, Ali AT, Pagni S, Koenig S,
Spence PA (1998): Evidence for improved cerebral function after minimally invasive
bypass surgery. J Card Surg 13:27-31.
Bigler ED (1998): Magnetic resonance imaging of the brain: relationship between
structure and function. Med Pediatr Oneol Suppl 1:17-24.
Bilder RM, Goldman RS, Robinson D, Reiter G, Bell L, Bates JA, Pappadopulos E,
Willson DF, Alvir JM, Woerner MG, Geisler S, Kane JM, Lieberman JA (2000):
Neuropsychology of first-episode schizophrenia: initial characterization and clinical
correlates. Am JPsychiatry 157:549-559.
Blackwood DH, Ebmeier KP, Muir WJ, Sharp CW, Glabus M, Walker M, Souza V,
Dunan JR, Goodwin GM (1994a): Correlation of regional cerebral blood flow
equivalents measured by single photon emission computerized tomography with
P300 latency and eye movement abnormality in schizophrenia. Acta Psychiatr Scand
90: 157-166.
Blackwood DH, Muir WJ, Roxborough HM, Walker MR, Townshend R, Glabus MF, Wolff
S (1994b): "Schizoid" personality in childhood: auditory P300 and eye tracking
responses at follow-up in adult life. J Autism Dev Disord 24:487-500.
Blackwood DH, Sharp CW, Walker MT, Doody GA, Glabus MF, Muir WJ (1996):
Implications of comorbidity for genetic studies of bipolar disorder: P300 and eye
tracking as biological markers for illness. Br J Psychiatry SuppI85-92.
Blackwood DH, Young AH, McQueen JK, Martin MJ, Roxborough HM, Muir WJ, St Clair
DM, Kean DM (1991): Magnetic resonance imaging in schizophrenia: altered brain
morphology associated with P300 abnormalities and eye tracking dysfunction. Biol
Psychiatry 30:753-769.
327
References
Blekher T, Beard JD, O'Connor S, Orr WE, Ramchandani VA, Miller K, Vee RD, Li TK
(2002): Response of Saccadic Eye Movements to Alcohol in African American and
Non-Hispanic White College Students. Alcohol Clin Exp Res 26:232-238.
Blekher T, Christian JC, Abel LA,Vee RD (1998): Influences of chorion type on saccadic
eye movements in twins. Invest Ophthalmol Vis Sci 39:2186-2190.
Blekher T, Miller K, Vee RD, Christian JC, Abel LA (1997): Smooth pursuit in twins
before and after alcohol ingestion. Invest Ophihalmol Vis Sci 38: 1768-1773.
Bleuler E (1950): Dementia praecox or the group of schizophrenias. New York:
International Universities Press.
Bond AJ, Lader MH (1974): The use of analogue scales in rating subjective feelings. Br
MedJ47:211-218.
Batzel K, Rottach K, Buttner U (1993): Normal and pathological saccadic dysmetria.
Brain 116 (Pt 2):337-353.
Braff DL (1993): Information processing and attention dysfunctions in schizophrenia.
Schizophr Bu1119:233-259.
Braff DL (1998): In reply: specific measures account for most of the variance in
qualitative ratings of smooth pursuit eye movements in schizophrenia. Arch Gen
Psychiatry 55:185-186.
Braff DL, Geyer MA, Swerdlow NR (2001): Human studies of pre pulse inhibition of
startle: normal subjects, patient groups, and pharmacological studies.
Psychopharmacology (Berl) 156:234-258.
Braunstein-Bercovitz H (2000): Is the attentional dysfunction in schizotypy related to
anxiety? Schizophr Res 46:255-267.
328
References
Braunstein-Bercovitz H, Lubow RE (1998): Are high-schizotypal normal participants
distractible or limited in attentional resources? A study of latent inhibition as a
function of masking task load and schizotypy level. J Abnorm Psycholl07:659-670.
Braunstein-Bercovitz H, Rammsayer T, Gibbons H, Lubow RE (2002): Latent inhibition
deficits in high-schizotypal normals: symptom-specific or anxiety-related? Schizophr
Res 53:109-121.
Brenner CA, McDowell JE, Cadenhead KS, Clementz BA (2001): Saccadic inhibition
among schizo typal personality disorder subjects. Psychophysiology 38:399-403.
Brezinova V, Kendell RE (1977): Smooth pursuit eye movements of schizophrenics and
normal people under stress. BrJ Psychiatry 130:59-63.
Brocks DR (1999): Anticholinergic drugs used in Parkinson's disease: An overlooked
class of drugs from a pharmacokinetic perspective. J Pharm Pharm Sci 2:39-46.
Broerse A, Crawford TJ, den Boer JA (2001a): Parsing cognition in schizophrenia using
saccadic eye movements: a selective overview. Neuropsychologia 39:742-756.
Broerse A, Holthausen EA, van den Bosch RJ, den Boer JA (2001b): Does frontal
normality exist in schizophrenia? A saccadic eye movement study. Psychiatry Res
103:167-178.
Bromet EJ, Fennig S (1999): Epidemiology and natural history of schizophrenia. Biol
Psychiatry 46:871-881.
Brown RG, Pluck G (2000): Negative symptoms: the 'pathology' of motivation and goal-
directed behaviour. Trends Neurosci 23:412-417.
Bruce V, Young AW (1998): In the eye of the beholder. The science of face perception.
Oxford: Oxford University Press.
329
References
Burch GS, Steel C, Hemsley DR (1998): Oxford-Liverpool Inventory of Feelings and
Experiences: reliability in an experimental population. Br J Clin Psychol 37 (Pt
1):107-108.
Burke JG, Reveley MA (2002): Improved antisaccade performance with risperidone in
schizophrenia. J Neurol Neurosurg Psychiatry 72:449-454.
Cadenhead KS, Braff DL (2002): Endophenotyping schizotypy: a prelude to genetic
studies within the schizophrenia spectrum. Schizophr Res 54:47-57.
Cadenhead KS, Caras so BS, Swerdlow NR, Geyer MA, Braff DL (1999): Prepulse
inhibition and habituation of the startle response are stable neurobiological
measures in a normal male population. Biol Psychiatry 45:360-364.
Cadenhead KS, Light GA, Geyer MA, McDowell JE, Braff DL (2002): Neurobiological
measures of schizotypal personality disorder: defining an inhibitory endophenotype?
Am J Psychiatry 159:869-871.
Calkins ME, Iacono WG (2000): Eye movement dysfunction in schizophrenia: A
heritable characteristic for enhancing phenotype definition. Am J Med Genet 97:72-
76.
Calkins ME, Katsanis J, Hammer MA, Iacono WG (2001): The misclassification of blinks
as saccades: implications for investigations of eye movement dysfunction in
schizophrenia. Psychophysiology 38:761-767.
Campion D, Thibaut F, Denise P, Courtin P, Pottier M, Levillain D (1992): SPEM
impairment in drug-naive schizophrenic patients: evidence for a trait marker. Biol
Psychiatry 32:891-902.
Cannon TD, van Erp TG, Glahn DC (2002): Elucidating continuities and discontinuities
between schizotypy and schizophrenia in the nervous system. Schizophr Res 54:151-
156.
Carpenter RHS (1988): Movements of the eyes. London: Pion.
330
References
Carpenter WT, Arango C, Buchanan RW, Kirkpatrick B (1999): Deficit psychopathology
and a paradigm shift in schizophrenia research. Biol Psychiatry 46:352-360.
Cassady SL, Thaker GK, Moran M, Birt A, Tamminga CA (1992): GABAagonist-induced
changes in motor, oculomotor, and attention measures correlate in schizophrenics
with tardive dyskinesia. Biol Psychiatry 32:302-311.
Castellanos FX, Marvasti FF, Ducharme JL, Walter JM, Israel ME, Krain A, Pavlovsky
C, Hommer DW (2000): Executive function oculomotor tasks in girls with ADHD. J
Am Acad Child Adolesc Psychiatry 39:644-650.
Castellanos FX, Tannock R (2002): Neuroscience of attention-deficit/hyperactivity
disorder: the search for endophenotypes. Nat Rev Neurosci 3:617-628.
Catts SV, Fox AM, Ward PB, McConaghy N (2000): Schizotypy: phenotypic marker as
risk factor. Aust N Z J Psychiatry 34 Suppl:S101-S107.
Cavegn D, Biscaldi M (1996): Fixation and saccade control in an express-saccade
maker. Exp Brain Res 109: 101-116.
Caviness VS, Lange NT, Makris N, Herbert MR, Kennedy DN (1999): MRI-based brain
volumetrics: emergence of a developmental brain science. Brain Dev 21 :289-295.
Cegalis JA, Hafez H, Wong PS (1983): What is deviant about deviant smooth pursuit eye
movements in schizophrenia? Psychiatry Res 10:47-58.
Cegalis JA, Sweeney JA (1979): Eye movements in schizophrenia: a quantitative
analysis. Biol Psychiatry 14:13-26.
Cegalis JA, Sweeney JA (1981): The effect of attention on smooth pursuit eye
movements of schizophrenics. J Psychiatr Res 16: 145-161.
Cegalis JA, Sweeney JA, Dellis EM (1982): Refixation saccades and attention in
schizophrenia. Psychiatry Res 7:189-198.
331
References
Censits DM, Ragland JD, Gur RC, Gur RE (1997): Neuropsychological evidence
supporting a neurodevelopmental model of schizophrenia: a longitudinal study.
Schizophr Res 24:289-298.
Chapman JP, Chapman W, Kwapil TR (1994a): Does the Eysenck Psychoticism scale
predict psychosis? A ten year longitudinal study. Personality & Individual Differences
17:369-375.
Chapman W, Chapman JP, Kwapil TR, Eckblad M, Zinser MC (1994b): Putatively
psychosis-prone subjects 10 years later. J Abnonn. Psycholl 03: 171-183.
Chapman W, Chapman JP, Miller EN (1982): Reliabilities and intercorrelations of eight
measures of proneness to psychosis. J Consult Clin Psychol 50: 187-195.
Chapman W, Edell WS, Chapman JP (1980): Physical anhedonia, perceptual
aberration, and psychosis proneness. Schizophr Bull 6:639-653.
Chaudhry IB, Soni SD, Hellewell JS, Deakin JF (2002): Effects of the 5HT antagonist
cyproheptadine on neuropsychological function in chronic schizophrenia. Schizophr
Res 53:17-24.
Chen WJ, Liu SK, Chang CJ, Lien YJ, Chang YH, Hwu HG (1998): Sustained attention
deficit and schizo typal personality features in nonpsychotic relatives of schizophrenic
patients. Am J Psychiatry 155:1214-1220.
Chen Y, Levy DL, Nakayama K, Matthysse S, Palafox G, Holzman PS (1999a):
Dependence of impaired eye tracking on deficient velocity discrimination in
schizophrenia. Arch Gen Psychiatry 56: 155-161.
Chen Y, Nakayama K, Levy DL, Matthysse S, Holzman PS (1999b): Psychophysical
isolation of a motion-processing deficit in schizophrenics and their relatives and its
association with impaired smooth pursuit. Proc Natl Acad Sci USA 96:4724-4729.
Chen Y, Palafox GP, Nakayama K, Levy DL, Matthysse S, Holzman PS (1999c): Motion
perception in schizophrenia. Arch Gen Psychiatry 56: 149-154.
332
References
Ciuffreda KJ, Alpert M, Blackstone T, Fudge R, Thaler J (1994): Pursuit eye movements
in chronic schizophrenics: relationship between increased saccades and negative
symptoms. Ophthalmic Physiol Opt 14:79-81.
Claridge G (1990): Can a disease model of schizophrenia survive? In Bentall RP (Ed.),
Reconstructing schizophrenia. London: Routledge, pp 157-183.
Claridge G, Broks P (1984): Schizotypy and hemisphere function I: Theoretical
considerations and the measurement of schizotypy. Personality & Individual
Differences 5:633-648.
Claridge G, Davis C (2001): What's the use of neuroticism? Personality & Individual
Differences 31 :383-400.
Claridge G, Robinson DL, Birchall P (1983): Characteristics of schizophrenics' and
neurotics' relatives. Personality & Individual Differences 4:651-664.
Clark OM, McManus F (2002): Information processing in social phobia. Biol Psychiatry
51:92-100.
Clementz BA (1996a): Saccades to moving targets in schizophrenia: evidence for normal
posterior cortex functioning. Psychophysiology 33:650-654.
Clementz BA (1996b): The ability to produce express saccades as a function of gap
interval among schizophrenia patients. Exp Brain Res 111: 121-130.
Clementz BA (1998): Psychophysiological measures of (dis)inhibition as liability
indicators for schizophrenia. Psychophysiology 35:648-668.
Clementz BA, Farber RH, Lam MN, Swerdlow NR (1996a): Ocular motor responses to
unpredictable and predictable smooth pursuit stimuli among patients with
obsessive-compulsive disorder. J Psychiatry Neurosci 21:21-28.
333
References
Clementz BA, Geyer MA, Braff DL (1997): P50 suppression among schizophrenia and
normal comparison subjects: a methodological analysis. Biol Psychiatry 41:1035-
1044.
Clementz BA, Geyer MA, Braff DL (1998): Poor P50 suppression among schizophrenia
patients and their first-degree biological relatives. Am J Psychiatry 155: 1691-1694.
Clementz BA, Grove WM, Iacono WG, Sweeney JA (1992): Smooth-pursuit eye
movement dysfunction and liability for schizophrenia: implications for genetic
modeling. J Abnorm Psychol 101: 117-129.
Clementz BA, Iacono WG, Grove WM (1996b): The construct validity of root-mean-
square error for quantifying smooth-pursuit eye tracking abnormalities in
schizophrenia. Biol Psychiatry 39:448-450.
Clementz BA, McDowell JE (1994): Smooth pursuit in schizophrenia: abnormalities of
open- and closed-loop responses. Psychophysiology 31 :79-86.
Clementz BA, McDowell JE, Zisook S (1994): Saccadic system functioning among
schizophrenia patients and their first-degree biological relatives. J Abnorm Psychol
103:277-287.
Clementz BA, Reid SA, McDowell JE, Cadenhead KS (1995): Abnormality of smooth
pursuit eye movement initiation: specificity to the schizophrenia spectrum?
Psychophysiology 32:130-134.
Clementz BA, Sweeney JA (1990): Is eye movement dysfunction a biological marker for
schizophrenia? A methodological review. Psychol Bull 108:77-92.
Clementz BA, Sweeney JA, Hirt M, Haas G (1990): Pursuit gain and saccadic intrusions
in first-degree relatives of probands with schizophrenia. J Abnonn Psychol 99:327-
335.
334
References
Clementz BA, Sweeney JA, Hirt M, Haas G (1991): Phenotypic correlations between
oculomotor functioning and schizophrenia-related characteristics in relatives of
schizophrenic probands. Psychophysiology 28:570-578.
Cohen J (1988): Statistical power analysis for the behavioral sciences. Hillsdale, NJ:
Lawrence Earlbaum Associates, Inc.
Collewijn H, Went LN, Tamminga EP, Vegter-Van der VIis M (1988): Oculomotor defects
in patients with Huntington's disease and their offspring. JNeurol Sci 86:307-320.
Copolov D, Velakoulis D, McGorry P, Carina M, Yung A, Rees S, Jackson G, Rehn A,
Brewer W, Pantelis C (2000): Neurobiological findings in early phase schizophrenia.
Brain Res Brain Res Rev 31: 157-165.
Cornblatt BA, Malhotra AK (2001): Impaired attention as an endophenotype for
molecular genetic studies of schizophrenia. Am JMed Genet 105:11-15.
Cornelissen FW, Kimmig H, Schira M, Rutschmann RM, Maguire RP, Broerse A, den
Boer JA, Greenlee MW (2002): Event-related fMRI responses in the human frontal
eye fields in a randomized pro- and antisaccade task. Exp Brain Res 145:270-274.
Corr PJ (2000): Psychoticism. In Kazdin AE (Ed.), Encyclopedia of psychology.
Washington: Oxford University Press/APA, pp 469-470.
Corr PJ, Pickering AD, Gray JA. (1997): Personality, punishment, and procedural
learning: a test of J.A. Gray's anxiety theory. JPers Soc Psycho173:337-344.
Corr PJ, Tynan A, Kumari V (2002): Personality Correlates of Prepulse Inhibition of the
Startle Reflex at Three Lead Intervals. JPsychophysiology 16:82-91.
Costa PT, McCrae RR (1997): Stability and change in personality assessment: The
Revised NEO Personality Inventory in the year 2000. JPers Assess 68:86-94.
Couch FH, Fox JC (1934): Photographic study of ocular movements in mental disease.
Archives of Neurology and psychiatry 34:556-578.
335
References
Coull JT (1998): Neural correlates of attention and arousal: insights from
electrophysiology, functional neuroimaging and psychopharmacology. Prog Neurobiol
55:343-361.
Coursey RD, Lees RW, Siever W (1989): The relationship between smooth pursuit eye
movement impairment and psychological measures of psychopathology. Psychol Med
19:343-358.
Crawford TJ, Haeger B, Kennard C, Reveley MA, Henderson L (1995a): Saccadic
abnormalities in psychotic patients. I. Neuroleptic-free psychotic patients. Psychol
Med 25:461-471.
Crawford TJ, Haeger B, Kennard C, Reveley MA, Henderson L (1995b): Saccadic
abnormalities in psychotic patients. II. The role of neuroleptic treatment. Psychol
Med 25:473-483.
Crawford TJ, Henderson L, Kennard C (1989): Abnormalities of nonvisually-guided eye
movements in Parkinson's disease. Brain 112 (Pt 6):1573-1586.
Crawford TJ, Purl BK, Nijran KS, Jones B, Kennard C, Lewis SW (1996): Abnormal
saccadic distractibility in patients with schizophrenia: a 99mTc-HMPAO SPET study.
Psychol Med 26:265-277.
Crawford TJ, Sharma T, Purl BK, Murray RM, Berridge DM, Lewis SW (1998): Saccadic
eye movements in families multiply affected with schizophrenia: the Maudsley Family
Study. Am J Psychiatry 155:1703-1710.
Crevits L, Versijpt J, Hanse M, De Ridder K (2000): Antisaccadic effects of a dopamine
agonist as add-on therapy in advanced Parkinson's patients. Neuropsychobiology
42:202-206.
Croft RJ, Lee A, Bertolot J, Gruzelier JH (2001): Associations of P50 suppression and
desensitization with perceptual and cognitive features of "unreality" in schizotypy.
BioI Psychiatry 50:441-446.
336
References
Cronbach L (1951): Coefficient alpha and the internal structure of tests. Psychometrika
16:297-334.
Crow TJ (1980a): Molecular pathology of schizophrenia: more than one disease process?
Br Med J 280:66-68.
Crow TJ (1980b): Positive and negative schizophrenic symptoms and the role of
dopamine. BrJ Psychiatry 137:383-386.
Currie J, Joyce S, Maruff P, Ramsden B, McArthur-Jackson C, Malone V (1993):
Selective impairment of express saccade generation in patients with schizophrenia.
Exp Brain Res 97:343-348.
Currie J, Ramsden B, McArthur C, Maruff P (1991): Validation of a clinical antisaccadic
eye movement test in the assessment of dementia. Arch Neuro148:644-648.
Curtis CE, Calkins ME, Grove WM, Feil KJ, Iacono WG (2001a): Saccadic disinhibition
in patients with acute and remitted schizophrenia and their first-degree biological
relatives. Am J Psychiatry 158: 100-1 06.
Curtis CE, Calkins ME, Iacono WG (2001 b): Saccadic disinhibition in schizophrenia
patients and their first-degree biological relatives. A parametric study of the effects of
increasing inhibitory load. Exp Brain Res 137:228-236.
Daniel DG, Weinberger DR, Jones OW, Zigun JR, Coppola R, Handel S, Bigelow LB,
Goldberg TE, Berman KF, Kleinman JE (1991): The effect of amphetamine on
regional cerebral blood flow during cognitive activation in schizophrenia. J Neurosci
11: 1907-1917.
de Geus EJ, Wright MJ, Martin NG, Boomsma DI (2001): Genetics of brain function and
cognition. Behau Genet 31 :489-495.
Delgado-Garcia JM (2000): Why move the eyes if we can move the head? Brain Res Bull
52:475-482.
337
References
DeRosa A, Patalano F (1991): Effects of familiar proctor on fifth and sixth grade
students' test anxiety. Psycho I Rep 68:103-113.
Detterman DK (1989): The future of intelligence research. Intelligence 13: 199-203.
Deutch AY, Roth RH (1999): Neurotransmitters. In Zigmond MJ, Bloom FE, Landis SC,
Roberts JL, Squire LR (Eds.), Fundamental neuroscience. San Diego: Academic Press,
pp 193-234.
Dickey CC, McCarley RW, Voglmaier MM, Niznikiewicz MA, Seidman W, Hirayasu Y,
Fischer I, Teh EK, Van Rhoads R, Jakab M, Kikinis R, Jolesz FA, Shenton ME (1999):
Schizotypal personality disorder and MRI abnormalities of temporal lobe gray matter.
BioI Psychiatry 45: 1393-1402.
Diefendorf AR, Dodge R (1908): An experimental study of the ocular reactions of the
insane from photographic records. Brain 31:451-489.
Dinn WM, Harris CL, Aycicegi A, Greene P, Andover MS (2002): Positive and negative
schizotypy in a student sample: neurocognitive and clinical correlates. Schizophr Res
56: 171-185.
Domino EF, Ni LS, Zhang H (1997): Effects of tobacco smoking on human ocular
smooth pursuit. Clin Pharmacol Ther 61:349-359.
Doricchi F, Perani 0, Incoccia C, Grassi F, Cappa SF, Bettinardi V, Galati G, Pizzamiglio
L, Fazio F (1997): Neural control of fast-regular saccades and antisaccades: an
investigation using positron emission tomography. Exp Brain Res 116:50-62.
Duka T, Lupp A (1997): The effects of incentive on antisaccades: is a dopaminergic
mechanism involved? Behau Pharmaco18:373-382.
Dunn G (1989): Design and analysis of reliabilitq studies. London: Edward Arnold.
338
References
Dursun SM, Burke JG, Andrews H, Mlynik-Szmid A, Reveley MA (2000a): The effects of
antipsychotic medication on saccadic eye movement abnormalities in Huntington's
disease. Prog Neuropsychopharmacol Biol Psychiatry 24:889-896.
Dursun SM, Burke JG, Reveley MA (2000b): Antisaccade eye movement abnormalities
in Tourette syndrome: evidence for cortico-striatal network dysfunction? J
Psychopharmacol14:37-39.
Dursun SM, Wright N, Reveley MA (1999): Effects of amphetamine on saccadic eye
movements in man: possible relevance to schizophrenia? J Psychopharmacol13:245-
247.
Eckblad M, Chapman W (1983): Magical ideation as an indicator of schizotypy. J
Consult Clin Psychol51:215-225.
Eden GF, Stein JF, Wood HM, Wood FB (1994): Differences in eye movements and
reading problems in dyslexic and normal children. Vision Res 34:1345-1358.
Egan MF, Goldberg TE, Gscheidle T, Weirich M, Bigelow LB, Weinberger DR (2000):
Relative risk of attention deficits in siblings of patients with schizophrenia. Am J
Psychiatry 157:1309-1316.
Egan MF, Goldberg TE, Gscheidle T, Weirich M, Rawlings R, Hyde TM, Bigelow L,
Weinberger DR (2001a): Relative risk for cognitive impairments in siblings of patients
with schizophrenia. Biol Psychiatry 50:98-107.
Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman
D, Weinberger DR (2001b): Effect of COMTVal108/158 Met genotype on frontal lobe
function and risk for schizophrenia. Proc Natl Acad Sci USA 98:6917-6922.
Egan MF, Hyde TM, Bonomo JB, Mattay VS, Bigelow LB, Goldberg TE, Weinberger DR
(2001c): Relative risk of neurological signs in siblings of patients with schizophrenia.
AmJ Psychiatry 158:1827-1834.
339
References
Ettinger U, Chitnis XA, Kumari V, Fannon DG, Sumich AL, Q'Ceallaigh S, Doku VC,
Sharma T (2001): Magnetic resonance imaging of the thalamus in first-episode
psychosis. Am J Psychiatry 158: 116-118.
Ettinger U, Corr PJ (2001): The Frequency Accrual Speed Test (FAST): Psychometric
intelligence and personality correlates. European Journal of Personality 15:143-152.
Ettinger U, Kumari V, Chitnis XA, Corr PJ, Sumich AL, Rabe-Hesketh S, Crawford TJ,
Sharma T (2002): Relationship between brain structure and saccadic eye movements
in healthy humans. Neurosci Lett 328:225-228.
Evans WJ, Schwartz BD (1997): Attentional mechanisms of saccadic eye movements in
schizophrenia. Neuropsychiatry Neuropsychol Behau NeurollO: 17-24.
Evdokimidis I, Liakopoulos D, Constantinidis TS, Papageorgiou C (1996): Cortical
potentials with antisaccades. Electroencephalogr Clin NeurophysioI98:377-384.
Everitt BJ, Robbins TW (1997): Central cholinergic systems and cognition. Annu Rev
Psycho148:649-684.
Everling S, Fischer B (1998): The antisaccade: a review of basic research and clinical
studies. Neuropsychologia 36:885-899.
Everling S, Krappmann P, Flohr H (1997): Cortical potentials preceding pro- and
antisaccades in man. Electroencephalogr Clin Neurophysioll02:356-362.
Everling S, Krappmann P, Preuss S, Brand A, Flohr H (1996): Hypometric primary
saccades of schizophrenics in a delayed-response task. Exp Brain Res 111 :289-295.
Everling S, Munoz DP (2000): Neuronal correlates for preparatory set associated with
pro-saccades and anti-saccades in the primate frontal eye field. J Neurosci 20:387-
400.
EYsenck HJ, Barrett P (1993): The nature ofschizotypy. Psycho I Rep 73:59-63.
340
References
Eysenck HJ, Eysenck SBG (1976): Psychoticism as a dimension of personality. London:
Hodder and Stoughton.
Eysenck HJ, Eysenck SBG (1991): Manual of the Eysenckpersonality scales (EPSAdult).
London: Hodder & Stoughton.
Eysenck HJ (1992): The definition and measurement of psychoticism. Personality &
Individual Differences 13:757-785.
Fannon 0, Chitnis X, Doku V, Tennakoon L, Q'Ceallaigh S, Soni W, Sumich A, Lowe J,
Santamaria M, Sharma T (2000): Features of structural brain abnormality detected
in first-episode psychosis. Am J Psychiatry 157: 1829-1834.
Fanous A, Gardner C, Walsh D, Kendler KS (2001): Relationship between positive and
negative symptoms of schizophrenia and schizotypal symptoms in non psychotic
relatives. Arch Gen Psychiatry 58:669-673.
Faraone SV, Green AI, Seidman W, Tsuang MT (2001): "Schizotaxia": clinical
implications and new directions for research. Schizophr Bull 27: 1-18.
Farber RH, Clementz BA, Swerdlow NR (1997): Characteristics of open- and closed-loop
smooth pursuit responses among obsessive-compulsive disorder, schizophrenia, and
nonpsychiatric individuals. Psychophysiology 34: 157-162.
Farber RH, Swerdlow NR, Clementz BA (1999): Saccadic performance characteristics
and the behavioural neurology of Tourette's syndrome. J Neurol Neurosurg Psychiatry
66:305-312.
Fein G, Galin D, Yingling CD, Johnstone J, Nelson MA (1984): EEG spectra in 9-13-
year-old boys are stable over 1-3 years. Electroencephalogr Clin NeurophysioI58:517-
518.
First MB, Gibbon M, Spitzer RL, Williams JBW (1996a): Structured Clinical Interview for
DSM-W Axis II Disorders Research Version (SCID-II). New York State Psychiatric
Institute: Biometrics Research.
341
References
First MB, Spitzer RL, Gibbon M, Williams JBW (1996b): Structured Clinical Interview for
DSM-N Axis I Disorders Research Version (SCID-I). New York State Psychiatric
Institute: Biometrics Research.
Fischer B (1986): Express saccades in man and monkey. Prog Brain Res 64: 155-160.
Fischer B, Gezeck S, Hartnegg K (1997): The analysis of saccadic eye movements from
gap and overlap paradigms. Brain Res Brain Res Protoc 2:47-52.
Fischer B, Gezeck S, Hartnegg K (2000): On the production and correction of
involuntary prosaccades in a gap antisaccade task. Vision Res 40:2211-2217.
Fischer B, Weber H (1997): Effects of stimulus conditions on the performance of
antisaccades in man. Exp Brain Res 116: 191-200.
Fischer B, Weber H, Biscaldi M, Aiple F, Otto P, Stuhr V (1993): Separate populations of
visually guided saccades in humans: reaction times and amplitudes. Exp Brain Res
92:528-541.
Flechtner KM, Mackert A, Thies K, Frick K, Muller-Oerlinghausen B (1992): Lithium
effect on smooth pursuit eye movements of healthy volunteers. Biol Psychiatry
32:932-938.
Flechtner KM, Steinacher B, Mackert A (2000): Subthreshold symptoms and
vulnerability indicators (e.g., eye tracking dysfunction) in schizophrenia. Compr
Psychiatry 41 :86-89.
Flechtner KM, Steinacher B, Sauer R, Mackert A (1997): Smooth pursuit eye
movements in schizophrenia and affective disorder. Psychol Med 27:1411-1419.
Flechtner KM, Steinacher B, Sauer R, Mackert A (2002): Smooth pursuit eye
movements of patients with schizophrenia and affective disorder during clinical
treatment. Eur Arch Psychiatry Clin Neurosci 252:49-53.
342
References
Francis PT, Palmer AM, Snape M, Wilcock GK (1999): The cholinergic hypothesis of
Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatry 66: 137-147.
Freedman R, Adler LE, Bickford P, Byerley W, Coon H, Cullum CM, Griffith JM, Harris
JG, Leonard S, Miller C (1994): Schizophrenia and nicotinic receptors. Haru Rev
Psychiatry 2: 179-192.
Friedman JI, Temporini H, Davis KL (1999): Pharmacologic strategies for augmenting
cognitive performance in schizophrenia. Biol Psychiatry 45: 1-16.
Friedman L, Abel LA, Jesberger JA, Malki A, Meltzer HY (1992a): Saccadic intrusions
into smooth pursuit in patients with schizophrenia or affective disorder and normal
controls. Biol Psychiatry 31: 1110-1118.
Friedman L, Jesberger JA, Meltzer HY (1991): A model of smooth pursuit performance
illustrates the relationship between gain, catch-up saccade rate, and catch-Up
saccade amplitude in normal controls and patients with schizophrenia. Biol
Psychiatry 30:537-556.
Friedman L, Jesberger JA, Meltzer HY (1992b): Effect of typical antipsychotic
medications and clozapine on smooth pursuit performance in patients with
schizophrenia. Psychiatry Res 41 :25-36.
Friedman L, Jesberger JA, Siever W, Thompson P, Mohs R, Meltzer HY (1995a): Smooth
pursuit performance in patients with affective disorders or schizophrenia and normal
controls: analysis with specific oculomotor measures, RMS error and qualitative
ratings. Psychol Med 25:387-403.
Friedman L, Kenny JT, Jesberger JA, Choy MM, Meltzer HY (1995b): Relationship
between smooth pursuit eye-tracking and cognitive performance in schizophrenia.
Biol Psychiatry 37:265-272.
Frumin M, Golland P, Kikinis R, Hirayasu Y, Salisbury OF, Hennen J, Dickey CC,
Anderson M, Jolesz FA, Grimson WE, McCarley RW, Shenton ME (2002): Shape
343
References
differences in the corpus callosum in first-episode schizophrenia and first-episode
psychotic affective disorder. Am JPsychiatry 159:866-868.
Fukushima J, Fukushima K, Chiba T, Tanaka S, Yamashita I, Kato M (1988):
Disturbances of voluntary control of saccadic eye movements in schizophrenic
patients. Biol Psychiatry 23:670-677.
Fukushima J, Fukushima K, Miyasaka K, Yamashita I (1994): Voluntary control of
saccadic eye movement in patients with frontal cortical lesions and parkinsonian
patients in comparison with that in schizophrenics. Biol Psychiatry 36:21-30.
Fukushima J, Fukushima K, Morita N, Yamashita I (1990a): Disturbances in the
control of saccadic eye movement and eye-head coordination in schizophrenics. J
Vestib Res 1:171-180.
Fukushima J, Fukushima K, Morita N, Yamashita I (1990b): Further analysis of the
control of voluntary saccadic eye movements in schizophrenic patients. Biol
Psychiatry 28:943-958.
Fukushima J, Morita N, Fukushima K, Chiba T, Tanaka S, Yamashita I (1990c):
Voluntary control of saccadic eye movements in patients with schizophrenic and
affective disorders. JPsychiatr Res 24:9-24.
Gaebel W (1989): Visual search, EEG, and psychopathology in schizophrenic patients.
Eur Arch Psychiatry Neurol Sci 239:49-57.
Gale BW, Abel LA, Christian JC, Sorbel J, Yee RD (1996): Saccadic characteristics of
monozygotic and dizygotic twins before and after alcohol administration. Invest
Ophthalmol Vis Sci 37:339-344.
Gambini 0, Abbruzzese M, Scarone S (1993a): Smooth pursuit and saccadic eye
movements and Wisconsin Card Sorting Test performance in obsessive-compulsive
disorder. Psychiatry Res 48: 191-200.
344
References
Gambini 0, Colombo C, Cavallaro R, Scarone S (1993b): Smooth pursuit eye
movements and saccadic eye movements in patients with delusional disorder. Am J
Psychiatry 150:1411-1414.
Gambini 0, Scarone S (1992): Smooth pursuit eye movements and neuropsychological
tests in schizophrenic patients: possible involvement of attentional components. Eur
Arch Psychiatry Clin Neurosci 241 :333-336.
Ganguli R, Brar JS (1992): Generalizability of first-episode studies in schizophrenia.
Schizophr Bull 18:463-469.
Gaymard B, Pierrot-Deseilligny C, Rivaud S (1990): Impairment of sequences of
memory-guided saccades after supplementary motor area lesions. Ann Neurol
28:622-626.
Gaymard B, Ploner CJ, Rivaud-Pechoux S, Pierrot-Deseilligny C (1999): The frontal eye
field is involved in spatial short-term memory but not in reflexive saccade inhibition.
Exp Brain Res 129:288-301.
Gaymard B, Ploner CJ, Rivaud S, Vermersch AI, Pierrot-Deseilligny C (1998a): Cortical
control of saccades. Exp Brain Res 123: 159-163.
Gaymard B, Rivaud S, Cassarini JF, Dubard T, Rancurel G, Agid Y, Pierrot-Deseilligny
C (1998b): Effects of anterior cingulate cortex lesions on ocular saccades in humans.
Exp Brain Res 120:173-183.
Gershon ES, Guroff JJ (1984): Information from relatives. Diagnosis of affective
disorders. Arch Gen Psychiatry 41: 173-180.
Gibbons RD, Dorus E, Ostrow DG, Pandey GN, Davis JM, Levy DL (1984): Mixture
distributions in psychiatric research. Biol Psychiatry 19:935-961.
Goldman-Rakic PS (1999): The physiological approach: functional architecture of
working memory and disordered cognition in schizophrenia. Biol Psychiatry 46:650-
661.
345
References
Goldrnan-Rakic PS, Selemon LD (1997): Functional and anatomical aspects of
prefrontal pathology in schizophrenia. Schizophr Bull 23:437-458.
Gooding DC (1999): Antisaccade task performance in questionnaire-identified
schizotypes. Schizophr Res 35:157-166.
Gooding DC, Grabowski JA, Hendershot CS (2000a): Fixation stability in schizophrenia,
bipolar, and control subjects. Psychiatry Res 97: 119-128.
Gooding DC, Iacono WG, Beiser M (1994): Temporal stability of smooth-pursuit eye
tracking in first-episode psychosis. Psychophysiology 31:62-67.
Gooding DC, Iacono WG, Katsanis J, Beiser M, Grove WM (1993): The association
between lithium carbonate and smooth pursuit eye tracking among first-episode
patients with psychotic affective disorders. Psychophysiology 30:3-9.
Gooding DC, Miller MD, Kwapil TR (2000b): Smooth pursuit eye tracking and visual
fixation in psychosis-prone individuals. Psychiatry Res 93:41-54.
Gooding DC, Tallent KA (2001): The association between antisaccade task and working
memory task performance in schizophrenia and bipolar disorder. J Nero Ment Dis
189:8-16.
Gordon E, Coyle S, Anderson J, Healey P, Cordaro J, Latimer C, Meares R (1992): Eye
movement response to a facial stimulus in schizophrenia. Biol Psychiatry 31 :626-
629.
Gottesman II, Erlenmeyer-Kimling L (2001): Family and twin strategies as a head start
in defining prodromes and endophenotypes for hypothetical early-interventions in
schizophrenia. Schizophr Res 51:93-102.
Gould SJ (1981): The mismeasure of man. London: Penguin Books.
Gravetter FJ, Wallnau LB (1996): Statistics for the behavioral sciences 4th edition. St
Paul, MN:West Publishing Company.
346
References
Grawe RW, Levander S (1995): Smooth pursuit eye movements and neuropsychological
impairments in schizophrenia. Acta Psychiatr Scand 92: 108-114.
Gray JA, Joseph MH, Hemsley DR, Young AM,Warburton EC, Boulenguez P, Grigoryan
GA, Peters SL, Rawlins IN, Taib CT (1995): The role of meso limbic dopaminergic and
retrohippocampal afferents to the nucleus accumbens in latent inhibition:
implications for schizophrenia. Behau Brain Res 71: 19-31.
Gray NS, Pickering AD, Gray JA (1994): Psychoticism and dopamine D2 binding in the
basal ganglia using single photon emission tomography. Personality & Individual
Differences 17:431-434.
Green JF, King DJ (1998): The effects of chlorpromazine and lorazepam on abnormal
antisaccade and no-saccade distractibility. Biol Psychiatry 44:709-715.
Green JF, King DJ, Trimble KM (2000): Antisaccade and smooth pursuit eye movements
in healthy subjects receiving sertraline and lorazepam. J PsychophannacoI14:30-36.
Green MF (2001): Schizophrenia revealed. NewYork/London: W.W. Norton.
Griffiths AN, Marshall RW, Richens A (1984): Saccadic eye movement analysis as a
measure of drug effects on human psychomotor performance. Br J Clin Pharmacal 18
Suppll:73S-82S.
Grove WM, Clementz BA, Iacono WG, Katsanis J (1992): Smooth pursuit ocular motor
dysfunction in schizophrenia: evidence for a major gene. Am J Psychiatry 149: 1362-
1368.
Gruzelier J (2002): A Janusian perspective on the nature, development and structure of
schizophrenia and schizotypy. Schizophr Res 54:95-103.
Gruzelier JH (1996): The factorial structure of schizotypy: Part I. Affinities with
syndromes of schizophrenia. Schizophr Bull 22:611-620.
347
References
Gruzelier JH (1999): Functional neuropsychophysiological asymmetry in schizophrenia:
a review and reorientation. Schizophr BulI25:91-120.
Gruzelier JH, Kaiser J (1996): Syndromes of schizotypy and timing of puberty.
Schizophr Res 21: 183-194.
Guitton D, Buchtel HA, Douglas RM (1985): Frontal lobe lesions in man cause
difficulties in suppressing reflexive glances and in generating goal-directed saccades.
Exp Brain Res 58:455-472.
Gunderson JG, Siever W (1985): Relatedness of schizotypal to schizophrenic disorders:
editors'introduction. Schizophr Bull 11:532-537.
Gurrera RJ, Nestor PG, ODonnell BF (2000): Personality traits in schizophrenia:
comparison with a community sample. J Nero Ment Dis 188:31:-35.
Hallmayer J (2000): The epidemiology of the genetic liability for schizophrenia. Aust N Z
J Psychiatry 34 Suppl:S47 -S55.
Harrison PJ (1999): The neuropathology of schizophrenia. A critical review of the data
and their interpretation. Brain 122 (Pt 4):593-624.
Harvey PD, Moriarty PJ, Serper MR, Schnur E, Lieber D (2000): Practice-related
improvement in information processing with novel antipsychotic treatment.
Schizophr Res 46:139-148.
Hashimoto M, Ohtsuka K (1995): Transcranial magnetic stimulation over the posterior
cerebellum during visually guided saccades in man. Brain 118 (Pt 5):1185-1193.
Hauptmann B, Karni A (2002): From primed to learn: the saturation of repetition
priming and the induction of long-term memory. Brain Res Cogn Brain Res 13:313-
322.
Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtiss G (1993): Wisconsin Card Sorting
Test manual. Odessa, Florida: Psychological Assessment Resources Inc.
348
References
Henn FA, Braus DF (1999): Structural neuroimaging in schizophrenia. An integrative
view of neuromorphology. Eur Arch Psychiatry Clin Neurosci 249 SuppI4:48-56.
Hewitt JK, Claridge G (1989): The factor structure of schizotypy in a normal population.
Personality & Individual Differences 10:323-329.
Hirayasu Y, Asato N, Ohta H, Hokama H, Arakaki H, Ogura C (1998): Abnormalities of
auditory event-related potentials in schizophrenia prior to treatment. Bioi Psychiatry
43:244-253.
Hirayasu Y, Tanaka S, Shenton ME, Salisbury DF, DeSantis MA, Levitt JJ, Wible C,
Yurgelun-Todd D, Kikinis R, Jolesz FA, McCarley RW (2001): Prefrontal gray matter
volume reduction in first episode schizophrenia. CerebCortex 11:374-381.
Ho LW, Carmichael J, Swartz J, Wyttenbach A, Rankin J, Rubinsztein DC (2001): The
molecular biology of Huntington's disease. Psycho 1Med 31 :3-14.
Hoff AL, Riordan H, O'Donnell DW, Morris L, DeLisi LE (1992): Neuropsychological
functioning of first-episode schizophreniform patients. Am J Psychiatry 149:898-903.
Hoff AL, Sakuma M, Wieneke M, Horon R, Kushner M, DeLisi LE (1999): Longitudinal
neuropsychological follow-up study of patients with first-episode schizophrenia. Am J
Psychiatry 156:1336-1341.
Holzman PS (1983): Smooth pursuit eye movements in psychopathology. Schizophr Bull
9:33-36.
Holzman PS (1985): Eye movement dysfunctions and psychosis. Int Rev Neurobiol
27: 179-205.
Holzman PS (1992): Behavioral markers of schizophrenia useful for genetic studies. J
Psychiatr Res 26:427-445.
Holzman PS (2000): Eye movements and the search for the essence of schizophrenia.
Brain Res Brain Res Rev 31:350-356.
349
References
Holzman PS, Kringlen E, Levy DL, Haberman SJ (1980): Deviant eye tracking in twins
discordant for psychosis. A replication. Arch Gen Psychiatry 37:627-631.
Holzman PS, Kringlen E, Levy DL, Proctor LR, Haberman S (1978a): Smooth pursuit eye
movements in twins discordant for schizophrenia. J Psychiatr Res 14:111-120.
Holzman PS, Kringlen E, Levy DL, Proctor LR, Haberman SJ, Yasillo NJ (1977):
Abnormal-pursuit eye movements in schizophrenia. Evidence for a genetic indicator.
Arch Gen Psychiatry 34:802-805.
Holzman PS, Kringlen E, Matthysse S, Flanagan SD, Lipton RB, Cramer G, Levin S,
Lange K, Levy DL (1988): A single dominant gene can account for eye tracking
dysfunctions and schizophrenia in offspring of discordant twins. Arch Gen Psychiatry
45:641-647.
Holzman PS, Levy DL (1977): Smooth pursuit eye movements and functional psychoses;
a review. Schizophr Bull 3:15-27.
Holzman PS, Levy DL, Matthysse SW, Abel LA (1997): Smooth pursuit eye tracking in
twins. A critical commentary. Arch Gen Psychiatry 54:429-431.
Holzman PS, Levy DL, Proctor LR (1976): Smooth pursuit eye movements, attention,
and schizophrenia. Arch Gen Psychiatry 33: 1415-1420.
Holzman PS, Levy DL, Proctor LR (1978b): The several qualities of attention in
schizophrenia. J Psychiatr Res 14:99-110.
Holzman PS, Levy DL, Uhlenhuth EH, Proctor LR, Freedman DX (1975): Smooth-
pursuit eye movements, and diazepam, CPZ, and secobarbital. Psychophannacologia
44:112-115.
Holzman PS, O'Brian C, Watemaux C (1991): Effects of lithium treatment on eye
movements. Biol Psychiatry 29: 1001-1015.
350
References
Holzman PS, Proctor LR, Hughes DW (1973): Eye-tracking patterns in schizophrenia.
Science 181: 179-181.
Holzman PS, Proctor LR, Levy DL, Yasillo NJ, Meltzer HY, Hurt SW (1974): Eye-tracking
dysfunctions in schizophrenic patients and their relatives. Arch Gen Psychiatry
31:143-151.
Holzman PS, Solomon CM, Levin S, Waternaux CS (1984): Pursuit eye movement
dysfunctions in schizophrenia. Family evidence for specificity. Arch Gen Psychiatry
41:136-139.
Hommer DW, Clem T, Litman R, Pickar D (1991): Maladaptive anticipatory saccades in
schizophrenia. Biol Psychiatry 30:779-794.
Honey GD, Bullmore ET, Soni W, Varatheesan M, Williams SC, Sharma T (1999):
Differences in frontal cortical activation by a working memory task after substitution
of risperidone for typical antipsychotic drugs in patients with schizophrenia. Proc
Natl Acad Sci USA 96: 13432-13437.
Hutton JT, Albrecht JW, Kuskowski M, Schut W (1987): Abnormal ocular motor
function predicts clinical diagnosis of familial ataxia. Neurology 37:698-701.
Hutton SB, Crawford TJ, Gibbins H, Cuthbert I, Barnes TR, Kennard C, Joyce EM
(2001a): Short and long term effects of antipsychotic medication on smooth pursuit
eye tracking in schizophrenia. Psychopharmacology (Berl) 157:284-291.
Hutton SB, Crawford TJ, Kennard C, Barnes TR, Joyce EM (2000): Smooth pursuit eye
tracking over a structured background in first-episode schizophrenic patients. Eur
Arch Psychiatry Clin Neurosci 250:221-225.
Hutton SB, Crawford TJ, Puri BK, Duncan W, Chapman M, Kennard C, Barnes TR,
Joyce EM (1998a): Smooth pursuit and saccadic abnormalities in first-episode
schizophrenia. Psychol Med 28:685-692.
351
References
Hutton SB, Cuthbert I, Crawford TJ, Kennard C, Barnes TR, Joyce EM (2001b):
Saccadic hypometria in drug-naive and drug-treated schizophrenic patients: a
working memory deficit? Psychophysiology 38: 125-132.
Hutton SB, Joyce EM, Barnes TR, Kennard C (2002): Saccadic distractibility in first-
episode schizophrenia. Neuropsychologia 40: 1729-1736.
Hutton SB, Kennard C (1998): Oculomotor abnormalities in schizophrenia: a critical
review. Neurology 50:604-609.
Hutton SB, Puri BK, Duncan W, Robbins TW, Barnes TR, Joyce EM (1998b): Executive
function in first-episode schizophrenia. Psycho I Med 28:463-473.
Hyman SE (1999): Introduction to the complex genetics of mental disorders. Biol
Psychiatry 45:518-521.
Iacono WG (1982): Eye tracking in normal twins. Behau Genet 12:517-526.
Iacono WG (1998): Identifying psychophysiological risk for psychopathology: examples
from substance abuse and schizophrenia research. Psychophysiology 35:621-637.
Iacono WG, Beiser M (1992): Where are the women in first-episode studies of
schizophrenia? Schizophr Bull 18:471-480.
Iacono WG, Koenig WG (1983): Features that distinguish the smooth-pursuit eye-
tracking performance of schizophrenic, affective-disorder, and normal individuals. J
Abnorm Psycho I 92:29-41.
Iacono WG, Lykken DT (1979a): Electro-oculographic recording and scoring of smooth
pursuit and saccadic eye tracking: a parametric study using monozygotic twins.
Psychophysiology 16:94-107.
Iacono WG, Lykken DT (1979b): Eye tracking and psychopathology. New procedures
applied to a sample of normal monozygotic twins. Arch Gen Psychiatry 36:1361-
1369.
352
References
Iacono WG, Lykken DT (1981): Two-year retest stability of eye tracking performance and
a comparison of electro-oculographic and infrared recording techniques: evidence of
EEG in the electro-oculogram. Psychophysiology 18:49-55.
Iacono WG, Lykken DT (1983): The assessment of smooth tracking dysfunction.
Schizophr Bull 9:44-50.
Iacono WG, Moreau M, Beiser M, Fleming JA, Lin TY (1992): Smooth-pursuit eye
tracking in first-episode psychotic patients and their relatives. J Abnonn Psychol
101: 104-116.
Iacono WG, Peloquin W, Lumry AE, Valentine RH, Tuason VB (1982): Eye tracking in
patients with unipolar and bipolar affective disorders in remission. J Abnonn Psychol
91:35-44.
Iacono WG, Tuason VB, Johnson RA (1981): Dissociation of smooth-pursuit and
saccadic eye tracking in remitted schizophrenics. An ocular reaction time task that
schizophrenic perform well. Arch Gen Psychiatry 38:991-996.
Ingraham W, Kety SS (2000): Adoption studies of schizophrenia. Am J Med Genet
97:18-22.
Irwin HJ, Green MJ, Marsh PJ (1999): Dysfunction in smooth pursuit eye movements
and history of childhood trauma. Percept Mot Skills 89: 1230-1236.
Iwata N, Cowley DS, Radel M, Roy-Byrne PP, Goldman D (1999): Relationship between a
GABAA alpha 6 Pro385Ser substitution and benzodiazepine sensitivity. Am J
Psychiatry 156:1447-1449.
Jacobsen LK, Hong WL, Hommer DW, Hamburger SD, Castellanos FX, Frazier JA,
Giedd IN, Gordon CT, Karp BI, McKenna K, Rapoport JL (1996): Smooth pursuit eye
movements in childhood-onset schizophrenia: comparison with attention-deficit
hyperactivity disorder and normal controls. Biol Psychiatry 40: 1144-1154.
353
References
John B, Lewis KR (1966): Chromosome variability and geographic distribution in
insects. Science 152:711-721.
Johns LC, van Os J (2001): The continuity of psychotic experiences in the general
population. Clin Psychol Rev 21: 1125-1141.
Johnstone EC, Crow TJ, Frith CD, Husband J, Kreel L (1976): Cerebral ventricular size
and cognitive impairment in chronic schizophrenia. Lancet 2:924-926.
Jorgensen TH, Borglum AD, Mors 0, Wang AG, Pinaud M, Flint TJ, Dahl HA, Vang M,
Kruse TA, Ewald H (2002): Search for common haplotypes on chromosome 22q in
patients with schizophrenia or bipolar disorder from the Faroe Islands. Am J Med
Genet 114:245-252.
Kaiser J, Gruzelier JH (1999): Timing of puberty and syndromes of schizotypy: a
replication. Ini J Psychophysio134:237-247.
Kapur S, Remington G (2001): Dopamine D(2) receptors and their role in atypical
antipsychotic action: still necessary and may even be sufficient. Biol Psychiatry
50:873-883.
Karoumi B, Saoud M, d'Amato T, Rosenfeld F, Denise P, Gutknecht C, Gaveau V,
Beaulieu FE, Dalery J, Rochet T (2001): Poor performance in smooth pursuit and
antisaccadic eye-movement tasks in healthy siblings of patients with schizophrenia.
Psychiatry Res 101:209-219.
Karoumi B, Ventre-Dominey J, Dalery J (1998a): Predictive saccade behavior is
enhanced in schizophrenia. Cognition 68:B81-B91.
Karoumi B, Ventre-Dominey J, Vighetto A, Dalery J, d'Amato T (1998b): Saccadic eye
movements in schizophrenic patients. Psychiatry Res 77:9-19.
Karson CN (1979): Oculomotor signs in a psychiatric population: a preliminary report.
Am J Psychiatry 136: 1057-1060.
354
References
Kathmann N, Hochrein A, Uwer R (1999): Effects of dual task demands on the accuracy
of smooth pursuit eye movements. Psychophysiology 36: 158-163.
Kato C, Petronis A, Okazaki Y, Tochigi M, Umekage T, Sasaki T (2002): Molecular
genetic studies of schizophrenia: challenges and insights. Neurosci Res 43:295-304.
Katsanis J, Iacono WG (1991): Clinical, neuropsychological, and brain structural
correlates of smooth-pursuit eye tracking performance in chronic schizophrenia. J
Abnorm Psycholl00:526-534.
Katsanis J, Iacono WG, Beiser M (1990): Anhedonia and perceptual aberration in first-
episode psychotic patients and their relatives. JAbnorm Psychol99:202-206.
Katsanis J, Iacono WG, Beiser M (1991): Relationship of lateral ventricular size to
psychophysiological measures and short-term outcome. Psychiatry Res 37:115-129.
Katsanis J, Iacono WG, Beiser M (1996): Eye-tracking performance and adaptive
functioning over the short-term course of first-episode psychosis. Psychiatry Res
64:19-26.
Katsanis J, Kortenkamp S, Iacono WG, Grove WM (1997): Antisaccade performance in
patients with schizophrenia and affective disorder. JAbnonn Psycholl 06:468-472.
Katsanis J, Taylor J, Iacono WG, Hammer MA (2000): Heritability of different measures
of smooth pursuit eye tracking dysfunction: a study of normal twins.
Psychophysiology 37:724-730.
Kay SR, Fiszbein A, Opler LA (1987): The positive and negative syndrome scale (PANSS)
for schizophrenia. Schizophr Bull 13:261-276.
Keefe RS, Siever W, Mohs RC, Peterson AE, Mahon TR, Bergman RL, Davis KL (1989):
Eye tracking, schizophrenic symptoms, and schizo typal personality disorder. Eur
Arch Psychiatry Neurol Sci 239:39-42.
355
References
Keefe RS, Silverman JM, Mohs RC, Siever W, Harvey PO, Friedman L, Roitman SE,
DuPre RL, Smith CJ, Schmeidler J, Davis KL (1997): Eye tracking, attention, and
schizotypal symptoms in nonpsychotic relatives of patients with schizophrenia. Arch
Gen Psychiatry 54: 169-176.
Kelley MP, Coursey RD (1992): Factor structure of schizotypy scales. Personality &
Individual Differences 13:723-731.
Kelly P, Rennie C, Gordon E, Anderson J, Howson A, Meares R (1990): Smooth pursuit
eye tracking dysfunction and negative symptoms in schizophrenia. Psychiatry Res
34:89-97.
Kendler KS, Hewitt J (1992): The structure of self-report schizotypy in twins. Journal of
Personality Disorders 6: 1-17.
Kendler KS, Lieberman JA, Walsh 0 (1989): The Structured Interview for Schizotypy
(SIS): a preliminary report. Schizophr Bull 15:559-571.
Kendler KS, McGuire M, Gruenberg AM, Walsh 0 (1995): Schizo typal symptoms and
signs in the Roscommon Family Study. Their factor structure and familial
relationship with psychotic and affective disorders. Arch Gen Psychiatry 52:296-303.
Kennard C, Crawford TJ, Henderson L (1994): A pathophysiological approach to
saccadic eye movements in neurological and psychiatric disease. J Neurol Neurosurg
Psychiatry 57:881-885.
King OJ (1994): Psychomotor impairment and cognitive disturbances induced by
neuroleptics. Acta Psychiatr Scand Suppl380:53-58.
King OJ, Mills PJ, Mannion MF, Green JF (1999): Smooth pursuit eye movements in
chronic schizophrenics and healthy volunteers using a quantitative objective
measure for detecting saccadic intrusions. Human Psychopharmacology 14:87-94.
Kirkpatrick B, Buchanan RW, Ross DE, Carpenter WT (2001): A separate disease within
the syndrome of schizophrenia. Arch Gen Psychiatry 58: 165-171.
356
References
Kissler J, Clementz BA (1998): Fixation stability among schizophrenia patients.
Neuropsychobiology 38:57-62.
Klein C, Berg P (2001): Four-week test-retest stability of individual differences in the
saccadic CNV, two saccadic task parameters, and selected neuropsychological tests.
Psychophysiology 38:704-711.
Klein C, Fischer B, Hartnegg K, Heiss WH, Roth M (2000a): Optomotor and
neuropsychological performance in old age. Exp Brain Res 135:141-154.
Klein C, Fischer BJr, Fischer B, Hartnegg K (2002): Effects of methylphenidate on
saccadic responses in patients with ADHD. Exp Brain Res 145:121-125.
Klein C, Foerster F (2001): Development of pro saccade and antisaccade task
performance in participants aged 6 to 26 years. Psychophysiology 38: 179-189.
Klein C, Heinks T, Andresen B, Berg P, Moritz S (2000b): Impaired modulation of the
saccadic contingent negative variation preceding antisaccades in schizophrenia. Biol
Psychiatry 47:978-990.
Klein CH, Brugner G, Foerster F, Muller W, Schweickhardt A (2000c): The gap effect in
pro-saccades and anti-saccades in psychometric schizotypes. Biol Psycho155:25-39.
Knox PC (1998): Stimulus predictability and the gap effect on pre-saccadic smooth
pursuit. Neuroreport 9:809-812.
Knox PC, O'Mullane G, Gray R (1999): Smooth pursuit latency in gap and non-gap
conditions in schizophrenic subjects. Neuroreport 10:2635-2639.
Kojima T, Matsushima E, Ando K, Ando H, Sakurada M, Ohta K, Moriya H, Shimazono
Y (1992): Exploratory eye movements and neuropsychological tests in schizophrenic
patients. Schizophr Bull 18:85-94.
Kojima T, Matsushima E, Ohta K, Toru M, Han YH, Shen YC, Moussaoui D, David I,
Sato K, Yamashita I, Kathmann N, Hippius H, Thavundayil JX, Lal S, Vasavan Nair
357
References
NP, Potkin SG, Prilipko L (2001): Stability of exploratory eye movements as a marker
of schizophrenia--a WHO multi-center study. World Health Organization. Schizophr
Res 52:203-213.
Kraepelin E (1971): Dementia praecox and paraphrenia. Huntington, NY: Robert E.
Krieger Publishing.
Krappmann P, Everling S (1998): Spatial accuracy of primary and secondary memory-
guided saccades in schizophrenic patients. Schizophr Res 30:183-185.
Krappmann P, Everling S, Flohr H (1998): Accuracy of visually and memory-guided
antisaccades in man. Vision Res 38:2979-2985.
Krebs MO, Gut-Fayand A, Amado I, Daban C, Bourdel MC, Poirier MF, Berthoz A
(2001): Impairment of predictive saccades in schizophrenia. Neuroreport 12:465-469.
Kringlen E (2000): Twin studies in schizophrenia with special emphasis on concordance
figures. Am JMed Genet 97:4-11.
Kristjansson A, Chen Y, Nakayama K (2001): Less attention is more in the preparation
of antisaccades, but not prosaccades. Nat Neurosci 4: 1037-1042.
Kuechenmeister CA, Linton PH, Mueller TV, White HB (1977): Eye tracking in relation
to age, sex, and illness. Arch Gen Psychiatry 34:578-579.
Kufferle B, Friedmann A, Topitz A, Foldes P, Anderer P, Kutzer M, Steinberger K (1990):
Smooth pursuit eye movements in schizophrenia: influences of neuroleptic treatment
and the question of specificity. Psychopathology 23: 106-114.
Kumari V (2000): A human perspective: commentary on Swerdlow et al., 'Animal models
of deficient sensorimotor gating: what we know, what we think we know, and what
we hope to know soon'. Behav Pharmacolll:209-210.
358
References
Kumari V, Corr PJ, Mulligan OF, Cotter PA, Checkley SA, Gray JA (1997a): Effects of
acute administration of d-amphetamine and haloperidol on procedural learning in
man. Psychopharmacology (Berl) 129:271-276.
Kumari V, Crawford TJ, Soni W, Ettinger U, Chitnis X, Sharma T (2000): Prepulse
inhibition effects do not correlate with antisaccade abnormalities in schizophrenia. J
Psychophysiology 14 (Suppl.):A53.
Kumari V, Gray J, Honey G, Soni W, Bullmore E, Williams S, Ng V, Vythelingum G,
Simmons A, Suckling J, Corr P, Sharma T (2002): Procedural learning in
schizophrenia: a functional magnetic resonance imaging investigation. Schizophr Res
57:97.
Kumari V, Toone B, Gray JA (1997b): Habituation and prepulse inhibition of the
acoustic startle reflex: effects of smoking status and psychosis-proneness.
Personality & Individual Differences 23: 183-191.
Kumari V, Zachariah E, Galea A, Mehrotra R, Taylor D, Sharma T (2001): Effects of
procyc1idine on prepulse inhibition of the acoustic startle response in healthy human
volunteers. Psychopharmacology (Berl) 154:221-229.
Kurtz MM, Moberg PJ, Mozley LH, Hickey T, Arnold SE, Bilker WB, Gur RE (2001):
Cognitive impairment and functional status in elderly institutionalized patients with
schizophrenia. Int J Geriatr Psychiatry 16:631-638.
Larrison AL, Ferrante CF, Briand KA, Sereno AB (2000): Schizotypal traits, attention
and eye movements. Prog Neuropsychopharmacol Biol Psychiatry 24:357-372.
Lasker AG, Zee DS (1997): Ocular motor abnormalities in Huntington's disease. Vision
Res 37:3639-3645.
Latham C, Holzman PS, Manschreck TC, Tole J (1981): Optokinetic nystagmus and
pursuit eye movements in schizophrenia. Arch Gen Psychiatry 38:997-1003.
359
References
Lawrie SM, Abukmeil SS (1998): Brain abnormality in schizophrenia. A systematic and
quantitative review of volumetric magnetic resonance imaging studies. Br J
Psychiatry 172: 110-120.
Leboyer M, Bellivier F, Nosten-Bertrand M, Jouvent R, Pauls D, Mallet J (1998):
Psychiatric genetics: search for phenotypes. Trends Neurosci 21:102-105.
Lee KH, Williams LM (2000): Eye movement dysfunction as a biological marker of risk
for schizophrenia. Aust N Z J Psychiatry 34 Suppl:S91-100.
Lee KH, Williams LM, Loughland CM, Davidson DJ, Gordon E (2001): Syndromes of
schizophrenia and smooth-pursuit eye movement dysfunction. Psychiatry Res
101:11-21.
Leigh RJ, Zee DS (1999): The neurology of eye movements. Oxford: Oxford University
Press.
Lekwuwa GU, Barnes GR, Collins CJ, Limousin P (1999): Progressive bradykinesia and
hypokinesia of ocular pursuit in Parkinson's disease. J Neurol Neurosurg Psychiatry
66:746-753.
Lencer R, Malchow CP, Krecker K, Nolte A, Pinnow M, von Siefart SZ, Schwinger E,
Arolt V (1999): Smooth pursuit performance in families with multiple occurrence of
schizophrenia and nonpsychotic families. Biol Psychiatry 45:694-703.
Lencer R, Malchow CP, Trillenberg-Krecker K, Schwinger E, Arolt V (2000): Eye-tracking
dysfunction (ETD) in families with sporadic and familial schizophrenia. Biol
Psychiatry 47:391-401.
Lencz T, Raine A, Scerbo A, Redmon M, Brodish S, Holt L, Bird L (1993): Impaired eye
tracking in undergraduates with schizo typal personality disorder. Am J Psychiatry
150:152-154.
Lenzenweger MF (1994): Psychometric high-risk paradigm, perceptual aberrations, and
schizotypy: an update. Schizophr Bull 20:121-135.
360
References
Lenzenweger MF (1999): Schizophrenia: refining the phenotype, resolving
endophenotypes. Behav Res Ther 37:281-295.
Leonard BE (1997): Fundamentals of pssjchopharmacoloqg, Chichester: Wiley.
Levin S (1983): Smooth pursuit impairment in schizophrenia--what does it mean?
Schizophr Bull 9:37-44.
Levin S (1984): Frontal lobe dysfunctions in schizophrenia=I. Eye movement
impairments. JPsychiatr Res 18:27-55.
Levin S, Holzman PS, Rothenberg SJ, Lipton RB (1981a): Saccadic eye movements in
psychotic patients. Psychiatry Res 5:47-58.
Levin S, Jones A, Stark L, Merrin EL, Holzman PS (1982a): Identification of abnormal
patterns in eye movements of schizophrenic patients. Arch Gen Psychiatry 39: 1125-
1130.
Levin S, Jones A, Stark L, Merrin EL, Holzman PS (1982b): Saccadic eye movements of
schizophrenic patients measured by reflected light technique. Biol Psychiatry
17:1277-1287.
Levin S, Lipton RB, Holzman PS (1981b): Pursuit eye movements in psychopathology:
effects of target characteristics. Biol Psychiatry 16:255-267.
Levin S, Luebke A, Zee DS, Hain TC, Robinson DA, Holzman PS (1988): Smooth pursuit
eye movements in schizophrenics: quantitative measurements with the search-coil
technique. J Psychiatr Res 22: 195-206.
Levy DL, Bogerts B, Degreef G, Dorogusker B, Watemaux C, Ashtari M, Jody D, Geisler
S, Lieberman JA (1992): Normal eye tracking is associated with abnormal
morphology of medial temporal lobe structures in schizophrenia. Schizophr Res 8: l-
ID.
361
References
Levy DL, Dorus E, Shaughnessy R, Yasillo NJ, Pandey GN, Janicak PG, Gibbons RD,
Gaviria M, Davis JM (1985): Pharmacologic evidence for specificity of pursuit
dysfunction to schizophrenia. Lithium carbonate associated with abnormal pursuit.
Arch Gen Psychiatry 42:335-341.
Levy DL, Holzman PS, Matthysse S, Mendell NR (1993): Eye tracking dysfunction and
schizophrenia: a critical perspective. Schizophr Bull 19:461-536.
LevyDL, Holzman PS, Matthysse S, Mendell NR (1994): Eye tracking and schizophrenia:
a selective review. Schizophr Bull 20:47-62.
Levy DL, Holzman PS, Proctor LR (1978): Vestibular responses in schizophrenia. Arch
Gen Psychiatry 35:972-981.
Levy DL, Holzman PS, Proctor LR (1983a): Vestibular dysfunction and psychopathology.
Schizophr Bull 9:383-438.
Levy DL, Lajonchere eM, Dorogusker B, Min D, Lee S, Tartaglini A, Lieberman JA,
Mendell NR (2000): Quantitative characterization of eye tracking dysfunction in
schizophrenia. Schizophr Res 42: 171-185.
Levy DL, Lipton RB, Holzman PS, Davis JM (1983b): Eye tracking dysfunction unrelated
to clinical state and treatment with haloperidol. Biol Psychiatry 18:813-819.
Levy DL, Yasillo NJ, Dorus E, Shaughnessy R, Gibbons RD, Peterson J, Janicak PG,
Gaviria M, Davis JM (1983c): Relatives of unipolar and bipolar patients have normal
pursuit. Psychiatry Res 10:285-293.
Lezak MD (1983): Neuropsychological assessment. New York/Oxford: Oxford University
Press.
Lichtermann D, Karbe E, Maier W (2000): The genetic epidemiology of schizophrenia
and of schizophrenia spectrum disorders. Eur Arch Psychiatry Clin Neurosci 250:304-
310.
362
References
Liddle PF (1987a): Schizophrenic syndromes, cognitive performance and neurological
dysfunction. Psycho I Med 17:49-57.
Liddle PF (1987b): The symptoms of chronic schizophrenia. A re-examination of the
positive-negative dichotomy. Br JPsychiatry 151: 145-151.
Liddle PF, Friston KJ, Frith CD, Frackowiak RS (1992): Cerebral blood flow and mental
processes in schizophrenia. JR Soc Med 85:224-227.
Lieberman J, Jody D, Geisler S, Alvir J, Loebel A, Szymanski S, Woerner M, Borenstein
M (1993): Time course and biologic correlates of treatment response in first-episode
schizophrenia. Arch Gen Psychiatry 50:369-376.
Lieberman JA (1999): Is schizophrenia a neurodegenerative disorder? A clinical and
neurobiological perspective. Biol Psychiatry 46:729-739.
Lieberman JA, Alvir JM, Woerner M, Degreef G, Bilder RM, Ashtari M, Bogerts B,
Mayerhoff DI, Geisler SH, Loebel A (1992): Prospective study of psychobiology in
first-episode schizophrenia at Hillside Hospital. Schizophr Bull 18:351-371.
Lieberman JA, Perkins D, Belger A, Chakos M, Jarskog F, Boteva K, Gilmore J (2001):
The early stages of schizophrenia: speculations on pathogenesis, pathophysiology,
and therapeutic approaches. Biol Psychiatry 50:884-897.
Lim KO, Tew W, Kushner M, Chow K, Matsumoto B, DeLisi LE (1996): Cortical gray
matter volume deficit in patients with first-episode schizophrenia. Am J Psychiatry
153: 1548-1553.
Lindsey DT, Holzman PS, Haberman S, Yasillo NJ (1978): Smooth-pursuit eye
movements: a comparison of two measurement techniques for studying
schizophrenia. JAbnorm Psycho I 87:491-496.
Lipp OV, Arnold SL, Siddle DAT (1994): Psychosis proneness in a non-clinical sample I:
A psychometric study. Personality & Individual Differences 17:395-404.
363
References
Lipton RB, Frost LA, Holzman PS (1980a): Smooth pursuit eye movements,
schizophrenia, and distraction. Percept Mot Skills 50: 159-167.
Lipton RB, Levin S, Holzman PS (1980b): Horizontal and vertical pursuit eye
movements, the oculocephalic reflex, and the functional psychoses. Psychiatry Res
3:193-203.
Lipton RB, Levy DL, Holzman PS, Levin S (1983): Eye movement dysfunctions in
psychiatric patients: a review. Schizophr Bull 9: 13-32.
Lister RG, Hilakivi LA (1988): The effects of novelty, isolation, light and ethanol on the
social behavior of mice. Psychopharmacology (Berl) 96:181-187.
Litman RE, Hommer DW, Clem T, Omsteen ML, 0110 C, Pickar D (1991): Correlation of
Wisconsin Card Sorting Test performance with eye tracking in schizophrenia. Am J
Psychiatry 148:1580-1582.
Litman RE, Hommer DW, Clem T, Rapaport MH, Pato CN, Pickar D (1989): Smooth
pursuit eye movements in schizophrenia: effects of neuroleptic treatment and
caffeine. Psychopharmacol Bull 25:473-478.
Litman RE, Hommer DW, Radant A, Clem T, Pickar D (1994): Quantitative effects of
typical and atypical neuroleptics on smooth pursuit eye tracking in schizophrenia.
Schizophr Res 12:107-120.
Litman RE, Torrey EF, Hommer DW, Radant AR, Pickar D, Weinberger DR (1997): A
quantitative analysis of smooth pursuit eye tracking in monozygotic twins discordant
for schizophrenia. Arch Gen Psychiatry 54:417-426.
Loughland CM, Williams LM, Gordon E (2002): Visual scanpaths to positive and
negative facial emotions in an outpatient schizophrenia sample. Schizophr Res
55: 159-170.
Lubow RE, Gewirtz JC (1995): Latent inhibition in humans: data, theory, and
implications for schizophrenia. Psychol Bull 117:87-103.
364
References
Lueck CJ, Tanyeri S, Crawford TJ, Henderson L, Kennard C (1990): Antisaccades and
remembered saccades in Parkinson's disease. J Neurol Neurosurg Psychiatry 53:284-
288.
Luna B, Sweeney JA (2001): Studies of brain and cognitive maturation through
childhood and adolescence: a strategy for testing neurodevelopmental hypotheses.
Schizophr Bull 27:443-455.
Lund TR, Sponheim SR, Iacono WG, Clementz BA (1995): Internal consistency reliability
of resting EEG power spectra in schizophrenic and normal subjects.
Psychophysiology 32: 66-71.
Lykken DT, Iacono WG, Lykken JD (1981): Measuring deviant eye tracking. Schizophr
Bu117:204-205.
Lynch G, King DJ, Green JF, Byth W, Wilson-Davis K (1997): The effects of haloperidol
on visual search, eye movements
Psychopharmacology (Ber1) 133:233-239.
and psychomotor performance.
Lynch JC, Mountcastle VB, Talbot WH, Yin TC (1977): Parietal lobe mechanisms for
directed visual attention. J Neurophysio140:362-389.
MacAvoy MG, Bruce CJ (1995): Comparison of the smooth eye tracking disorder of
schizophrenics with that of nonhuman primates with specific brain lesions. Int J
Neurosci 80:117-151.
MacCabe J, Simon H, Murray RM (2002): Is antisaccade performance a marker of
genetic liability in schizophrenia? Schizophrenia Research 53:78-79.
MacDonald AW, III, Pogue-Geile MF, Debski TT, Manuck S (2001): Genetic and
environmental influences on schizotypy: a community-based twin study. Schizophr
Bu1127:47-58.
Mackert A, Flechtner M (1989): Saccadic reaction times in acute and remitted
schizophrenics. Eur Arch Psychiatry Neurol Sci 239:33-38.
365
References
Mahlberg R, Steinacher B, Mackert A, Flechtner KM (2001): Basic parameters of
saccadic eye movements--differences between unmedicated schizophrenia and
affective disorder patients. Eur Arch Psychiatry Cliri Neurosci 251 :205-21 O.
Maier W, Rietschel M, Lichtermann D, Wildenauer DB (1999): Family and genetic
studies on the relationship of schizophrenia to affective disorders. Eur Arch
Psychiatry Clin Neurosci 249 SuppI4:57-61.
Malaspina D, Amador XF, Coleman EA, Mayr TL, Friedman JH, Sackeim HA (1994a):
Smooth pursuit eye movement abnormality in severe major depression: effects of
ECT and clinical recovery. JNeuropsychiatry Clin Neurosci 6:36-42.
Malaspina D, Coleman E, Goetz RR, Harkavy-Friedman J, Corcoran C, Amador X, Yale
S, Gorman JM (2002): Odor identification, eye tracking and deficit syndrome
schizophrenia. Biol Psychiatry 51:809-815.
Malaspina D, Colemann EA, Quitkin M, Amador XF, Kaufmann CA, Gorman JM,
Sackeim HA (1994b): Effects of pharmacologic catecholamine manipulation on
smooth pursuit eye movements in normals. Schizophr Res 13:151-159.
Malaspina D, Friedman JH, Kaufmann C, Bruder G, Amador X, Strauss D, Clark S,
Yale S, Lukens E, Thoming H, Goetz R, Gorman J (1998): Psychobiological
heterogeneity of familial and sporadic schizophrenia. Biol Psychiatry 43:489-496.
Malaspina D, Storer S, Furman V, Esser P, Printz D, Berman A, Lignelli A, Gorman J,
Van Heertum R (1999): SPECT study of visual fixation in schizophrenia and
comparison subjects. Biol Psychiatry 46:89-93.
Malone SM, Iacono WG (2002): Error rate on the antisaccade task: heritability and
developmental change in performance among preadolescent and late-adolescent
female twin youth. Psychophysiology 39:664-673.
Mancama D, Arranz MJ, Kerwin RW (2002): Genetic predictors of therapeutic response
to clozapine: current status of research. CNS Drugs 16:317-324.
366
References
Manor BR, Gordon E, Williams LM, Rennie CJ, Bahramali H, Latimer CR, Barry RJ,
Meares RA (1999): Eye movements reflect impaired face processing in patients with
schizophrenia. BioI Psychiatry 46:963-969.
Maruff P, Danckert J, Pantelis C, Currie J (1998): Saccadic and attentional
abnormalities in patients with schizophrenia. Psychol Med 28: 1091-1100.
Maruff P, Pantelis C, Danckert J, Smith D, Currie J (1996): Deficits in the endogenous
redirection of covert visual attention in chronic schizophrenia. Neuropsychologia
34: 1079-1084.
Maruff P, Purcell R, Tyler P, Pantelis C, Currie J (1999): Abnormalities of internally
generated saccades in obsessive-compulsive disorder. Psychol Med 29:1377-1385.
Mason 0, Claridge G, Clark K (1997): Electrodermal relationships with personality
measures of psychosis-proneness in psychotic and normal subjects. Int J
Psychophysiol27:137-146.
Mason 0, Claridge G, Jackson M (1995): New scales for the measurement of schizotypy.
Personality & Individual Differences 18:7-13.
Masson GS, Mestre DR, Martineau F, Soubrouillard C, Brefel C, Rascol 0, Blin °
(2000): Lorazepam-induced modifications of saccadic and smooth-pursuit eye
movements in humans: attentional and motor factors. Behav Brain Res 108:169-
180.
Mathalon DH, Ford JM, Pfefferbaum A (2000): Trait and state aspects of P300
amplitude reduction in schizophrenia: a retrospective longitudinal study. Biol
Psychiatry 47:434-449.
Mather JA (1985): Eye movements of teenage children of schizophrenics: a possible
inherited marker of susceptibility to the disease. J Psychiatr Res 19:523-532.
Mather JA, Neufeld RW, Merskey H, Russell NC (1989): Release of saccades in
schizophrenics: inattention or inefficiency? Eur Arch Psychiatry Neurol Sci 239:23-26.
367
References
Mather JA, Putchat C (1982): Motor control of schizophrenics--I. Oculomotor control of
schizophrenics: a deficit in sensory processing, not strictly in motor control. J
Psychiatr Res 17:343-360.
Matsue Y, Okuma T, Saito H, Aneha S, Ueno T, Chiba H, Matsuoka H (1986): Saccadic
eye movements in tracking, fixation, and rest in schizophrenic and normal subjects.
BioI Psychiatry 21 :382-389.
Matsue Y, Osakabe K, Saito H, Goto Y, Ueno T, Matsuoka H, Chiba H, Fuse Y, Sato M
(1994a): Smooth pursuit eye movements and express saccades in schizophrenic
patients. Schizophr Res 12:121-130.
Matsue Y, Saito H, Osakabe K, Awata S, Ueno T, Matsuoka H, Chiba H, Fuse Y, Sato M
(1994b): Smooth pursuit eye movements and voluntary control of saccades in the
antisaccade task in schizophrenic patients. Jpn J Psychiatry Neurol48: 13-22.
Matsue Y, Sugawara S, Oyama K, Osakabe K, Awata S, Goto Y, Sato M (1993): Smooth
pursuit eye movement dysfunction as a biological marker for prediction of disease
courses of schizophrenia: a preliminary report. Jpn J Psychiatry NeuroI47:71-74.
Matsushima E, Kojima T, Ohbayashi S, Ando H, Ando K, Shimazono Y (1992):
Exploratory eye movements in schizophrenic patients and patients with frontal lobe
lesions. Eur Arch Psychiatry Clin Neurosci 241 :210-214.
Matsushima E, Kojima T, Ohta K, Obayashi S, Nakajima K, Kakuma T, Ando H, Ando
K, Toru M (1998): Exploratory eye movement dysfunctions in patients with
schizophrenia: possibility as a discriminator for schizophrenia. J Psychiatr Res
32:289-295.
Matthysse S, Holzman PS (1987): Genetic latent structure models: implication for
research on schizophrenia. Psychol Med 17:271-274.
Matthysse S, Holzman PS, Lange K (1986): The genetic transmission of schizophrenia:
application of Mendelian latent structure analysis to eye tracking dysfunctions in
schizophrenia and affective disorder. J Psychiatr Res 20:57-67.
368
References
May HJ (1979): Oculomotor pursuit in schizophrenia. Arch Gen Psychiatry 36:827.
McCartan D, Bell R, Green JF, Campbell C, Trimble K, Pickering A, King DJ (2001): The
differential effects of chlorpromazine and haloperidol on latent inhibition in healthy
volunteers. J PsychophannacoI15:96-104.
McDonald C, Murray RM (2000): Early and late environmental risk factors for
schizophrenia. Brain Res Brain Res Rev 31: 130-137.
McDowell JE, Brenner CA, Myles-Worsley M, Coon H, Byerley W, Clementz BA (2001):
Ocular motor delayed-response task performance among patients with schizophrenia
and their biological relatives. Psychophysiology 38: 153-156.
McDowell JE, Brown GG, Paulus M, Martinez A, Stewart SE, Dubowitz OJ, Braff DL
(2002): Neural correlates of refixation saccades and antisaccades in normal and
schizophrenia subjects. Biol Psychiatry 51 :216-223.
McDowell JE, Clementz BA (1996): Ocular-motor delayed-response task performance
among schizophrenia patients. Neuropsychobiology 34:67-71.
McDowell JE, Clementz BA (1997): The effect of fixation condition manipulations on
antisaccade performance in schizophrenia: studies of diagnostic specificity. Exp
Brain Res 115:333-344.
McDowell JE, Clementz BA (2001): Behavioral and brain imaging studies of saccadic
performance in schizophrenia. Biol PsychoI57:5-22.
McDowell JE, Clementz BA,Wixted JT (1996): Timing and amplitude of saccades during
predictive saccadic tracking in schizophrenia. Psychophysiology 33:93-101.
McDowell JE, Myles-Worsley M, Coon H, Byerley W, Clementz BA (1999): Measuring
liability for schizophrenia using optimized antisaccade stimulus parameters.
Psychophysiology 36: 138-141.
369
References
McGaughy J, Everitt BJ, Robbins TW, Sarter M (2000): The role of cortical cholinergic
afferent projections in cognition: impact of new selective immunotoxins. Behau Brain
Res 115:251-263.
McGue M, Gottesman II (1989): A single dominant gene still cannot account for the
transmission of schizophrenia. Arch Gen Psychiatry 46:478-480.
Mialet JP, Pichot P (1981): Eye-tracking patterns in schizophrenia. An analysis based
on the incidence of saccades. Arch Gen Psychiatry 38: 183-186.
Mindham RH, Lamb P, Bradley R (1977): A comparison of piribedil, procyclidine and
placebo in the control of phenothiazine-induced parkinsonism. Br J Psychiatry
130:581-585.
Minshew NJ, Luna B, Sweeney JA (1999): Oculomotor evidence for neocortical systems
but not cerebellar dysfunction in autism. Neurology 52:917-922.
Mishlove M, Chapman W (1985): Social anhedonia in the prediction of psychosis
proneness. J Abnorm Psycho194:384-396.
Mitchell JP, Macrae CN, Gilchrist ID (2002): Working memory and the suppression of
reflexive saccades. J Cogn Neurosci 14:95-103.
Moises HW, Yang L, Kristbjarnarson H, Wiese C, Byerley W, Macciardi F, Arolt V,
Blackwood D, Liu X, Sjogren B (1995): An international two-stage genome-wide
search for schizophrenia susceptibility genes. Nat Genet 11:321-324.
Moniz-Cook E, Woods R, Gardiner E, Silver M, Agar S (2001): The Challenging
Behaviour Scale (CBS): development of a scale for staff caring for older people in
residential and nursing homes. Br J Clin Psycho140:309-322.
Mood A, Graybill F (1963): Introduction to the theory of statistics. McGraw Hill.
370
References
Mori K, Yamashita H, Nagao M, Horiguchi J, Yamawaki S (2002): Effects of
anticholinergic drug withdrawal on memory, regional cerebral blood flow and
extrapyramidal side effects in schizophrenic patients. Pharmacopsychiatry 35:6-11.
Moser PC, Hitchcock JM, Lister S, Moran PM (2000): The pharmacology of latent
inhibition as an animal model of schizophrenia. Brain Res Brain Res Rev 33:275-
307.
Mosimann UP, Muri RM, Felblinger J, Radanov BP (2000): Saccadic eye movement
disturbances in whiplash patients with persistent complaints. Brain 123 (Pt 4):828-
835.
Mostofsky SH, Lasker AG, Cutting LE, Denckla MB, Zee OS (2001a): Oculomotor
abnormalities in attention deficit hyperactivity disorder: a preliminary study.
Neurology 57:423-430.
Mostofsky SH, Lasker AG, Singer HS, Denckla MB, Zee OS (2001b): Oculomotor
abnormalities in boys with Tourette syndrome with and without AOHO. JAm Acad
Child Adolesc Psychiatry 40: 1464-1472.
Muir WJ, St Clair OM, Blackwood OH, Roxburgh HM, Marshall I (1992): Eye-tracking
dysfunction in the affective psychoses and schizophrenia. Psychol Med 22:573-580.
Mulligan R, Mackinnon A, Jorm AF, Giannakopoulos P, Michel JP (1996): A comparison
of alternative methods of screening for dementia in clinical settings. Arch Neural
53:532-536.
Muntaner C, Garcia-Sevilla L, Fernandez A, Torrubia R (1988): Personality dimensions,
schizotypal, and borderline personality traits and psychosis proneness. Personality &
Individual Differences 9:257-268.
Murphy KC (2002): Schizophrenia and velo-cardio-facial syndrome. Lancet 359:426-
430.
371
References
Muller N, Riedel M, Eggert T, Straube A (1999): Internally and externally guided
voluntary saccades in unmedicated and medicated schizophrenic patients. Part II.
Saccadic latency, gain, and fixation suppression errors. Eur Arch Psychiatry Clin
Neurosci 249:7-14.
Muri RM, Heid 0, Nirkko AC, Ozdoba C, Felblinger J, Schroth G, Hess CW (1998):
Functional organisation of saccades and antisaccades in the frontal lobe in humans:
a study with echo planar functional magnetic resonance imaging. J Neural Neurosurg
Psychiatry 65:374-377.
Myles-Worsley M, Coon H, McDowell J, Brenner C, Hoff M, Lind B, Bennett P,
Freedman R, Clementz B, Byerley W (1999): Linkage of a composite inhibitory
phenotype to a chromosome 22q locus in eight Utah families. Am J Med Genet
88:544-550.
Nakashima Y, Momose T, Sano I, Katayama S, Nakajima T, Niwa S, Matsushita M
(1994): Cortical control of saccade in normal and schizophrenic subjects: a PET
study using a task-evoked rCBF paradigm. Schizophr Res 12:259-264.
Nelson HE (1991): National Adult Reading Test (NART) manual. Windsor, England:
NFER-Nelson.
Newsome WT, Wurtz RH, Dursteler MR, Mikami A (1985): Deficits in visual motion
processing following ibotenic acid lesions of the middle temporal visual area of the
macaque monkey. J Neurosci 5:825-840.
Nickoloff SE, Radant AD, Reichler R, Hommer DW (1991): Smooth pursuit and saccadic
eye movements and neurological soft signs in obsessive-compulsive disorder.
Psychiatry Res 38: 173-185.
Nieman DH, Bour W, Linszen DH, Goede J, Koelman JH, Gersons BP, Ongerboer d, V
(2000): Neuropsychological and clinical correlates of antisaccade task performance in
schizophrenia. Neurology 54:866-871.
372
References
Nigg JT, Butler KM, Huang-Pollock CL, Henderson JM (2002): Inhibitory processes in
adults with persistent childhood onset ADHD. J Consult Clin Psycho170: 153-157.
Nkam I, Thibaut F, Denise P, Van Der EA, Segard L, Brazo P, Menard J, Thery S,
Halbeck I, Delamilleure P, Vasse T, Etard 0, Dollfus S, Champion D, Levillain D,
Petit M (2001): Saccadic and smooth-pursuit eye movements in deficit and non-
deficit schizophrenia. Schizophr Res 48: 145-153.
Nobre AC, Gitelman DR, Dias EC, Mesulam MM (2000): Covert visual spatial orienting
and saccades: overlapping neural systems. Neuroimage 11:210-216.
Norris H (1971): The action of sedatives on brain stem oculomotor systems in man.
Neuropharmacology 10:181-191.
Nunn J, Peters E (2001): Schizotypy and patterns of lateral asymmetry on hemisphere-
specific language tasks. Psychiatry Res 103: 179-192.
O'Driscoll GA, Alpert NM, Matthysse SW, Levy DL, Rauch SL, Holzman PS (1995):
Functional neuroanatomy of antisaccade eye movements investigated with positron
emission tomography. Proc Natl Acad Sci USA 92:925-929.
O'Driscoll GA, Benkelfat C, Florencio PS, Wolff AL, Joober R, Lal S, Evans AC (1999):
Neural correlates of eye tracking deficits in first-degree relatives of schizophrenic
patients: a positron emission tomography study. Arch Gen Psychiatry 56: 1127 -1134.
O'Driscoll GA, Lenzenweger MF, Holzman PS (1998): Antisaccades and smooth pursuit
eye tracking and schizotypy. Arch Gen Psychiatry 55:837-843.
O'Reilly T, Dunbar R, Bentall R (2001): Schizotypy and creativity: An evolutionary
connection? Personality & Individual Differences 31:1067-1078.
Oepen G, Thoden U, Wannke C (1990): Association of tardive dyskinesia with increased
frequency of eye movement disturbances in chronic schizophrenic patients. A clinical
note. Eur Arch Psychiatry Neurol Sci 239:241-245.
373
References
Office of Population Censuses and Surveys (1991): Classification of Occupations and
Classification of Ethnicity. London: HMSO.
Oldfield RC (1971): The assessment and analysis of handedness: the Edinburgh
inventory. Neuropsychologia 9:97-113.
Olincy A, Ross RG, Young DA, Roath M, Freedman R (1998): Improvement in smooth
pursuit eye movements after cigarette smoking in schizophrenic patients.
Neuropsychophannacology 18:175-185.
Olincy A, Ross RG, Youngd DA, Freedman R (1997): Age diminishes performance on an
anti saccade eye movement task. NeurobiolAging 18:483-489.
Ong J, Harman GA (1979): Eye movements simultaneously recorded by
electrooculographic and photoelectric methods. Percept Mot Skills 48:619-624.
Ott J (1991): Analysis of human genetic linkage. Baltimore/London: Johns Hopkins
University Press.
Pallanti S, Grecu LM, Gangemi PF, Massi S, Parigi A, Arnetoli G, Quercioli L, Zaccara G
(1996): Smooth-pursuit eye movement and saccadic intrusions in obsessive-
compulsive disorder. Biol Psychiatry 40: 1164-1172.
Pallanti S, Quercioli L, Zaccara G, Ramacciotti AB, ArnetoIi G (1998): Eye movement
abnormalities in anorexia nervosa. Psychiatry Res 78:59-70.
Papageorgiou C, Kontaxakis VP, Havaki-Kontaxaki BJ, Stamouli S, Vasios C, Asvestas
P, Matsopoulos GK, Kontopantelis E, Rabavilas A, Uzunoglu N, Christodoulou GN
(2001): Impaired P600 in neuroleptic naive patients with first-episode schizophrenia.
Neuroreport 12:2801-2806.
Park S, Holzman PS (1992): Schizophrenics show spatial working memory deficits. Arch
Gen Psychiatry 49:975-982.
374
References
Park S, Holzman PS, Goldman-Rakic PS (1995): Spatial working memory deficits in the
relatives of schizophrenic patients. Arch Gen Psychiatry 52:821-828.
Pass HL, Salzman LF, Klorman R, Kaskey GB, Klein RH (1978): The effect of distraction
on acute schizophrenics'visual tracking. Biol Psychiatry 13:587-593.
Paus T (1991): Two modes of central gaze fixation maintenance and oculomotor
distractibility in schizophrenics. Schizophr Res 5: 145-152.
Paus T, Petrides M, Evans AC, Meyer E (1993): Role of the human anterior cingulate
cortex in the control of oculomotor, manual, and speech responses: a positron
emission tomography study. J Neurophysio170:453-469.
Pearls on GD, Marsh L (1999): Structural brain imaging in schizophrenia: a selective
review. Biol Psychiatry 46:627-649.
Penn DL, Mueser KT (1996): Research update on the psychosocial treatment of
schizophrenia. Am JPsychiatry 153:607-617.
Pereira CB, Strupp M, Holzleitner T, Brandt T (2001): Smoking and balance: correlation
of nicotine-induced nystagmus and postural body sway. Neuroreport 12:1223-1226.
Perry RJ, Zeki S (2000): The neurology of saccades and covert shifts in spatial attention:
an event-related fMRI study. Brain 123 (Pt 11):2273-2288.
Petit L, Dubois S, Tzourio N, Dejardin S, Crivello F, Michel C, Etard 0, Denise P,
Roucoux A, Mazoyer B (1999): PET study of the human foveal fixation system. Hum
Brain Mapp 8:28-43.
Phillips ML, David AS (1997): Visual scan paths are abnormal in deluded
schizophrenics. Neuropsychologia 35:99-105.
Phillips ML, David AS (1998): Abnormal visual scan paths: a psychophysiological
marker of delusions in schizophrenia. Schizophr Res 29:235-245.
375
References
Phillips ML, Williams L, Senior C, Bullmore ET, Brammer MJ, Andrew C, Williams SC,
David AS (1999): A differential neural response to threatening and non-threatening
negative facial expressions in paranoid and non-paranoid schizophrenics. Psychiatry
Res 92:11-31.
Pierrot-Deseilligny C, Rivaud S, Gaymard B, Agid Y (1991): Cortical control of reflexive
visually-guided saccades. Brain 114 (Pt 3):1473-1485.
Pierrot-Deseilligny C, Rivaud S, Gaymard B, Miiri RM, Vermersch AI (1995): Cortical
control of saccades. Ann NeuroI37:557-567.
Pierrot-Deseilligny C, Rivaud S, Pillon B, Fournier E, Agid Y (1989): Lateral visually-
guided saccades in progressive supranuclear palsy. Brain 112 (Pt 2):471-487.
Pivik RT (1979a): Smooth pursuit eye movements and attention in psychiatric patients.
BioI Psychiatry 14:859-879.
Pivik RT (1979b): Target velocity and smooth pursuit eye movements in psychiatric
patients. Psychiatry Res 1:313-323.
Pivik RT (1991): Smooth pursuit eye tracking dysfunction in schizophrenia: subcortical
implications. J Psychiatry Neurosci 16:123-130.
Plomin R, DeFries JC, McClearn GE, McGuffin P (2000): Behavioral Genetics, 4th
Edition. NewYork: WH Freeman & Co.
Powell J, Dawkins L, Davis RE (2002): Smoking, reward responsiveness, and response
inhibition: tests of an incentive motivational model. Biol Psychiatry 51: 151-163.
Pulver AE (2000): Search for schizophrenia susceptibility genes. Biol Psychiatry 47:221-
230.
Rabe-Hesketh S, Toulopoulou T, Murray R (2001): Multilevel modeling of cognitive
function in schizophrenic patients and their first degree relatives. Multivariate
Behavioral Research 36:279-298.
376
References
Radant AD, Bowdle TA, Cowley DS, Kharasch ED, Roy-Byrne PP (1998): Does ketamine-
mediated N-methyl-D-aspartate receptor antagonism cause schizophrenia-like
oculomotor abnormalities? Neuropsychopharmacology 19:434-444.
Radant AD, Claypoole K, Wingerson DK, Cowley DS, Roy-Byrne PP (1997):
Relationships between neuropsychological and oculomotor measures in
schizophrenia patients and normal controls. Biol Psychiatry 42:797-805.
Radant AD, Hommer OW (1992): A quantitative analysis of saccades and smooth
pursuit during visual pursuit tracking. A comparison of schizophrenics with normals
and substance abusing controls. Schizophr Res 6:225-235.
Raemaekers M, Jansma JM, Cahn W, Van Der Geest IN, Der Linden JA, Kahn RS,
Ramsey NF (2002): Neuronal substrate of the saccadic inhibition deficit in
schizophrenia investigated with 3-dimensional event-related functional magnetic
resonance imaging. Arch Gen Psychiatry 59:313-320.
Raine A (1991): The SPQ: a scale for the assessment of schizotypal personality based on
DSM-I1I-Rcriteria. Schizophr Bull 17:555-564.
Raine A, Allbutt J (1989): Factors of schizoid personality. Br J Clin Psycho128 (Pt 1):31-
40.
Raine A, Lencz T (1995): Conceptual and theoretical issues in schizotypal personality.
In Raine A, Lencz T, Mednick SA (Eds.), Schizotypal personality. Cambridge:
Cambridge University Press, pp 3-15.
Rashbass C (1961): The relationship between saccadic and smooth pursuit tracking eye
movements. JPhysiology 159:326-338.
Rawlings D, Goldberg M (2001): Correlating a measure of sustained attention with a
multi-dimensional measure of schizotypal traits. Personality & Individual Differences
31:421-431.
377
References
Rea MM, Sweeney JA, Solomon CM, Walsh V, Frances A (1989): Changes in eye
tracking during clinical stabilization in schizophrenia. Psychiatry Res 28:31-39.
Reid RC (1999): Vision. In Zigmond MJ, Bloom FE, Landis SC, Roberts JL, Squire LR
(Eds.), Fundamental neuroscience. San Diego: Academic Press, pp 821-851.
Reulen JP, Marcus JT, van Gilst MJ, Koops 0, Bos JE, Tiesinga G, de Vries FR,
Boshuizen K (1988): Stimulation and recording of dynamic pupillary reflex: the IRIS
technique. Part 2. Med BioI Eng Comput 26:27 -32.
Reuter-Lorenz PA, Hughes HC, Fendrich R (1991): The reduction of saccadic latency by
prior offset of the fixation point: an analysis of the gap effect. Percept Psychophys
49:167-175.
Riley BP, McGuffIn P (2000): Linkage and associated studies of schizophrenia. Am J
Med Genet 97:23-44.
Riley EM, McGovern 0, Mockler 0, Doku VC, O'Ceallaigh S, Fannon DG, Tennakoon L,
Santamaria M, Soni W, Morris RG, Sharma T (2000): Neuropsychological functioning
in first-episode psychosis--evidence of specific deficits. Schizophr Res 43:47-55.
Rivaud S, Miiri RM, Gaymard B, Vermersch AI, Pierrot-Deseilligny C (1994): Eye
movement disorders after frontal eye field lesions in humans. Exp Brain Res
102:110-120.
Roberts RJ, Hager LD, Heron C (1994): Prefrontal cognitive processes: working memory
and inhibition in the antisaccade task. Journal of Experimental Psychology: General
123:374-393.
Robins E, Guze SB (1970): Establishment of diagnostic validity in psychiatric illness: its
application to schizophrenia. Am J Psychiatry 126:983-987.
Roitman SE, Keefe RS, Harvey PO, Siever W, Mohs RC (1997): Attentional and eye
tracking deficits correlate with negative symptoms in schizophrenia. Schizophr Res
26: 139-146.
378
References
Rosenberg DR, Averbach DH, O'Hearn KM, Seymour AB, Birmaher B, Sweeney JA
(1997a): Oculomotor response inhibition abnormalities in pediatric obsessive-
compulsive disorder. Arch Gen Psychiatry 54:831-838.
Rosenberg DR, Dick EL, O'Hearn KM, Sweeney JA (1997b): Response-inhibition deficits
in obsessive-compulsive disorder: an indicator of dysfunction in frontostriatal
circuits. J Psychiatry Neurosci 22:29-38.
Rosenberg DR, Sweeney JA, Squires-Wheeler E, Keshavan MS, Comblatt BA,
Erlenmeyer-Kimling L (1997c): Eye-tracking dysfunction in offspring from the New
York High-Risk Project: diagnostic specificity and the role of attention. Psychiatry
Res 66:121-130.
Rosenberg PB, Rosse RB, Johri SK, Kendrick K, Fay-McCarthy M, Collins JP, Tsui LC,
Wyatt RJ, Deutsch SI (1996): Smooth pursuit eye movements in the evaluation of
famotidine adjunctive therapy of schizophrenia: a preliminary report. Clin
Neurophannacol 19:276-281.
Rosenhan DL, Seligman MEP (1995): Abnormal psychology. New York/London: W.W.
Norton & Co.
Rosmark B, Osby U, Engelbrektson K, Nyman H (1999): Stability of performance on
neuropsychological tests in patients with schizophrenia. Eur Arch Psychiatry Clin
Neurosci 249:299-304.
Ross DE (2000): The deficit syndrome and eye tracking disorder may reflect a distinct
subtype within the syndrome of schizophrenia. Schizophr Bull 26:855-866.
Ross DE, Buchanan RW, Lahti AC, Medoff D, Bartko JJ, Compton AD, Thaker GK
(1998a): The relationship between smooth pursuit eye movements and tardive
dyskinesia in schizophrenia. Schizophr Res 31: 141-150.
Ross DE, Buchanan RW, Medoff D, Lahti AC, Thaker GK (1998b): Association between
eye tracking disorder in schizophrenia and poor sensory integration. Am J Psychiatry
155: 1352-1357.
379
References
Ross DE, Ochs AL, Hill MR, Goldberg SC, Pandurangi AK, Winfrey CJ (1988): Erratic
eye tracking in schizophrenic patients as revealed by high-resolution techniques. Biol
Psychiatry 24:675-688.
Ross DE, Ochs AL, Pandurangi AK, Thacker LR, Kendler KS (1996a): Mixture analysis
of smooth pursuit eye movements in schizophrenia. Psychophysiology 33:390-397.
Ross DE, Thaker GK, Buchanan RW, Kirkpatrick B, Lahti AC, Medoff D, Bartko JJ,
Goodman J, Tien A (1997): Eye tracking disorder in schizophrenia is characterized
by specific ocular motor defects and is associated with the deficit syndrome. Biol
Psychiatry 42:781-796.
Ross DE, Thaker GK, Buchanan RW, Lahti AC, Conley R, Medoff D (1998c): Specific
measures account for most of the variance in qualitative ratings of smooth pursuit
eye movements in schizophrenia. Arch Gen Psychiatry 55:184-186.
Ross DE, Thaker GK, Buchanan RW, Lahti AC, Medoff D, Bartko JJ, Moran M, Hartley
J (1996b): Association of abnormal smooth pursuit eye movements with the deficit
syndrome in schizophrenic patients. Am J Psychiatry 153: 1158-1165.
Ross DE, Thaker GK, Holcomb HH, Cascella NG, Medoff DR, Tamminga CA (1995):
Abnormal smooth pursuit eye movements in schizophrenic patients are associated
with cerebral glucose metabolism in oculomotor regions. Psychiatry Res 58:53-67.
Ross RG, Harris JG, Olincy A, Radant A, Adler LE, Freedman R (1998d): Familial
transmission of two independent saccadic abnormalities in schizophrenia. Schizophr
Res 30:59-70.
Ross RG, Hommer D, Radant A, Roath M, Freedman R (1996c): Early expression of
smooth-pursuit eye movement abnormalities in children of schizophrenic parents. J
Am Acad Child Adolesc Psychiatry 35:941-949.
Ross RG, Olincy A, Harris JG, Radant A, Adler LE, Compagnon N, Freedman R (1999a):
The effects of age on a smooth pursuit tracking task in adults with schizophrenia
and normal subjects. Biol Psychiatry 46:383-391.
380
References
Ross RG, Olincy A, Harris JG, Radant A, Adler LE, Freedman R (1998e): Anticipatory
saccades during smooth pursuit eye movements and familial transmission of
schizophrenia. Biol Psychiatry 44:690-697.
Ross RG, Olincy A, Harris JG, Radant A, Hawkins M, Adler LE, Freedman R (1999b):
Evidence for bilineal inheritance of physiological indicators of risk in childhood-onset
schizophrenia. Am J Med Genet 88: 188-199.
Ross RG, Olincy A, Harris JG, Sullivan B, Radant A (2000): Smooth pursuit eye
movements in schizophrenia and attentional dysfunction: adults with schizophrenia,
ADHD, and a normal comparison group. Biol Psychiatry 48: 197-203.
Ross RG, Oliney A, Radant A (1999c): Amplitude criteria and anticipatory saccades
during smooth pursuit eye movements in schizophrenia. Psychophysiology 36:464-
468.
Ross RG, Olincy A, Zerbe G, Radant A (2001): Which duration of postsaccadic slowing
identifies anticipatory saccades during smooth pursuit eye movements?
Psychophysiology 38:325-333.
Rosse RB, Malhotra AK, Kim SY, Deutsch SI (1992a): Visual fixation deficits and
evidence of cognitive impairment in schizophrenia. Biol Psychiatry 31:412-414.
Rosse RB, McCarthy MF, Alim TN, Deutsch SI (1994): Saccadic distractibility in cocaine
dependent patients: a preliminary laboratory exploration of the cocaine-OCD
hypothesis. Drug Alcohol Depend 35:25-30.
Rosse RB, Risher-Flowers D, Peace T, Deutsch SI (1992b): Evidence of impaired smooth
pursuit eye movement performance in crack cocaine users. Biol Psychiatry 31:1238-
1240.
Rosse RB, Schwartz BL, Kim SY, Deutsch SI (1993): Correlation between anti saccade
and Wisconsin Card Sorting Test performance in schizophrenia. Am J Psychiatry
150:333-335.
381
References
Rothlind JC, Brandt J, Zee 0, Codori AM, Folstein S (1993): Unimpaired verbal memory
and oculomotor control in asymptomatic adults with the genetic marker for
Huntington's disease. Arch Neurol 50:799-802.
Rottach KG, Riley DE, DiScenna AO, Zivotofsky AZ, Leigh RJ (1996): Dynamic
properties of horizontal and vertical eye movements in parkinsonian syndromes. Ann
NeuroI39:368-377.
Roy-Byrne P, Radant A, Wingerson 0, Cowley OS (1995): Human oculomotor function:
reliability and diurnal variation. Biol Psychiatry 38:92-97.
Roy-Byrne PP, Cowley OS, Radant A, Hommer 0, Greenblatt OJ (1993): Benzodiazepine
pharmacodynamics: utility of eye movement measures. Psychopharmacology (Berl)
110:85-91.
Rust J (1987): The Rust Inventory of Schizoid Cognitions (RISC): a psychometric
measure of psychoticism in the normal population. Br J Clin Psychol26 (Pt 2):151-
152.
Rust J (1988): The Rust Inventory of Schizotypal Cognitions (RISC). Schizophr Bull
14:317-322.
Rust J (1989): Rust Inventory of Schizotypal Cognitions manual. Sidcup, Kent:
Psychological Corporation Ltd.
Rust J, Chiu H (1988): Schizo typal estimators in adolescence: The concurrent validity of
the RISC. Soc Behav Pers 16:25-31.
Rust J, Golombok S (1999): Modem psychometrics: The science of psychological
assessment. London and NewYork: Routledge.
Rust J, Moncada A, Lepage B (1988): Personality dimensions through the schizophrenia
borderline. BrJ Med Psychol61 (Pt 2): 163-166.
382
References
Rybakowski JK, Borkowska A (2002): Eye movement and neuropsychological studies in
first-degree relatives of schizophrenic patients. Schizophr Res 54: 105-110.
Rybakowski JK, Borkowska A, Czerski PM, Hauser J (2001): Dopamine D3 receptor
(DRD3) gene polymorphism is associated with the intensity of eye movement
disturbances in schizophrenic patients and healthy subjects. Mol Psychiatry 6:718-
724.
Salisbury DF, Shenton ME, Sherwood AR, Fischer lA, Yurgelun-Todd DA, Tohen M,
.McCarley RW (1998): First-episode schizophrenic psychosis differs from first-episode
affective psychosis and controls in P300 amplitude over left temporal lobe. Arch Gen
Psychiatry 55:173-180.
Salzman LF, Klein RH, Strauss JS (1978): Pendulum eye-tracking in remitted
psychiatric patients. J Psychiatr Res 14:121-126.
Saoud M, d'Amato T, Gutknecht C, Triboulet P, Bertaud JP, Marie-Cardine M, Dalery J,
Rochet T (2000): Neuropsychological deficit in siblings discordant for schizophrenia.
Schizophr Bull 26:893-902.
Sawa A, Snyder SH (2002): Schizophrenia: diverse approaches to a complex disease.
Science 296:692-695.
Saykin AJ, Shtasel DL, Gur RE, Kester DB, Mozley LH, Stafiniak P, Gur RC (1994):
Neuropsychological deficits in neuroleptic naive patients with first-episode
schizophrenia. Arch Gen. Psychiatry 51:124-131.
Schalen L, Pyykko I, Juhola M, Magnusson M, Jantti V, Henriksson N (1984): Intra-
individual variation in oculomotor performance in man. Acta Otolaryngol Suppl
406:212-217.
Scharfetter J (2001): Dopamine receptor polymorphisms and drug response in
schizophrenia. Pharmacogenomics 2:251-261.
383
References
Schlenker R, Cohen R (1995): Smooth-pursuit eye-movement dysfunction and motor
control in schizophrenia: a follow-up study. Eur Arch Psychiatry Clin Neurosci
245:125-126.
Schlenker R, Cohen R, Berg P, Hubman W, Mohr F, Watzl H, Werther P (1994): Smooth-
pursuit eye movement dysfunction in schizophrenia: the role of attention and general
psychomotor dysfunctions. Eur Arch Psychiatry Clin Neurosci 244: 153-160.
Schmid-Burgk W, Becker W, Diekmann V, Jurgens R, Kornhuber HH (1982): Disturbed
smooth pursuit and saccadic eye movements in schizophrenia. Arch Psychiatr
Neruenkr 232:381-389.
Schmid-Burgk W, Becker W, Jurgens R, Kornhuber HH (1983): Saccadic eye
movements in psychiatric patients. Neuropsychobiology 10:193-198.
Schreiber H, Rothmeier J, Becker W, Jurgens R, Born J, Stolz-Born G, Westphal KP,
Kornhuber HH (1995): Comparative assessment of saccadic eye movements,
psychomotor and cognitive performance in schizophrenics, their first-degree relatives
and control subjects. Acta Psychiatr Scand 91: 195-201.
Schreiber H, Stolz-Born G, Born J, Rothmeier J, Rothenberger A, Jurgens R, Becker W,
Kornhuber HH (1997): Visually-guided saccadic eye movements in adolescents at
genetic risk for schizophrenia. Schizophr Res 25:97-109.
Schwartz BD, Evans WJ (1999): Neurophysiologic mechanisms of attention deficits in
schizophrenia. Neuropsychiatry Neuropsychol Behav NeurolI2:207-220.
Schwartz BD, Maron BA, Evans WJ, Winstead DK (1999): Smooth pursuit tracking
deficits of patients with schizophrenia at specific within-sine wave bins.
Neuropsychiatry Neuropsychol Behav Neurol12:221-229.
Schwartz BD, O'Brien BA, Evans WJ, McDermott BE, Sautter FJ, Winstead DK (1995a):
Abnormal saccadic eye movements associated with positive family history
schizophrenics. Biol Psychiatry 38:487-491.
384
References
Schwartz BD, O'Brien BA, Evans WJ, Sautter FJ, Winstead DK (1995b): Smooth pursuit
eye movement differences between familial and non-familial schizophrenia. Schizophr
Res 17:211-219.
Schwartz BD, Tomlin HR, Evans WJ, Ross KV (2001): Neurophysiologic mechanisms of
attention: a selective review of early information processing in schizophrenics. Front
Biosci 6:D120-D134.
Sereno AB, Holzman P (1993): Express saccades and smooth pursuit eye movement
function in schizophrenic, affective disorder, and normal subjects. Journal of
Cognitive Neuroscience 5:303-316.
Sereno AB, Holzman PS (1995): Antisaccades and smooth pursuit eye movements in
schizophrenia. Biol Psychiatry 37:394-401.
Shadmehr R, Holcomb HH (1997): Neural correlates of motor memory consolidation.
Science 277:821-825.
Shafiq-Antonacci R, Maruff P, Whyte S, Tyler P, Dudgeon P, Currie J (1999): The effects
of age and mood on saccadic function in older individuals. J Gerontol B Psychol Sci
Soc Sci 54:361-368.
Shagass C, Amadeo M, Overton DA (1974): Eye-tracking performance in psychiatric
patients. Biol Psychiatry 9:245-260.
Shagass C, Roemer RA, Amadeo M (1976): Eye-tracking performance and engagement
of attention. Arch Gen Psychiatry 33: 121-125.
Sharma T, Galea A, Zachariah E, Das M, Taylor D, Ruprah Met al (2002): Effects of 10
mg and 15 mg oral procyc1idine on critical flicker fusion threshold and cardiac
functioning in healthy human subjects. J Psychopharmacol16: 181-185.
Sharma T, Harvey P (2000): Cognition in schizophrenia. Oxford: Oxford University Press.
385
References
Sharpley MS, Peters ER (1999): Ethnicity, class and schizotypy. Soc Psychiatry
Psychiatr Epidemio134:507-512.
Shenton ME, Dickey CC, Frumin M, McCarley RW (2001): A review of MRI findings in
schizophrenia. Schizophr Res 49: 1-52.
Shergill SS, Brammer MJ, Williams SC, Murray RM, McGuire PK (2000): Mapping
auditory hallucinations in schizophrenia using functional magnetic resonance
imaging. Arch Gen Psychiatry 57:1033-1038.
Sibony PA, Evinger C, Manning KA (1988): The effects of tobacco smoking on smooth
pursuit eye movements. Ann Neuro123:238-241.
Siever W, Coursey RD, Alterman IS, Buchsbaum MS, Murphy DL (1984): Impaired
smooth pursuit eye movement: vulnerability marker for schizotypal personality
disorder in a normal volunteer population. Am J Psychiatry 141: 1560-1566.
Siever W, Coursey RD, Alterman IS, Zahn T, Brody L, Bernad P, Buchsbaum M, Lake
CR, Murphy DL (1989): Clinical, psychophysiological, and neurological
characteristics of volunteers with impaired smooth pursuit eye movements. Biol
Psychiatry 26:35-51.
Siever W, Friedman L, Moskowitz J, Mitropoulou V, Keefe R, Roitman SL, Merhige D,
Trestman R, Silverman J, Mohs R (1994): Eye movement impairment and schizotypal
psychopathology. Am J Psychiatry 151: 1209-1215.
Siever W, Haier RJ, Coursey RD, Sostek AJ, Murphy DL, Holzman PS, Buchsbaum MS
(1982): Smooth pursuit eye tracking impairment: relation to other 'markers' of
schizophrenia and psychologic correlates. Arch Gen Psychiatry 39: 1001-1005.
Siever W, Keefe R, Bernstein DP, Coccaro EF, Klar HM, Zemishlany Z, Peterson AE,
Davidson M, Mahon T, Horvath T (1990): Eye tracking impairment in clinically
identified patients with schizotypal personality disorder. Am J Psychiatry 147:740-
745.
386
References
Siever W, Torgersen S, Gunderson JG, Livesley WJ, Kendler KS (2002): The borderline
diagnosis III: identifying endophenotypes for genetic studies. Biol Psychiatry 51:964-
968.
Siever W, van Kammen DP, Linnoila M, Alterman I, Hare T, Murphy DL (1986): Smooth
pursuit eye movement disorder and its psychobiologic correlates in unmedicated
schizophrenics. BioI Psychiatry 21: 1167-1174.
Silverman J, Gaarder K (1967): Rates of saccadic eye movement and size judgments of
normals and schizophrenics. Percept Mot Skills 25:661-667.
Simons RF, Katkin W (1985): Smooth pursuit eye movements in subjects reporting
physical anhedonia and perceptual aberrations. Psychiatry Res 14:275-289.
Skuse DH (2001): Endophenotypes and child psychiatry. Br J Psychiatry 178:395-396.
Smeraldi E, Gambini 0, Bellodi L, Sacchetti E, Vita A, di Rosa M, Macciardi F, Cazzullo
CL (1987): Combined measure of smooth pursuit eye movements and ventricle-brain
ratio in schizophrenic disorders. Psychiatry Res 21 :293-30 1.
Smith A, Rich N, Sturgess W, Brice C, Collison C, Bailey J, Wilson S, Nutt D (1999):
Effects of the common cold on subjective alertness, reaction time, and eye
movements. J Psychophysiology 13:145-151.
Snitz BE, Curtis CE, Zald DH, Katsanis J, Iacono WG (1999): Neuropsychological and
oculomotor correlates of spatial working memory performance in schizophrenia
patients and controls. Schizophr Res 38:37-50.
Solomon CM, Holzman PS, Levin S, Gale HJ (1987): The association between eye-
tracking dysfunctions and thought disorder in psychosis. Arch Gen. Psychiatry 44:31-
35.
Spantekow A, Krappmann P, Everling S, Flohr H (1999): Event-related potentials and
saccadic reaction times: effects of fixation point offset or change. Exp Brain Res
127:291-297.
387
References
Spaulding WD, Fleming SK, Reed 0, Sullivan M, Storzbach 0, Lam M (1999): Cognitive
functioning in schizophrenia: implications for psychiatric rehabilitation. Schizophr
BuI125:275-289.
Spohn HE, Coyne L, Lacoursiere R, Mazur 0, Hayes K (1985): Relation of neuroleptic
dose and tardive dyskinesia to attention, information-processing, and
psychophysiology in medicated schizophrenics. Arch Gen Psychiatry 42:849-859.
Spohn HE, Coyne L, Spray J (1988): The effect of neuroleptics and tardive dyskinesia on
smooth-pursuit eye movement in chronic schizophrenics. Arch Gen Psychiatry
45:833-840.
Spohn HE, Strauss ME (1989): Relation of neuroleptic and anticholinergic medication to
cognitive functions in schizophrenia. J Abnorm Psychol98:367-380.
Sponheim SR, Iacono WG, Thuras PO, Beiser M (2001): Using biological indices to
classify schizophrenia and other psychotic patients. Schizophr Res 50:139-150.
Stahl JS, van Alphen AM, De Zeeuw CI (2000): A comparison of video and magnetic
search coil recordings of mouse eye movements. J Neurosci Methods 99: 101-110.
Startup M (1999): Schizotypy, dissociative experiences and childhood abuse:
relationships among self-report measures. Br J Clin Psychol38 (Pt 4):333-344.
Steel C, Hemsley DR, Jones S (1996): 'Cognitive inhibition' and schizotypy as measured
by the Oxford-Liverpool Inventory of Feelings and Experiences. Personality &
Individual Differences 20:769-773.
Stern JA, Dunham ON (1990): The ocular system. In Cacioppo JT, Tassinary LG (Eds.),
Principles of psychophysiology: physical, social, and inferential elements. Cambridge:
Cambridge University Press, pp 513-553.
Stoltenberg SF, Burmeister M (2000): Recent progress in psychiatric genetics-some
hope but no hype. Hum Mol Genet 9:927-935.
388
References
Straube A, Mennicken JB, Riedel M, Eggert T, Muller N (1997): Saccades in Gilles de la
Tourette's syndrome. Moo Disord 12:536-546.
Straube A, Riedel M, Eggert T, Muller N (1999): Internally and externally guided
voluntary saccades in unmedicated and medicated schizophrenic patients. Part I.
Saccadic velocity. Eur Arch Psychiatry Clin Neurosci 249: 1-6.
Stuart GW, Pantelis C, Klimidis S, Minas IH (1999): The three-syndrome model of
schizophrenia: meta-analysis of an artefact. Schizophr Res 39:233-242.
Stuve TA, Friedman L, Jesberger JA, Gilmore GC, Strauss ME, Meltzer HY (1997): The
relationship between smooth pursuit performance, motion perception and sustained
visual attention in patients with schizophrenia and normal controls. Psychol Med
27:143-152.
Stuyven E, Van der Goten K, Vandierendonck A, Claeys K, Crevits L (2000): The effect of
cognitive load on saccadic eye movements. Acta Psychol (Amst) 104:69-85.
Suhr JA, Spitznagel MB (2001): Factor versus cluster models of schizotypal traits. I: a
comparison of unselected and highly schizotypal samples. Schizophr Res 52:231-
239.
Sumich A, Chitnis XA, Fannon DG, Q'Ceallaigh S, Doku VC, Falrowicz A, Marshall N,
Matthew VM, Potter M, Sharma T (2002): Temporal lobe abnormalities in first-
episode psychosis. AmJ Psychiatry 159:1232-1235.
Sweeney JA, Bauer KS, Keshavan MS, Haas GL, Schooler NR, Kroboth PO (1997):
Adverse effects of risperidone on eye movement activity: a comparison of risperidone
and haloperidol in antipsychotic-naive schizophrenic patients.
Neuropsychopharmacology 16:217-228.
Sweeney JA, Brew BJ, Keilp JG, Sidtis JJ, Price RW (1991): Pursuit eye movement
dysfunction in HIV-l seropositive individuals. J Psychiatry Neurosci 16:247-252.
389
References
Sweeney JA, Clementz BA, Escobar MD, Li S, Pauler OK, Haas GL (1993): Mixture
analysis of pursuit eye-tracking dysfunction in schizophrenia. Biol Psychiatry
34:331-340.
Sweeney JA, Clementz BA, Haas GL, Escobar MD, Drake K, Frances AJ (1994a): Eye
tracking dysfunction in schizophrenia: characterization of component eye movement
abnormalities, diagnostic specificity, and the role of attention. J Abnorm Psychol
103:222-230.
Sweeney JA, Haas GL, Li S (1992a): Neuropsychological and eye movement
abnormalities in first-episode and chronic schizophrenia. Schizophr Bull 18:283-293.
Sweeney JA, Haas GL, Li S, Weiden PJ (1994b): Selective effects of antipsychotic
medications on eye-tracking performance in schizophrenia. Psychiatry Res 54: 185-
198.
Sweeney JA, Luna B, Haas GL, Keshavan MS, Mann JJ, Thase ME (1999): Pursuit
tracking impairments in schizophrenia and mood disorders: step-ramp studies with
unmedicated patients. Biol Psychiatry 46:671-680.
Sweeney JA, Luna B, Srinivasagam NM, Keshavan MS, Schooler NR, Haas GL, Carl JR
(1998a): Eye tracking abnormalities in schizophrenia: evidence for dysfunction in the
frontal eye fields. Biol Psychiatry 44:698-708.
Sweeney JA, Mintun MA, Kwee S, Wiseman MB, Brown DL, Rosenberg DR, Carl JR
(1996): Positron emission tomography study of voluntary saccadic eye movements
and spatial working memory. JNeurophysiol75:454-468.
Sweeney JA, Palumbo DR, Halper JP, Shear MK (1992b): Pursuit eye movement
dysfunction in obsessive-compulsive disorder. Psychiatry Res 42:1-11.
Sweeney JA, Strojwas MH, Mann JJ, Thase ME (1998b): Prefrontal and cerebellar
abnormalities in major depression: evidence from oculomotor studies. Biol Psychiatry
43:584-594.
390
References
Swerdlow NR, Braff DL, Geyer MA (2000): Animal models of deficient sensorimotor
gating: what we know, what we think we know, and what we hope to know soon.
Behau PharmacoI11:185-204.
Swerdlow NR, Geyer MA (1998): Using an animal model of deficient sensorimotor gating
to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull
24:285-301.
Szeszko PR, BHder RM, Lencz T, Ashtari M, Goldman RS, Reiter G, Wu H, Lieberman JA
(2000): Reduced anterior cingulate gyrus volume correlates with executive
dysfunction in men with first-episode schizophrenia. Schizophr Res 43:97-108.
Tabachnick BG, Fidell LS (2001): Using multivariate statistics. Needham Heights: Allyn
& Bacon.
Takagi M, Zee DS, Tamargo RJ (1998): Effects of lesions of the oculomotor vermis on
eye movements in primate: saccades. J Neurophysiol 80: 1911-1931.
Tandon R (1999): Moving beyond findings: concepts and model-building in
schizophrenia. J Psychiatr Res 33:467-471.
Tennakoon L, Fannon D, Doku V, O'Ceallaigh S, Soni W, Santamaria M, Kuipers E,
Sharma T (2000): Experience of care giving: relatives of people experiencing a first
episode of psychosis. Br J Psychiatry 177:529-533.
Thaker G, Kirkpatrick B, Buchanan RW, Ellsberry R, Lahti A, Tamminga C (1989a):
Oculomotor abnormalities and their clinical correlates in schizophrenia.
Psychopharmacol Bull 25:491-497.
Thaker GK, Cassady S, Adami H, Moran M, Ross DE (1996a): Eye movements in
spectrum personality disorders: comparison of community subjects and relatives of
schizophrenic patients. Am J Psychiatry 153:362-368.
391
References
Thaker GK, Ellsberry R, Moran M, Lahti A, Tamminga C (1991): Tobacco smoking
increases square-wave jerks during pursuit eye movements. Biol Psychiatry 29:82-
88.
Thaker GK, Nguyen JA, Tamminga CA (1989b): Increased saccadic distractibility in
tardive dyskinesia: functional evidence for subcortical GABA dysfunction. Biol
Psychiatry 25:49-59.
Thaker GK, Nguyen JA, Tamminga CA (1989c): Saccadic distractibility in schizophrenic
patients with tardive dyskinesia. Arch Gen Psychiatry 46:755-756.
Thaker GK, Ross DE, Buchanan RW, Adami HM, Medoff DR (1999): Smooth pursuit eye
movements to extra-retinal motion signals: deficits in patients with schizophrenia.
Psychiatry Res 88:209-219.
Thaker GK, Ross DE, Buchanan RW, Moran MJ, Lahti A, Kim C, Medoff 0 (1996b):
Does pursuit abnormality in schizophrenia represent a deficit in the predictive
mechanism? Psychiatry Res 59:221-237.
Thaker GK, Ross DE, Cassady SL, Adami HM, LaPorte 0, Medoff DR, Lahti A (1998):
Smooth pursuit eye movements to extraretinal motion signals: deficits in relatives of
patients with schizophrenia. Arch Gen Psychiatry 55:830-836.
Thaker GK, Ross DE, Cassady SL, Adami HM, Medoff DR, Sherr J (2000): Saccadic eye
movement abnormalities in relatives of patients with schizophrenia. Schizophr Res
45:235-244.
Tien AY, Costa PT, Eaton WW (1992a): Covariance of personality, neurocognition, and
schizophrenia spectrum traits in the community. Schizophr Res 7:149-158.
Tien AY, Pearlson GO, Machlin SR, Bylsma FW, Hoehn-Saric R (1992b): Oculomotor
performance in obsessive-compulsive disorder. Am JPsychiatry 149:641-646.
392
References
Tien AY, Ross DE, Pearlson G, Strauss ME (1996): Eye movements and
psychopathology in schizophrenia and bipolar disorder. J Nero Ment Dis 184:331-
338.
Torrey EF, Yolken RH (2000): Familial and genetic mechanisms in schizophrenia. Brain
Res Brain Res Rev 31:113-117.
Trenerry MR, Crosson B, DeBoe J, Leber WR (1989): Stroop neuropsychological
screening test manual. Odessa, Florida: Psychological Assessment Resources Inc.
Trillenberg P, Heide W, Junghanns K, Blankenburg M, Arolt V, Kampf D (1998): Target
anticipation and impairment of smooth pursuit eye movements in schizophrenia. Exp
Brain Res 120:316-324.
Troost BT, Daroff RB, Dell'Osso LF (1974): Eye-tracking patterns in schizophrenia.
Science 184: 1202-1203.
Tsuang MT, Faraone SV (2000): The frustrating search for schizophrenia genes. Am J
Med Genet 97: 1-3.
Tsuang MT, Stone WS, Faraone SV (2000): Toward reformulating the diagnosis of
schizophrenia. Am JPsychiatry 157:1041-1050.
Tsuang MT, Stone WS, Faraone SV (2001): Genes, environment and schizophrenia. BrJ
Psychiatry Suppl40:s18-s24.
Tsunoda M, Kurachi M, Yuasa S, Kadono Y, Matsui M, Shimizu A (1992): Scanning eye
movements in schizophrenic patients. Relationship to clinical symptoms and regional
cerebral blood flow using 123I-IMP SPECT. Schizophr Res 7:159-168.
Turkington D, Kingdon D (2000): Cognitive-behavioural techniques for general
psychiatrists in the management of patients with psychoses. Br J Psychiatry
177:101-106.
393
References
Vahedi K, Rivaud S, Amarenco P, Pierrot-Deseilligny C (1995): Horizontal eye movement
disorders after posterior vermis infarctions. J Neurol Neurosurg Psychiatry 58:91-94.
van den Bosch RJ (1984): Eye tracking impairment: attentional and psychometric
correlates in psychiatric patients. J Psychiatr Res 18:277-286.
van den Bosch RJ, Rozendaal N (1988): Subjective cognitive dysfunction, eye tracking,
and slow brain potentials in schizophrenic and schizoaffective patients. Biol
Psychiatry 24:741-746.
Van Der Geest IN, Frens MA (2002): Recording eye movements with video-oculography
and scleral search coils: a direct comparison of two methods. J Neurosci Methods
114:185-195.
Van Gelder P, Anderson S, Herman E, Lebedev S, Tsui WH (1990): Saccades in pursuit
eye tracking reflect motor attention processes. Compr Psychiatry 31 :253-260.
van Os J, Hanssen M, Bijl RV, Ravelli A (2000): Strauss (1969) revisited: a psychosis
continuum in the general population? Schizophr Res 45: 11-20.
van Os J, Marcelis M (1998): The ecogenetics of schizophrenia: a review. Schizophr Res
32: 127-135.
Venables PH, Rector NA (2000): The content and structure of schizotypy: a study using
confirmatory factor analysis. Schizophr BulI26:587-602.
Vermersch AI, Muri RM, Rivaud S, Vidailhet M, Gaymard B, Agid Y, Pierrot-Deseilligny
C (1996): Saccade disturbances after bilateral lentiform nucleus lesions in humans.
J Neurol Neurosurg Psychiatry 60:179-184.
Versino M, Castelnovo G, Bergamaschi R, Romani A, Beltrami G, Zambarbieri D, Cosi V
(1993): Quantitative evaluation of saccadic and smooth pursuit eye movements. Is it
reliable? Invest Ophthalmol Vis Sci 34: 1702-1709.
394
References
Vidailhet M, Rivaud S, Gouider-Khouja N, Pillon B, Bonnet AM, Gaymard B, Agid Y,
Pierrot-Deseilligny C (1994): Eye movements in parkinsonian syndromes. Ann Neurol
35:420-426.
Volkow NO, Wolf AP, Van Gelder P, Brodie JD, Overall JE, Cancro R, Gomez-Mont F
(1987): Phenomenological correlates of metabolic activity in 18 patients with chronic
schizophrenia. Am JPsychiatry 144:151-158.
Vollema MG, van den Bosch RJ (1995): The multidimensionality of schizotypy.
Schizophr Bull 21: 19-31.
Waldo MC, Adler LE, Leonard S, Olincy A, Ross RG, Harris JG, Freedman R (2000):
Familial transmission of risk factors in the first-degree relatives of schizophrenic
people. Biol Psychiatry 47:231-239.
Waring EM (1995): The psychobiology of first-episode schizophrenia. Can J Psychiatry
40:S33-S37.
Waxham MN (1999): Neurotransmitter receptors. In Zigmond MJ, Bloom FE, Landis SC,
Roberts JL, Squire LR (Eds.), Fundamental neuroscience. San Diego: Academic Press,
pp 235-267.
Wearden AJ, Tarrier N, Barrowc1ough C, Zastowny TR, Rahill AA (2000): A review of
expressed emotion research in health care. Clin Psychol Rev 20:633-666.
Wechsler 0 (1981): Wechsler Adult Intelligence Scale - Revised. San Antonio:
Psychological Corporation Hartcourt Brace Jovanovich Inc.
Wechsler 0 (1987): WMS-R Wechsler Memory Scale - Revised manual. San Antonio:
Psychological Corporation Hartcourt Brace Jovanovich Inc.
Weiler MA, Thaker GK, Lahti AC, Tamminga CA (2000): Ketamine effects on eye
movements. Neuropsychopharmacology 23:645-653.
395
References
Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, Lipska BK, Berman KF,
Goldberg TE (2001): Prefrontal neurons and the genetics of schizophrenia. Biol
Psychiatry 50:825-844.
Weinberger DR, McClure RK (2002): Neurotoxicity, neuroplasticity, and magnetic
resonance imaging morphometry: what is happening in the schizophrenic brain?
Arch Gen Psychiatry 59:553-558.
Weinberger DR, Wyatt RJ (1982): Cerebral ventricular size: a biological marker for
subtyping chronic schizophrenia. In Usdin E, Hanin I (Eds.), Biological markers in
psychiatry and neurology. NewYork: Pergamon Press, pp 505-512.
Wenban-Smith MG, Findlay JM (1991): Express saccades: is there a separate
population in humans? Exp Brain Res 87:218-222.
Whicker L, Abel LA,Dell'Osso LF (1985): Smooth pursuit eye movements in the parents
of schizophrenics. Neuroophthalmology 5: 1-8.
Whiteman PO, Fowle AS, Hamilton MJ, Peck AW, Bye A, Dean K, Webster A (1985):
Pharmacokinetics and Pharmacodynamics of procyclidine in man. Eur J Clin
Pharmacol28:73-78.
Wilson SJ, Glue P, Ball D, Nutt DJ (1993): Saccadic eye movement parameters in
normal SUbjects. Electroencephalogr Clin Neurophysiol86:69-74.
Wolff AL, O'Driscoll GA (1999): Motor deficits and schizophrenia: the evidence from
neuroleptic-naive patients and populations at risk. J Psychiatry Neurosci 24:304-
314.
World Health Organization (1992): International Statistical Classification of Diseases and
Related Health Problems, Tenth Revision - Volume 1. Geneva: WHO.
Wright IC, Rabe-Hesketh S, Woodruff PW, David AS, Murray RM, Bullmore ET (2000):
Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 157:16-
25.
396
References
Wuthrich V, Bates TC (2001): Schizotypy and latent inhibition: non-linear linkage
between psychometric and cognitive markers. Personality & Individual Differences
30:783-798.
Vee CM, Nuechterlein KH, Dawson ME (1998): A longitudinal analysis of eye tracking
dysfunction and attention in recent-onset schizophrenia. Psychophysiology 35:443-
451.
Vee RD, Baloh RW, Marder SR, Levy DL, Sakala SM, Honrubia V (1987): Eye
movements in schizophrenia. Invest Ophthalmol Vis Sci 28:366-374.
Zaccara G, Gangemi PF, Muscas GC, Paganini M, Pallanti S, Parigi A, Messori A,
Arnetoli G (1992): Smooth-pursuit eye movements: alterations in Alzheimer's
disease. J Neural Sci 112:81-89.
Zachariah E, Kumari V, Galea A, Das M, Mehrotra R, Taylor D, Ruprah M, Sharma T
(2002): Effects of oral procyclidine administration on cognitive functions in healthy
subjects: implications for schizophrenia. J Clin Psychopharmacol22:224-226.
Zahn TP, Roberts BR, Schooler C, Cohen R (1998): Manual and saccadic reaction time
with constant and variable preparatory intervals in schizophrenia. J Abnorm Psychol
107:328-337.
Zipursky RB, Lambe EK, Kapur S, Mikulis DJ (1998): Cerebral gray matter volume
deficits in first episode psychosis. Arch Gen Psychiatry 55:540-546.
Zuckerman M, Kuhlman DM, Camac C (1988): What lies beyond E and N? J Pers Soc
Psychol54:96-107.
397
List of Abbreviations
List of Abbreviations
o/s
5-HT
AC
AD
ADHD
ANOVA
AS
BOI
BPRS
BUS
CBT
CD
cm
CNV
COMT
CPT
CRO
CSTQ
CT
CUS
Degrees per second
5- hydroxytryptamine
Active syndrome scale (PSQ-BO)
Analogue-to-Digital (converter card)
Attention Deficit/Hyperactivity Disorder
Analysis Of Variance
Anticipatory Saccades
Beck Depression Inventory
Brief Psychiatric Rating Scale
Back-up Saccades
Cognitive Behavioural Therapy
Cognitive Disorganisation scale (O-LIFE)
Centimetre
Contingent Negative Variation
Catechol-O-methyltransferase
Continuous Performance Test
Cathode-ray Oscilloscope
Combined Schizotypal Traits Questionnaire
Computed Tomography
Catch-up Saccades
398
DA
DLPFC
DRD3
DSM-IV
DV
DZ
E
EE
EEG
EOG
EPI
EPQ
EPQ-R
EPS
ETD
FEF
FIGS
fMRI
Hz
IA
ICC
ICD-lO
List of Abbreviations
Dopamine
Dorsolateral Prefrontal Cortex
D3 Dopamine Receptor
Diagnostic and Statistical Manual of Mental Disorders, Version IV
Dependent Variable
Dizygotic
Extraversion scale (EPQ-R)
Expressed Emotions
Electroencephalography
Electrooculography
Eysenck Personality Inventory
Eysenck Personality Questionnaire
Eysenck Personality Questionnaire - Revised
Extrapyramidal Side Effects
Eye-tracking Dysfunction
Frontal Eye Fields
Family Interview for Genetic Studies
Functional Magnetic Resonance Imaging
Hertz
Introvertive Anhedonia scale (O-LIFE)
Intraclass Correlation
International Statistical Classification of Diseases and Related
Health Problems, Version 10
399
IN
IQ
IRO
IT
Kg
KMO
L
LED
LI
In
MANOVA
MCI
MMPI
MMQ
MPI
MRI
MRS
Ms
MSC
MST
MT
MZ
N
Impulsive Nonconformity scale (O-LIFE)
Intelligence Quotient
Infrared Oculography
Inattentiveness scale (PSQ-BO)
Kilogram
Kaiser- Meyer-Olkin
Lie scale (EPQ-R)
Light-Emitting Diode
Latent Inhibition
Natural Logarithm
Multivariate Analysis Of Variance
Minnesota Counselling Inventory
Minnesota Multiphasic Personality Inventory
Maudsley Medical Questionnaire
Maudsley Personality Inventory
Magnetic Resonance Imaging
Magnetic Resonance Spectroscopy
Millisecond
Magnetic Search Coil
Medial Superior Temporal area
Middle Temporal area
Monozygotic
Neuroticism scale (EPQ-R); Number of participants
List of Abbreviations
400
NAA
NMDA
NSS
OCD
OKR
O-LIFE
P
PANSS
PCA
PEF
PET
PKU
PPC
PPI
PSQ-80
rCBF
RISC
RMSE
SIN
SANS
SC
scm
SD
List of Abbreviations
N Acetyl-aspartate
N-methyl-D-aspartate
Neurological Soft Signs
Obsessive-compulsive Disorder
Optokinetic Reflex
Oxford-Liverpool Inventory of Feelings and Experiences
Psychoticism scale (EPQ-R)
Positive and Negative Syndrome Scale
Principal Components Analysis
Parietal Eye Fields
Positron Emission Tomography
Phenylketonuria
Posterior Parietal Cortex
Prepulse Inhibition
Personality Syndrome Questionnaire - 80
Regional Cerebral Blood Flow
Rust Inventory of Schizotypal Cognitions
Root Mean Square Error
Signal-to-Noise Ratio
Schedule for the Assessment of Negative Symptoms
Superior Colliculus
Structured Clinical Interview for DSM-IV Axis I Disorders
Social Desirability scale (PSQ-80); standard deviation
401
SEF
SES
SIS
SMC
SPD
SPEM
SPET
SPQ
SPSS
SWJ
TD
TMT
UE
UR
VI
VOR
WAIS
WCST
WD
List of Abbreviations
Supplementary Eye Fields
Socio-Economic Status
Structured Interview for Schizotypy
Squared Multiple Correlations
Schizotypal Personality Disorder
Smooth Pursuit Eye Movements
Single Photon Emission Tomography
Schizotypal Personality Questionnaire
Statistical Package for the Social Sciences
Square-wave Jerks
Tardive Dyskinesia
Trail Making Test
Unusual Experiences scale (O-LIFE)
Unreality syndrome scale (PSQ-80)
Visual Cortex Area I
Vestibulo-ocular Reflex
Wechsler Adult Intelligence Scales
Wisconsin Card Sorting Test
Withdrawn syndrome scale (PSQ-80)
402
